<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        39-124-95
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1995
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        CAPOCARD 50MG TAB
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CAPTOPRIL
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        48
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        25.4
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="DAR ALDAWA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            DAR ALDAWA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 530]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Salehiya Trading Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            DAR ALDAWA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C09AA01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The name of this medicine is <strong>Capocard</strong><strong><sup>&reg;</sup></strong>. Each tablet contains captopril (25mg or 50mg) as the active ingredient.</p><p><strong>Capocard</strong><strong><sup>&reg;</sup></strong> belongs to the group of medicines called angiotensin converting enzyme (ACE) inhibitors. ACE inhibitors work by helping to widen your blood vessels, which then make it easier for your heart to pump blood through them.</p><p><strong>Capocard</strong><strong><sup>&reg;</sup></strong> is used to treat high blood pressure and certain heart conditions. If high blood pressure is left uncontrolled it can increase the risk of heart disease or stroke. <strong>Capocard</strong><strong><sup>&reg;</sup></strong> works by lowering your blood pressure which reduces this risk.</p><p><strong>Capocard</strong><strong><sup>&reg;</sup></strong> can also help people whose heart no longer pumps blood as well as it once did.</p><p>This condition is known as heart failure.</p><p><strong>Capocard</strong><strong><sup>&reg;</sup></strong> may also be used to treat patients who recently suffered a heart attack. A heart attack happens once one of the major blood vessels supplying blood to the heart muscle becomes blocked. This means that the heart does not receive the oxygen it needs and the heart muscle becomes damaged.</p><p>In addition, <strong>Capocard</strong><strong><sup>&reg;</sup></strong> can be used for the treatment of kidney disease in patients with diabetes.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Capocard<sup>&reg;</sup></strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you allergic to captopril or any of the other ingredients of this medicine.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are more than 3 months pregnant. (It is also better to avoid <strong>Capocard<sup>&reg;</sup></strong> in early pregnancy).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If have ever had an allergic reaction to any ingredients of <strong>Capocard<sup>&reg;</sup></strong> or to any other medicines, including other ACE inhibitors.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If have ever had a reaction which included swelling of the hands, lips, face or tongue where the cause was unknown.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;If you suffer from any auto-immune disease (e.g. rheumatoid arthritis, systemic lupus erythematosus or scleroderma).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren.</p><p>If any of the above affects you, or you are unsure if they do, tell your doctor who will be able to advise you.</p><p>&nbsp;</p><p><strong>Take special care with Capocard<sup>&reg;</sup> </strong></p><p>Talk to your doctor or pharmacist before taking <strong>Capocard</strong><sup>&reg;</sup>.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are taking any of the following medicines used to treat high blood pressure:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; An angiotensin II receptor blocker (ARBs) (also known as sartans &ndash; for example valsartan, telmisartan, irbesartan), in particular if you have diabetes-related kidney problems.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aliskiren.</p><p>Your doctor may check your kidney function, blood pressure, and the amount of electrolytes (e.g. potassium) in your blood at regular intervals.</p><p><strong><em>You must tell your doctor if you: </em></strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Think you are (or might become) pregnant. <strong>Capocard</strong><strong><sup>&reg;</sup></strong> is not recommended in early pregnancy, and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used at that stage.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Suffer from kidney disease.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Suffer from liver disease.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Are undergoing dialysis.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Suffer from heart disease, in particular problems with the valves of the heart.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Have diabetes.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Have recently suffered from excessive vomiting or diarrhoea.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Are receiving immuno-suppressant therapy.</p><p>If you are to have desensitization treatment for wasp or bee stings you should tell the doctor who is treating you that you are taking <strong>Capocard</strong><strong><sup>&reg;</sup></strong>. &nbsp;</p><p>If you are about to have treatment for the removal of cholesterol from your blood by a machine, (called LDL apheresis) you should tell your doctor you are taking <strong>Capocard</strong><strong><sup>&reg;</sup></strong>.</p><p>Tell your doctor that you are taking <strong>Capocard</strong><strong><sup>&reg;</sup></strong> tablets before you have any blood or urine tests as <strong>Capocard</strong><strong><sup>&reg; </sup></strong>tablets may interfere with the results of some tests.</p><p>Some Afro-Caribbean patients may require higher doses of <strong>Capocard</strong><strong><sup>&reg;</sup></strong> to obtain an adequate reduction in blood pressure.</p><p><strong>Children and adolescents </strong></p><p>Safety and effectiveness in children have not been established.</p><p><strong>If you are due to have surgery </strong></p><p>Before surgery and anaesthesia (even at the dentist) you should tell your doctor or dentist that you are taking <strong>Capocard<sup>&reg;</sup></strong> as there may be a sudden fall in your blood pressure.</p><p>&nbsp;</p><p><strong>Taking other medicines, herbal or dietary supplements</strong></p><p>Tell your doctor or pharmacist if you are taking or have recently taken any other medicines. It is especially important to tell your doctor if you are taking any of the following:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-steroidal anti-inflammatory painkillers NSAIDs<strong> </strong>(e.g. indomethacin, ibuprofen),</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Immunosuppressants (e.g. azathioprine and cyclophosphamide),</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Potassium supplements, salt substitutes containing potassium or any other medicines which can increase potassium in your body, e.g. (amiloride, spironolactone),</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Water tablets (diuretics),</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines for gout (e.g. allopurinol),</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines for diabetes (as the amount you need to use may have to be changed while taking <strong>Capocard</strong><strong><sup>&reg;</sup></strong>).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines that cause dilation of the blood vessels (e.g. minoxidil, clonidine),</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat mental health problems including depression (such as lithium or amitriptyline),</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Any other medicines to treat high blood pressure (e.g. beta-blockers such as propranolol, atenolol or calcium channel blockers such as amlodipine, nifedipine),</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Any medicine that may be used during and after a heart attack.</p><p>Your doctor may need to change your dose and/or to take other precautions: If you are taking an angiotensin II receptor blocker (ARB) or aliskiren</p><p><strong>&nbsp;</strong></p><p><strong>Taking Capocard<sup>&reg;</sup> with food and drink</strong></p><p><strong>Capocard</strong><strong><sup>&reg;</sup></strong> can be taken with or without food.</p><p>Moderate amounts of alcohol will not affect <strong>Capocard</strong><strong><sup>&reg;</sup></strong>, however, you should check with your doctor first to see if drinking is advisable for you.</p><p>&nbsp;</p><p><strong>Pregnancy and breast-feeding</strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p><strong>Pregnancy </strong></p><p>You must tell your doctor if you think you are (or might become) pregnant. Your doctor will normally advise you to stop taking <strong>Capocard</strong><strong><sup>&reg;</sup></strong> before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of <strong>Capocard</strong><strong><sup>&reg;</sup></strong>. <strong>Capocard</strong><strong><sup>&reg;</sup></strong> is not recommended in early pregnancy, and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy.</p><p><strong>Breastfeeding </strong></p><p>Tell your doctor if you are breast-feeding or about to start breast-feeding. Breast-feeding newborn babies (first few weeks after birth), and especially premature babies, is not recommended whilst taking <strong>Capocard</strong><strong><sup>&reg;</sup></strong>.</p><p>In the case of an older baby your doctor should advise you on the benefits and risks of taking <strong>Capocard</strong><strong><sup>&reg;</sup></strong> whilst breast-feeding, compared with other treatments.</p><p>&nbsp;</p><p><strong>Driving and using machines</strong></p><p><strong>Capocard</strong><strong><sup>&reg;</sup></strong> can affect your ability to drive, usually when you first start taking your medicine or if your doctor changes your dose. If you do feel light-headed or dizzy when taking <strong>Capocard</strong><strong><sup>&reg;</sup></strong> tablets, you should not drive or use machinery</p><p><strong>&nbsp;</strong></p><p><strong>Important information about some of the ingredients of Capocard<sup>&reg;</sup></strong></p><p><strong>Capocard</strong><strong><sup>&reg;</sup></strong> contains lactose, thus, if you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take <strong>Capocard<sup>&reg; </sup></strong>exactly as your doctor or health care provider has told you. You should check with your doctor, health care provider or pharmacist if you are not sure.</p><p>The recommended doses are:</p><p><u>For the treatment of high blood pressure </u></p><p>The usual starting dose is 12.5 - 25mg twice a day. Your doctor may gradually increase this dose to 100 - 150mg a day. You may also need to be given other medicines to lower your blood pressure.</p><p>Older patients and those with kidney problems may be given a lower starting dose.</p><p><u>In heart failure </u></p><p>The usual starting dose is 6.25 &ndash; 12.5mg two or three times a day. Your doctor may gradually increase this dose to a maximum of 150mg a day.</p><p><u>After a heart attack </u></p><p>The usual starting dose is 6.25mg, which will then be increased by your doctor to a maximum of 150mg a day.</p><p><u>For the treatment of diabetic patients with kidney disease </u></p><p>The usual dose is 75 - 100mg a day.</p><p><u>For children </u></p><p>The starting dose is 0.3mg/kg bodyweight, which may be increased gradually by the doctor.</p><p><u>For children with kidney problems, premature babies and newborn babies and infants </u></p><p>The starting dose should be 0.15mg/kg bodyweight.</p><p>Doctors sometimes prescribe different doses to the above and if this applies to you, you should discuss it with your doctor.</p><p>Sometimes patients may feel dizzy after taking the first one or two doses of <strong>Capocard</strong><strong><sup>&reg;</sup></strong>. If this happens to you, lie down until these symptoms disappear.</p><p>You should try to take <strong>Capocard</strong><strong><sup>&reg;</sup></strong> at about the same time each morning. It can be taken before, during or after meals.</p><p>Even if you feel well, continue to take <strong>Capocard</strong><strong><sup>&reg;</sup></strong> until your doctor tells you otherwise.</p><p>&nbsp;</p><p><strong>If you take more Capocard<sup>&reg;</sup> than you should</strong></p><p>If you or anyone else takes too many tablets you should go to your nearest hospital emergency department or tell your doctor immediately. Take the carton and any remaining tablets you have with you.</p><p>&nbsp;</p><p><strong>If you forget to take </strong><strong>Capocard<sup>&reg;</sup> </strong></p><p>If you miss a dose do not worry. Just carry on taking your normal dose when the next one is due.</p><p>Do not<strong> </strong>take a double dose to make up for the one you missed.</p><p>If you have any further questions on the use of this product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, <strong>Capocard</strong><sup>&reg;</sup> can cause side effects, although not everybody gets them.</p><p>If you experience any of the following reactions stop taking <strong>Capocard</strong><sup>&reg;</sup> and contact your doctor immediately:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swelling of the hands, face, lips or tongue,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Difficulty in breathing,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A sudden, unexpected rash or burning, red or peeling skin,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sore throat or fever,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe dizziness or fainting,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe stomach pain,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Unusually fast or irregular heartbeat,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Yellowing of the skin and/or eyes (jaundice).</p><p><strong><em>Common side effects</em></strong><strong> </strong>(affecting between 1 in 10 and 1 in 100 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dizziness,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dry mouth,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Itching,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sleep problems,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rashes,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diarrhoea or constipation,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hair loss,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dry, irritating cough,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in the way things taste,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Upset stomach, feeling sick, vomiting, abdominal pain.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shortness of breath</p><p><strong><em>Uncommon side effects</em></strong><strong> </strong>(affecting between 1 in 100 and 1 in 1000 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fast, irregular, louder heartbeat,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tiredness,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chest pain,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Generally feeling unwell,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Low blood pressure,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Looking pale,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reduced blood flow to the hands and feet (e.g. Raynaud syndrome),</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swelling of the eyes and lips (angioedema)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Flushing,</p><p><strong><em>Rare side effects</em></strong><em> </em>(affecting between 1 in 1000 and 1 in 10,000 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loss of appetite,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mouth ulcers,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Drowsiness,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Kidney disorders or failure,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Headache,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in frequency of passing urine.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pins and needles, numbness or tingling,</p><p><strong><em>Very rare side effects</em></strong><strong> </strong>(affecting less than 1 in 10,000 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Impaired liver function and raised liver enzymes,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Liver damage, inflammation of the liver or jaundice,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Confusion, depression, fainting,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stomach ulcers,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mini-stroke,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Muscle pain,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blurred vision,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Joint pain,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Heart problems including heart attack, and chest infections,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Wheezing or difficulty breathing.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the pancreas,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rashes or skin reactions,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Runny nose,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swelling of breast tissue in men,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swollen tongue,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fever,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Impotence,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sensitivity of the skin to light,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stevens-Johnson syndrome (a serious illness with blistering of the skin, mouth, eyes and genitals),</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in levels of chemicals in the blood or lymphatic systems (e.g. potassium, sugars).</p><p>If any of the side effects become serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist immediately. It will help if you make a note of what you experienced, when it started and how long it lasted.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.</p><p>Protect from light. Store in a dry place. Do not store above 30&deg;C.</p><p>Do not take <strong>Capocard</strong><sup>&reg;</sup> after the expiry date which is printed on the outside of the pack. The expiry date refers to the last day of that month.</p><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required.&nbsp; These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Capocard<sup>&reg;</sup> contains</strong></p><p><strong>Capocard</strong><sup>&reg;</sup> contains captopril as active ingredient. Each tablet <strong>Capocard<sup>&reg;</sup></strong> 25 tablet contains 25 mg captopril. And each <strong>Capocard<sup>&reg;</sup></strong> 50 tablet contains 50 mg captopril</p><p>The other ingredients are: Microcrystalline cellulose, lactose, maize starch and stearic acid.<strong> </strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Capocard® 25 mg tablets are white round normal biconvex tablets with a cross engraved on one side, plain on the other side.

Capocard® 50 mg tablets are white round normal biconvex tablets with DAD and a mid-groove on one side.

Both Capocard® 25 mg and 50 mg tablets are available in packs of 20 (2 blisters of 10), 400 (40 blisters of 10), 500 (50 blisters of 10) as well as an insert.

Not all pack sizes may be marketed.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Dar Al Dawa Development &amp; Investment Co Ltd (Na&rsquo;ur &minus; Jordan).</p><p>Tel. (+962 6) 57 27 132</p><p>Fax. (+962 6) 57 27 776 &nbsp;&nbsp;&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                01/2015
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">إن إسم هذا الدواء هو <strong>كابوكارد. </strong>يحتوي كل قرص على (25 ملغم أو 50 ملغم) كابتوبريل كمادة فعالة.</p><p dir="RTL">ينتمي <strong>كابوكارد </strong>إلى مجموعة من الأدوية تسمى<strong> </strong>مثبطات الإنزيم المحول للأنجيوتنسين (ACE). تعمل مثبطات الإنزيم المحول للأنجيوتنسين عن طريق مساعدة الأوعية الدموية على التوسع مما يجعل القلب أكثر قدرة على ضخ الدم.</p><p dir="RTL">يستخدم <strong>كابوكارد </strong>لعلاج إرتفاع ضغط الدم وأمراض معينة في القلب. إذا لم يتم التحكم بضغط الدم فإنه<strong> </strong>من الممكن أن يزيد من خطر الإصابة بأمراض القلب أو السكتة الدماغية .يعمل <strong>كابوكارد </strong>عن طريق خفض ضغط الدم مما يقلل من هذه المخاطر.</p><p dir="RTL">يمكن أيضا أن يساعد <strong>كابوكارد</strong> الأشخاص الذين لم يعد قلبهم يضخ الدم بشكل طبيعي. تعرف هذا الحالة بقصور القلب.</p><p dir="RTL">ويمكن أيضا أن يستخدم <strong>كابوكارد</strong> لعلاج المرضى الذين حدثت لديهم مؤخرا نوبة قلبية. تحدث النوبة القلبية عند حدوث إنسداد في أحد الأوعية الدموية الرئيسية التي تعمل على تزويد عضلة القلب بالدم. وهذا يعني أن القلب لا يتلقى الأوكسجين الذي يحتاجه ويحدث تلف في عضلة القلب.</p><p dir="RTL">بالإضافة إلى ذلك، يمكن استخدام <strong>كابوكارد</strong> لعلاج أمراض الكلى في المرضى الذين يعانون من مرض السكري.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>موانع استعمال</strong><strong> كابوكارد </strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من فرط حساسية تجاه كابتوبريل أو لأي من المكونات الاخرى في هذا الدواء.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت حامل وتجاوزت الأشهر الثلاثة الأولى من الحمل (ومن الأفضل تجنب <strong>كابوكارد</strong> في المرحلة المبكرة من الحمل أيضا).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سبق حدوث فرط حساسية تجاه مكونات <strong>كابوكارد</strong> أو لأي أدوية أخرى، تشمل الأدوية مثبطات الإنزيم المحول للأنجيوتنسين (ACE).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا سبق حدوث رد فعل غير معروف السبب اشتمل تورم في اليدين ،الشفتين ،الوجه أو اللسان.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اذا كنت تعاني من أي مرض من أمراض المناعة الذاتية (مثل إلتهاب المفاصل الروماتويدي، الذئبة الحمامية الجهازية أو تصلب الجلد).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من السكري أو لديك إختلال في وظائف الكلى وكنت تتلقى دواء خافض لضغط الدم يحتوي على اليسكيرين.</p><p dir="RTL">إذا انطبقت عليك أي من الحالات السابقة أو لم تكن متأكدا. قم باستشارة الطبيب الذي سيقدم لك النصيحة اللازمة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاحتياطات</strong><strong> </strong><strong>عند</strong><strong> </strong><strong>استعمال كابوكارد </strong></p><p dir="RTL">تحدث الى طبيبك أو الصيدلي قبل تناول <strong>كابوكارد. </strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تتناول أي من الأدوية التالية التي تستخدم لعلاج ضغط الدم:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حاصرات مستقبلات الأنجيوتنسين II (ARBs) (وتعرف أيضا ب &ndash; سارتان- على سبيل المثال فالسارتان، تيلميسارتان، اربيسارتان)، وخاصة إذا كنت تعاني من مشاكل في الكلى مرتبطة بمرض السكري.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اليسكيرين.</p><p dir="RTL">على طبيبك ان يتحقق من وظائف الكلى، ضغط الدم ومستوى الكهارل (مثل البوتاسيوم) في الدم على فترات منتظمة.</p><p dir="RTL"><strong><em>يجب ان تخبر طبيبك في الحالات التالية:</em></strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعتقدين انك حامل (أو تتوقعين الحمل). لا ينصح بتناول <strong>كابوكارد</strong> في المراحل المبكرة من الحمل، يمنع استخدامه اذا كنت حامل وتجاوزت الاشهر الثلاثة الاولى من الحمل، لانه قد يسبب ضرر خطير على الجنين في هذه المرحلة من الحمل.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مرض في الكلى.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مرض في الكبد.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تخضع للديلزة الدموية.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مرض في القلب، وخصوصا اذا كان هناك مشكلة في صمامات القلب.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من السكري.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اذا عانيت مؤخرا من قيء أو إسهال بشكل مفرط.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اذا كنت تتلقى علاج مثبط للمناعة.</p><p dir="RTL">إذا كنت ستتلقى علاج لإزالة التحسس نتيجة لسعات الدبابير أو النحل، يجب أن تخبر طبيبك بأنك تتناول <strong>كابوكارد</strong>.</p><p dir="RTL">إذا كنت على وشك أن تتلقى علاج لإزالة الكوليسترول من الدم عن طريق جهاز يسمى (فصادة البروتين الدهني منخفض الكثافة) ، يجب عليك إخبار طبيبك بأنك تتناول <strong>كابوكارد</strong>.</p><p dir="RTL">أخبر طبيبك بأنك تتناول أقراص <strong>كابوكارد</strong> قبل القيام بأي فحوص للدم أو البول، فقد يؤثر <strong>كابوكارد</strong> على نتائج بعض الفحوص.</p><p dir="RTL">قد يحتاج بعض المرضى من منطقة البحر الكاريبي المنحدرين من اصول افريقية جرعات أعلى من <strong>كابوكارد</strong> لخفض ضغط الدم بالشكل المطلوب.</p><p dir="RTL"><strong>الأطفال والمراهقين: </strong></p><p dir="RTL">لم يتم تأسيس سلامة وفعالية كابوكارد في الأطفال.</p><p dir="RTL"><strong>اذا كنت ستخضع لجراحة: </strong></p><p dir="RTL">يجب أن تخبر طبيبك أو طبيب الأسنان (حتى عند طبيب الأسنان) قبل الجراحة والتخدير بأنك تتناول <strong>كابوكارد</strong> حيث أنه قد يسبب انخفاض مفاجئ في ضغط الدم.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التداخلات</strong><strong> </strong><strong>الدوائية</strong><strong> </strong><strong>من </strong><strong>تناول</strong><strong> </strong><strong>هذا</strong><strong> </strong><strong>المستحضر</strong><strong> </strong><strong>مع</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>أدوية</strong><strong> </strong><strong>أخرى</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>أعشاب</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>مكملات</strong><strong> </strong><strong>غذائية</strong><strong> </strong></p><p dir="RTL">يرجى إخبار الطبيب أو الصيدلي إذا كنت تتناول أو تناولت مؤخرا أي أدوية أخرى، من المهم أن تخبر طبيبك اذا كنت تتناول أي من الادوية التالية بشكل خاص:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مضادات الإلتهاب غير الستيرويدية المسكنة للألم (مثل اندوميثاسين، ايبوبروفين).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الادوية المثبطة للمناعة (مثل ازاثيوبرين وسيكلوفوسفامايد).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مكملات البوتاسيوم، بدائل الملح التي تحتوي على البوتاسيوم أو أي أدوية أخرى من الممكن أن تزيد من نسبة البوتاسيوم في الجسم، على سبيل المثال (أميلورايد، سبيرونولاكتون).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مدرات البول.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;الأدوية المستخدمة في علاج مرض النقرس (مثل الوبيورينول).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المستخدمة في علاج مرض السكري (قد تحتاج الى تغيير الجرعة إذا كنت تتناول <strong>كابوكارد</strong>).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تسبب توسع في الأوعية الدموية (مثل مينوكسيديل، كلونيدين).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المستخدمة في علاج مشاكل الصحة العقلية بما فيها الاكتئاب (مثل الليثيوم أو أميتريبتيلين).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أي أدوية أخرى لعلاج ارتفاع ضغط الدم (على سبيل المثال حاصرات بيتا مثل بروبرانولول، أتينولول أو حاصرات قنوات الكالسيوم مثل أملوديبين، نيفيديبين).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أي دواء من الممكن أن تتناوله خلال أو بعد الاصابة بأزمة قلبية.</p><p dir="RTL">قد يحتاج طبيبك إلى تغيير الجرعة و / أو إتخاذ إحتياطات أخرى:</p><p dir="RTL">اذا كنت تتناول مثبط لمستقبلات الأنجيوتنسين II او اليسكيرين.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تناول كابوكارد مع الطعام والشراب</strong></p><p dir="RTL">من الممكن تناول <strong>كابوكارد</strong> مع الطعام أو بدونه.</p><p dir="RTL">لا يتأثر <strong>كابوكارد</strong> بشرب كميات معتدلة من الكحول، على كل حال، يجب عليك التحقق من الطبيب اولا قبل تناول المشروبات الكحولية.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الحمل و</strong><strong>الرضاعة </strong></p><p dir="RTL">اذا كنت حامل او مرضع، تعتقدين بأنك حامل او تخططين لحدوث حمل، اطلبي استشارة طبيبك او الصيدلي قبل تناول هذا الدواء.</p><p dir="RTL"><strong>الحمل </strong></p><p dir="RTL">يجب عليك إخبار الطبيب إذا كنت تعتقدين بأنك حامل (أو تتوقعين الحمل .(سوف ينصحك الطبيب بالتوقف عن تناول <strong>كابوكارد</strong> قبل أن تصبحي حاملا أو فور علمك بالحمل. وسيحدد لك الطبيب دواء اخر بديل عن <strong>كابوكارد</strong>. لا ينصح بتناول <strong>كابوكارد</strong> في المرحلة المبكرة من الحمل، ويمنع اخذه بعد الاشهر الثلاثة الاولى من الحمل لأنها قد تسبب ضررا خطيرا على طفلك في حال استخدامه بعد الشهر الثالث من الحمل.</p><p dir="RTL"><strong>الرضاعة </strong></p><p dir="RTL">يجب عليك إخبار الطبيب في حال كنت مرضعة أو تريدين البدء بالرضاعة الطبيعية. لا ينصح بالرضاعة الطبيعية للأطفال حديثي الولادة (بعد الأسابيع القليلة الأولى من الولادة)، وخصوصا الأطفال الخدج في حال كنت تتناولين <strong>كابوكارد.</strong></p><p dir="RTL">في حال كان الطفل اكبر سنا. سيقوم الطبيب بتقييم الفوائد والمخاطر لتناول <strong>كابوكارد</strong> بالتزامن مع الرضاعة الطبيعية، مقارنة مع العلاجات الأخرى.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تأثير كابوكارد على القيادة واستخدام الالات</strong></p><p dir="RTL">من الممكن أن يؤثر <strong>كابوكارد</strong> على قدرتك على القيادة، خصوصا عند بدء تناول الدواء أو عندما يقوم طبييك بتغيير الجرعة. في حال شعرت بدوخة أو دوار عند تناول أقراص <strong>كابوكارد</strong>، تجنب القيادة أو استخدام الالات.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>معلومات هامة حول بعض مكونات</strong><strong> </strong><strong>كابوكارد</strong><strong> </strong></p><p dir="RTL">تحتوي اقراص <strong>كابوكارد</strong> على لاكتوز أحادي الماء لذا فانه في حال إعلام الطبيب المريض أنه غير قادر على تحمل بعض أنواع السكر، فإن على المريض مراجعة الطبيب قبل تناول هذا الدواء.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تناول <strong>كابوكارد</strong> دائما حسب ارشادات الطبيب أو مقدم الرعاية الصحية. يجب أن تتحقق من طبيبك، مقدم الرعاية الصحية او الصيدلي اذا لم تكن متاكدا.</p><p dir="RTL">الجرعات الاعتيادية هي:</p><p dir="RTL"><u>علاج إرتفاع ضغط الدم</u></p><p dir="RTL">الجرعة الابتدائية المعتادة هي 12.5 - 25 ملغم مرتين يوميا. قد يزيد طبيبك الجرعة تدريجيا إلى 100-150ملغم يوميا. قد تحتاج أيضا إلى تناول أدوية أخرى لخفض ضغط الدم.</p><p dir="RTL">يمكن إعطاء المرضى من كبار السن والذين يعانون من مشاكل في الكلى جرعة ابتدائية أقل.</p><p dir="RTL"><u>علاج </u><u>قصور</u><u> القلب</u></p><p dir="RTL">الجرعة الابتدائية المعتادة هي 6.25-12.5 ملغم-مرتين أو ثلاث مرات في اليوم . قد يزيد طبيبك الجرعة تدريجيا إلى 150 ملغم يوميا كحد أقصى.</p><p dir="RTL"><u>بعد الاصابة بالنوبة القلبية</u></p><p dir="RTL">الجرعة الابتدائية المعتادة هي 6.25 ملغم، ثم سيزيد طبيبك الجرعة تدريجيا إلى 150 ملغم يوميا كحد أقصى.</p><p dir="RTL"><u>علاج</u><u> مرضى السكري الذي يعانون من مرض في الكلى</u></p><p dir="RTL">الجرعة المعتادة هي 75-100 ملغم يوميا.</p><p dir="RTL"><u>في الاطفال</u></p><p dir="RTL">الجرعة الابتدائية هي 0.3 ملغم / كغم من وزن الجسم، والتي قد يزيدها الطبيب تدريجيا.</p><p dir="RTL"><u>ا</u><u>لأطفال الذين يعانون</u><u> من مشاكل في الكلى، الأطفال الخدج والأطفال حديثي الولادة والرضع</u></p><p dir="RTL">الجرعة الابتدائية هي 0.15 ملغم / كغم من وزن الجسم.</p><p dir="RTL">قد يوصي الأطباء احيانا بأخذ جرعات تختلف عن تلك التي سبق ذكرها. إذا كان هذا ينطبق عليك، يجب عليك مناقشة هذا الأمر مع الطبيب.</p><p dir="RTL">قد يشعر المرضى أحيانا بالدوار بعد تناول أول جرعة أو جرعتين من <strong>كابوكارد</strong>. يجب عليك الاستلقاء حتى تختفي هذه الأعراض في حال حدثت.</p><p dir="RTL">يجب محاولة تناول <strong>كابوكارد</strong> في نفس الوقت تقريبا كل صباح. يمكن اخذ القرص قبل أو أثناء أو بعد وجبات الطعام.</p><p dir="RTL">استمر في تناول <strong>كابوكارد</strong> حتى لو شعرت بتحسن ما لم يطلب طبيبك خلاف ذلك.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الجرعة</strong><strong> </strong><strong>الزائدة</strong><strong> </strong><strong>من كابوكارد </strong></p><p dir="RTL">إذا تناولت أو أي شخص آخر جرعة زائدة من الاقراص، عليك أن تذهب إلى أقرب قسم طوارئ في المستشفى أو أخبر طبيبك فورا .قم بأخذ العلبة الكرتونية وأي أقراص متبقية لديك.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>نسيان تناول جرعة من كابوكارد</strong></p><p dir="RTL">إذا نسيت تناول جرعة لا تقلق. استمر في تناول الجرعة التالية في موعدها المعتاد.</p><p dir="RTL">لا تقم بمضاعفة الجرعة لتعويض الجرعة الفائتة.</p><p dir="RTL">إذا كان لديك أي أسئلة أخرى عن استخدام هذا المنتج، إسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">شأنه شأن الأدوية الاخرى؛ قد يسبب <strong>كابوكارد</strong><strong> </strong>أعراض جانبية. إلا أنها لا تحدث عند كل المرضى.</p><p dir="RTL">إذا حدثت لديك أي من ردود الفعل التالية، توقف عن تناول <strong>كابوكارد</strong> واتصل بطبيبك <strong>فورا</strong><strong>:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم في اليدين، الوجه، الشفاه أو اللسان،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صعوبة في التنفس،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي مفاجئ و غير متوقع أو حرق، إحمرار أو تقشير في الجلد،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الحلق أو حمى،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دوار شديد أو إغماء،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آلام شديدة في المعدة،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تسارع أو عدم انتظام في ضربات القلب بشكل غير اعتيادي،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اصفرار الجلد و / أو العينين (اليرقان).</p><p dir="RTL"><strong><em>الآثار الجانبية الشائعة</em></strong> (تؤثر بين 1 من كل 10 و 1 من كل 100 شخص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دوخة،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جفاف الفم،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حكة،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في النوم،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إسهال أو إمساك،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تساقط الشعر،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سعال جاف ومزعج،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغييرات في المذاق،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطراب في المعدة، غثيان، تقيؤ، آلام في البطن،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضيق في التنفس،</p><p dir="RTL"><strong><em>الآثار الجانبية غير الشائعة</em></strong><em> </em>(تؤثر بين 1 من كل 100 و على 1 من كل 1000 شخص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضربات قلب سريعة، غير منتظمة، وبصوت أعلى،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تعب،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في الصدر،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعور بالاعياء،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إنخفاض ضغط الدم،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شحوب في اللون،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إنخفاض في تدفق الدم لليدين والقدمين (مثل متلازمة رينود)،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم في العينين والشفتين (وذمة وعائية)،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; توهج،</p><p dir="RTL"><strong><em>آثار جانبية نادرة</em></strong> (تؤثر بين 1 من كل 1000 أو على 1 من كل 10000 شخص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الشهية،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تقرحات في الفم،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نعاس،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إضطرابات في الكلى أو فشل كلوي،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صداع،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في عدد مرات التبول،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خدران، تنميل أو وخز،</p><p dir="RTL"><em>آثار جانبية</em><em> نادرة جدا</em> ) تؤثر على اقل من 1 من كل 10000 شخص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خلل في وظائف الكبد وارتفاع في إنزيمات الكبد،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تلف في الكبد، إلتهاب الكبد أو يرقان،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إرتباك، اكتئاب، إغماء،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قرحة المعدة،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سكتة دماغية مصغرة،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آلام في العضلات،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدم وضوح في الرؤية،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آلام المفاصل،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في القلب بما في ذلك نوبات قلبية، إلتهابات في الصدر،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أزير أو صعوبة في التنفس،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب البنكرياس،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي أو تفاعلات في الجلد،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سيلان الأنف،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم أنسجة الثدي لدى الرجال،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم اللسان،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حمى،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عجز جنسي،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حساسية الجلد للضوء،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; متلازمة ستيفنز جونسون (مرض خطير يرافقه ظهور تقرحات في الجلد، الفم ،العينين والأعضاء التناسلية) ،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في مستويات المواد في الدم أو الجهاز الليمفاوي (مثل البوتاسيوم والسكريات).</p><p dir="RTL">إذا أصبحت أي من الآثار الجانبية السابقة خطيرة، أو لاحظت حدوث أي آثار جانبية غير المذكورة في هذه النشرة، تحدث الى الطبيب أو الصيدلي فورا . قد يساعدك تدوين العارض الذي شعرت به، متى بدأ وكم استمر.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحفظ بعيدا عن متناول أيدي الاطفال ونظرهم.</p><p dir="RTL">يحفظ بعيداً عن الضوء في مكـان جــاف. يحفظ على درجة حرارة لا تزيد عن 30 درجة مئوية.</p><p dir="RTL">لا تستخدم <strong>كابوكارد</strong> بعد تاريخ الانتهاء المذكور على العبوة الخارجية. يدل تاريخ الانتهاء على آخر يوم في الشهر المذكور.</p><p dir="RTL">لا تتخلص من الادوية في المياه العادمة او النفايات المنزلية. اسأل الصيدلي حول الطريقة السليمة للتخلص من الادوية التي لم تعد بحاجة اليها. سيساعد هذا في حماية البيئة.</p><p dir="RTL"><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحتوي<strong> كابوكارد </strong>على كابتوبريل كمادة فعالة. يحتوي كل قرص <strong>كابوكارد </strong>25 على 25 ملغم كابتوبريل ويحتوي كل قرص <strong>كابوكارد</strong> 50 على 50 ملغم كابتوبريل.</p><p dir="RTL">المكونات الأخرى هي: سيليلوز دقيق البلورية، لاكتوز أحادي الماء ، نشا، حمض الستياريك.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">أقراص<strong> كابوكارد</strong> 25 ملغم هي أقراص بيضاء اللون مستديرة محدبة الوجهين محفور على جهة واحدة خطين متقاطعين، فارغ من الجهة الأخرى.</p><p dir="RTL">أقراص<strong> كابوكارد</strong> 50 ملغم هي أقراص بيضاء اللون مستديرة محدبة الوجهين، مع حفر منصف و حفر رمز &ldquo;DAD&rdquo;على احد الوجهين، فارغ من الجهة الأخرى.</p><p dir="RTL">يتوافر<strong> </strong>كل من<strong> كابوكارد</strong> 25 ملغم و 50 ملغم في عبوات من 20 قرص (شريطين في كل منها 10 أقراص)، 400 قرص (40 شريط في كل منها 10 أقراص)، 500 قرص (50 شريط في كل منها 10 أقراص) بالاضافة الى نشرة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">شركة دار الدواء للتنمية والإستثمار المساهمة المحدودة (ناعور - الأردن)</p><p dir="RTL">هاتف. 132 27 57 (6 962 +)</p><p dir="RTL">فاكس.776 27 57 (6 962 +)</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            01/2015
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Capocard® 50 Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Capocard® 50 Tablets. Each tablet contains 50 mg Captopril.
For excipients, see 6.1

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Tablets.
Capocard® 50 mg tablets are white round normal biconvex tablets with DAD and a 
mid-groove on one side.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Hypertension:</strong> Capocard<strong><sup>&reg;</sup></strong> is indicated for the treatment of essential hypertension.</p><p><strong>Heart Failure:</strong> Capocard<strong><sup>&reg;</sup></strong> is indicated for the treatment of chronic heart failure.</p><p><strong>Myocardial Infarction:</strong></p><p><em>- short-term (4 weeks) treatment: </em>Capocard<strong><sup>&reg;</sup></strong> is indicated in any clinically stable patient within the first 24 hours of an infarction.</p><p><em>- long-term prevention of symptomatic heart failure:</em> Capocard<strong><sup>&reg;</sup></strong> is indicated in clinically stable patients with asymptomatic left ventricular dysfunction</p><p><strong>Type I Diabetic Nephropathy:</strong> Capocard<strong><sup>&reg;</sup></strong> is indicated for the treatment of macroproteinuric diabetic nephropathy in patients with type I diabetes.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Dose should be individualised according to patient&#39;s profile (see 4.4) and blood pressure response. The recommended maximum daily dose is 150mg.</p><p>Capocard<sup>&reg;</sup> may be taken before, during and after meals.</p><p><strong>Hypertension:</strong> the recommended starting dose is 25-50mg daily in two divided doses. The dose may be increased incrementally, with intervals of at least 2 weeks, to 100-150mg/day in two divided doses as needed to reach target blood pressure. Captopril may be used alone or with other antihypertensive agents, especially thiazide diuretics. A once-daily dosing regimen may be appropriate when concomitant antihypertensive medication such as thiazide diuretics is added.</p><p>In patients with a strongly active renin-angiotensin-aldosterone system (hypovolaemia, renovascular hypertension, cardiac decompensation) it is preferable to commence with a single dose of 6.25mg or 12.5mg. The inauguration of this treatment should preferably take place under close medical supervision. These doses will then be administered at a rate of two per day. The dosage can be gradually increased to 50mg per day in one or two doses and if necessary to 100mg per day in one or two doses.</p><p><strong>Heart failure:</strong> treatment with captopril for heart failure should be initiated under close medical supervision. The usual starting dose is 6.25mg - 12.5mg BID or TID. Titration to the maintenance dose (75 - 150mg per day) should be carried out based on patient&#39;s response, clinical status and tolerability, up to a maximum of 150mg per day in divided doses. The dose should be increased incrementally, with intervals of at least 2 weeks to evaluate patient&#39;s response.</p><p><strong>Myocardial infarction:</strong></p><p><em>- short-term treatment</em> Capocard<sup>&reg;</sup> treatment should begin in hospital as soon as possible following the appearance of the signs and/or symptoms in patients with stable haemodynamics. A 6.25mg test dose should be administered, with a 12.5mg dose being administered 2 hours afterwards and a 25mg dose 12 hours later. From the following day, captopril should be administered in a 100mg/day dose, in two daily administrations, for 4 weeks, if warranted by the absence of adverse haemodynamic reactions. At the end of the 4 weeks of treatment, the patient&#39;s state should be reassessed before a decision is taken concerning treatment for the post-myocardial infarction stage.</p><p><em>- chronic treatment:</em> if captopril treatment has not begun during the first 24 hours of the acute myocardial infarction stage, it is suggested that treatment be instigated between the 3rd and 16th day post-infarction once the necessary treatment conditions have been attained (stable haemodynamics and management of any residual ischaemia). Treatment should be started in hospital under strict surveillance (particularly of blood pressure) until the 75mg dose is reached. The initial dose must be low (see 4.4), particularly if the patient exhibits normal or low blood pressure at the initiation of therapy. Treatment should be initiated with a dose of 6.25mg followed by 12.5mg 3 times daily for 2 days and then 25mg 3 times daily if warranted by the absence of adverse haemodynamic reactions. The recommended dose for effective cardioprotection during long-term treatment is 75 to 150mg daily in two or three doses. In cases of symptomatic hypotension, as in heart failure, the dosage of diuretics and/or other concomitant vasodilators may be reduced in order to attain the steady state dose of captopril. Where necessary, the dose of captopril should be adjusted in accordance with the patient&#39;s clinical reactions. Captopril may be used in combination with other treatments for myocardial infarction such as thrombolytic agents, beta-blockers and acetylsalicylic acid.</p><p><strong>Type I Diabetic nephropathy:</strong> in patients with type I diabetic nephropathy, the recommended daily dose of captopril is 75-100mg in divided doses. If additional lowering of blood pressure is desired, additional antihypertensive medications may be added.</p><p><strong>Renal impairment:</strong> since captopril is excreted primarily via the kidneys, dosage should be reduced or the dosage interval should be increased in patients with impaired renal function. When concomitant diuretic therapy is required, a loop diuretic (e.g. furosemide), rather than a thiazide diuretic, is preferred in patients with severe renal impairment.</p><p>In patients with impaired renal function, the following daily dose may be recommended to avoid accumulation of captopril.</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p>Creatinine clearance</p><p>(ml/min/1.73 m&sup2;)</p></td><td style="vertical-align:top"><p>Daily starting dose</p><p>(mg)</p></td><td style="vertical-align:top"><p>Daily maximum dose</p><p>(mg)</p></td></tr><tr><td style="vertical-align:top"><p>&gt;40</p></td><td style="vertical-align:top"><p>25-50</p></td><td style="vertical-align:top"><p>150</p></td></tr><tr><td style="vertical-align:top"><p>21-40</p></td><td style="vertical-align:top"><p>25</p></td><td style="vertical-align:top"><p>100</p></td></tr><tr><td style="vertical-align:top"><p>10-20</p></td><td style="vertical-align:top"><p>12.5</p></td><td style="vertical-align:top"><p>75</p></td></tr><tr><td style="vertical-align:top"><p>&lt;10</p></td><td style="vertical-align:top"><p>6.25</p></td><td style="vertical-align:top"><p>37.5</p></td></tr></tbody></table><p><strong>Elderly patients:</strong> as with other antihypertensive agents, consideration should be given to initiating therapy with a lower starting dose (6.25mg BID) in elderly patients who may have reduced renal function and other organ dysfunctions (see above and section 4.4).</p><p>Dosage should be titrated against the blood pressure response and kept as low as possible to achieve adequate control.</p><p><strong>Children and adolescents:</strong> the efficacy and safety of captopril have not been fully established. The use of captopril in children and adolescents should be initiated under close medical supervision. The initial dose of captopril is about 0.3mg/kg body weight. For patients requiring special precautions (children with renal dysfunction, premature infants, new-borns and infants, because their renal function is not the same with older children and adults) the starting dose should be only 0.15mg captopril/kg weight. Generally, captopril is administered to children 3 times a day, but dose and interval of dose should be adapted individually according to patient&#39;s response.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                1.	History of hypersensitivity to captopril, to any of the excipients or any other ACE inhibitor. History of angioedema associated with previous ACE inhibitor therapy.
2.	Hereditary / idiopathic angioneurotic oedema.
3.	Second and third trimester of pregnancy (see sections 4.4 and 4.6)
4.	Lactation (see section 4.6).
5.	The concomitant use of Captopril with aliskiren-containing products is contraindicated in patients with diabetes mellitus or renal impairment (GFR < 60 ml/min/1.73 m2) (see sections 4.5 and 5.1). 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hypotension: rarely hypotension is observed in uncomplicated hypertensive patients. Symptomatic hypotension is more likely to occur in hypertensive patients who are volume and/or sodium depleted by vigorous diuretic therapy, dietary salt restriction, diarrhoea, vomiting or haemodialysis. Volume and/or sodium depletion should be corrected before the administration of an ACE inhibitor and a lower starting dose should be considered.</p><p>Patients with heart failure are at higher risk of hypotension and a lower starting dose is recommended when initiating therapy with an ACE inhibitor. Caution should be used whenever the dose of captopril or diuretic is increased in patients with heart failure.</p><p>As with any antihypertensive agent, excessive blood pressure lowering in patients with ischaemic cardiovascular or cerebrovascular disease may increase the risk of myocardial infarction or stroke. If hypotension develops, the patient should be placed in a supine position. Volume repletion with intravenous normal saline may be required.</p><p>Renovascular hypertension: there is an increased risk of hypotension and renal insufficiency when patients with bilateral renal artery stenosis or stenosis of the artery to a single functioning kidney are treated with ACE inhibitors. Loss of renal function may occur with only mild changes in serum creatinine. In these patients, therapy should be initiated under close medical supervision with low doses, careful titration and monitoring of renal function.</p><p>Renal impairment: in cases of renal impairment (creatinine clearance &le;40 ml/min), the initial dosage of captopril must be adjusted according to the patient&#39;s creatinine clearance (see 4.2), and then as a function of the patient&#39;s response to treatment. Routine monitoring of potassium and creatinine are part of normal medical practice for these patients.</p><p>Angioedema: angioedema of the extremities, face, lips, mucous membranes, tongue, glottis or larynx may occur in patients treated with ACE inhibitors including Captopril. This may occur anytime during treatment. However, in rare cases, severe angioedema may develop after long-term treatment with an ACE inhibitor. In such cases, Captopril should be discontinued promptly and appropriate monitoring should be instituted to ensure complete resolution of symptoms prior to dismissing the patient. In those instances where swelling has been confined to the face and lips the condition generally resolved without treatment, although antihistamines have been useful in relieving symptoms. Angioedema involving the tongue, glottis or larynx may be fatal. Where there is involvement of the tongue, glottis or larynx, likely to cause airway obstruction, appropriate therapy, which may include subcutaneous epinephrine solution 1:1000 (0.3 ml to 0.5 ml) and/or measures to ensure a patent airway, should be administered promptly. The patient should be hospitalised and observed for at least 12 to 24 hours and should not be discharged until complete resolution of symptoms has occurred.</p><p>Black patients receiving ACE inhibitors have been reported to have a higher incidence of angioedema compared to non-blacks.</p><p>Patients with a history of angioedema unrelated to ACE inhibitor therapy may be at increased risk of angioedema while receiving an ACE inhibitor (see 4.3).</p><p>Intestinal angioedema has also been reported rarely in patients treated with ACE inhibitors. These patients presented with abdominal pain (with or without nausea or vomiting); in some cases there was no prior facial angioedema and C-1 esterase levels were normal. The angioedema was diagnosed by procedures including abdominal CT scan, or ultrasound or at surgery and symptoms resolved after stopping the ACE inhibitor. Intestinal angioedema should be included in the differential diagnosis of patients on ACE inhibitors presenting with abdominal pain (see 4.8).</p><p>Cough: cough has been reported with the use of ACE inhibitors. Characteristically, the cough is non-productive, persistent and resolves after discontinuation of therapy.</p><p>Hepatic failure: rarely, ACE inhibitors have been associated with a syndrome that starts with cholestatic jaundice and progresses to fulminant hepatic necrosis and (sometimes) death. The mechanism of this syndrome is not understood. Patients receiving ACE inhibitors who develop jaundice or marked elevations of hepatic enzymes should discontinue the ACE inhibitor and receive appropriate medical follow-up.</p><p>Hyperkalaemia: elevations in serum potassium have been observed in some patients treated with ACE inhibitors, including captopril. Patients at risk for the development of hyperkalaemia include those with renal insufficiency, diabetes mellitus, or those using concomitant potassium-sparing diuretics, potassium supplements or potassium-containing salt substitutes; or those patients taking other drugs associated with increases in serum potassium (e.g. heparin). If concomitant use of the above mentioned agents is deemed appropriate, regular monitoring of serum potassium is recommended.</p><p>Combination with lithium: Captopril is not recommended in association with lithium due to the potentiation of lithium toxicity (see 4.5).</p><p>Aortic and mitral valve stenosis/Obstructive hypertropic cardiomyopathy: ACE inhibitors should be used with caution in patients with left ventricular valvular and outflow tract obstruction and avoided in cases of cardiogenic shock and haemodynamically significant obstruction.</p><p>Neutropenia/Agranulocytosis: neutropenia/agranulocytosis, thrombocytopenia and anaemia have been reported in patients receiving ACE inhibitors, including captopril. In patients with normal renal function and no other complicating factors, neutropenia occurs rarely. Captopril should be used with extreme caution in patients with collagen vascular disease, immunosuppressant therapy, treatment with allopurinol or procainamide, or a combination of these complicating factors, especially if there is pre-existing impaired renal function. Some of these patients developed serious infections which in a few instances did not respond to intensive antibiotic therapy.</p><p>If captopril is used in such patients, it is advised that white blood cell count and differential counts should be performed prior to therapy, every 2 weeks during the first 3 months of captopril therapy, and periodically thereafter. During treatment all patients should be instructed to report any sign of infection (e.g. sore throat, fever) when a differential white blood cell count should be performed. Captopril and other concomitant medication (see 4.5) should be withdrawn if neutropenia (neutrophils less than 1000/mm&sup3;) is detected or suspected.</p><p>In most patients neutrophil counts rapidly return to normal upon discontinuing captopril.</p><p>Proteinuria: proteinuria may occur particularly in patients with existing renal function impairment or on relatively high doses of ACE inhibitors.</p><p>Total urinary proteins greater than 1 g per day were seen in about 0.7% of patients receiving captopril. The majority of patients had evidence of prior renal disease or had received relatively high doses of captopril (in excess of 150mg/day), or both. Nephrotic syndrome occurred in about one-fifth of proteinuric patients. In most cases, proteinuria subsided or cleared within six months whether or not captopril was continued. Parameters of renal function, such as BUN and creatinine, were seldom altered in the patients with proteinuria.</p><p>Patients with prior renal disease should have urinary protein estimations (dip-stick on first morning urine) prior to treatment, and periodically thereafter.</p><p>Anaphylactoid reactions during desensitisation: sustained life-threatening anaphylactoid reactions have been rarely reported for patients undergoing desensitising treatment with hymenoptera venom while receiving another ACE inhibitor. In the same patients, these reactions were avoided when the ACE inhibitor was temporarily withheld, but they reappeared upon inadvertent rechallenge. Therefore, caution should be used in patients treated with ACE inhibitors undergoing such desensitisation procedures.</p><p>Anaphylactoid reactions during high-flux dialysis / lipoprotein apheresis membrane exposure: anaphylactoid reactions have been reported in patients haemodialysed with high-flux dialysis membranes or undergoing low-density lipoprotein apheresis with dextran sulphate absorption. In these patients, consideration should be given to using a different type of dialysis, membrane or a different class of medication.</p><p>Surgery/Anaesthesia: hypotension may occur in patients undergoing major surgery or during treatment with anaesthetic agents that are known to lower blood pressure. If hypotension occurs, it may be corrected by volume expansion.</p><p>Diabetic patients: the glycaemia levels should be closely monitored in diabetic patients previously treated with oral antidiabetic drugs or insulin, namely during the first month of treatment with an ACE inhibitor.</p><p>Risk of hypokalaemia: the combination of an ACE inhibitor with a thiazide diuretic does not rule out the occurrence of hypokalaemia. Regular monitoring of kalaemia should be performed.</p><p>Lactose: Captopril contains lactose, therefore it should not be used in cases of congenital galactosaemia, glucose and galactose malabsorption or lactase deficiency syndromes (rare metabolic diseases).</p><p>Ethnic differences: as with other angiotensin converting enzyme inhibitors, captopril is apparently less effective in lowering blood pressure in black people than in non-blacks, possibly because of a higher prevalence of low-renin states in the black hypertensive population.</p><p>Pregnancy: ACE inhibitors should not be initiated during pregnancy. Unless continued ACE inhibitor therapy is considered essential, patients planning pregnancy should be changed to alternative antihypertensive treatments which have an established safety profile for use in pregnancy. When pregnancy is diagnosed, treatment with ACE inhibitors should be stopped immediately, and, if appropriate, alternative therapy should be started (see 4.3 and 4.6).</p><p>Dual blockade of the renin-angiotensin-aldosterone system (RAAS): There is evidence that the concomitant use of ACE-inhibitors, angiotensin II receptor blockers or aliskiren increases the risk of hypotension, hyperkalaemia and decreased renal function (including acute renal failure). Dual blockade of RAAS through the combined use of ACE-inhibitors, angiotensin II receptor blockers or aliskiren is therefore not recommended (see sections 4.5 and 5.1).</p><p>If dual blockade therapy is considered absolutely necessary, this should only occur under specialist supervision and subject to frequent close monitoring of renal function, electrolytes and blood pressure.</p><p>ACE-inhibitors and angiotensin II receptor blockers should not be used concomitantly in patients with diabetic nephropathy.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Potassium sparing diuretics or potassium supplements: ACE inhibitors attenuate diuretic induced potassium loss. Potassium sparing diuretics (e.g. spironolactone, triamterene or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. If concomitant use is indicated because of demonstrated hypokalaemia they should be used with caution and with frequent monitoring of serum potassium (see 4.4).</p><p>Diuretics (thiazide or loop diuretics): prior treatment with high dose diuretics may result in volume depletion and a risk of hypotension when initiating therapy with captopril (see 4.4). The hypotensive effects can be reduced by discontinuation of the diuretic, by increasing volume or salt intake or by initiating therapy with a low dose of captopril. However, no clinically significant drug interactions have been found in specific studies with hydrochlorothiazide or furosemide.</p><p>Other antihypertensive agents: captopril has been safely co-administered with other commonly used anti-hypertensive agents (e.g. beta-blockers and long-acting calcium channel blockers). Concomitant use of these agents may increase the hypotensive effects of captopril. Treatment with nitroglycerine and other nitrates, or other vasodilators, should be used with caution.</p><p>Alpha blocking agents: concomitant use of alpha blocking agents may increase the antihypertensive effects of captopril and increase the risk of orthostatic hypotension.</p><p>Treatments of acute myocardial infarction: captopril may be used concomitantly with acetylsalicylic acid (at cardiologic doses), thrombolytics, beta-blockers and/or nitrates in patients with myocardial infarction.</p><p>Lithium: reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with ACE inhibitors. Concomitant use of thiazide diuretics may increase the risk of lithium toxicity and enhance the already increased risk of lithium toxicity with ACE inhibitors. Use of captopril with lithium is not recommended, but if the combination proves necessary, careful monitoring of serum lithium levels should be performed (see 4.4)</p><p>Tricyclic antidepressants / Antipsychotics: ACE inhibitors may enhance the hypotensive effects of certain tricyclic antidepressants and antipsychotics (see 4.4). Postural hypotension may occur.</p><p>Allopurinol, procainamide, cytostatic or immunosuppressive agents: concomitant administration with ACE inhibitors may lead to an increased risk for leucopenia especially when the latter are used at higher than currently recommended doses.</p><p>Non-steroidal anti-inflammatory medicinal products: it has been described that non-steroidal anti-inflammatory medicinal products (NSAIDs) and ACE inhibitors exert an additive effect on the increase in serum potassium whereas renal function may decrease. These effects are, in principle, reversible. Rarely, acute renal failure may occur, particularly in patients with compromised renal function such as the elderly or dehydrated. Chronic administration of NSAIDs may reduce the antihypertensive effect of an ACE inhibitor.</p><p>Sympathomimetics: may reduce the antihypertensive effects of ACE inhibitors; patients should be carefully monitored.</p><p>Antidiabetics: pharmacological studies have shown that ACE inhibitors, including captopril, can potentiate the blood glucose-reducing effects of insulin and oral antidiabetics such as sulphonylurea in diabetics. Should this very rare interaction occur, it may be necessary to reduce the dose of the antidiabetic during simultaneous treatment with ACE inhibitors.</p><p>Clinical Chemistry: Captopril may cause a false-positive urine test for acetone.</p><p>Clinical trial data has shown that dual blockade of the renin-angiotensin-aldosterone-system (RAAS) through the combined use of ACE-inhibitors, angiotensin II receptor blockers or aliskiren is associated with a higher frequency of adverse events such as hypotension, hyperkalaemia and decreased renal function (including acute renal failure) compared to the use of a single RAAS-acting agent (see sections 4.3, 4.4 and 5.1).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy: Controlled studies with ACE inhibitors have not been done in humans, but limited number of cases of first trimester exposures have not shown malformations. The use of ACE inhibitors is not recommended during the first trimester of pregnancy (see 4.4). The use of ACE inhibitors is contraindicated during the second and third trimesters of pregnancy (see section 4.3 and 4.4).</p><p>Epidemiological evidence regarding the risk of teratogenicity following exposure to ACE inhibitors during the first trimester of pregnancy has not been conclusive; however a small increase in risk cannot be excluded. Unless continued ACE inhibitor therapy is considered essential, patients planning pregnancy should be changed to alternative antihypertensive treatments which have an established safety profile for use in pregnancy. When pregnancy is diagnosed, treatment with ACE inhibitors should be stopped immediately, and, if appropriate, alternative therapy should be started. Exposure to ACE inhibitor therapy during the second and third trimesters is known to induce human feototoxicity (decreased renal function, oligohydramnios, skull ossification retardation) and neonatal toxicity (renal failure, hypotension, hyperkalaemia) (see 5.3). Should exposure to ACE inhibitors have occurred from the second trimester of pregnancy, ultrasound check of renal function and skull is recommended. Infants whose mothers have taken ACE inhibitors should be closely observed for hypotension (see 4.3 and 4.4).</p><p>Lactation: Limited pharmacokinetic data demonstrate very low concentrations in breast milk (see 5.2). Although these concentrations seem to be clinically irrelevant, the use of Captopril in breastfeeding is not recommended for preterm infants and for the first few weeks after delivery, because of the hypothetical risk of cardiovascular and renal effects and because there is not enough clinical experience.</p><p>In the case of an older infant, the use of Captopril in a breast-feeding mother may be considered if this treatment is necessary for the mother and the child is observed for any adverse effect.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>As with other antihypertensives, the ability to drive and use machines may be reduced, namely at the start of the treatment, or when posology is modified, and also when used in combination with alcohol, but these effects depend on the individual&#39;s susceptibility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Frequency is defined using the following convention: common (&gt; 1/100, &lt; 1/10), uncommon (&gt; 1/1,000, &lt; 1/100), rare (&gt; 1/10,000, &lt; 1/1,000) and very rare (&lt; 1/10,000).</p><p>Undesirable effects reported for captopril and/or ACE inhibitor therapy include:</p><p><strong>Blood and lymphatic disorders:</strong></p><p>Very rare: neutropenia/agranulocytosis (see 4.4), pancytopenia particularly in patients with renal dysfunction (see 4.4), anaemia (including aplastic and haemolytic), thrombocytopenia, lymphadenopathy, eosinophilia, auto-immune diseases and/or positive ANA-titres.</p><p><strong>Metabolism and nutrition disorders:</strong></p><p>Rare: anorexia</p><p>Very rare: hyperkalaemia, hypoglycaemia (see 4.4)</p><p><strong>Psychiatric disorders:</strong></p><p>Common: sleep disorders</p><p>Very rare: confusion, depression.</p><p>Nervous system disorders:</p><p>Common: taste impairment, dizziness</p><p>Rare: drowsiness, headache and paraesthesia</p><p>Very rare: cerebrovascular incidents, including stroke, and syncope.</p><p><strong>Eye disorders:</strong></p><p>Very rare: blurred vision</p><p>Cardiac disorders:</p><p>Uncommon: tachycardia or tachyarrhythmia, angina pectoris, palpitations.</p><p>Very rare: cardiac arrest, cardiogenic shock</p><p><strong>Vascular disorders:</strong></p><p>Uncommon: hypotension (see 4.4), Raynaud syndrome, flush, pallor</p><p><strong>Respiratory, thoracic and mediastinal disorders:</strong></p><p>Common: dry, irritating (non-productive) cough (see 4.4) and dyspnoea</p><p>Very rare: bronchospasm, rhinitis, allergic alveolitis / eosinophilic pneumonia</p><p><strong>Gastrointestinal disorders:</strong></p><p>Common: nausea, vomiting, gastric irritations, abdominal pain, diarrhoea, constipation, dry mouth.</p><p>Rare: stomatitis/aphthous ulcerations, intestinal angioedema (see 4.4).</p><p>Very rare: glossitis, peptic ulcer, pancreatitis.</p><p><strong>Hepato-biliary disorders:</strong></p><p>Very rare: impaired hepatic function and cholestasis (including jaundice), hepatitis including necrosis, elevated liver enzymes and bilirubin.</p><p><strong>Skin and subcutaneous tissue disorders:</strong></p><p>Common: pruritus with or without a rash, rash, and alopecia.</p><p>Uncommon: angioedema (see 4.4)</p><p>Very rare: urticaria, Stevens Johnson syndrome, erythema multiforme, photosensitivity, erythroderma, pemphigoid reactions and exfoliative dermatitis.</p><p><strong>Musculoskeletal, connective tissue and bone disorders:</strong></p><p>Very rare: myalgia, arthralgia.</p><p><strong>Renal and urinary disorders:</strong></p><p>Rare: renal function disorders including renal failure, polyuria, oliguria, increased urine frequency.</p><p>Very rare: nephrotic syndrome.</p><p><strong>Reproductive system and breast disorders:</strong></p><p>Very rare: impotence, gynaecomastia.</p><p><strong>General disorders and administration site conditions:</strong></p><p>Uncommon: chest pain, fatigue, malaise</p><p>Very rare: fever</p><p><strong>Investigations:</strong></p><p>Very rare: proteinuria, eosinophilia, increase of serum potassium, decrease of serum sodium, elevation of BUN, serum creatinine and serum bilirubin, decreases in haemoglobin, haematocrit, leucocytes, thrombocytes, positive ANA-titre, elevated ESR.</p><p><strong>To report any side effects:</strong></p><p><u>Saudi Arabia </u></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fax: + 966 112057662</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Call NPC at + 966 112038222, Exts: 2317-2356-2353-2354-2334-2340</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Toll free phone: 8002490000</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: www.sfda.gov.sa/npc</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Symptoms of overdosage are severe hypotension, shock, stupor, bradycardia, electrolyte disturbances and renal failure. Measures to prevent absorption (e.g. gastric lavage, administration of adsorbents and sodium sulphate within 30 minutes after intake) and hasten elimination should be applied if ingestion is recent. If hypotension occurs, the patient should be placed in the shock position and salt and volume supplementations should be given rapidly. Treatment with angiotensin-II should be considered. Bradycardia or extensive vagal reactions should be treated by administering atropine. The use of a pacemaker may be considered. Captopril may be removed from circulation by haemodialysis.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: ACE inhibitors, plain, ATC code: C09AA01.</p><p>Captopril is a highly specific, competitive inhibitor of angiotensin-I converting enzyme (ACE inhibitors).</p><p>The beneficial effects of ACE inhibitors appear to result primarily from the suppression of the plasma renin-angiotensin-aldosterone system. Renin is an endogenous enzyme synthesised by the kidneys and released into the circulation where it converts angiotensinogen to angiotensin-I a relatively inactive decapeptide. Angiotensin-I is then converted by angiotensin converting enzyme, a peptidyldipeptidase, to angiotensin-II. Angiotensin-II is a potent vasoconstrictor responsible for arterial vasoconstriction and increased blood pressure, as well as for stimulation of the adrenal gland to secrete aldosterone. Inhibition of ACE results in decreased plasma angiotensin-II, which leads to decreased vasopressor activity and to reduced aldosterone secretion. Although the latter decrease is small, small increases in serum potassium concentrations may occur, along with sodium and fluid loss. The cessation of the negative feedback of angiotensin-II on the renin secretion results in an increase of the plasma renin activity.</p><p>Another function of the converting enzyme is to degrade the potent vasodepressive kinin peptide bradykinin to inactive metabolites. Therefore, inhibition of ACE results in an increased activity of circulating and local kallikrein-kinin-system which contributes to peripheral vasodilation by activating the prostaglandin system; it is possible that this mechanism is involved in the hypotensive effect of ACE inhibitors and is responsible for certain adverse reactions.</p><p>Reductions of blood pressure are usually maximal 60 to 90 minutes after oral administration of an individual dose of captopril. The duration of effect is dose related. The reduction in blood pressure may be progressive, so to achieve maximal therapeutic effects, several weeks of therapy may be required. The blood pressure lowering effects of captopril and thiazide-type diuretics are additive.</p><p>In patients with hypertension, captopril causes a reduction in supine and erect blood pressure, without inducing any compensatory increase in heart rate, nor water and sodium retention.</p><p>In haemodynamic investigations, captopril caused a marked reduction in peripheral arterial resistance. In general there were no clinically relevant changes in renal plasma flow or glomerular filtration rate. In most patients, the antihypertensive effect began about 15 to 30 minutes after oral administration of captopril; the peak effect was achieved after 60 to 90 minutes. The maximum reduction in blood pressure of a defined captopril dose was generally visible after three to four weeks.</p><p>In the recommended daily dose, the antihypertensive effect persists even during long-term treatment. Temporary withdrawal of captopril does not cause any rapid, excessive increase in blood pressure (rebound). The treatment of hypertension with captopril leads also to a decrease in left ventricular hypertrophy.</p><p>Haemodynamic investigations in patients with heart failure, showed that captopril caused a reduction in peripheral systemic resistance and a rise in venous capacity. This resulted in a reduction in pre-load and after-load of the heart (reduction in ventricular filling pressure). In addition, rises in cardiac output, work index and exercise capacity have been observed during treatment with captopril. In a large, placebo-controlled study in patients with left ventricular dysfunction (LVEF &le; 40%) following myocardial infarction, it was shown that captopril (initiated between the 3rd to the 16th day after infarction) prolonged the survival time and reduced cardiovascular mortality. The latter was manifested as a delay in the development of symptomatic heart failure and a reduction in the necessity for hospitalisation due to heart failure compared to placebo. There was also a reduction in re-infarction and in cardiac revascularisation procedures and/or in the need for additional medication with diuretics and/or digitalis or an increase in their dosage compared to placebo.</p><p>A retrospective analysis showed that captopril reduced recurrent infarcts and cardiac revascularisation procedures (neither were target criteria of the study).</p><p>Another large, placebo-controlled study in patients with myocardial infarction showed that captopril (given within 24 hours of the event and for a duration of one month) significantly reduced overall mortality after 5 weeks compared to placebo. The favourable effect of captopril on total mortality was still detectable even after one year. No indication of a negative effect in relation to early mortality on the first day of treatment was found.</p><p>Captopril cardioprotection effects are observed regardless of the patient&#39;s age or gender, location of the infarction and concomitant treatments with proven efficacy during the post-infarction period (thrombolytic agents, beta-blockers and acetylsalicylic acid).</p><p>Type I diabetic nephropathy</p><p>In a placebo-controlled, multicentre double blind clinical trial in insulin-dependent (Type I) diabetes with proteinuria, with or without hypertension (simultaneous administration of other antihypertensives to control blood pressure was allowed), captopril significantly reduced (by 51%) the time to doubling of the baseline creatinine concentration compared to placebo; the incidence of terminal renal failure (dialysis, transplantation) or death was also significantly less common under captopril than under placebo (51%). In patients with diabetes and microalbuminuria, treatment with captopril reduced albumin excretion within two years.</p><p>The effects of treatment with captopril on the preservation of renal function are in addition to any benefit that may have been derived from the reduction in blood pressure.</p><p>Two large randomised, controlled trials (ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial) and VA NEPHRON-D (The Veterans Affairs Nephropathy in Diabetes)) have examined the use of the combination of an ACE-inhibitor with an angiotensin II receptor blocker.</p><p>ONTARGET was a study conducted in patients with a history of cardiovascular or cerebrovascular disease, or type 2 diabetes mellitus accompanied by evidence of end-organ damage. VA NEPHRON-D was a study in patients with type 2 diabetes mellitus and diabetic nephropathy.</p><p>These studies have shown no significant beneficial effect on renal and/or cardiovascular outcomes and mortality, while an increased risk of hyperkalaemia, acute kidney injury and/or hypotension as compared to monotherapy was observed. Given their similar pharmacodynamic properties, these results are also relevant for other ACE-inhibitors and angiotensin II receptor blockers.</p><p>ACE-inhibitors and angiotensin II receptor blockers should therefore not be used concomitantly in patients with diabetic nephropathy.</p><p>ALTITUDE (Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints) was a study designed to test the benefit of adding aliskiren to a standard therapy of an ACE-inhibitor or an angiotensin II receptor blocker in patients with type 2 diabetes mellitus and chronic kidney disease, cardiovascular disease, or both. The study was terminated early because of an increased risk of adverse outcomes. Cardiovascular death and stroke were both numerically more frequent in the aliskiren group than in the placebo group and adverse events and serious adverse events of interest (hyperkalaemia, hypotension and renal dysfunction) were more frequently reported in the aliskiren group than in the placebo group.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Captopril is an orally active agent that does not require biotransformation for activity. The average minimal absorption is approximately 75%. Peak plasma concentrations are reached within 60-90 minutes. The presence of food in the gastrointestinal tract reduces absorption by about 30-40%. Approximately 25-30% of the circulating drug is bound to plasma proteins.</p><p>The apparent elimination half-life of unchanged captopril in blood is about 2 hours. Greater than 95% of the absorbed dose is eliminated in the urine within 24 hours; 40-50% is unchanged drug and the remainder are inactive disulphide metabolites (captopril disulphide and captopril cysteine disulphide). Impaired renal function could result in drug accumulation. Therefore, in patients with impaired renal function the dose should be reduced and/or dosage interval prolonged (see 4.2).</p><p>Studies in animals indicate that captopril does not cross the blood-brain barrier to any significant extent.</p><p>Lactation:</p><p>In the report of twelve women taking oral captopril 100mg 3 times daily, the average peak milk level was 4.7&mu;g/L and occurred 3.8 hours after the dose. Based on these data, the maximum daily dosage that a nursing infant would receive is less than 0.002% of the maternal daily dosage.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Animal studies performed during organogenesis with captopril have not shown any teratogenic effect but captopril has produced foetal toxicity in several species, including foetal mortality during late pregnancy, growth retardation and postnatal mortality in the rat. Preclinical data reveal no other specific hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicology, genotoxicity and carcinogenicity</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Microcrystalline cellulose, lactose monohydrate, maize starch and stearic acid.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>none</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 months 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Protect from light. Store in a dry place. Do not store above 30&deg;C</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Primary package: Blister (Aluminium- PVDC)</p><p>Secondary package: Carton and leaflet.</p><p><strong>Capocard</strong><sup>&reg;</sup> 50 mg tablets are available in packs of 20 (2 blisters of 10), 400 (40 blisters of 10), 500 (50 blisters of 10) as well as an insert.</p><p>Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Medicines should not be disposed of via wastewater or household waste.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dar Al Dawa Development & Investment Co. Ltd.
P.O. Box 9364 
Na’ur – Jordan
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                04/2015
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="data:image/png; base64,iVBORw0KGgoAAAANSUhEUgAABAAAAAQACAYAAAB/HSuDAAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAAyZpVFh0WE1MOmNvbS5hZG9iZS54bXAAAAAAADw/eHBhY2tldCBiZWdpbj0i77u/IiBpZD0iVzVNME1wQ2VoaUh6cmVTek5UY3prYzlkIj8&#x2B;IDx4OnhtcG1ldGEgeG1sbnM6eD0iYWRvYmU6bnM6bWV0YS8iIHg6eG1wdGs9IkFkb2JlIFhNUCBDb3JlIDcuMC1jMDAwIDc5LmRhYmFjYmIsIDIwMjEvMDQvMTQtMDA6Mzk6NDQgICAgICAgICI&#x2B;IDxyZGY6UkRGIHhtbG5zOnJkZj0iaHR0cDovL3d3dy53My5vcmcvMTk5OS8wMi8yMi1yZGYtc3ludGF4LW5zIyI&#x2B;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&#x2B;IDwvcmRmOlJERj4gPC94OnhtcG1ldGE&#x2B;IDw/eHBhY2tldCBlbmQ9InIiPz4VkwMZAAKelElEQVR42uzdB3xV9f3/8c/dyc1ehAxCIISQQUgIewoIIiI4QHCvaq22arWt/WuH1tH&#x2B;tK11ttU6qyiKewBuFAsK4mLvDWEkISHzjvM/9yB4uZw7ktxAEl5PH/EmN&#x2B;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&#x2B;vlZAQAAAAAAwEmAAgAAAAAAAAoAAAAAAABAAQAAAAAAADoEM98CAAAA4BjHc0q1wrcbAAUAAAAA0LHDfTjuDwUBAAoAAAAAoIOF/XB8DRQCACgAAAAAgBMQ&#x2B;o93QDdQBgCgAAAAAACh/8R/rObcXgnj56IMAEABAAAAAEJ/M29vaMXHCDWIK628vb/7QhEAgAIAAAAAJ3XoN7TiuuN1H/VKAaWFn58iAAAFAAAAAE6K0G8IU9gP1&#x2B;EFSgs&#x2B;rm8hoLTg66cIAEABAAAAgJMu9BtacduW3C8lSCAPVAooIbwd6veEEgAABQAAAAA6fPAPFNwNIdzG0MzPH&#x2B;p9VIKUCEqQUsBf&#x2B;FcCFArB7jNFAEABAAAAAHTq0K/3/uaWAy0pAPy9reh8HiXAxzCEUDJQBACgAAAAAECnCP2BwnmgoG4IoTho7qqBUO&#x2B;r4uf2is6loZllgCLBVxNQBACgAAAAAMBJEfoNLXx/qKVAKEI55t&#x2B;7CAhWBoS7CKAEACgAAAAAgHYR&#x2B;gMF9lBDfUveF44SQPEJ2XqB318gD1YGhFIEsBoAwI8/7Ipy4n/ODQYDjwQAAAChvznH9bc09Ae6PtSioTnhX&#x2B;86vfCv6Ly/JdtLkO1ber8BhMGJzt&#x2B;sAAAAAMCJDP4tHeZnaEHoN7Tg4wT7ukJ59tz3OH&#x2B;9gG/Qeb/eM/y&#x2B;qwLE6zb&#x2B;BgYyHwAABQAAAAA6XOj3F&#x2B;5DDf0GCd&#x2B;KgFAEembf93rFTyng/bYhQBEgfooDigAAFAAAAAA4bqE/UNBvSeiXZgZ8Q4DbBvp4odzXYMFfJPiyfsVP8PcN4t7X&#x2B;SsH9IoABgUCoAAAAADASRH6QykBQlkJEMr3wl/Y1wv8vuE/0NvipxwIpQhgUCAACgAAAAB02NAvQUJ&#x2B;c94OdF1LC4BAz/43J/y7gwT/UIoAf2cM4LAAgAIAAAAAhP5W3S7cE/zbIvSHWgocrwLAX/g3BdgmlCLA33a&#x2B;95kiAKAAAAAAAMG/1aHfX5gPFvolDKHeGMYCoCUzAIIVAO4AZYAhQEkQqAjwvi7Q/aMIACgAAAAAQOgPe&#x2B;jX2z6UCf7hCv0t&#x2B;TgtCf&#x2B;BSgC9AsDgpww4/Lo7hBLAO9C7/dwXBgUCFAAAAAAg9B/X0O8b/oOFb0OIYT5Y6G/O6gB/1wX7Hio6bzenADB4hX7vUK40oxQwCoMCAVAAAAAAEPpbeLv2MsHfGEIh0NyXUD5vKN8DkZYd92&#x2B;UwMfsu3VKAQmhCFAktPkAvvedQYEABUDnV//eR2Ip6C2mjAy&#x2B;GQAAoGMnflUnCv3NfXY/0IsxyMf097a/r/OInJwc68zsnKzZCz7Zut7Z1CiBn/l367zurwDwXQkQrAhw&#x2B;9k20LwAkTYaFLg9paditEeKu7pGDDHRolRVi9LkUP/m7ipSWysSGSmm1C7i3LFLDG63KJ5d12gQz3&#x2B;u8r1iiLWLwRYhju0bxWixizmru7grD4gxLlrcDU0iTU1i8Nwbs1HdziaG6CgxJCeJa/M29XpFXC6XGKPsIjW1ojgc4qjYJ6aYGHFp350G9X0JYomNlaaqSjFZLNKo3jdxNIkxOlpMPbLEvb9SxGoV99594jAaJUK9v4Z9&#x2B;8Wofi21u3eJ26pGqnr1PsTHq/fdKIl2u1TX1Up9lHo/du4UQ0KCGM1mUUxm9X4liOFAtfo5msSu3rcm9fOm1DdIXX297K&#x2B;qksikRGlUv0&#x2B;JiQlSVVOjfj6TGNTbufbt1L52SUlSf7bVrzPaLjG19VLrdolTUb9TCbHirKhS76dFjOr3xmUxaw9QelS0bNu1WwxWo7YjuOvUr8UcJxFdkqVJ/b7Eq19vZdUBsajfM6d6C6f6NVlcbqlQ70Os&#x2B;jgokRGiHDwopgj1&#x2B;79rl/ZYuZxOEZNJ3Op9N1RWaY&#x2B;pS73v6jdanElJYla/VqP68XIdblnTUCcR6sepi40Ro/p9NKn7gUP9ujy3b3Sq&#x2B;4DNrj4EtWKoOyCmxGRpqFQ/V1K8WBocophN2otDvS&#x2B;ez9uUmiKuykqJVvcLp/o4GNXHUtT7b1X3p1r18XKqj6lF/SrNDvV&#x2B;qF9rU4O6j4hJXOp9v7xmP/8oUAAAAAAQ&#x2B;v0EvfY2wT/QKgBjM0J/sG1DuV9Hfa1q2DH06tXL9uSTT05RL4dErV5XPPmPxjdf&#x2B;PKLNx&#x2B;srdwYoAQw&#x2B;rzuu7RfrwBw&#x2B;wR13yJAb3uTzu1CfWY&#x2B;LEVA5t6Nh4qAhCxWBAAUAAAAADgBwb&#x2B;9T/APJfQHCvV6od8Y4sfyF/yPvC8jI8Ny//33DxsxYsSE5OTkvhaLJUF7T0qKDHzh2fPz35k/4YKnnv34iS8XvfJ408Et4n9pvm/wP1wGGHXKAH&#x2B;Xh4sA31UAJq&#x2B;P5W9QoG&#x2B;B0GaDAjMrtxp2xBRQAgAUAAAAAGjnoV9v&#x2B;7aY4O8bwvWW7Lcm9IdSBOjex6SkJMtvf/vbPtOnT5/apUuXosjIyFS975spNUXirrgoaeCMs6f1&#x2B;u&#x2B;Lo8bdec&#x2B;zT&#x2B;3cvHC&#x2B;uPcFKAGMPiWA4vW23qXb53se6BCBthwUqOgUCX5lbF2p3X5bRCpFAEABAAAAgHYe&#x2B;n3Dv7/ALBL&#x2B;Cf7NCfgGP28363CAuLg48913310yfvz4U1JTU/NiYmK6G43GkP6GNkZFSdI1V3Y5d8K4m8e89OqF8/92/7OX7Nv&#x2B;rp8CQNEJ&#x2B;YGe&#x2B;ffcf5ccO3TQdy6A78qAcA8K9FcOBNStodwgG8plZ9deFAEABQAAAABaEfoDBf2ONsE/lGf99bYLtRDQHRD4q1/9KufCCy88NT09vXeXLl2KW/UHd89sQ5ff3pQ2fcK4mwf95e8T/vf22&#x2B;9dXV8x3&#x2B;k/&#x2B;Hs/y&#x2B;&#x2B;9OsCoUwwEKgr0CoF2NSgwffd6bdvy1HEUAQAFAAAAAKG/g4f&#x2B;1k7wb8kz/M0pBo68b8aMGV2vu&#x2B;66sTk5OYVpaWkl6sMQ1r&#x2B;VI/r3M&#x2B;e99ExpzxUrS/tefUP/Z79e&#x2B;spD9VXrvAK1Syfs&#x2B;xYCBp8iwHslQLBZASKhDwp0S2injwxLEZC6&#x2B;ENt250ZfSgCAAoAAAAAQn8IoT9Y8A91gn&#x2B;wY/3beoJ/KEv9A4X&#x2B;QGXAkfeZzWbjJZdckjF58uTCAQMGDE9NTc23Wq0xbf1YWwoLpGz&#x2B;a&#x2B;N7z35t9IX/evzT579d9tpDjto1cvQcAO/w79IpBFw&#x2B;RYC/lQF6l6EMCtQrBbyDfZsMCkzfsdqwIzOfEgCgAAAAACD4tyD06wV3CSHgi5zYCf6hPsMfLOwfczlx4sTkCy&#x2B;8sGj48OEjMjMzSy0WzwnWj/PjHh0tsVdebB18wbRT8557adCwP975/JO7tyx8X3HuDRL&#x2B;3TqhXm8lQKhnDgjnoEDf1QAtGxS4fdWh1QBZhRQBAAUAAAAAoV/CP8G/taHfN9yHa4J/q8L&#x2B;4cucnJzI2267bWBZWVnf3NzcYZGRkYntYmeIjJT4qy6NnTZ88DVj/vviOe899czLl5RvfjtI&#x2B;Pf34l0KGP2EfBH9wwH8DQoMNh9A8XnMwzcfYOsKbdvtkk0RAFAAAAAAEPqbGfp9A36gUC8S/Dj&#x2B;QO8LpQBozvH9zb40mUzGf/zjHwNLS0t7FxcXj46Jiclot3&#x2B;UF/QxpP759tTzzjrzZ0W3/qH/h0u&#x2B;/PDXNfv&#x2B;FyTwexcEvq/7e4ZebyVAoEGBJjnBgwIz927Wtt0sVooAgAIAAACgU4X&#x2B;QEH/RA3zC/V9zZng39Lj&#x2B;wNdGtPT021XX3117pAhQ/LKyspGJCcn50low&#x2B;zaBdvgMlPJvNeHFSz&#x2B;cljZLX9441dfLXphWVP9gRDC/&#x2B;HQ7e/1UOYE&#x2B;FsZINIOBgVmS5Nhq9gpAQAKAAAAAEJ/mEO/SPuY4B/0MiYmxnLeeedpw/xGjx59Rnx8fLb6MBg77D5ksYht5HAZ/cZLU997fvaYpc&#x2B;/MO/mZV/MWeF2HPwh1Lt1wr/vYQB6r/vOBvA3F8B7FcBheoMCjaJ/fH9LBwUGDfdZjiqDbKiS7YkcFgBQAAAAAHTc0B8s&#x2B;J/oCf7&#x2B;jvcP9wT/kC5NqqlTp3aZNm1aXzX0j01LS&#x2B;urPgymzrRfGVOSJOnGa2PHX3Te9Dfv&#x2B;Xu/91&#x2B;eM/c/u7Z8sdTVVOUV7L2LAN8VAt7DAdtqUKAi4RsUGPphARWbDVIhsj2tN0UAQAEAAADQboN/S0K/SMeY4B/KUv&#x2B;WHOdvOvx2//79Y37xi1&#x2B;UDhkyZEBeXt7YjvxMf8hFQHKyoed9d&#x2B;VdedVleROfnbXho1mz3r1i67p5OmHf39t6r&#x2B;sVACIdbFBg5q612rY7WBEAUAAAAAB0wNAv0vEn&#x2B;Id1qF9hYWH0NddcUzRp0qRxGRkZRTabLU460HH9YWEyijm/t3T/8&#x2B;05F14087rCG3/d79Mvvlh4R82&#x2B;xQdFccjRqwACrQrQGxoYjkGB7gABv80HBWZUHBoUuLNbPkUAQAEAAADQ4UO/b8APFOpFOvgEf89p&#x2B;84444z0q6&#x2B;&#x2B;&#x2B;szs7OySqKioVPbEQ6yFfYyD5r0&#x2B;qt9X34wcevNvP/rrwg9mvyWywxV4FYD32wbRXwmgVwCEOijQ6FUOiPgfFKj42f&#x2B;DzQcIqQhI37bKsCt/ACUAQAEAAADQ5qE/UNA/2Sb4N/c4f22C/&#x2B;jRo1Ouv/768fn5&#x2B;UNjY2MzToYl/i1iMoltUJlh2Duvjnv8mecHrn3uhaW3Lvn8mQWKa68cu&#x2B;zftwzwtypA70wBbTEo0N98AAkS/kMaFJi2aumhwwK6FVAEABQAAAAAnT70ixzfCf4tHurnGeZ37rnndv3lL385Pjc3tywxMTGH0N&#x2B;MHS82RpJ/cU1s8k8uHfv8H&#x2B;7K&#x2B;&#x2B;Thh&#x2B;b9n6Ph/e9djmoJ7ZAA31MGtnRQoG/4P&#x2B;GDAjO2rdS23cagQIACAAAAIIyhP1jwb08T/FsS&#x2B;kXCOMHfczlq1KiEW2&#x2B;99ZSSkpKhSUlJvcxmcwR7YytERkrGfXdnzLz2qivH3v/wWXNnv/zilXu2zvUK/eEYFOj2Cd96hw34zgfQO6PAcR0U2O3woMDUXIoAUADwLQAAAIT&#x2B;Exr6RU6SCf59&#x2B;/aNvuWWWwaOGzfuNM/yfrvdnsTeGF6mHtmS9uBfky6&#x2B;6orr&#x2B;lx7Q9Hs77556181&#x2B;1c3KYr3KoBghwR4rwTwPjzAd3WAv0GBis77WjIoUHxCfusGBZav07bdJNEUAaAAAAAAIPi3OvQHC/7tdYJ/sNDf4mf8e/bsab/mmmv6zJw5c2pCQkK36OjoNPbEtmfpWyBD339rdMlHnw4/5y9/nXfjogWzvnE2VXk9PoEOCQi0EkAktEGBbp3wb9QJ/m45djBgoPkAIq0cFNhDDhq2SgwlACgAAAAACP1tEvp9A34ooV4v2BtCCPqtneAfbKhf0MvU1FTrnXfeOXDIkCFl2dnZxWroT2/Fqgu0dN&#x2B;PiBD7pAnmUUMGTH7r/n&#x2B;WrHh37qLrv186Z62jsUaCHxIQrkGBviHe&#x2B;xABxU8p0OaDArNqdh1aDWBPoAgABQAAAMBJGPoDBX0m&#x2B;PuZ3O993V133dV33LhxZX369BkYHx&#x2B;f7ef7huP985CYKJl33paZdv0109&#x2B;6456CV1955bX792xftsftapC2GRQo0jaDAsWnBBBp5aDAHnWVBqmrlJ2xJRQBoAAAAAAg9B/30O8dyJsT&#x2B;ptzPH9YJvh7Lq&#x2B;&#x2B;&#x2B;ursCy64YEhBQcHApKSkHKPRaGVvbJ9MKUnS&#x2B;4F7C3950cw&#x2B;5zw7a&#x2B;0Dzz7zn3/XVq5xtd2gQN&#x2B;5AIe1dFCg789i2AYFpm/45tAZA7r2oggABQAAAEAnDv3&#x2B;An04Qr9IJ5vgb7fbzdOmTUu75JJLhvbp06dfampqvtlstrM3dpQWwCS2IQNNvQcNyP/z&#x2B;DF3XvTIY4vf/OzTDx5z1K6oUNxNErgMMErwQYGhnDpQpPmDAkUCL&#x2B;8PzxkDdq/Xtl0fk0YRAAoAAACAThj6QykE2ssE/5Y&#x2B;468X5kWCL&#x2B;8/8vbkyZNTrrrqqkFFRUX9unfvPshkMvFMf0dmNEjs2VPsQyZOGFvy&#x2B;aLRZ//f3z/9/Ufv/fc9d9Nu0T8kwCihDQr0PTzALeEZFCh&#x2B;gn2bDArsVbPLsDGa0waCAgAAAKAjBf/WDPM7HqHfN&#x2B;i3pwn&#x2B;pv79&#x2B;8fcdNNNAwoKCvqowX&#x2B;cxWLhmf7O9nMVGSGRp44xDRw5bMyz/3i0cOWs2Uv&#x2B;uOKblz5zNe6V4IcE&#x2B;K4KMErgwwNCGRSoNxPghAwK7LlrnUF2rZNNef0pAkABAAAA0AlDv972ga43tOLtdjnBPz093XbbbbeVqPLVl7F2uz2FPfEk&#x2B;Fmz2ST1ll926fLLn58x69Y/9nvr8afmPFpdvni5KNXy4yqAYIcE6K0EMMqxZw3wnhNwmPfHV6Q9DQpcs0zbdgPzAUABAAAA0C5Cf6Cg35an7RPpBBP8CwsLo04//fSMs88&#x2B;e0heXt6ApKSkXPbEk/Tnz2qRzPvuzvzJjHNvOPPpWdMe/8&#x2B;/H7&#x2B;7qfYr149hPtghAd4v/lYCBDpzgHch0K4GBeb8MB9gc04/igBQAAAAAJwEoV&#x2B;kk0zwT0hIsM6YMSNz5syZQ0pKSkbHxcVlCaftw6EfSLEMLDNkDizL/PW40f9v6j8e&#x2B;fq1hZ&#x2B;9e6/S8HWTKM05JOBEDAoMJCxFQPaGbw&#x2B;dMSCmD0UAKAAAAAA6SegX6WQT/D2Xl1xyScaZZ55ZOHLkyAldunTpoz4MRvZG&#x2B;BN9zpSI0kmnDe391txBU&#x2B;9/aNEZX3x6/x63s16Oz6BA31UAoQwK9C0Q2mxQYLftqw2rzXGUAKAAAAAAaMPQHyz4t3SCf7hCv3do9w31wZ7xD3Z8f4sm&#x2B;M&#x2B;YMaPrmDFjek6cOHFcZmZmqclkimBvRMg/fBE2iZ5&#x2B;lqls4qkjvrnn3t4L3pn31h2rvnt/tbOxWtp2UKDesn&#x2B;Rth0UqOgUCX71cR4wiFNkpSGGIgAUAAAAAK0I/kzwb/lQP5Ma&#x2B;BOmTJmSc&#x2B;65557ZpUuXXJvNFs&#x2B;eiFb9HMdES9qf/9Rl&#x2B;vXXXjn4rw&#x2B;OfPTJJ5584sC&#x2B;1ZWKu&#x2B;mHcO&#x2B;vDFCkeYMCRfzPBWjrQYH&#x2B;yoGACpQag1TWyMrE7hQBoAAAAACE/uMQ&#x2B;vW2P1ET/P2tAGjTCf65ubn26dOn97j88ssnp6en97Xb7UnsiQg3U1pX6XHfXb3/dOakO6964eVVj8x&#x2B;4dkHD&#x2B;xdJaEfEhBsJYB3AO9QgwILKrYYpEJkbWIWRQAoAAAAAKE/hODfXif4G4Ns19wJ/q0Z6nfkdTXkm9TAn33ZZZeNLSgoGKm&#x2B;nSwM80NbMxol8pQRlt6njCi&#x2B;49RTfjf1Hw9/9urXyz7&#x2B;V33VWlfwQwJ8VwUYfa43iP6pA32vFzn6mf3DcwD0BgW6Q/y5CEsR0Ltiq1YEfGdiRgAoAAAAAKH/RIR&#x2B;f0VAayf4h7rUP1xD/bTX1dCfNW3atJKRI0dO8TzTbzKZbOyNOBHip58dP2bShDPL3pk/ZsbDjy28deF7LyxUlL1y7CoAf4cEuHVe1zt1oN5cAO9VAIfpDQo0iv7x/S0dFBhSsC92HTB8LwmUAKAAAAAAhP52EvpDfXa/uRP8Qzm&#x2B;v1mXF1xwQfrVV189qrCwcEhcXFymxWKxszeiXfxOiIqSuPPOiR4x6bSJL/7twcKlz/738wc3rZv3keLcI0c/0x9oVYBR53V/BUBLBgWGMh9A73ADvfAf8mqAvvs2a9suz&#x2B;C0gaAAAAAAJ1foDxb8O8oE/1BO2xcozPt7v8n7bZOqb9&#x2B;&#x2B;UXfdddeYkpKSQSkpKb2tVmsMeyPa7e&#x2B;J6CjJ&#x2B;OP/65b282tmDv7n46OeueNPzzzkali6Q3HVS&#x2B;BBgf5WAvg7U4D4ufQ&#x2B;HEAv&#x2B;AebD6D4/J4I23yAoh2rDbJDZGV2IUUAKAAAAECnCv7tfYJ/KKE/WAHQZhP8Pcf1P/LII8NHjRo1PCMjo9hms8WxJ6IjMSYlSNff/Sb9xtNO/e3M/zy9/ekXXnz89pq9X0ngQYFuCe30gYEGBbol8KBAvfkAx3dQ4OYV2rZr0npRBIACAAAAnJShX2/7tpjg39rT9om00QT/9PR02&#x2B;233z5gxIgRg7KysvrZ7fYU9WEwsjeiI7MN7G/oPrB/t5snTvj9Kb&#x2B;746M3tmz48P7ayuXS/EGBeisBWjoo0OhVDoj4HxSo&#x2B;PndFWw&#x2B;QEhFQN6u9YbvY/tTAoACAAAAnLSh3zf8&#x2B;wv1Iu13gr&#x2B;/gkB3u3vvvbd0woQJQ3JycsqioqLSWnGoBdBuRZ892TLq1NGn9X9z7piRt93&#x2B;0n1b1s5fJK79cuyy/0CHBLjl&#x2B;A8K9DcfQIKE/5AGBfZds0y7zcaUHhQBoAAAAADtMvQHCvpM8A9hgv&#x2B;NN97Y6&#x2B;KLLx6Tnp6em5qaWkjox0nx&#x2B;yYmRmIuPM86ZcjACwc&#x2B;&#x2B;vjYL1559YMHd2z54FNnwz4J7ZCAcA0K9A3/J3xQYM&#x2B;9mw4NCpREigBQAAAAAEJ/gLc7xAT/008/PeW22247LTMzs2dWVtZA9WEwsTfiZGTK6WHI/Ns96V1//tNLBj3y71P&#x2B;8fjjD/&#x2B;9et9Kr9AfjkGBbp/wrTc3oP0NCty9Qdt2UyKnDgQFAAAAOLGhP1jw70wT/IOFft9tj1ni75ngf/HFF2dMnjy5qLS0tL8a/EusVms0eyPwQxDp0V26/fWerDtHj/zz5bNe&#x2B;uaRuW8/968D&#x2B;9bK0asAfMN/qIMCfVcH&#x2B;BsUqBf&#x2B;WzIoUHxCfquKgB7b12jbfpnQjSIAFAAAAKBNgz8T/Fs21E97mThxYtK5556bP3r06GE9evQYbDabI9kTAf/sZ55uKpp8etm9b7ydf9of73xt9rrVC1&#x2B;sr97i9bMV6JAA72f/fVcCiE4BoDco0K0T/vUGBbrl2MGAgeYDiLRyUOCgym2GJcnMBwAFAAAAaD&#x2B;hX2/7cId&#x2B;33Af7gn&#x2B;oQz183tZXFwcfdVVVxWqoX9wTk7OILvdnsSeCDTvN1DMWZPtU4YPuXDsJ5&#x2B;dPeX3d8y6a/3KD1a6HNUS/JAAf6sC9M4UEGgugG&#x2B;I950V4Ds08LgMChy479B8gC/FThEACgAAANDhJvjrfRxjgO39HeMfrABozvH9/pb&#x2B;&#x2B;w39qamp1ptvvrlo5MiRxfn5&#x2B;cPi4uK6sScCrWNMSZbY6Wfbp5WVXjH8sSfHLpz10ofP7tj4v/luR7mEPijQ&#x2B;/SBwQYFinSQQYGDHJUG2VkpSzJ6UwSAAgAAAEJ/i4J/exjmF&#x2B;r7WnPaPpEwTPCPiYkx33DDDXmnnnpqvwEDBkyw2&#x2B;0p6sNgZG8EwsvSM9uY9Zc/9Tzvp1f2HPmfp8e/8Mijzz94YM9XO0TqpW0GBbp1ArvI0YMC3TpFwXEfFDhwx1pt2zWZeRQBoAAAAIDQ3yFCv0gHmeBvs9lMP/nJT3qMHDmy54QJE6bGxcVlGY1GC3sj2oLb4ZLy7zZJUl6mWKMjCCueQYF3/zH7&#x2B;tNO/e0ZDz26/K2333zr/zUcXCTNGxTovRLA6FMGBDt1oPgE&#x2B;lAGBYoEXt4fliIg7/CgwLRcigBQAAAAQOhvkwn&#x2B;oRzr394n&#x2B;Ae99Ezwnz59etdx48blnKFKTU3NV0O/lb0RbUFxK1L&#x2B;/WbZ9dV6WffuEln/4RI548GfS7&#x2B;Lx/HN&#x2B;UHEqOGmwlHD&#x2B;/Vc8HnRwJ/&#x2B;fO6sDWvff9JZt05CHxSotxLA9/AAtzR/UKDvM/tuP4G/7QYF7lpnWJJQRgkACgAAAAj9IYV&#x2B;kY4xwT&#x2B;Upf4tHepn9IT&#x2B;fv36Rd94441lY8aMGZuWllakXsVTsGgzTXUNsv7dr2TNm4tl00ffSO2eA9r1LodTVrz4GQWAjsjRw01jv108efDsV08/6&#x2B;6/zPnp&#x2B;hUv7XK76iU8gwL9rQIINijQe9n/iRkUuPIr7TaLsvpQBIACAACATh78meDfimf809PTI2655ZZ&#x2B;kyZNOqV79&#x2B;6DLBZLpJ/vGxBWVnuErJizUL6f/YHY7NFisdsO7ehOs2xfvEoctY1iibIdFRMVxS2V63ZJxZZycTU2SUPFQWk8WC/RXRNEcSliMBkluU&#x2B;mmCxmSczNEEMn3JMNNptEX3K&#x2B;6fQRQ877/K77Bn3x/vsf/2LHxrf2Ke5GOXpQoEv8HxKgtxLAKMeeNcB7ToB36A/HoEDxKQFEWjkocOjW1dq2/0vsRhEACgAAAAj9J8UE/1BCv&#x2B;3SSy/tMWPGjFN79eo10G63JzPMDydC/ytPk/Xzlqg75o8/egajUQ5WVEjVpt2SlN9NKtZul1WvL5byFZvlwPpdUrV1rzTW1ouzrtHz&#x2B;0NbMWCyWjztgOf4FTHHmMVqi5L4nikSm5Ei2aP7So8x/SSuexcx2zrP&#x2B;Apzzx6GHk8&#x2B;2iNz1ZoefX51a&#x2B;FzH33w2t8aqr8X/UGAwVYF&#x2B;FsJEOjMAd6FQEsGBfr&#x2B;jg7boMBhFdu0bTdF5VMEgAIAAIAOGvoDBf2TbYJ/c4/z1yb4ew7n//nPfz62qKhoVGxsbJr6MJjYG3EipZflSJfCbNm7fMuRnyKj0SAmo1UW3PWCNNU2yO5l66VmV6Wa&#x2B;tyeY1XEZLaI2&#x2B;VUXzeL2&#x2B;kUs9UqTodDu9QKgRqnNByslu27K9TtVsqKFxdIRJcYScjqKv0vmyC5kwZIXHZqp/keWvLzpN/Lzw3Ofe/D/hc/8fTXT37&#x2B;2UsPVu5ZJUevAtA7RMAoJ3ZQYCBhKQJ6bFulbfuZNYkiABQAAAAQ&#x2B;lsU&#x2B;kU6yAR/NfRbJk&#x2B;e3PXGG288rWfPnkWJiYm9jEYjf/&#x2B;g3YhMjJHsU/rKji/WiDU2Uo2Lh3KaNdYuq19fJK4mNeBHWLXDA1yNDm33VsxuSe6dpb0vOi1eXPUOscRFSvWWfeKoqZfGunppqm8QxekUS0SEmKwmcR50yK6lG&#x2B;Tdrx&#x2B;ViLtiJeeUUhn&#x2B;62nStaSHdIbjBAz2SIk6a7Kl35mnD7rn7XnFI/509wv/WvHdpwsaa/e4jg37bp3w39pBgb6rAEIZFOhbILTZoMCRdfsNC&#x2B;yUAKAAAACgI4T&#x2B;YMH/RE/wb23oFwnjBH/PZUlJSfS99947oaCgoMwzzI/T9qE9yxzYWxpddWJTIn9Me&#x2B;orRotJ3C639ix/dFqSpJX2lKzhhZI&#x2B;qLdkDs6Txuo6rUDwLP13OVxaIeApCfas2Cx1&#x2B;6plzbtfSMXactm/epv2wxERZ1c3VcRRWS/LX1wgmxd8Lznj&#x2B;0u/i8dKunofPAVEh68CTCaJmnpGxFn9&#x2B;l4&#x2B;9v0Pz3n/gUfn3LDy63f3KCENCvQtCpozKFBv2b&#x2B;I/kyAEzIocHTdfu02H4e&#x2B;CgEUAAAAoIOFfpHOPcHfdPjtnj17Rv7pT38aMmrUqDHJyck5kZGRCeyNaAvOxiap2rRH1s1dIvX7qyVvylDJUEN5S6UNzBWbxS5uh1MUo0E7tt&#x2B;zV3vCfbdh&#x2B;dJ9VF8pnDZSEnK6itH841ErnpUBhxkt5iNDBHuklmiXWSMKZeMH38jn981R72&#x2B;5KD/8ajJH2MRks8jB8kr53zNzZOl/35XRvzlfxv/5ik7zGFmysyTpqsvjzh0/9sqiO&#x2B;8tXfrRR4tu2rL2/UrF3fRDuPdXBijSvEGBIv7nAviuDGgXgwLHOCsNsrNSFqT2pAigAAAAAMc5&#x2B;LdmmN/xCP2&#x2B;4b4lE/yDhf4WP&#x2B;Ofm5sb9bvf/W6gGvpHJSUldY&#x2B;JiUlnT0SbUBTZt2aHrJu/VDbMXSbl32&#x2B;S2r0HxO1yyRcPvS0jb50upVecJlEpcc3&#x2B;0LHpSZLeP1c2ffG1xCSkSPaoIkkbkCvF54&#x2B;RlL7djwr9Ae&#x2B;iW5FaNdTvXLpONn70jax/Z6lU765Qf2AM2lkBPM/&#x2B;uxqdUt9QLSaDRbr0z5KBp06W3AkDJL1vr072cCk/FAHdpeCxB/v33r6zf/FNt/R/8Z133ni4sXpFvYhTQjskINhKAL0g3iEGBY4u36ht&#x2B;0l0V4oACgAAANBOQ7&#x2B;/7Zt7DL9esDeEEPRbO8E/2FC/kCb433bbbaVjx44dnpaWlhcXF5cpnLYPbZ//xdnQJNsXrZLl8z8Rm9glMjbaM7Jfe&#x2B;b&#x2B;o9uekW&#x2B;f&#x2B;1CKZ46RwddPFWtMZHN&#x2B;kUjZT06Trv16SNGMkdJteKH2DH2oavdUyZ7lW2T5C5/Ilk&#x2B;Xy4Ht&#x2B;8RZ3yTmCIsa/C2iuN1SW1WpDQhM6JMmJVNOlZ7DSyV3/ICjVhF0Rm71axejUczdu0nxc08M7fXxp6Uz/vXEt&#x2B;98OH/e3XU1S5pECXZIgO&#x2B;qAKPP9QY59tSBrR0U6A7xd1pYioBTDu42yEGRBV1ZEXBS/N1yuB07wX88tYtvRv17H4mloLeYMjLYMwAA4Q79gYI&#x2B;E/z9TO73vu6OO&#x2B;4omjhx4oCePXuWJicn57In4oQUAS5FvnvhA/n&#x2B;xQWy6f1vxXP2SE&#x2B;I9pzGzzN4z&#x2B;V0So8xxTLgqtOl16RBYmtOEdAMntUHlRt2yco5C2Xd3KVycHelNFQeFJMa&#x2B;i0WqxZ8Gw/WidPQKLFpKdJnxhDJLCmQvtNGicUecRIUNspRr2tvq7&#x2B;6PadYVFwuqXnvw4ZFv7r1vf&#x2B;u&#x2B;nbeC4pzsxx7ukCXVxh3if6pAw&#x2B;/KD7bu71e17tUvEK/3iEC3teLzvvE5229oYGBXvfrw9xixeJyS0V1jcSq3y8lMkKUg579KkIcu3aJREZq&#x2B;7hn1oI7NlYMlVViiIkWV1WV&#x2B;h1wiTMpScxmsxijoyTX4ZY1DXUSoX6cutgYMe6vFJM9Uhw1NdrtG50OMdns4m6oFUPdATElJh/ah5PixdLgEMVs0l4c6n3xfN6m1BRxVVZKtPqz5lQfR6PDIerOLtaqaql1NIkzJkYs6rfN7HBpyzuaGg6o/3iYxKXe98tr9rfLffNEYAUAAAAnV&#x2B;j3DuTNCf3NOZ6/NafrO&#x2B;rymmuuyZ42bdqAwsLCgV26dMlngj9O&#x2B;O8Ck0H6XTReis8/Vb6f/Yl8dOszUr2jQkxmo1jUsGRV99zNn3wvWxeskPRBeTL4F1OkaOaosHxuz9C/inU7ZcP7y2T57E&#x2B;leuteaThQqx0i4DkFoCXSKo76JqmrPyD2pFgpUsN&#x2B;9xFFkj95uESnnpwjMQ6HLc&#x2B;vcM/rnoGKnhIg5vQJEeOGDJwy4KXXxl341/vfm7lh5dMHFbdDjn6mvzmDAg&#x2B;H7PY2KND39gGNW/eddvvXk7uzGqCT4h9RAADaNvT7C/ThCP0inWyCv81mM1166aXdzjzzzH6lpaVD1NDf22KxRLE3oj0WAcUXjNGOn1/99mL57K4XZf&#x2B;GXWKJsIotNkoUp0u2LV4lu75erwX2ovNPkZ5j&#x2B;6nhs3m/VjxL&#x2B;feu3iYrXvpMti1cIXtXbZOGqlr1J8YgZptFKx0a6&#x2B;ukrrFG4rNSJKu0SPLOGiw5o8sksUcaj9MPwf/w61oy9hwWoL4YExIk8adXRI2bNOHsJb/&#x2B;Xen/Pvxw7h0Vuz/c6nbWScsGBbp9yoNAgwK9g7y/QYHB5gOEMijQXzkQ0Fn7tmjbfpjVhyKAAgAAAEJ/M0J/KIVAe5ng39Jn/PXCvEjw5f1H3p40aVKyGvz7Dx48eGhmZmaJyWSysTei3VGj0P6128USHymxqUnaVZHJMVJ62XjpPqJQvnz4bVn37hLZv2672KIiJTIuWtwOl3z95Huy4sVPpfTKCTL4&#x2B;imSmJOmLUf3G/obHbJ35VbZ8N4y2TDfM3Bws3a2AaPnWPZIq1ijIqShtlbqD9ZLRGqU5IwplZzT&#x2B;0vRlNESm5HM46T30CnKMYcdKw6Hdr05M0N6Pv9EdrflK3/W//d3DvnPvLnPP&#x2B;moXVMvSksGBbpE/xl6fysBAg0KNMkJHhQ4buvqQ6cOTO9FEdBZ/s5hBsCPmAEAAAT/Ngz9/kJ8W4Z&#x2B;36Dfnib4mwoLC6N&#x2B;&#x2B;9vfDlIv&#x2B;xQVFY2xWCzR7Ilob1xNTjXQ79CG/3kG7G37fKXUN9ZKv4vHyPDrp0tMWtJR2&#x2B;9fs0M&#x2B;vv05Wf3mInHUNUhEtF2MFou4HE5xNzkkWt0&#x2B;b/Ig6XvRWEkp6Ca2WLt2u8aaeqlQP8&#x2B;Opetk5UufSfnyTdJQUatNH/QMBDQaTdLYUC9uNbQa7CbpMaavdBtSIMUzx0lyr0weKJ3A732pd53v&#x2B;wxWq7gPVEv1K280bpr14re3L/j4sbnO&#x2B;p1y7HwAvbeVAK/7zgvQmxPg&#x2B;7pvQeA7E8D7sAN/qwv0Qn6wuQEBvWdPVpgBEJ59kwKAAgAA0PlDv972ga43tOLtdjnB3xP6r7322r6qXmVlZafZ7XaerkT7DZFut3Y8/xtX/l32bt4uZoNVbJER2uC/2toDkpSfLuN&#x2B;d6n0OKVEYtKTvEoDh2z5bIV8O&#x2B;tDWfXG59JUWS8RUdGeEwaIUw0nrkaHRMTZJSkvU3s23xxtlfJvt4hLDT11&#x2B;w5ofxt7TtvnWebvOfOAUw03pmiLpA7Jlh4D&#x2B;knhtBGS0b8P575oYQFw&#x2B;HXd93mGBKoBVjlQLeX3P7x3wSuvvv7AupWfLGusr9QJ/cGGA/obGBiOQYGKTtA/LoMC51rjFQoACgAKAABAZw79gYJ&#x2B;W562T&#x2B;TETvBvzVC/I6/n5ubazz///B6nnXbagOLi4tHR0dEcmIwOUgAo4na5Zd07X8g3z3wgG9//Rjsm3xIToWZzkzgbG6WxqU4Se6bLuNsvk4LpI9XgbjrqY2xe&#x2B;L3M&#x2B;82/pXzZRjUgGcRis4nRpIZMNdK5GpvE/cPf4lrgN4j2TL9n1UFj00Ex222S0rebZA8rlrKfnC5d8rPbzd/NnbEAOHIbzy8vTxGghlTnhk2y7/mXyhe8POfty1Yue00CrwIIZVVAqAVAoJUBLS0Cwroa4J3UHgoFAAUABQAAgNDf8tAv0kkm&#x2B;KemptomTpzY9eKLLx5cVlY2Nj4&#x2B;Pps9ER2Z2&#x2B;nSDgH46vF5smrOQu00e7YYu3b6v8a6Bu3Zfc&#x2B;S/H4XnSLFl44/qghwHGyQfet3yLybH5P9K7dK7Z5qLWcZDCb14zi10K/9Se5W/xcpkpiXLt1G5MuASydJRmlvMZiMPACtCFmHw73nnwLP43Z4MKC/wwO8VwN4gqrn0rF2vay&#x2B;/e4lny1Y8Mnf9&#x2B;xYvMPlqAuxDAhlNYBvORDocAC9QYESQhGgd3hAWIqAuUndFAoACgAKAABAZwj9/gJ9OEK/SMuX9LfbCf7jx49PvuKKK8qGDh06NjU1tdDA05XoZDzL97977mP5btbHsu1/K7Vn7o2e5dAutzjrGrRn9Aumj5DhN50r6YN6H33bJofsW7Nddn&#x2B;9Qfau2ir7Vu2QyLQYaayok5TcbmK2mSV1QI70Pn0Q3&#x2B;gwhy29gB/KfIAj21jVaKk&#x2B;vk2rVitr73946UOvvPzMy876zU2K4pLQVwUoOq8HKwDc4v9wAN/rTmgR8LbYFQoACgAKAABARw79oRQCoQ7zC9dp&#x2B;7xDu2&#x2B;ob27oD8sE/3HjxiWef/75hWPGjBmRnZ091Oh5OpOjk9HJeVYELH7gDfnglifFEmk76ln6ugPVEt89RU6772opnD4qYBAwHB7aTlfWZiHLN/zrrQDwfr&#x2B;/bbTXrFZRamul6uXXqja&#x2B;/Nryv3/w7nOvuxxbJbRDAgKtBNArADrkoMC3U3soFADttwDgNIAAgJM1&#x2B;HfkCf6hFgChnLYvWNjXneA/bNiwuAsuuCB/6tSpk1JSUnJsNlsCeyLaXQh0uaVuf43U7q2Sfau2qaHdKZWb90hMRqJEJcSIs9Ep6QNyxRxhkajU5u3CRjWYDLv5HHE3OeXTe2Yf9UshOiFBKraUy8e/f04yh&#x2B;RLXLcUf7&#x2B;7AvzKQRv9e3Hk0t8MAL33HblsaFATlFniL7sovmTmtBF/ffjfudMeevSD/&#x2B;7Y8PF8kcNnDPA9RaDBT/D3Pn2gQY4&#x2B;3Z9B9E8baPApAcQr/Bt9rjfKsacNFNE/TaHobGvw2T6k5Dq5fJPh3egiThvYTlEAAAAI/aGFfr3tT9QEf38FQJtP8B83blz6ddddd3Z6enp&#x2B;dHR0V/ZEtEf71&#x2B;6QjR9&#x2B;LVs/WyE7lq2V2j0HxHnQM3DPpQ3f8&#x2B;QYk7prG6xmiUiyS3RKoiT2TJOsEQVSevkEscVHBS8X1DC46&#x2B;sNsvHjb0V8ntFzu11iUf/zFBBE&#x2B;xNcAnk9Nt7P6uv9E&#x2B;Ib/H2vP3wbzxwBqa/XBgWm3vTz1MnTz7lw2JzXTv/6P099ctP6lbO2KK46&#x2B;fFZf6P4XxVwOFS7vH7fugIUAIEKAe/wH2hIoMHnOoNOOSB&#x2B;wr/BZxu/Jm1Yrm37dpdsigAKAAAAjmvoDxT029ME/1CO8T/uE/xTU1OtEyZMSL3pppvOyMnJGRATE8Nxcmi33E63fPS7Z&#x2B;XrZ9&#x2B;Xhr3V2nH5JpvlUIBzK1r4N1gNYnAYxKmGdJN66Tn&#x2B;vmFfnZR/t0lWvrpQlj0xXzKH5suI30yXxNz0o8Ok&#x2B;jH2rtyizQDYt3q7bFu8ShoqDorFbvthwJwijro6can3o9vgPjLhr1dJTOahM116Zgd4tt/86QrJ6N9Lcs8YyAPWtv9eBCwCgpUGemWA7woBxeXSBt8Z01Ml&#x2B;aZfJI49f/o5r93yh35fzJ//7kNVez5f6XYeEP1VAL5v673uWwC4fcK3ohPQAw0KNIRQBIif7Y76NjSnCJi8Z7O27ZuxxRQBFAAAAHSq0O&#x2B;vCGjtBP9AoT&#x2B;UZ/ib&#x2B;2y/9vpVV13V/Yorrhidn58/1BP6jUYjfzOgXWs6WC9vXvWArHz5czFZzWKOsmnP0LqbXNpp9wrOHSFdS3pIfK80qVy3U&#x2B;ora2TLghWy8&#x2B;u14na4xBYdqW1fsX6X7F6xSbZ8tlwGXnOG9D5zkPqxG9Rtl8vWhStkx&#x2B;I1UrWtXExm9XNE2MQcaVVDf6M0ORvEardJ11E5MuiyKVJwzgixRkVI5YZd8snfZ0nVit1S/u1maaiu1U4F2P&#x2B;qCVI0Y7SkD8pTP5aJBzDM/J3&#x2B;z7ck8H2f3j853oWA922OvO5witLkEFNSouQ89mBO&#x2B;pJlvyi7/&#x2B;Gxj85/94mXm2rX16pbeAX/UA8J8D08wHd1gF7wFz/h3&#x2B;RVIAQqAnz/XQxbETBl3XfatnPtvSkCKAAAAOjUob&#x2B;tJviHcnx/sy6nTZvW9ZprrhlRUlIyMjY2NsNisdjZG9FRrHp1kayc8z81dNt&#x2B;HKjnVsRoNcpZT98sfc4ccsxvAk9w3/D&#x2B;MvnygTdl2xerRXE71VBvVUO9TQ5s2SvzfvW4/O/&#x2B;17R4U7NjvxiMBjFbzWKLjhKXGvpqD1aJzR4pcSVdpP/MiZI/dZgkdEtVP&#x2B;ePf2Ib1HBfX1UjW79fIc4DDjEqJvW2Dln3/lcSm9VFEnPSmj1/ACH9O3JMCeD9T4veEEB/hYFe&#x2B;NfbXlEfV0XdJmLYIOnV71&#x2B;Ff3x61j2XvjD7u399&#x2B;9Wzsx31G71&#x2B;5wY6JMD72X/flQCiUwDozQ9w64T/w/&#x2B;W&#x2B;BYBbp9/0xQ//2YGmw8QUhFw&#x2B;va1hjfj0igBKAAAAPyxxgR/Cc8E/0BL/02&#x2B;13uG&#x2B;d10001DVSOTkpKyGeaHtuBZOr/7u02ye9k67Zl4W1xUeD&#x2B;&#x2B;GsA8U/kNJkU7HN/7t4m7yS1VG3YdOh7fbDzqdp6l&#x2B;32mDtVedixZKx/d&#x2B;rRsXbRae0bebLOoYd8i9XurtY9ni47QPrBn2bfb6hR7VqwMnn6mFJ83TjuFn9Gi/yx&#x2B;fPcucsHzt0vd3gMy9w//lgijXXqeWqq&#x2B;9BdbTCQ7x3EqAwIFfN/3Hd7ee/jfoUM83IGLBu1QE898gAYxWCwSf91PIoovmjHo7n//J2/sQ/&#x2B;c85/KvZ8scTbsl&#x2B;CHBIRrUKDv4L5QBwX6mw8gQcJ/SIMCpxzYpd3m5dhUigAKAAAAwT/sod9fmA8W&#x2B;kVaPswvlNAfrABoiwn&#x2B;2ktJSUn0XXfdNSY/P784NTW1d1RUVAp7IsLN1eiSqi3lsmvZetkw/ytZO2&#x2B;JVO/eIwk90iR7THHYA17RzNGybfFy&#x2B;erx&#x2B;RIRE6Ut5z8URxSZ&#x2B;&#x2B;vHZNc3G2TgdWdqw/4i4qLEaDaKy&#x2B;GSA9v2yO5lG2Wnej/rKg6K0XB0GDRZzNoz/1rI8xQN6vXnzbpNep024IdT&#x2B;IXGnhIn5/7zN&#x2B;wYx6t00jmVn79n9o8J8n7KA39nB9AbLug544RnRYAh0iaJN98QN3XSxCtHvvTa1KefefrBe8u3LZOjVwGEc1CgSAcZFDi9ulzbdk5MF4oACgAAAKE/rKFfb/u2mODv77R9oR7LL9JGE/w9w/zuvffeYaWlpcU5OTkD7XZ7Mnsi2orjYIO8/osHpHzRRqnatFsNRm41SFvUPzxtsn7&#x2B;V2EvADwsdqtMeeyX4mp0y6pXPpemg3Xas/imCKvYzdHa4L7Vry&#x2B;W6C7xkpCbJtHp8VKxeqccLD8gNdv3i6OxUSwREdptnI1N4mxoFFts1KFg5/4h2KkvJoNRPv/Lq5LQPU2S&#x2B;2TyYLfff2cCLuXXQrrOM/qBCoVABcLhtw9/zCOrCBxObUaAJS9XUv9wS/J1Qwf&#x2B;7vQnn1n6zqJF85&#x2B;tKP9uj9vVIG0zKNAtwQcFunWKguM&#x2B;KHBazR5t29dDPM0gKAAAAIT&#x2B;UEO/b/j3F&#x2B;pF2u8Ef38Fge52f/7zn4vHjh1blp&#x2B;fPyw6OjpNfRiM7I1o8593s1H2r98mVZvLtSF5h5lsZtm2aNVR2zobmqR&#x2B;f41UbNgl5d9vkgb19QO796nxR1HDeZV2Sj5bbKQo6ttdCrpLQnZXsSVGSXJuhtiT44753Gc8cq30OWuYrJ&#x2B;/VDZ9&#x2B;I16P3aKZ683mczq53JI1ZY9UrFxl5p2XGJwG488w&#x2B;9Z9u9oapS6hiqJTkuQATMmSf&#x2B;LTpf5Nz2m3ueVYomM&#x2B;OGLMMqmT76WZU/Mk/H/d6V2W3T8ksD7GXy9VQO&#x2B;8wO8L32v1y0QGhu1Ailq3Ghr4bDBw3IWLxk46an/Lr33vblPzaur3iFHrwIIdkiA90oAo08ZEOiUgb6DAr3fF2hQoPd1ul9eOIqAs/buOHRogMRTBFAAAABOotAfKOgzwT&#x2B;ECf433nhjrxkzZgzLyckpSU5OzlUfBkaM47gyWS2Sf&#x2B;pwWfD58yKRliN/&#x2B;ntOyXdg8x4p/3ajNiH/uxc&#x2B;ka2frtAOFTiwfa846x1aUHe5Hdpere26ilsUg6JFHYPJJJ5XzTFWiUlJlKwxfSU&#x2B;I0X6XniKxGenilEN8dboSMk/e6j24ikgVr&#x2B;&#x2B;SPau2aZ&#x2B;zk1Ss7tCXPVN0lTboJ0dwBITKQb17sWkJGlnAYjrlSLFV4yTLjndxZ4YI0v&#x2B;/a5Ubdwt5oiII1&#x2B;bo7Zeknqka8fxG8j&#x2B;HS7oB3pfoOX&#x2B;erfTKw585wcclYY9qwOaHNp&#x2B;HDlmpKVwUNnQv/93cN61r7219Jmvvnz1labarRL6oEC9lQC&#x2B;hwe4pfmDAn2f2Xf7Cfz&#x2B;5gOItHJQ4PTyLYbX49IpAdrq5yHQjn08fyjbg/r3PhJLQW8xZXCKYwAg9B95u91P8LfZbKZLL720&#x2B;0UXXTQsKysrt1u3bmWctg8n2o4v18gLZ94htVUHxGaP0o6fP/znf0JOVzlYXim1u6vUN384zt7kOWWfU5xOh3h2X4P8MNDvcGrxFALqNmabVRvo55nw72hsEs9R&#x2B;dFp8ZLRv49knVoopRdMkKgux64McDU6pNqz1L&#x2B;hSRqr6w4t8Y&#x2B;xa4P4IpNjtY9rjf4x6H9w61Py/p&#x2B;fFJvYJTI6WprqG8XtcmiHD1zw6p&#x2B;kS1EWD3I75ju139&#x2B;ld4gP5e1Al8GuO2Z&#x2B;gMmkrShxVh&#x2B;Uilmz931w3/1zXjuw/4sFzoZyP&#x2B;HfLf5XBSg61ys6r&#x2B;tdKl5B3/s6fzMCfN8WnfdLgNdDDqCvpmYrjuoakchIaUpNEVdlpUSrvxWcRqMYHQ4Ri0WsVdVS62gSZ0yMWNS7b3a4xKnetqnhgPqPpElcERFyec3&#x2B;drVvUgBQAAAAoT948O9ME/yDhX7fbXWX&#x2B;M&#x2B;YMaPrJZdcMrigoKBYDf4DCf1oT1wNDnnzpw/IsmfnS1Rc/NHvU4O&#x2B;9gy/5w95NZh7BvLFZCRJVNd4SR&#x2B;SK&#x2B;I0SErvDKnbXyOWSKvUV9VK5cadWoCv2lQudZXV4na4xRph0w438AwcdDWqwV6pk4zCPCmYPlJ6TRwgaSU9xGhp2Y&#x2B;F53NvmL9Uvp/9iWz5fLmkleZIwdQR0ufc4RKblsQD3IGKAL3Bfc299Bfsfd/2nivgrwDwvq1ne8&#x2B;KAMVslqaVa5TKDz7aP/fvDzx3T/XeT6oVd5NP8Hf5Cf96wd/lpwDwfVv8FAKhDAtU/AR/RSfkBysHApqdmKlQAFAAUAAAQMcM/kzwb8UE/3HjxiXOnDmzYPjw4QN69eo13GKxRLEnor1a9&#x2B;5Sefm8u7Xd2LM8X0sanj/O1bDumdIfrQb&#x2B;tH450mNCqeRNGSIxqQliirD4/XiOOvWP/MbGH84s8LUse2yuuD2n9zMZf/hBNoqjvkHcTrfYYu2SN3WwDL5hiqQW9xSjqWXjL9xNDtm3bqck5WaIyUrH1tHCv78QrxfWAwV9vRkBejMDDn9MvYIg0HXa/z0/I1arNCxe6tz6j0dWf/bpgnnP1lZ9uVZx1Yj/QwLcIb74KwCUAIWA93W&#x2B;r5&#x2B;QIuDprtkKBUDr8FsMANDeQ7/e9h1tgn8oQ/38Xk6cODF5woQJ2aNHj/YM8xsdGRmZwJ6IjqD7KUWSPbpI1s9bJgY13HjCf1RKnGSNKpRuQ/pI4czRWrAOdZCeOcIstXsqxVHboC3j9zxzKu5DhzVrhwyor3vOONDgPiiu6iZZu2iJFEwfLmmlvVr8NRitFulS2J0Hs4OG/x/&#x2B;3fJ7ir/mDPILNhfAewaAb4HgOzPgmI/peXE4RWlyiK2sxNzrqX8WZS39umj0o4&#x2B;vfu6D9596vLF6hfvHY/z9nTXAKK0bFGiQdj4o8LLdm7VtX0zPYUYABQAAoJOHft/wHyjUiwQ/jj/Q&#x2B;0IpAJpzfH&#x2B;zJ/gXFxdHT5kypfu55547Mi8vb4Qa&#x2B;llzjA7Hao&#x2B;QgmmjZPsXa7Ul9GkDekvhtOHStaTnofAeSpBTQ71ncv&#x2B;OJetk5YsLZNsXq6V&#x2B;X7X2LL81JlIbGthUXy&#x2B;NjfVijDRJ5rA86XPOMMkaWCQZpblijrDyQJy8/3YFfbbVe3if3ioAf&#x2B;/3DvWBPp/vHALfIYG&#x2B;n0d7u6FBG3phHTxAskv69rlh9iu3n/H4U0tfX73ijSeVppXy48A&#x2B;71UARgnvoEDfVQDtalDgzJ0bDC&#x2B;lZFECtOTngkMAfsQhAADQ6tAfKOh3pgn&#x2B;rTm&#x2B;3&#x2B;8Sf5vNZvzZz36Wc8455wwuLS0dEx0dnc6eiHDznNO&#x2B;vqJG1ry5WLYvXi09xvZTQ/qII0v0w61ODev7Vm&#x2B;TzCF9mvU5PKF/36pt8v2sj2XLZyukbm&#x2B;1NrjPE&#x2B;i1U/o5HNKoBn&#x2B;32SHpxb0k75yh0n1wkfQ6tczPrxucVPu5zvJ83&#x2B;AdyqDAw9v4O7bf9&#x2B;1QBgb6Hibge9ujrjeq989qFff&#x2B;Kql5&#x2B;dX6eff97Zl/Hqz8ZIPLUS3BDwnwngPgb1BgsAGBvkVAS&#x2B;cDiLTRoMDX7SkKhwBQAFAAAAChv0NN8J8wYULeKaecMik&#x2B;Pr67yWTiKUuEnbOhSda&#x2B;9aWsmLNQqjbukvLvt0hTY71YbRFSfNEYKb1yoqSX9Tqhx7kf3F0h&#x2B;1bvkDVvLJa173wpNTsrtPvtuU&#x2B;eMwV4Zgc4GhvEof6X1DtNCqeOluxxxdJrVKmYI208yPAbspo75O8wvTkB/oYBhjoAMFAh4fc2RqN2vLtj&#x2B;Uql8sU5FXPefOOff9m9bbFXuA8W/jv9oMBnEjMVCgAKAAoAADg&#x2B;oT9Y8A91gn&#x2B;wY/07wgT/kC4vuOCC9KFDh3abNm3a2cnJyb3NZnMEeyPa2sL/myML73lRaqorJdIWIxa7TdwOpzjqGsUWHy3dRxbIwGvPlJwJpcftD2HPsfy7v1ovy2d7lvevlcr1O9XQf&#x2B;jMACarRRSnWxoaDmqn&#x2B;0spyJLuI/pK77MGS/eBRWJPiuVBRdB9LJQhgN7bej/jH&#x2B;wMAsHKAm3Kv87HC7YaQO922ns8Z7WwWKTu/U8cax7556efrljxyeNVe7&#x2B;rOXTGAAYFql6KSVUoACgAKAAA4MSFfpHON8G/uUP9tJfx48cnnXfeefkTJ06ckJqams8Ef5wIlRt2yZq3v5SF970k1Tv2ii3SLmarVVxOpzhqG8USZZP&#x2B;V54meVOHaIcHtAVP6N&#x2B;3cqt8/9Jnsu2z5bJ39TZtsJ9n4J5ZffFEiPq6am0uWnzvFOkx5v&#x2B;zdx3wUVV592R6JpNeCYSQQEggPbRQE5o0BUEpithYrLiu&#x2B;&#x2B;2qW13L6reWT1d3dXfdddcu6gKiKB2kl4QSekIChCSE9Dq9fO/eODgM7715kwSYwD38hvfy&#x2B;rx55Z5z///zz8Kgm0chMS8b6kAt&#x2B;xEZvCZbUnr8PRF8PsIvlh7Q2egAT5ED9H/uPrE1tcBYuN9y5uPPC97YvuXf61ubKiFeNpAvKoAvEsDb1ACHgDgAiEcGAMJpAV0WAv6j1DiYAMAEACYAMDAwMOJ/ZUk/4L2Df1dJvzu59ykH/8DAQOUzzzyTOXPmzIl9&#x2B;/bNUavVrMuSwSdQc7wchX//FkeWb4O&#x2B;soka9vkpFTQiwNymh5L7e9iD0zH88VkIiY/q8v4IwW8sq8ax5TtQ/M1eNJ&#x2B;tgb6&#x2B;FXKFHAq1khIks8EIm90KbUwQkmYORVz2YGTcOQH&#x2B;QTr2gzF0mWiJRQMIEXexEn5ShAChbTmXF4o4cG7TdZ3Ltkde6XKO4La2ovHz5fVHV6za8tGJo2s2GNsq4dkbwFMkgFB6gJg/AASEATFRAB6EACnjgvhAGeBgAgATAJgAwMDAwEj/1Sf97gRfjNQDvu3gL4X0Kx5&#x2B;&#x2B;OEBCxYsmJCcnDxKo9GEyGQyObsaGXwR9cVV2PS793F64yG01TdBrfWnhNxmttJQ/JDEGCRNHYKxv54PXYx3FSht3PqNHNE/s/kgDn20GS3ltWitrIOM5PTLlRyBscNqsMBsM0DXJxxx45IRPzQd6bePQ3BcNPtxGLqVbAmRcr7lPAkE3kQPiJr8iawjli5wqVGgjLJha30Dmletrl/z17&#x2B;//1F99d5ih/V6NArsVDSAl8syAYAJAAwMDAw3BOkXI/rXysxP6rxr7uCv1WrlDz30UP977733pn79&#x2B;mVxf0fJCcNhYPAhtNc0o/ibPTS8fui9M6DS&#x2B;XcQC47sVxSUoOjDDTi2fCfaaxuhDgiATC6DzWShYkB0Wj&#x2B;k3pmH1NvHIrR/jDDpt9hQf7KC7uf0lsM01L&#x2B;tupGG8yvUCu75JIPFaILR2o7AmFD0yuyPpOnDkD53PIJ6RbAfieGKkX8&#x2B;Mi9G4qWSdinE35MQILWygGuUwSVRAyRa4IeIAPOR46hbvbZ86&#x2B;efr3iutnKDGQ6nSaCQGOCAeFSAeySADeK&#x2B;AD5rFOgLQgATAJgAwMDAwMBIfw918CfDRYsW9Vm6dOmkhISEjLCwsASO9DMrcgbfIUAcQWgsrUZVQTH3KUHpxoOoKToLk6Md8RPTMfqhOUiePpKaATpxnltu43Pv4/SOQ3A026EiOfcO0GgAm9mCoIQIZN9zE9IXjIc6UNNh1Mftp/lcLc5sPYyz3x9F&#x2B;fYjMDYQ4z4HlBoVZAoFTHojLFYD1GFa9E5PQsKMLGTNnYzQfjHsh2K4okSLrySgWHqAUIlAIeHAPVxfjMALEXoxIUEstYB3O0runiRCwKHDtuI/vVZQsLdw85um5l3cHSnVKFAsKkBIAOhRRoHXUghgAgATABgYGBiuNen3RPyvtYO/UL7/NXHw5wi&#x2B;PD09PeDll1&#x2B;ekpKSkhkbG5vGTWIO/gy&#x2B;SYBsdmx78TPsemMlWhvqoVSoac&#x2B;&#x2B;n0wGY1sbLA4T&#x2B;gwbhIm/vRvx&#x2B;enUB4C22q02VBeVYcvzH6LkqwJueTlUARpak5xEBJgNBviH6qAJD6IpA4aWFhjr9FQgIOsS/wA5tw&#x2B;T0Qir2QyZVobew1LQb3w60m8dh5jMAezHYbjqIoA7&#x2B;ZLiAeCpGoDUNAGpvgIee/ohLVWAjPmpVLAbTTAfPYajz7646cuiAyv/C2spPBsFukcFuI&#x2B;LRQeIpQO4&#x2B;gC4ewLYecj&#x2B;FTcKvBZCABMAmADAwMDA0JNJP&#x2B;AbDv5SQv07k&#x2B;cvh0te/7vvvps/bNiwEXFxcVnMwZ&#x2B;hxxAgjgxcKDqLsvWFOPDeelSfKIVapeUIvT/sNjssHEknvfhxowYjdf44DJo1Ev7hgXRdUh6wePVeFL2/Eac2FsJuskGhVkGuJr3&#x2B;Dkr2SVtSRmqUc3eKn8wPVpIyYLHATy1DZE5fxOemYvDsceg3Ko0KDwwMV4tkuffge0PkPRF8T0RebFtSiLyUygBCngCXVQxQq2GrqUXbt2vbSj79ZPfykydXrYSt1P4jqbfBu5QAKQJAjzEKvNoiABMAmADAwMDAcCWJ/43g4O&#x2B;J9He6xz81NVX3xBNP5OTl5Y2OiYlJ0ul0vdiVyNCT0XTmAna/uRInvt6FhlNV8NcFwk8uo2Te0magecS9hifhpld&#x2B;gj4jkiEnNcdJg9Vmw4lVe3B42fe4UFCK5oo6mE16EhIDuUMOq90Mlb8WMu7vgJRg9MtJw9CHbkb04ARqKMjAcC2FALGhK2l2D&#x2B;N3Jdl8f0vJ&#x2B;xdbXmqEgBQ/AL5KAZdEDnD3Ji0d2NCItlXf6re&#x2B;9bcP32ms3nTabm2FtJQAoagAqQLAlTAK7JHRAEwAYAIAAwMDg6&#x2B;TfneCL4XU8xF7PwlEv6sO/kIh/5KHoaGhyt/&#x2B;9rcZ06ZNy&#x2B;vTp8/gwMDAWIHzxsDQY6FvaMGaX/wDRz7fCofBxpF3NWQc2SftQnO7EXY/G&#x2B;Lz0jDlT0sQm5N0ybqt5xtQueskLFYTms/UkFpk8I8MhDY0CEG9IxCTmUAjBBgYfIX8SxEAhOYJEXhPy4sJCVJSADzm&#x2B;UM8NcD9OC4uI5PBT62C&#x2B;fAx1H3wScXerdu&#x2B;&#x2B;nXNue9ciL63JQOFKgXYRAQAMRHguvcHYAIAEwAYGBgYuoP0ixH9G83BX2qe/8VxuVwue/rpp1Nmz549pm/fvimRkZEpjPQzXO&#x2B;wW2yo2HMCBz/YiCOfbYW5tR3qAH/IlErYrVaY2vTQhAcifV4ecpZMRa/s/uykMfRYAYCPlEuNDhAi5FLz/cWWEevdd41I8ETyhYQBXiGBDFUqGtlj2FfoKHn1za17S0s2v93eWGBxOGxgRoFXVAhgAgATABgYGBiuNwd/WSdIvzf5/J0h&#x2B;7zD559/Pm306NGpAwYMSI2LixvCSD&#x2B;DL8LSbkJD6XkYm1rRfK4OdpsVcj8FbNyQhO&#x2B;TXH5NSABCB8QiMDqE5vN7cyUTj4BTa/fjwL/X49SmfTA16aENDCYd&#x2B;3CYrTAbTQiOi0Le7xcg655JLI&#x2B;foUeKAFJMAIUIfGdL/0nZjlRhgG95PqNAPgFAdF2VCta6epgPHrYf&#x2B;9u7a144cfiDUoupBd6nBAj5AvR0o0DHlbommQDABAAGBgZG&#x2B;jtD&#x2B;oUIfXeQfqB7Hfw7U7YP6GYH/4cffrhffn5&#x2B;8siRI8fGxMSkyWQyFqvM4FMg5fPqS6tQWViMU98V0jB7Q0ML9A2tcNgc1GBP5ifryFnmyLhMLoPCXwV1SAACI0MQkhCD/tOHoO/oNATFhEKpk1akgjQJa4&#x2B;ewY63v8S&#x2B;d76BLjC8w9yPm2632WAzWTHqF3OQ/4eFLMSf4boSANzJuus8vtB9sW174wXgqbyfWJlBofB/T1UE&#x2B;EwCidjnp1LCUnUBjcv&#x2B;W3t085a1H5UWb9xnMV7gEQC8SQnobqNAb/wBxAi/oxPk3tHd1yQTAJgAwMDAwEh/Z0i/FEHAVxz8O9vjz0fmAS8c/KdPnx4xf/781HEcSE&#x2B;/XC5XsauRwZdgNVtwcsVOHF&#x2B;1Gw3FVagvqYCpVd/RMnd0tJVIyT45FBwpl9NefpvRDJvMBoWfkluEIwjcXOLCT5g86dX3jw5CTGoCcn85G/Gj0qHSSa9Wue7pf6Lgr6shkyt&#x2B;bLTa7Ghtq8Mtrz2BkT&#x2B;/lf1oDD2C/PNVAhAi856W88ZQ0Bv3fzEiT4ZOAUCM9HsTXcArCJAHDfdsIWaB1gsX0Lx6fe3mjz76&#x2B;O81lVtr7TYjrq5RoFSTwB6ZFnCt&#x2B;beCPRoYGBgYfJb4d8XM72qQfnei70sO/vKcnJzAhx56KH3MmDHDExMTR6jV6mB2JTL4KuxmC6xGC05vOYSmqmoooYFcqYRMLUdgTAQiBsYieFAU&#x2B;mQO4i5wB9ShOljaTDDp29F0ugZVBSWoKz6H1jP19A5QBWphaTaibHMRynYUITK1D1JnjkP24ikIig33eDzZi6bg2LIdMNS3dogK5OZSyLnj0uJ8YTH7wRh6yruXl3QJ9faLbUcKaeOLJHCu715NgG//Qsfl3L/7cbjOdxU8XPfl&#x2B;rdznPf7UKpug8NqhTwiAqH33BF585DMnw5fuXrK3s2b1v6ppnKjhZvrQvb93Mi/69984873ucNlGgRIux/4IwP8eMYdLu0OPsLPt5z7N/fzgtz74SqXDez2&#x2B;4JFAPwIFgHAwMDQw0k/3/Ji0/268LdPOvhHR0erfvvb32ZnZmYm5eTkTA4ICIhiVyJDT0LLuToc&#x2B;ex7lKwpQHRmApJvGYGg3pEITYymBFwMzedqUPzNPpzbeZwb7nHJonXAYjLDYjagd1YKRj95O3qPTEFov&#x2B;jLtkEqAJzffwprfvYPNJZV02gCP5JuYLdRU8CE8ZmY8toS7tgS2Y/F4POQku8vRN47k8vvTr67kt/vqbKA1JB/ofXFjAIvjnPPHIeVu/ePF1tPvfHW1u0H92/80mo82uhwmCBcNUCqUaC3pQOFUgTcxzuTFnBVvQFYCgATABgYGBjpFyP6V7JsH3AdOPgT0r906dLkvLy8dI7036TVaiO4n0HOrkaGngw71&#x2B;j2RPjd0V7bjKp9xShdvx9FH2ym2yB3CSUlNjvsZhvaTI3wU/ihX14m7v/6FSj8f8zlJ8vUHT&#x2B;Hbx9/G8c37YROEcwdgxIGYysUMiXGPX0Hxjw9F6pAf/YDMfQYAcA9d14qyRcSC8Ry&#x2B;oXIeVcEAE&#x2B;CQmc8APjmC&#x2B;6PjHDPIlu7HsbCg9ayf72/7S8H9/6nEI5aSEsJEPMF8CY9oKv&#x2B;AN6kBVxREYAJAEwAYGBgYKT/apF&#x2B;4Dpx8I&#x2B;IiFDNnj2796xZszJGjRo1JSQkJMHPV14mDAxXEcamdpRtOICKPSdRuqYANScqIONuBaVGRR5OsFus0BtaoFRpoO0XjEHTR2LI/dMQGBMOXWQob8NUX9uMPW&#x2B;uwvGVO2B1mJExfwKSpg1Hn2HJ7IQz9EgRwF0IkCoKCIkEUpbhI/FiEQOeyL1Uki&#x2B;F/Dt9BSQLB06mS0qEtrSgadny&#x2B;vLVa/b/tbz0w0M2c52X5F8oEqAz/gCeygaKRQN0lzeAozPXJBMAmADAwMBwY5J&#x2B;IULfHaQfuM4c/AMDA5WTJk0Knzt3bvqECROmRkZGpsiIG5oPo6WqHlVFJeiV2h/BcZHsxmHoFrRdaERVYQnObT9Gc/wv7C&#x2B;D1WKGQqWCQq2kBoCGtjb4qf0Q1C8cWXdNRuLYbPQemgxVgHQjwPaaJnoLBkQx&#x2B;wyGnkv&#x2B;3ck&#x2B;H1EXI&#x2B;9SpguF64stzycACIkGYtsQ249zG2IpAc6/hYwML9sPaf5wzxp7ayvq/vqP87tXrPrvGot&#x2B;b6E0IUBKVIBUQUCojKDUaIDuTAlweHtdMgGACQAMDAw3JumXIghINfPrLtLvStrdSb23pL&#x2B;zDv6XhPhnZWXpnn766dy8vLxJUVFRg3y9bB8hTRX7TuLczmM4/MX3qDtdgaiEvhj7uwW099U/PJDdTAxeshiujdLUhguHynBm6xGc&#x2B;O8ONJXXwtjUyhF&#x2B;NfdRcQ1KkqNvgFVuhi4sDKl3jkHSpGFInJANlb&#x2B;GnUOGG1YAkELyheZJcfv3tKy3jv/eVA/wNO4k9mL7lZJW4C4SUAFBJqNFSsxFR9GwanX50c3fr/3f1rpv2rlJEsm/N/4AnqIAhHwChCIDAOGUgCsuAjABgAkADAwM1yfx78kO/lIFACll&#x2B;zyRfV4H/5SUFO3jjz&#x2B;eOW3atMm9evVKUyqVAb4c4m9uNaCioBhlG/fj6Gdb0VhZDZgApUZNCZrVZKIl3CJT&#x2B;iL7jpsw4vGZrI46g7SGos1Ow/u/&#x2B;&#x2B;k7OH&#x2B;gjJrxKTUayFUK2gi3Gkww2tqhCwnGgFnDkDFvAnoPTUFgVCg7eQwMkGb0J0S4PU0XI99ChNobIu&#x2B;EK/kW2p5rqUCp&#x2B;/HWR4B330oFHBYrzEePO8r/760Da4pPfrbSZjhhcDgsLqTf20gAIQHAxiMEAJ0vHwiRad6KAEwAYAIAAwMDI/091sFfSAC4og7&#x2B;SUlJ2vnz5yfcdddd03v37j1Yp9PF&#x2B;PI1YjWYUXOsHKUbC1H06SbUn6qErc0Klb8/5FyDiK/QkNlgpDnZvYenIH1xPgbPGIOg3uHshmMQbijaHTC16nH4o804&#x2B;P4GnD9YArPFTC8oTagOfUakYPhjN6PXoP4ITejFThgDgwDZklIFgG/oXr5PSt5/Z3vs3bflbV6/&#x2B;zw&#x2B;su&#x2B;tYCBWNeDifNJkUipha2mBceceR9lnX276/Ymid2psVj0P8fcUCeBK9sXSAsSiAcTMAiHh7ysqAjABgAkADAwMPZv0ixF9X3Lwl3lYzlsH/66Y&#x2B;l0cj4iIUN5///39lyxZMpsb7xsSEtLPl68R4qJOiP7pHUU49OEG1Bwqh7GlDSq1PxQc6ZfJ5XCIvP&#x2B;duahWvQlGazt0vcOQ9z93IHPRZGhZagCDB1jajDi5ei&#x2B;OfPs9Bs8YjdjMAQhP6gM/mYydHAYGiYRLSmi/J4LvOt299J&#x2B;Qa79Q1QA&#x2B;wi3VHFDqvvhEACFfADGyL3QMF&#x2B;eRZ5FKBVtdPer&#x2B;&#x2B;f7Z8sIDm/92rnRdsdXcJED8O1tC0JNXACBePaCzIgATAJgAwMDAwEj/VSP9QkJAVx38xUi/lB5&#x2B;b3v7ZWq1WjZv3rzeS5cundy/f//ssLCwRD9SaNxXSb/VhqbyGlQVlODgR&#x2B;tRse0E2luboZSpoVQpISPhj514l5KvbDWbYTGZENG/N5Jnj8aYp26DfygTAhgYGBi6WwAQc/93HboTeqk9/XyEW4qgwEf0nX97YyjI17vPtw0h93&#x2B;p6QBC0y/Zj0JOy4qaz19A3aefH9&#x2B;yYeNnH7Y3HjTY7WL&#x2B;AJ2pHNCVEoLXTARgAgATABgYGBjpB8/fnQ3p7y4Hfyn5/V4NJ0&#x2B;eHP7LX/4yLyMjY2RERESSXC5X&#x2B;fJ10lbdiDPbinDo4w2o2ncKbbWNkDsUNK&#x2B;f1Gd3dLzFu349cv8sRhNsZivCh/VBzsIpSJszDkF9ItjNysDAwNCNAgAf&#x2B;RJz8pdC9D1N74qpn7fmgULbkpI&#x2B;ILZNscoE7ikEl0wjZQONRpgPHbbWbdhycueunSv&#x2B;1VS7x9ThD&#x2B;DuB2CD9x4BYt4A3hgFdqcIwAQAJgAwMDBcR6TfE/G/ERz8xUL/5e7Thw0bFvTkk0/mjh49enxISEicv79/mC9fJ4b6VlQVnsSBDzfh7NYitFQ3wM/qgMpfy5H&#x2B;Kx&#x2B;kQIQAk0mPqKR4jPrZbAyeNw7aiCB2AzMwMDB0kvg7e8LFiLoQyfa0nFTHf74IA7EygFKIuZgIYbPZeLftqRefr1ffNZJAiq&#x2B;Aq9BA55FqAXI57CYzLCdOWE//64PNm44dWfO1sf2kCZcIAWIeAd6kBvCJAd0lAkjxA2ACABMAGBgYeiDx72kO/p7Gr6qDf3p6uu7ZZ58dk52dPTQiIqKfTqeL9eVrxNSsR11xBfa/twal3x9AS2kdbGbLRTM/P5nfVXtZk6vV4fCD1WiC1WRByKBIZN83FaMenQOlVs1uaAYGBoZOiADuf4sJAmIpAJ7IvicRQGxbfETcU0&#x2B;/GHkXIvru39F9yCcUCIkH3qQVOMgLTi6Dta0Nxr379VVff7vrnQMF7xfZLXVuxJ8vEsAGaaaBYmkCnSkZCAlDr0UAJgAwAYCBgaHnk36&#x2B;5a&#x2B;Eg79Q2T6pufzAFXLwj4uLUz/33HO5w4cPz46Pj88KCAiI9uVrxNJuQvXhMuqqfnbPYTSX1MLcboRSpaLl&#x2B;WSkx&#x2B;Javx/9iBBghsmsp07vg28Zg5RZIxA5OJ7d5AwMDAxeigDeVAHw5BfgTeSAt&#x2B;X&#x2B;PG3L26oCfL3yrlEInjwJvIke8OQPQMdJE417x9rb29H0&#x2B;YrK8k3f71lZdXb1Dpu5kof0S4kG6Ex6gLsA4DwBYv4A3ogATABgAgADA8MNQvrdyb8QqQd818FfSCC4bDm5XC576aWXskaPHp0&#x2B;ePDgUSTEX&#x2B;C8&#x2B;UYDkGuA1J6oQNFnG1G26SBqj5TD0mKGXCXjiL8afsTB32H3vWub&#x2B;0fKB9qsVvgH6zDmt/ORTaoGRLLUAAYGBgZvBADXdAB3YipFJHAn6ELredvDLzTNNQRfil&#x2B;AFOFAqHdfrCSgN73/rkKDuwhxyTESEYBrMdgbGtH0xVcVe5Z/8dmXNsuuSrutDcI9/50RBDylBQDSywUC/NEBTABgAgADA4MPk34xos8c/D04&#x2B;AcGBip&#x2B;85vfpA0dOjQpMzNzTFhYWIJMJlP68nXSfLYGR5dvxak1&#x2B;1FZWAxjfSvkSiWUGg0N7&#x2B;9RjVibHQZjO4KTIpF5&#x2B;wSMXDobAVEh7GHAwMDAIEC0usMDwJNgIMUjwFvvALFQfiGiLUbexcQC9&#x2B;2JzfMkFEjZxyXCgVzGsWU/mA8V2Vs3fV&#x2B;5fu3af7xvNe6DcDSAVFHAAeEUAU9pAWIigJQoACYAMAGAgYGBkX7Bv33ewV&#x2B;r1Srmzp3be&#x2B;HChcMzMjJGREdHp/l4iw/6ulYc/2YHTny5C5VHS9B2tgFymQIqrYb29Et4P/vyXQCrwQSzxYiogX2ROj8P2fdPRkh8NHtAMDAwMIgQLj7S797D7i4YeFMGsDOmgHwpB3w980JCgNTtSxEPpEYZiPX2S4kOcBVU6DyyjEJBqwYYN2yyVHz8xZ5t584sX2s1nmxx2E085N9TmgCfT4BQ6UBPIkC3RwEwAYAJAAwMDFeH9Hsi/jeKgz9fNMBlIf5yDjNmzIhcsmTJiPT09Jy&#x2B;ffsO5X4GuS9fJ&#x2B;01zTixaidKNx5A1YFiNJZUc19GDoVaxX2UoE0Mx3VzT9ChxUDMAs0IiA9F3m/uQMq0UQjqE84eGgwMDAw8ZMud94j16Lt7AEgh3EIk3VtRgI8oSyH5UkQCKb3zfORektGfhHKCHkUC7p1ta2iEcdc&#x2B;W/U3a3Z8fvbUe9vNhkrwRwJ4Yx4o1RzQPS0AEI8CYAIAEwAYGBiuMfH3dQd/b938r5aDP/2MGjUq&#x2B;NFHHx3Ckf7UlJSUPKVSqfXla4QY951aV4DiNXtRvv0o6k9WUtIvVyioa77D7rgRbhTYLVYYTK2ISOyLfmPSkfe7OxHSL4o9RBgYGBgAwd59IYGgM&#x2B;H9Qrn6UkUBT2RcikjAF6LPJyR0htDzknVcHgHgOl/KPtxLDdL5pCKOXAFbbT1alq&#x2B;8UL51&#x2B;6YvG&#x2B;u&#x2B;Omgz17kRfz4BwFN0gMODCOApGgA85N&#x2B;rNAAmADABgIGB4dqSfr7lbygH/7y8vNBZs2b1HzlyZFpmZuZkf3//UPiwmR95pZJe/uJ1e3F282FcOHSaI8A2KDVqKNXqjp7&#x2B;G/HeITmUtHygiaYDZD8yGWkz8xCREsceLAwMDDc0&#x2B;XcOneTYlayLuf0LEXBPIkFX8/2FtiOUGiC0jJgJoaewffdtCE0XEgj4xoW2KSg0EKNAwtrLz6F19bqq5Vu3vLiqpeGEiAAgVQSQWiGArzSggwkATABgYGC4Pki/O/kXI/VA1x38PQkA3uT3e&#x2B;3gP2TIkMCpU6fGzZkzZ0xycvLogIAAn&#x2B;4uthktOLP9CMq2HETF9uM4t/c4rAYjlAoNlFoN7QX38L69oWAzW2A0tEPdS4txjyxA&#x2B;p3jEZoYw04MAwPDDS8C8IkBrkTUnViLEXk&#x2B;8i0lGkCqOCAlt55vfSlRCJ7ItxDRFyozKDWKwL33X2h5Op2bT5dQyEGK9Jh377XVbdt5YMuBwn9/0dp4DJenAogJAlLSATylAtjBHwXABAAmADAwMFwh0i9G9K8nB38xIaDTDv7R0dGqmTNnxi5atGhMRkbGuODgYJ/uGrZbbag6eAql6/ejbMN&#x2B;jvifgMlshIqQfn81ZNQ52ME4v&#x2B;CN4kdLB5raDQjuE4XkmcNpaoAuJpSdHAYGhhtOAHAnxHwk3XVZIQ8AMVLtvi8&#x2B;Qu0uMAiNC0UKCLnwS/EA6EwKgOs0vuPj26bYtsXSCDwZBUKhgN1shmnX3rbTK79Zta&#x2B;ifPNKQ0uxgAggFhHgahDoKSWgs1EATABgAgADAwNz8L/6Dv7EzO/WW2&#x2B;Nuffee4fm5uZOCAsLGyCTyXzazK/2xDmc2VKE4nX7cGbTIZha9Nw7XwWVPynbx5F&#x2B;h53dTF7ddyQiwAaz0Yig1AjkLJiC9NvyEJ7ch50cBgaGG0oAkErq&#x2B;YZ8pNzZrOHeq7BYLKIl8tyJvJigwDdO9qEgBJhb18yRYKVSBZPJKNmkT0hg8Ma5X6ycn5gAIHR8ngQA3kgCMkMuh6WmFtZjJ1ovrN&#x2B;88eNjRf/Zb7fUeRAC&#x2B;EwCpZgDAvypAZ4EAEERgAkATABgYGCk3zPp90T8pTr4e8r19wUHfymk3/mRCy03c&#x2B;bMqDvvvDPjpptumh0YGBjNNRp82syv9ng5qgpLcGrzfpSs3gdjTSt9N6gCtLTR42Dd/N0Ci8kEi9GIkLhoDH/kFmQsmoig3qxqAAMDw/UvAAiNC5Fw8g6Sc0RT/kPpWELwrVYrnadUKumHEHEj90xtampCnz59OEJuouuR6Z4iAaQIAARkP4T419fX48SJE/jwww/Q0tyMe&#x2B;69F2PHjqP7I8dms9m8cvnvbLWAzggFUnwCJAsAzuMhYgvxCGhqRvvqNadPb/r&#x2B;643N9Vt2WU1VkBYNICQEdDYKgAkATABgYGCk/yqRfuD6c/CXkud/mYP/5MmTw2&#x2B;77bbkWbNmzQwNDY1Xq9XBvnydNJ&#x2B;tRcX&#x2B;kzj51R6c&#x2B;HYHzHUGkGw/jVZHw/t92Iaw596bP5xU4hFgMhgQ0CsEA27JxoSn70VIQjQ7QQwMDNcd8Xd1/neSS2czhc98z3W8trYGx4&#x2B;foD3teXnjodX6U6J98mQx1q79DsXFJ1FaWooLF2rQt29fJCQk4MEHH8LAgQOpWOAUDIQEAL5jIMfGvb8pqSeCwvHjx/HPf77L7asYkZERdPrp06e59RyYMGECZsyYgbS0dLqON&#x2B;H8nU0TEAvpF1pHKql3jSDwxiiQHgf3G7Rt2nbm6Lq1/1zW1rTtvMOuh7RoACnGgIDnKAAmADABgIGBEf8rQPoB7x38u0r63cl9dzv4e0v2Lxmmpqbq5s2bl3DnnXdOj42NTddqtT7dnauva0HFvpO0bN/JVbvQWl4PWvaXa1TJ5HL4yfw63pYO1uN/hZWAjtaM2YZ2fTPCE2OROjsPaXPHoveIZHZ&#x2B;GBgYrksBQErov&#x2B;t6y5cvxzPP/B7nz1di/PiJeP755zmynYGVK5dz48&#x2B;Be&#x2B;9i9uw5CA0Nxeeff44VK/7LkfQYTJs2DUuW/AQpKYNEy&#x2B;S5&#x2B;hGQaDciLrS2tuLQoYMICwvHwIFJWLhwITZv3sIR/el49dXXEBAQQNe7444F2LlzF8LDQ7l5N&#x2B;OXv3wSXBugUw7/nen9FxIPxIwAxQQAT&#x2B;u5RxK4lhC0ke9FIjW4NoTlyHFH2/pNx07tP/DJa&#x2B;2Na10IvxXC1QKklAkUMgb02geACQBMAGBgYKT/2jr4y0SWvxYO/pKGjz76aOLixYunDBw4cDjXGPDprltzuxHn95egbNMhHP1yG&#x2B;qKz8FhsUOl0UChUtFv5WCE/5pB5ieDxWiCzWSBKliL4T&#x2B;7Bdl3T0ZoQi92chgYGK4bAcDd&#x2B;d/JQQjp5hMCSOg/WbampgZff/013n337zQiYPz4Sfj5z59AYmJ/qLh32Hvv/Qvbtm1FYeF&#x2B;GAx6pKamccQ9GQsWzKc9887QfHdy6zwusg8SKXDhwgUaRbB58yY89thSRERE4M9/fgtVVVV48slf0p7/jIwM9OvXD8HBwVi5ciXuu&#x2B;8&#x2B;REVFISIyCpncPOf3kioAdGYZb6IL&#x2B;IQBb7bpSSjg3ZZKCQd3zi0FByy1ny77rqzy3Np37NbtEDcG5CP/QiIA38ddCGACABMAGBgY6fdA9K&#x2B;VmZ/UedfcwZ9riMgee&#x2B;yx/osWLRrfv3//YTqdLoKbpvHVa8RmNKP68BlU7D2Jgx&#x2B;uR/XRMjjabFCoVVBo1PSLsbx&#x2B;3wNpTBn0rQjqG47BM8dg9BO3IySepQYwMDBcHyKAqwM/Id0EhMQTEILtXJ70xhNC/txzf4BOF4T777&#x2B;X9si//PLL&#x2B;O9/v&#x2B;RIvR3/8z&#x2B;/wMiRI/G3v72NEydOYsqUKRg9ejRycoZQgk6IPwnhd&#x2B;VaZLtO7kP2R8L2Cwr24Te/&#x2B;TUaGhqQlJSM3NyRWLNmNXbt2oW&#x2B;fePx17&#x2B;&#x2B;w&#x2B;07BIWFhTh06BDCw8Ppsd1yy0y6f/J9yIfsi89bQEqFAE/TXEk8X2UAVzFDaD/e&#x2B;AO4ihDkPLqaK0pNDbAr5LA1NsF29Diql335n19fqHgd0tMBpFQGkJIGwAQAJgAwMDDS7wOkH&#x2B;ghDv5keNddd/V&#x2B;4IEH8tPS0kYFBgbGKBQKf59tZFnsqC0uR&#x2B;nmgyh6fwNqS87B0myCXKWASu3/41lj8O17nftntXR4BITGRWPQbaOROn8s4kYMYieHgYHhuhABSA79I488SEWA&#x2B;fPvwKxZtyIyMpKSRyfhrK6uxvPP/wFffbWKmvrdeeed&#x2B;OMfX6RmfK&#x2B;//gb27NlDw/AffXQpDdsnaQBkXbKsa68/iSQgxJ&#x2B;Y&#x2B;TU2NqKlpQX//e8X&#x2B;PLLL9G//wDk5&#x2B;dTYv/VVyuh1QZgwID&#x2B;aGhoxKlTJWhqasaYsWPw/n8&#x2B;oKKCM2KBDMmxEwNCqSUAvSHrnqIBPE3nI/ueygbyiQViywjtz&#x2B;XcG81Wa6lFpSrZ/errq/5zoGA/PFcGECoRKOYJwAQAJgAwMDDSj57l4C&#x2B;U73&#x2B;lHPw9DsePHx/61FNP5Q8ePDg7Ojo6WaVSBfrqNWK32tB8rhZntx3GgY/Wo/pAGYx1rVCo1NxHCT&#x2B;57DIDJoYec//DYjDDSnqVAhzIfWgmRjx4K8KTYtnJYWBg6FHkv62tDatXf40PP/wQc&#x2B;fOw6hRo3D2bDmefPIX1OQvJycHzz77LDd9NM2xd5b0Izh27Bjeffddbt33kZycgtde&#x2B;z8MHToUer2e5twTgk9c&#x2B;snyZJrT&#x2B;I9MJ6SfCAbEwG/lyhXYvXsXJf2TJk2CWq3B&#x2B;vXraASAyWRGXV0tFQpGjMjF008/TR3/LRYrEhMTMHhw6sXoASkE3X2elLx&#x2B;oV57Tz4BrqKC1NKCnioCdMZIkCP&#x2B;3MBh4X4LE3c8reHh4b0mTpw4Dh25/zaXobemgK7TXYm/WGUAJgAwAYCBgZH&#x2B;TpJ&#x2B;wDcc/KWE&#x2B;ncmz/9iGb&#x2B;srCzdK6&#x2B;8MrVfv36JcXFx2b7s4E/eG/qaZpTvOYoDH27A&#x2B;d0laKms5Ro7KijUSsi5Bo/DYWc303XzUCBNIQcM&#x2B;jbowkOQkJ&#x2B;J8c8tQnhyH3ZuGBgYegQIMS8sLKA9&#x2B;Fu2bMKgQYOwdOlPqVnfvn178eabf6Y9&#x2B;hkZWXjmmWeQn5/HtYc6CDdJESBl/khO/9q167B48X147bXXL7ruk9574gHg7&#x2B;&#x2B;PmTNnISYmhooA58&#x2B;fx7PP/gFFRYcQEhJKUwPKy89Sgz9CZG&#x2B;6aRruueduSuzLy89QQz/iMUBEhgUL7kB0dDSNJiBwhveLlQsUIspiBFxKxIDUcoJiBF2ItHuT&#x2B;&#x2B;/cvnOc9PRzfzu4ZquVG28ODAxUcuTfHhQUFMJNs3Mf&#x2B;ciRI/N4BAArxMsDelMaUCgdgAkATABgYLhuif&#x2B;N4ODvifR3usc/MTFR&#x2B;&#x2B;yzz&#x2B;bm5ORkJCQkDOMaD2G&#x2B;fI2YmttxZusRFLz/LWr3n0VTdQ38TH5QaFS0t5/18l/3zwhaPtCsN0EXF4pBc0che&#x2B;FNiM1OYiUbGRgYegRIJMCaNWuwbNkn2L17D83Zv&#x2B;&#x2B;&#x2B;xUhPT8O///0ffP75MtTX1&#x2B;H3v38Gd921iPbiEyHgyJHD&#x2B;NOf/sSR&#x2B;ygsWfIAEhIS6fZIz/&#x2B;uXTvx2muvUSGhd&#x2B;84/O53v8XUqVNpSP&#x2B;CBXfS5T744H0sWnQ3TRX48MMP8PjjP6URAKR3/29/&#x2B;zsVBwjJNxoNdLozjcATsecTAvjy6KUIAlIqAvCF6XtjLOitoZ/7us7wfu5j5aa3aLVaNTerPTQ0NJj7LWTce0rpuvyoUaPGu5B&#x2B;KzxHAfCRfyERAPCcBsAEACYAMDAw0o&#x2B;uOfi7LiOD9Bx/T&#x2B;NSHfyFQv4lD7mXlPKpp55KnT59&#x2B;hiO9OfodLoY&#x2B;DB9srQbUVlQjIMfbkD5jqNoOn0BVrMNao0GcqWCEb8b8sHBtZDMVpj0Bqii1Bhx7yxk3jMRkSl9aRlHBgYGhmuN5uYW7N9fwBF&#x2B;PaqrqyhhHzx4EGJjO9r4dXV1ePvtv&#x2B;DVV19Fe7seN998Mz755FNKwElKAHHaJy787qHtJOTfae7XUSXAhm3btmHFihUoLNyHM2fK0dLSirFjx&#x2B;L&#x2B;&#x2B;xfjwIECrF&#x2B;/EbW1F&#x2B;gxkMgDEmkQHByEF154kR5Lv37x8PfXXkaE3cm8&#x2B;7G4k29vzf6ESgJ6KxzwiQ5i86RUGXBd30n6LRaLSaVS2a1Wqz48PFzDEX4/jUbjT9qyfGLJDwLAJNKUwaW9/64igFhpQLGqAA43QYAJAEwAYGC47ki/GNG/0Rz8peb5XzLtySefTJ47d&#x2B;5YrlExmHtxJfv5yoOPj/QbzKg7cRaHPtqMU1sK0XjyPKztZqg0/hzpl9O8ftbbz0Aub7vFBqO&#x2B;DUFR4eg1Mgl5v7oDfUaksFPDwMBwTUBC/f/97/fw6aefULO9wMAgas5HHPXDwyOwaNFdOHv2DCXhxJAvOTkZw4blIicni7rqkzB&#x2B;J0FzmuwdOLAfb775Jl3&#x2B;xRdfRHp6BjjiyZH903jsscewY8d2TJo0mY4HBgbSv1999TWa&#x2B;//AA0uQm5vLbc8P589X0W0TD4Dc3BHU8M/Vvd/1vSqlV15IAJDi5i&#x2B;2vJQeffcIANfqCt6WBxSa/0OIv4WE&#x2B;HNo435HLQeZWq32dz9W9zaJ82/u3E/Gpb3/7uRfKBXAmzQAe08TABTsUcHAwEh/DyL9roTcG9LvTT5/Z8g&#x2B;7/BXv/pV8pQpU7I50p/ct2/f4b5M&#x2B;qmZX0UdDn2wASUb96GuqALGpjYoVCpauk8VorkszJDhRocDMqUMASHBMLcZUfzVHpzZeRg5iyYjeVouEidls1PEwMBwRVFRUYGqqkpKQJOSBkKn0&#x2B;G2226jpfIGDx4M7t3LEfiDHDl/BMePn8Qbb7yOAQOSMGHCREycOBH5&#x2B;eMRFBR0cXuEdJLoALlcRvP2CaEnpflmzJiBv/3tb9Q8cOrU6fif//k5Bg4cSEUCYhhotVroekQYyMzM4si9P/eJ447vHHd8fWmaAYkecJYaJKTfYDBcfKc6mwfu71dXYu0&#x2B;3bWygeu6Quu47st1P66RBc6/hZZ1P0Yy37m80H7F2gzuwgHJ6ec&#x2B;NqPRqA8ICPDz99fIuN/H389PppbJZH7cPD/X70v8E8j6ZOg63eW4ZTwfO7zrUHJOu24aPywCwAUsAoCBkX5ecu93hUg/0L0O/p0p2wd0s4P/Aw880HfmzJmZWVlZw3v16pXJvZR8V2jlHv&#x2B;Np8/j0MebcXZnEWoOlKOttgFy7pCVGjVkCjkj&#x2B;75/n3f8RuR2d/5Wjo5WCplEhB04G2ekgfeD2OPnbCxxH&#x2B;LfALlfl5s2tCHHbdvQ1gaVWoOs&#x2B;2/C0AenISYzkf1QDAwMXoPkwZ84cZwj7scpmU9LS7/IGUiP/scff0h727OycqjLPiHvhNyTXv4pU6bSecRNn6yfnp7OEfNMzJlzG4YMGUKd/l1IJx1&#x2B;&#x2B;eUX2LBhAw4fLqKEMiUlBTfffAuGDx&#x2B;OuLg4GI0mvPLKn/Cvf72HxsYGPPHEz3HTTVO4ddbT46muPg&#x2B;lUkU9A9LSUnH/ffcjOyfH2ZMtycTPdZ5Uoz4p/gDeegDw7dd5/FKPRYppoPPckEX0en07R/a5FxIsERERNCdCoVDI3bcldP74zuWIESOmoSMFwIbLUwG8MQR0QLgsoJAZoEtrS7oowgQAJgAwMFxr0i9FEPAVB//O9vjzkXnACwf/2bNnR02ZMmXAxIkTx8bHxw9TKpVaX75O2qobcXTlNpR&#x2B;tx&#x2B;VhSfRXtnEfQs/qP018FPI2Y3Ug2DhGqRw&#x2B;MFqMXEXowzEtNrPIYcf14SymazQhATCYbdxjVk511Kx0koNmsgA2mxRB2hhbNbDUN9ySQ9Ul59D6BACzHojlCEq9J8&#x2B;BBN/dy8iWNUABgYGL1BZWUGN94hpHjHGe&#x2B;GFP2LBggW0lz8/fyy&#x2B;/347Hn98Kd544y1q7vftt9/iJz/5CQyGdtx&#x2B;&#x2B;1xaro&#x2B;E3Tc0NFKzPxLe79q77fw4e7GXLVuGX/3qKdTW1iI1NZWmDJAwf7lcQQWIrKxMzJx5K13/s88&#x2B;pf4BAdxz9MUXX6Ku/SQCgJB/UvovJib6oleA3e64WBnHE8l2Jcuu4&#x2B;4eAK4kW8wbQIzMCxF4IV8BsYoA3oT6O5c3m81WuVxus1qtFo74y9VqtUyr1apIW5bv&#x2B;PmGnpYZMWLEdDfy754KIGQKKFQNwM4EACYAMDD0ZOLfFTO/q0H63Ym&#x2B;Lzn4y6dPnx4xYcKEeG44NjExMZd7cQX58jViqG9D8Zo9OPVdAQ3Tbj5bAxlHFFVcg0hG8vp5wvwYfBzc79V7VAqSp42AyWCgPflh/WNhqGtGcL8omFsM0PUKpb395PeVqRWQKRTQRYdQN38S4UGaJV8/8hecXLEbKp2mmx9M3OatDhjaW6CLCsegWaORfkce4selMbNABgYGSSBRAISE//nPb&#x2B;Dvf/8HEhLi8Yc/PEfD7N9668&#x2B;0571PnzgMGDAAlZWVKCoqouR969YtePrpX&#x2B;PJJ5&#x2B;6jHg5Q8ddQcg6mbZ7927cfvscWuJv8eKf0BSBl1/&#x2B;X6xa9Q10Oi0N44&#x2B;N7YP58&#x2B;fRqIIzZ84gJyeHRicQ4u/cB0kNcM/rFzPsEyLjfPOEyDqfSOBOxsU8A7xx8/dkIMi3HvlYLBYrd4yO9vZ2fVhYmFqn0/kFBASoxb67ENF3TzfgO1fDhw&#x2B;/xYX8W7wQAIREAPdIAAgIAUwAYAIAA8N1Qfr5lheb7teFv33SwT8pKUm7ePHigVOnTh0zePDgPO5lr/Pla8TY1I4TX&#x2B;9E&#x2B;bZjOFtwFHWHyrmHvgxKrmGjUCtoaDgj/R5vNEq0HTZ7h/mhveN8yZxGiH5Opnv1zyPZf1CfcNy94SUE9up8Bcm6kxV4d/jP6Hfwc2sUd88plMFiMMFusUKhVSNzyUQMuWcqYjISLqYnMDAwMLiCkLuXXnqRI/i7cffdd2PevHnYvp2Y672MtWvXYdasmdS0j&#x2B;T9nzx5gvbuE7GgT58&#x2B;eOWVV1BQUIB3332XhvA7n5euefMcAeU&#x2B;bXj77XcQExPDkf7bqVkgcfZ/&#x2B;&#x2B;2/0hx/EmlAqgEEBwcjOzuHlvarqalBdXU1dfOfOHEyFAo5Jfukp5&#x2B;PqAsRdE/u/VJFAvftuJNwPhHAdV3X43Hm40tJMRBaxt2Nn/vbwX1IeL&#x2B;ZazM5goKCFKS3n4PM2Y7lEzfcSbJYygTfNOdw2LBhM93Iv1BFAKsH8u9eEYAvFQBu40wAYAIAA8M1I/1iRP9Klu0DrgMHf/KS&#x2B;t3vfjd4woQJWUOHDp2m0WhC/Aij8VFYjWaUbTyA0s0HcXr9QZw/Vgq5VQE5R/hV/hpG&#x2B;L0h2BzZJ8SVQB0UAGu7kfaikwuj3dACJdSU1NKgd7kMCqWCDmXONAq/Ky8MtDTXYvjdt&#x2B;Dmf/wUCrWy09v5fO5LOLFyB1QB/lfsPe/4QUhpb29BQEQQ4kYMRv6vF6LPSFY1gIGB4VK89dZb&#x2B;PnPf0bD8ImjfnJyClav/prm49fX1&#x2B;Gf//wnJecvvfQnxMbGXlyvqakJO3bsoD3148eP5xEWbKitrcPPfvZTKi7U1tZgypRpdH&#x2B;9ufY/IbDE&#x2B;f9///dFvPbaa0hMTMTHH3&#x2B;KjIyMi88yEtJPHu/ExE&#x2B;MoLsLAFJ7/cW2IyUH35t5nkL3paYAOKf9kNPvIOPcb2EIDw9XkF7/Xr16Eed&#x2B;h1KplLlvh&#x2B;/7CpF6vmXEhIJhw4aRnA0zLg//t0DcC8AO8VQAMQHAnfQzAYAJAAwM1y3pB64TB//AwEDlfffdF5&#x2B;fnz&#x2B;Q&#x2B;9wcHBzcRyaTqXz1GrFzpKpyzwmUrC9A6Yb9qNpXArvJBoVGTXv7ryPj2qt87wH9JmRiyAPTIFcoENArBKYWA3durbD52dBwrAJNZ2q5aXpcKCmD4Xw72mrqYaxt&#x2B;4H8Awp/JVGRqDBwJQQBBwmpNJhx898eQ87imzq9nZLvCrD8zpdhNVsgVyqu8HmVwWqxwNTeDl14KJJmDMPguWOQfPMIdtExMDBQEAO/2bNvpT3ypFefhNqTHnri3v/007&#x2B;i08g8KU2ksrIyfPfdt/j882VIT8/E4sWLac/9smWf4&#x2B;9/fwccOcWiRXfj7rvvQUhICDGeo&#x2B;R&#x2B;48YNiIiIpOSfpAS45txLyVH3xuTPfTpfWT0p67oTcr51pJTv4xMF&#x2B;IQIAkL6yThH9O3cOAnxt6tUKlJBQe7v76/4wb2f91yITeNbxnVcLAXAORw6dOjsH8i&#x2B;hYf4W9A9JQG9LgXIBAAmADAwXCnSL0Tou4P0A9eZgz&#x2B;JR5sxY0bkQw89NCo3N3ciR/rjfJn0E5w/WIayzYUoXXsQ53YcgbFND6VCDZVWw0KruwiL3oScn9yEGW8vlcDCO1z4W6saYGppR8Xuk2g8XY3GU1WoLCihpoumljbI5ApaUpGIAd2WA08abxYbwnN6Y/HaV6Hw79wlazNb8c1Db&#x2B;HgvzdAHay9Ws85ul9iFgiVAzmLp2HYT25GVFpfyFWsSjEDg6&#x2B;DhNETotzY2EjD6cmj8MKFauh0gZQwk5B8UhaPhNgTszyNxp/&#x2B;LQUNDfW45557cO5cOUfihnHEfzwmT56KyMiIS5Yj4fdECCBDZw4&#x2B;gV6vx&#x2B;uvv4ZNmzbTecTR32DQY9u2bfQ458yZTSsCkPG//OUt7Nu3B/ff/xMqAhBBgPgBkO3&#x2B;QGwvI8NCufZ8xNs1tJ7PsM9Tr7z7OlJ7/IXEAE8pAmL7cBUPyDTu9ydGfqS33xgREaHkCL8sJCREKfQdXYUHsdB/sZ5&#x2B;qSkAPwgAc3B5&#x2B;L&#x2B;rCGCFuA&#x2B;AO/nnSwVgAgATABgYfIb0SxEEpJr5dRfpdyXt7qTeU4&#x2B;/p/x&#x2B;qXn&#x2B;l4T4jxs3LpQj/UPy8vImREdHp3AvMo2vXiMkJL3m8Gmc5cj&#x2B;me&#x2B;PonR9AfSNLVDK1FBq1RdDz1mYf9dhbG5D3jN3YfwfFnatgXyhiYoB5du532vjATSWVKPlXA2sZhuUGiWtukD8BLr6DiU96ou/fwUxQwZ0ejuNZefx&#x2B;e0vovb4uS6lE3RGxCCpAcbWVviHBCEhPwOjn56HPiOS2YXIwOBDaGlpRmFhIQ4ePEhD7UtKTnGkW4awsEg6j/TKEyf80NCQjueo0URFgqCgQLS2tlEiTQh8YGAwRo4cieTkZERFRVGizdsuNxi49VrpMpc8qxobaZh/cfFJrFu3jkYG1NRUIysrm34mTJhE3f&#x2B;HDRtGlyfh/E899Ss6vmnTRsycOZM7FjP69&#x2B;&#x2B;PN974My3lV1ZWiuDgEJrvzxd&#x2B;707C&#x2B;QQAMTLvSSTwZpyPtIutI6WHX2wdV8JPcvqtVquD&#x2B;20s3N927nzJyUelUsn43Pu9IexdXZZv3ZycnNvAbwIoVQQQqwbgngbABAAmADAwXFHizxz8O2/qJyfq9AsvvDBkypQp&#x2B;f369RuqUCj8Bc6bT6CBI5Bntx3GqXUFOLW6EPqWVigcCqgC1NTV3eEs/M7QbTC3GRE5KA63L3sakYP7dss2rQYzTK16lO84hrJ1B1Cx&#x2B;wSazlRz0wz08iO99x3O/N7/mKY2PdLn5uHWD/6HVnXoLE5vLsLH039/dQUAl7ZAR/lAEzRhWgyYOhQZCydgwOQh8JOziBYGhmsBYm5HQudJib0zZ8qo4z5xxu/XLwG9esVg4MAUaLX&#x2B;NC9e4VZG1kkozWYT3U5FRSUNx6&#x2B;oOEfd&#x2B;p1meomJCZg9&#x2B;zYaHRAQECB4LCQNgJQEXL36W247p5CZmUlD981mC5qbG&#x2B;l0Ik706dMb8&#x2B;bNpxEHn376CU6fLsPYsXm0NF9Z2Wk0NTXiV7/6Nd1vXFxfhIWFXeyld5rYiZF0McLvGlLvDZEXmsYXps9H6qWOu6cx8Ikd7tECzpz&#x2B;uro6A3euFGaz2RYXF6ch07n2k4zvWIRIvPs4n4mh2LaE1uVbhyA7O3sufkwBcBcAPJkB8hkBMgGACQAMDD2G9PMtf60c/IUiAK6og390dLTq0UcfTZkzZ84EjvRn&#x2B;/v7h8tIcXQfRduFRkoQi9fuw4lvdqK9qgkyuwwqnfZHB3qGK/pe0je3YvQvbsfkl&#x2B;7ryOHvZhib2tBcXoPjy3ehePU&#x2B;1J48C2urCXKNiubhU9Lrxc9Moham/vlhZN89Ec1VddR7wNyih8VohiY4AM0VtdTLgPgWKP2VsFmsMLa0w9ZugrFdD5m/Ai1l9Sj&#x2B;Zg9NK7iW6BACjHDI7Ei7LR&#x2B;jfj4H0Rn9Op3iwMDA4B1IL/v77/8Ha9d&#x2B;B7lcgZtumorp06dRAUBqGL/oPc6Rt/3791NCv2zZZ5gx42bcd999GDVq9GUl&#x2B;pwg0QR79uyh66xcuQJqtQovv/wa7r57EX3VkwiDv/zlL/j1r5/&#x2B;oXzgOUREhGPfvr3YuXMnTUUg1QJIZQCn0OAsT&#x2B;eJsHoirULh&#x2B;u6knS&#x2B;SgK&#x2B;HXixtQChNgM&#x2B;kTywlwFOpQKvVajcajVbiicBNs4eEhCi0Wq3MSfr5SLmncyJG1qWKKa5liz0ZBWZnZ8/DjyaAnsoBivkAuA7dSwE6BD5MAGACAAMjFNe1g7/Mw3LeOvh3xdTv4nhoaKhyyZIl/RcvXnxLVFTUAGLm58sO/q3nG1Fz5AxKNxfi6Jfb0XK6DjarBRptQEfPML2EGPG/Ojcs91Y32&#x2B;AfHogHC/4MbVSI53W4n0bf0IK2qkaaR68J0kIV6C9JPDC3GVB98DSOLduKkvWFaD5dQxs&#x2B;NCpASmk&#x2B;0iDiSLPNbkVQvwiY6tu5Vgl3QCZSj9pCe/SNjW3ctriGHOnh4i4n0qg3mfRQqfxh4xrOdj875A4F1EFan/kZHDYHzHoDNME6RAzqg8kv34&#x2B;&#x2B;o1PZ9cnAcAVRW1uL226bQ3v0Fyy4A/ffv5ga43X5fuY4B&#x2B;nFP3z4MFasWI6GhgYkJCQgLy8f06ZNo8JCc3MTCgoKMXBgEu2dFxIPNmxYj/fee4/bzgqkp2fgJz9ZTMK98cILL2DdujVUqNiy5Xs6FNoGH2H0FIrubSSAt1EBYlUApJgGekoVENsXiX4gOf3kndPU1GQKCwuTBwQEkBB/JZ/xnli4viciL7Sep3li6Rd85y0rK2ueC&#x2B;kXEgDce/&#x2B;tAuTflfQzAYAJAAwMPZ70CwkBXXXwlxrq312mfjKtViufP39&#x2B;n8cff3xGbGxsUnh4eJIv9/QTUnbh6Bna61r05Wa0nW3iCJsJGnUALd1H6rKz3v5rB3O7EVn3TMSMd5Z6dMdvOVODZQteRO2RcvhH6KAJ4UhrUh&#x2B;EDIxB4oRs9MpIhDYy2OM&#x2B;myvqcG77MRS&#x2B;&#x2B;x2q95fC2NwOZYDGs1cAedzY7LCarT&#x2B;mEsj8OooPcET6x/KEPzZASEOPeEs4TQkdHTN8T4yxkGoHRigCVBg0exTS5uZjwNScH78TAwNDt2DLli14&#x2B;OEHkJqahi&#x2B;&#x2B;&#x2B;G&#x2B;3tNHPnj2LQ4cO4ZtvvkF5&#x2B;Vn06hWLuXNvp8Sf9MSTEP6tW7dg165dOH78GEpKSlBVVY3ly5djxAjx6iCfffYZnnnmdzh9uhzx8bGIi4vHpEmTMWvWrdx3SOUlXVLz01177IXEAk&#x2B;CgLdlAN1Ju/u63lQEkPI3If1Wq9VmMplsRqPRwpF&#x2B;pU6nk2k0GkVnz1t3Ov17Wt7T/rOyshb8QPj5ogBsuDQVwFM1ADuEvQCYAMAEAAZG&#x2B;n2a9AOdD&#x2B;nvLgd/Kfn9Xg1zc3ODnnvuuUncC39ITExMqi87&#x2B;NtMFo70n0bphgM4sux71J2ogM1ogUKlpj21JEjBQd4pjPdfcxBybDWaMfrJ2zHmV/OgChAOfW2prMfHs36PlpIa6jpNyjPCyjWubFYoNEqEJEWjT2YKeo9MwWCOxAbEhIq&#x2B;/yztJlTsOYFjX2zHoY82wmYwQ6ZSQE7y8x035MO1IzWgzUDPZ&#x2B;q8PKTfkYf&#x2B;U4awohcMDN0AEjbfr18cjRQ6cOAAIiOjOveO40hlTU0Njh49ii1bNtNQ/7CwcNx6662YNm0qR/p1aGtrw969eznSvxPHjh2FQqFESkoyR95vQlJSEg3l//jjj7jPJ7RnXwwkYmH79m00xH/IkKEgJeh4n&#x2B;cSe6z5lpdK/PnmSyH9fGkIntz6pQoI7h4AxMiP5O/X19ebgoKC5Ny4rXfv3v7cdLtSqZTxHYvrdoR69MVEAKlEv7MCgfv3dR5jVlbWHT&#x2B;Qf75KAHxRAK5CgB3C1QBcUwEgIAQwAYAJAAyM9Hsk/Z6If09x8JdStk&#x2B;MzAvNl7tPnz17dtTixYtHpKWl5fTq1WsQ99IP8tVrhJDBhlNVOLv9CA59uBGVRcWwNpug5Bo9CpJPKfPzvZ5XBnqlOax2GE165D91B8Y/f7fo4gf/sx5fP/gWFCrVj8Z1fh2/LcnFt5us8FMAwXHRiBs7CL2yBiBr0UT4R4hfuqc3HsTxlbtRvGo3WirqaNWHK&#x2B;FL0GNgd8DUboQ6QIO4cYMx6cX7EJXWr/vKKzIw3IBYv34dzfN//fU3sHTpY53ejl7fjsceewwfffQxpk6dwpH4j2lpQFIVYOfOHdi/vxC7d&#x2B;&#x2B;mOfxpaek073/s2LGXpTuNH59Hy/mtWvUNoqOju/z9vCGjUnuepfboiy0jpXSfELF3HfIZGLoa/ZFe/ra2NotOp5OT3v7w8HCVRqOREQd/sX16KtkndI7FtiWF7Av9Tq7nSEgscY5nZmbegctNALujHCCfCSATAJgAwMCIf7eQfiEy74n0A93n4O9p/Ko6&#x2B;JOe/qVLlw4ZzYGQfrVaHeqzFwj3fG08cwFVB0qx/1/foaLgOEw1BsiUMijVmh8IHCP9PeBGh81khtlgxLzPf43UueMEFyV17f8z8Wmc2X4IAUEhbnfsDx4Ojh9M7rjtkfGQ1GhkL5qM5CkjEJPVX/RQms7W4Nul76Bs/X7YrHaodZob&#x2B;qchwhpJDVCH&#x2B;GPgtJHoPzETg&#x2B;eNpQIJAwODd/jgg//gwQcfxLp16zlCPk7SOpWVlTh27BhWrlxJe&#x2B;7nzZuH2NhYKgIQ4713332XI/pqJCYm4vjx47Tk3&#x2B;DBg3HLLTPpUKkUrjjyyScfY&#x2B;HCu/B///cannji591C/j2Rfr6Qfz7yKVYG0FsfATE/Ak/mfULCgNPMj&#x2B;T0c8dKevvN3O&#x2B;iJMcdFhamchUHPJ0Xofl80QCe1u1KD7/YOkLTMjIy7uQRAMy4NPxfqAoAXxqAA5eaAfZIAUDBHncMDD5P&#x2B;vmWvxIO/l0t2wdcQQf/Z599dlh&#x2B;fv6o3r17D9LpdL18&#x2B;RohoeDlO49ypH8tqo&#x2B;Vob2iifZMqjjST9zYnT3CjPz3EHC/FQm7V3OX5LrfvIeQ&#x2B;Bj0Hj6Qd1G5SoGZ7yzFivtep/n7xFDvxxe94&#x2B;IdRUr1aVQ6uu32sgZsePrf2PXSCgx9eBqyF09B&#x2B;AB&#x2B;ITokPgq3f/IkTn6zF3v/8jUq95zsSEu4QTu&#x2B;iS&#x2B;CWqeFqVGPgo9W49BHG1B7vByT/nQ/u24ZGLwEyZ83Gs00B19MADh//jyOHDlCSwMS8h8eHo6RI3NpCT5SNWDMmDF46KGHaS7&#x2B;mDFj8fbbf0V7ux6/&#x2B;MUvkJWVw5F&#x2B;afQjKqqj17&#x2B;0tLQ72m6SSJc7kXQ2&#x2B;bxZ17WZyEdM3Z3/nccm9Rj5Kgc41yXTSU8/CedvaGgwRUVFqbRarR/XdgrgI9Cu&#x2B;3Tfv/v3cD0XrvOEluM7B&#x2B;774zs3fMu7DsWOiWdZTx1l7st4astfFw03FgHgAhYBwODjpJ/vIdXTHPyFBILLlpPL5bI//vGPGXl5ednJyclDQ0NDE&#x2B;DDNMfU1IZyjowd/Hgdzm0/jpZzdZA5ZJQ4KlRKyQ0IBl9&#x2B;EAA2oxX&#x2B;UYGY8eajSJ4lbE5Ve6wcqx/5C85sPdoh&#x2B;nj87f1g0RvRbmmGNjoQ0595BEMfni66RnttE76Y97&#x2B;o2Hkcco3SZ96lVwsWg5l0YdHvHjskCX1HD0bv3EHok5sMbXggNdBkYGCQDuIBkJs7HC0tLdi3rxDce/fiu6uxsYmbtgebN29BUVERgoKCMHnyZMyZM4cux5FOHD58BG&#x2B;&#x2B;&#x2B;To2btyEJUuW4JFHHuVIfFSnj&#x2B;ef//wHt50H8c47b1NBoavwxrjOUxlAvggAKYaCfMRdKALAtWddzA&#x2B;A5PRbrVZHXV2dSafT0SYrR/jVZDop2cfnnu/cL194v9RzxXfMnTnXfNsRc/x3FTvE0hMI0tLSFuLSCAAxDwChKAB3E0DXCgAsBYAJAAyM9IsSfebgL6F838svv5ydlZWVmJGRkcs1HFK4n8Fnbb6tJgvO7y/Boc82oXzzEdSeOgeHyQ4lNfNTcU98RvivRxjaWhEYGY5F3z2P6KxEweVazzfgw4m/xoXjZ&#x2B;EfGACQlA/XXh4HuYbMsFms9DYIHxiLwbeNQXx&#x2B;OmIyEhAgofRg05kL2P7HZSj81zqoAzW4vt3wiCGjFXarlRplRmf0485VBhInZiIhPxMKrYpdnAwMXQQx7Fu4cCHGjh2DF154kbryf/7557QXPjQ0BGPGjMZtt82lhnuEgBETP2IYuG3bNvpsy8zMovn82dnZ1IxPLMTfE4YNG0qjBdav30irBVxJAUCIhEoh90ICgRBp5yP4UlIDXEv9kY/FYrETI7/Q0FBFU1MTCfFXExM/ktdP/AA8kePOuPrz5fB3tjpAZysIiPkPuK&#x2B;XlpZ2Fy41AXStBuBeBUBIBGACABMAGBjp7zGkv0c4&#x2B;KvVavnDDz/cPz8/Pzk3NzefI/2D/Xy4K5PkblcVlGD/h2tRuasYdafPwdpkojn9hPR3EDBG/K/zBwWsBhNH/vvh5rcfQ6&#x2B;cAYKLnt9/Cut/&#x2B;R5ObdrPXfB&#x2B;9BohwhG5RvwUcgTHhmPgrJFIu30MwlP6SCL9l12TFhtW3P0qSr7dd/0JAKR3i/t&#x2B;VqOFPjWiUuMRPzYN8ePTkTRlCFSB/ux6ZGDoZnBkEnfcsQBGo4FWAiDu/RMmTLxI&#x2B;ol7/759e7Fnzx6OhJqRlDQQN998C3JyuHtSpezy/s&#x2B;dK6cmgrW1Nfj002Xo27dvNz1O&#x2B;ImjWE6/JwIq1EvtSTzg6913X959GTJdr9dbuXF7S0uLNSwsTMGB5PST3H4/of26b9s9zN7bvHxvhBOx8&#x2B;/tNjx5KfBtJzU19S54jgCw8AgAYqUAmQDABAAGRvolEf8bxcGfLxrgshB/OQeO8IdyxH/Y0KFDc7mX&#x2B;zA/0qXnqxzEZkftiXM49MkmnNlykNZ5N7S0Q63UQM41dkg&#x2B;Nwvvv9EeHICRuwaC46Iw7f8eQMrsUYIJKuY2I44t34Hy74tQV1yJkMQoBPWKQL/xmYhO7YfAPuFdPpwzm4vw2eznXfwlejLp7xDaLAYTyQVCcN8I9L9pKHrnJiP55uHwDw/s8i4sRhP15VCoWNQAAwMfSJk&#x2B;IgTExvaCwWBEcfFJSvxJ7n9TUyPi4/vRFIDc3JHU5K87QNIIVq36Cr///e9pz/93360loezd92iR0Isv1sPd2TKB3pQBdJ/mdO&#x2B;3Wq322tpaI8np5863X2hoqEpoPSGCKRbq7y6ESJnvbTUFT2JKd4gy7tMkCgBSjADdowDsPVkAYCaADIz4XznSL0TmPZF&#x2B;oPNmft66&#x2B;V8tB3&#x2B;S0y8fMWJE0EMPPZSdk5OTmZycPFahUGh9loNwz&#x2B;bmczU49sU2nNywFxf2n4ahpgUKpQpyjQq6kBDBFxfDDQDuJydh/W3nG7HqoTeh1Kk5kjqEd1GVToOsuycia9GEK9dD7wdaVYKIVT0VNo702wxmyLiGf1hiDGKHD6R5/f1vykFwfFSXt29o06PyZBnKDh1D4XdbYWjXI/&#x2B;OmzFu/s1MCGBgcINOp6MfAuLm/9prr9Ah6el/5ZVXu42YE9JPjASXLfuMRhUEBOjwxz/&#x2B;kYoLgYFXp7KvJ&#x2B;Ls1nbkXcadrHpj6EeWIyUQnYTfmdNPTPzIdH9/f1lkZKSSI/86rinl53qcfMZ8YsaCYqaGznl8xy5kxOc&#x2B;z3V9MhQ6L3xNcNftkO/taTkv2u1i7W14aMd7M7/ncCAWAeDSOGARAIz0dz/p51v&#x2B;hnLwT0lJ0T766KPp48ePz&#x2B;XGJ3AvL6UvP0Sbzl7AsRU7cHbXEZzffQrNFbX0RaTUqCFXKBjZZ7jsbiel/1RB/hj9xBwMeXgG1Fc5LL3xdDW2v7QMR5Zt63FGgCR9wWaxwG5z0AoHvXL6I2naUAy8ZUSn0iHcQUotXjhTgWPbC7Hn642oLDmNlrpGKFVKWkLQYGhH7vRJyL9rFtLzR0AToGXXNAODG2zcvWI06nHoUBF27txBzf5ID31CQgIGDRpMQ/TDwsLoh5gDEiJLQtMv3ud2B8xmEzUZvHDhAjhyi8LCAhQUFODs2bP0uTVs2DCMHDmS&#x2B;4zqtogCIbLvbc&#x2B;1lJD/ju95ubO/1Lx/krNPQvurq6uNISEhSoPBYImNjdVwkxz&#x2B;/v5yvjr3fMcnJGR4G17v7XY9bV8oUkHK8p6Oybk8n&#x2B;fBoEGDFuHHnn/X/H&#x2B;&#x2B;KAAbPHsA8EUBsBQAJgAwMNIvuLzUHH7Acx6/2DwpAoA3&#x2B;f1eO/gnJSVp77rrrv5Tp04dmpaWNp57eUX4cl6/vr4FJ77aidNbi1C26SBaz9VTkzG1v4b2RjIweGwgm600rDzl9pGY894voNJdeRGg/mQFDvx7PYq/3ktFAFKC0OdBere4xr/dYqfEP6h3JHoPG4g&#x2B;owchbe44Gu7f1SgJYqpYffocSg8cw87la3D60Am0NjTRdAKVRkWHzqejjLvP25tbaaWO2AHxmP/bpUgfNwxypZJd1AwMAiCpAfX19SgqOkRL/xFi39BQD6VSRcUCpbLjHiM9&#x2B;O3tbXQ&#x2B;oRsmkxEGgx6RkdHUUDA2tjdH&#x2B;EcjPj4ewcFBV&#x2B;Hx07m69J7C&#x2B;10N//iWERIJKPcwGGxGo5F&#x2B;tFqtjPT2BwUFKUhPv5B7f2dN/fi&#x2B;o9D3Ewr1l3qeOkP6vfUBkCISuAkAfGkAfEaATABgAgDDDUT6xYj&#x2B;tTLzkzqvK2X7gG5w8I&#x2B;Li1Pn5eVF3n///WOys7PHhYSEJPjyNWJpM&#x2B;Hk2j0oW7sfp7cdRsOJCvqE1mi1XONfQUkI6&#x2B;1n8JbcGtv06DsyFSN&#x2B;egsGzhgBZUD39WQ5uMZOa3UjTqzYhbJ1B1Cx/yTaqxqpDwUtNenDnf8kNYGYH5KhLiaUhvfH5gxA6rxxCE/u&#x2B;juX9J5Vl5bj3LFTHOlfixO7D0Df2s79JHaO9KshUyg62hp897TfD8dnscLMEZTUkUOQv2g2cmdNgoIJAQwM0t6pFgsaGhpozz8RB&#x2B;rqajlSHwK9vp1GBhiNJo7o96U3nDO14No8ph2ddq0XI/dSfAOc4&#x2B;3t7YRcOs6fP2&#x2B;IjIxUcfDjhmqx6AQphFhKdICQo78nIUBsP&#x2B;5EX2r1AW&#x2B;rCAida7H1UlJSOisAuI4zAYAJAAyM9F9x0g/0EAd/rVarmDRpUsSSJUtG5Obmjo&#x2B;IiEiGD9MQ4iR&#x2B;dvthlK7bj9It&#x2B;1F98DT8LA4oNB0O/h38gJF&#x2B;hi42hPVGroVgQ/zINNzy98cQkRLXJVGhubwWx1fuQvn2I7hQdAaNpefpbUZ6/OVqpc&#x2B;a/pF7yao30XKYAeHBiMlKpGX7Bs0ZhfCB3UD6rTbUnTuPkoIi7FqxHqWHjkPf1EzDi2n0jlx&#x2B;MY/UG&#x2B;ibW6lgkJE/AuMW3EJTAwKCA9mFzcDQw9Hd5eeklvcjOf2kZF9jY6OZhPSTnn7i3E9K9nHwEyPiUgm/lHB992nuPehC0zu7T28NBL0h&#x2B;mKihuu&#x2B;kpOT78aP4f/upQBdPxYe4m91If1MAGACAMN1Rvo9EX&#x2B;pDv6ecv19wcFfCul3fuRCy40ZMybkZz/72Yi8vLypoaGh8XK5XOOr1wjJMT695SDO7T6Bsq0HUbHjOOxGO&#x2B;RKOVT&#x2B;/h29f4z0M3R7S5Mjki2tCO8Xi7SFeci8ewIiBkoXAtqqG1C67gBK1hTifEFJB&#x2B;mX&#x2B;XHEVA6FRumzlSYp6TeYqSihCtQiOr0f4selIXX&#x2B;OEQOiqNGhV26n212NF6oQ9n&#x2B;I9i&#x2B;fC3OHD6Jxqoa2tNPPDpI9E5nSL97m4Ssb2zX08iAiPhY3PHbpRg6PZ9FBDAw9HDyz0cwpZJOKa7/TrJLiD4ZVlZW6gnZb21ttcTHx2tJnj8pfyxGsrsqAlyJcb7IATE/BCkCi9C59PQbeSPcdFEAkFoJwCEgAjABgAkADD5A/JmDv/Q8/8vK&#x2B;BHSv3DhwkGzZs2ayb3M4rkXWDB8tLffYXegqrAYZ3YcofnRZ3cVwWHoqLtOQvzhx&#x2B;4hhqvzbrMYzbBxH2UffwxfOAOJk3MQNagvAnqFXvLuM7Xooa9rwdmtR3D6&#x2B;yJK&#x2B;uuLK6m3gNJf7dP5/XYr19i1WjvMEHX&#x2B;iEzti7gRKUi7M5/2&#x2B;nfHsTfV1OHc8VJs//I7nNp3BBfOVlDST1IfSN7xlbqnyW9EhACuKY9BI7IxdMYEjF84E2qtP7vAGRh6sAggNb9cjIDyLU9y&#x2B;UmIP&#x2B;n1l8lkjsDAQEVAQICc9PZ3hnxLycV3vkucPd9SiLcU8s3nbeCtYOANWe&#x2B;MGOF6/vkiKQYOHMgnALimATABgAkATABgpN9rB/&#x2B;ukn53ct/dDv7ekv1LhllZWYEzZ87st2jRohm9evVK4V5i0T77YudIf0NJFQ3tP7WmAKc3FcHIkSqFQgU1R6BI7yn55wDr7We4NiTZzBFJmVqB0L7R0EWHIiypN0zNbZCpVGgsq0J7TTNaq&#x2B;o5Im2BUqOhUSrkuvXN&#x2B;81Oe&#x2B;OtBgs0wVqE9u&#x2B;F3sMHIvX2sdTQT6Huek95S30jKk6UYt83m3Fg4040nq&#x2B;BxcSdG27bpCeeRhNchTaMsxFsbG&#x2B;nzbuUkTnIv3Mmht8yEWqthl3cDAw9TADwtlfZU&#x2B;h/W1ubhTwnKisrDeHh4UqVSiWLiopSu4sDnsi8J7GCj/h7Iu3ekmtvCbj7d/LGw6CrVQikiBNJSUlCAoB7FQAmADABgAkAjPTzzrseHPw9Dola/Zvf/CbttttumxoZGZkQHBzc16dJf2kVKvaeRNn6/ShZsw&#x2B;tNQ1QyFRQ&#x2B;Wtoj/8PT1p2MzH4xLvOTko90dJ3Vnr90sYT94&#x2B;E9pOPnDjUXyVi2xlYzVYa0aDSaRDePxZxY1KROn8semX3hzKg62S4raEJp4tO0pJ9x3cUouFCLTVWJDn9cnKOuPNzrdotzoYuMRckFQwGDEnD7CcWI3XMUPgH6dgFzsDQQwQAqYRTiPCT8H6TyWRvbW21tre3W7h2kjIoKEhOevrd25liPfpiZFrqulIrAwgJBVKMAD0JKV0pQygU5dBdJoBMAOAHq2/FcL2QfjGizxz8PYf4&#x2B;/30pz9NXLRo0fgBAwYM5V5mfbifQe6r1wjpJa0sKMbRFdtxanUB2huboLArodCqoAsOo89g&#x2B;mxlxJ9BQDi62OAgjQ95R864TOYkl1fmuqENHZkMcrWsw7zP6Urv7k7vQ9ctESdsRisVLkiOfXj/XojOSEDmvZPQJzcZ6iBtl/dBvBKqS89h&#x2B;3&#x2B;/o6S/pvw8R/rbaRQB2acuJEg0jLV7hBmuIewh2sK57wCO7JPx8mMl&#x2B;Msjv0NiRgpypuQh/85boAsNZjcYA8N1IhK4TXcQg9GKigo9KdOn1&#x2B;utCQkJWm6aguT0CxFe57vGPTTf9fnj/rfruq6E3Z3ACzWX&#x2B;bbB&#x2B;z76YZ778kLr8p0bqcfLtw7fsfl5qMDEdx5c/yYeMK4RFwxMAGBgpJ85&#x2B;LsNZ8&#x2B;eHbN06dKxmZmZYwnpVygUPhvPqq9vpXn9p9YV4Mhn29BWWw9Y/aiRX0BA8MXQfpIXzMAgRGaJKz3pRbZZbNRMj1wvNpMJcpkCBnML5H4ktFzOkU9SNk52ZcPMndv1MaGK9nD9P3tXAR7Xdax/LYNWu2JGy5ItMspMMjt27LDDbqDBpk0baPpSymuT9PWlbdqXUrgUx2F2zMwkCy1mZlzWvjNnJVmWd1eyJctr&#x2B;46//bReuHvh3HPmn/nnH8r0M2dXLJbAOzoQ/gkRSLkrDVFpKVB4jzzbre/sRkN5FY58vgPpOw&#x2B;irqQC3e2dHPBLFTIovdT9cZhLlSmhSdDGlp6u1nbI1ErYLD2QymTDBghyNvfQ84JjmcjZdwwHPt6MG3/0ICbMngwvX2/hhhNMMDcF9q4yxwPr6ck6Ozst9JBKpR56vd4aHBzM3A6lWCaTcYq/mJkzYOwIaDvbL1fAd/B7A7czEEwP/sxwgLSz33f0fWfA3Rkop/VTJGXrrcF8nqaCs20NDG4M1jgYvD8DBV8Hn5NhrB2jvbBcURknIQAg2JUO&#x2B;ocC/pdbwd9Zvf&#x2B;lUvAf8u/KlSt9H3/88TnTp0&#x2B;f5&#x2B;3tHS6Xy3XuOkZMHXrUZZcx0H8MGR/uQltBA&#x2B;8lLmfOukLhac&#x2B;cclgnZPoFGxps05QTs3gKV6TXRvvzMhGxQor2ykbom7vQWFqK1oJGNBVXoSmzAlY21mi8kdAcOTFE0bejxqsyOsLb6tnMZua0SeAZ5I2wWROQcs8ShE6PhdJfO&#x2B;JsislgRGVuEQ5&#x2B;tpWB5gxU5Zeiu6ODO3EyhRwqotH3nV/bpR8PBr0Bxm49VjywHrNvWo6/fu8FdLW02a/z8Ncx&#x2B;3zkqULlmWL84TvPIHxiDFZ/717MXreMH5dgggnmFj7neQDVEXAma29vt1DGv6amRk&#x2B;1/AqFwmNgTf9Q2x4KeDuj1g8HwDrKrDvL1A/FBHB0LoYC9oP/OtoWzaFStZzr2jRlVEEbEQCZRnEu&#x2B;w6OmQdDsR5cHaerYxFs0DgSNADOmqABcM2BfsA9FPyHQ/W/mDr//jZ&#x2B;qampXr/61a&#x2B;WxsbGxgcHB09UqVR&#x2B;7gv6DWguqUbxrnRkvL&#x2B;TAbEqGLo6IZeruZq4SCwS2vZdFZMBeMaVriRl5C814iMg7xsfhoeO/MFOv3eFDa09qM0oQUthDWrSC1G2Jwt1WSUwdRp4jb6EhN&#x2B;uhjFos2e5LAY7K0Ll54VwBvopQBI6cwJz2vxHft7NZgb0S3Ds6904c/AkSrPy0dnaBolMBim7nynjP5TDPNr&#x2B;BjEbSIMhdnoyZl2/BEu&#x2B;czM//m9f34RNL77GWwle5MbphMJkMnHB0ZDYCCy843osvvdmIRAgmGDuNPUNqkHnbT971fubmppM3t7elOUXUW3/xbqtQ5UtDVUjP5y6flffG64Yn7OWfkNtx&#x2B;n&#x2B;s9Olb&#x2B;5A1qZ9yP50L4xN3fjO3t9CopD1r5sXor/g6lwO57sxMTFj1QVgcP2/oAEgmGCCgv9Ft&#x2B;276Ix/YGCg/I9//OOChISEeAb857DFzG05qSSK1lJai/zNx3D6P9vQnFcLQ2cnpCIZb4HmqfPpp/YL4P8qMasNUo2SD9au&#x2B;laIZdJ&#x2B;5fhLcY1tViv8xoc4BP/Gjm7omzp41pucFKItkqgdPRJuncfb29VlFrNHGQ7/4TPUZ5bwHvcj7Td/2ZxfixUWk5lPF2p/L/jNiOf0/shFyfCOCRr5pWXgurGqFke/3oWMnQdRlVfK2/hJGLAWS6XQeGvt3tAlrOt37HCD0/21/j5Y89Q9WPHd9ZDKZWipa2TgfyMydhwaGcujV89BJreD/cq8Evzr56/i5Jb9mHPTckxePh86f1/h3hdMsMsM/nsfVNNvq6ys1CsUCrHJZOoJDw9X6nQ6qVwuF42C3ztk1nrw/OeqNn7g&#x2B;44&#x2B;O/h7Q5UbDN7uUM8HByWcsRRobfzrlMfRVtEAD3YWV7/2BGQqBdeRcXWuhhNMcVam4IyRIJgQABDs2gX9gwH&#x2B;cEC9I2A/Fgr&#x2B;zij/w/7r7e0tfe6555LS0tKmTZgwYZZGowmBG3e9by2rQ9m&#x2B;TJz&#x2B;105UnyqAoamLOeAiSGUKqD2Fuv6r2SwMJGr9NFj31o&#x2B;Q9&#x2B;URnHhzM9prGiARy3gv&#x2B;VGfj8RimLqN572&#x2B;&#x2B;Ym/IuvjvfD08YaN3SkqPx0Ck8MRPicBgSlR8IkN4cGJkGlx/BG1IAnfPPE3FHxzFArtFaL8TvR&#x2B;6j5gsvBgm2ewN8KTo5F85yKEz03g9EyxbGSanySiRyA/fcdBXtdfV1aB&#x2B;tIqztihunq1VnNJhfyGt48WLL3vZqx57B4ERodx&#x2B;n/x6Vz8/t6nUJKZBy9vHWcZ0bHwNoN8VvXgWhCSi2AFKNQqfqy5h0/hzKF0BPzlP1h0x/VY8/g9veVLggkm2FgCf3JLjUajtb6&#x2B;3qRSqcQtLS3mwMBAGQF&#x2B;EvLjwEgiueQ3p7P6&#x2B;qECCc7q3Qer&#x2B;bsSHHRV1z8kNZ9q83vszD1H78vUCuz51Ua0ltdB6ekJ3bhgTLp7MSwG05AlCM6CAq4&#x2B;cyHiioINOr9CCcBZE0oALhvodwX0rzUF/&#x2B;HW&#x2B;fc/Dw8Plz/88MPxixYtmpSYmDjby8srQkRy5m5qnbUtqDqeh1PvbkPZ0SzoqzvYROTBI8RccO2qLbIW7BwwxoCoTC3Hg0dehS46EC0ltTjz5SGcfncHak&#x2B;X2IGjQj6kMvvwf88CiVKORzP/Ak2wjz0I0WXETzzToIQaZpggZ3&#x2B;tsDAQyACftwJRkxIRnTYZ07&#x2B;3BvIBQYmuxnZ8/cifkPPxQSi0avd1eC1WBvx7&#x2B;LErfTTwiw9H8h0LEbN0MrRRgRzsjsyh7kFTVQOOfb0T2fuOojynEM019QxA2yBTyOyMjjG6lanUgIQdpew37SUl5zuKNua4rn78btz89EP8NWOXHoUns1B0KgcSdi5aaxvRVF3HgLsa5bkF0Ld1csZIa20D1y&#x2B;gcoWRgA9iRpj0BkQmxWH2Dcuw8M51nI0gmGCCXWK/o7OTTRHmnrq6OiPR&#x2B;8lVdVXTf6mCD8NpjTec911tZ&#x2B;D/nVH5HX1uMKDuCyqQS0bMKIlcBkN7l9NSAT4PG814Y8aTMLR1obu9Hd/LfB3eMcF8DeLisqQzM0z6v6sShIFtDF2dH/obHR0tlAA4MIEBIJgA&#x2B;kdfwX&#x2B;4VP&#x2B;LFvXTaDTSu&#x2B;66K/z222&#x2B;flZCQkOrv7z/RnceIobULJbvTkf6vHajJKkRHcTOvlZXI5dzZpizb2ZpqAfxfE/MGG8lm5iyYGAgj844Owuzv34gpG5Yj/R/bkfvRfpQfzYWoR8TbO/JpZgRDg4JL1AEg/4sjmPbwKvuL7LXlP/0ujHWd0MUFwjcyBFJPBbzHBcNDIoIu3B/dzZ08EDHQ1H5eWPry/SjeeZqNYxvchmRjs0tikrNFZQtyjQp&#x2B;iaEc9EctTIbvhHBIlbIR/0wLA8Qnt&#x2B;xF9v4TKDyRicbKOv7jVOeuUKl40MbeYnGMgknWHviGBmL8tGQc/mI7L28gaj8FAgZmqYgF8unv3uJlCIvuWMtFByOT4xGREMvnIZPRCKWnmu9/e1ML1BpPdLZ18O395fFfIO/wKShJqPAiHDf6fQkvc5GhIq8YxS/8CUe&#x2B;3Im0u9Zh5rql0PjohElBMMFGEXBTTT9l&#x2B;6urqw2&#x2B;vr4yiUQimjBhguYy&#x2B;ckuXx9uJwBHwQRHWfDBlHhn1PjB2f/zVPV7tXqay&#x2B;pRtOUEmgqqsfx/H&#x2B;R0fkedCOozS7mmDAH9yFlJCEyK5sF9extZMRS&#x2B;Gj5/UqBg8LG5Ehl0VrrgqAzvAgQAr2mKgMAAGGACA2DMQf9QwH8koB8YXQX/i2nbB4yygv&#x2B;dd94Zcvfdd89ITEycHBERMcOdx4ipy8jb9p18ewuqT&#x2B;ajKa8SHmYPiOQS7gQLmf5r3EHr6eEg9c6vX0DMkskOP5P14V7sf&#x2B;kDNOdXw2wwMUA7gtIANtys3WYk3r4A6955koG8EZZ4srVzy1Nv4Nhfv&#x2B;FZ4su6ipFDxc4lLDaIlVLetm/iTXMwflUq/JMjuY7GSJ3pzpY2ZOw&#x2B;jFPb9qP4VC7qSiv5/UtA206X97hsGQ0zcziXbLgJ9774NG/J99Wf/4XTuw7yDD&#x2B;VHgyk21OwwNZjhXdIABQqJXNUe9BYXQs5e67v6MKkxXMQmTQei25fC13QWa3UrL1H8eItj0Ot0/QGfTCisUgigcQqoIcv25dbfvwwpq9cBE8frTA5CCbYxc1TNpPJRMr9BrGdBeQRFBTEJz8C/&#x2B;5GCb&#x2B;YjP5w/j&#x2B;UYN5Qnxv4GmX&#x2B;D7/6Kfa8sBHdhnbELZqBOze/cB6At/Xqnxz6/Sfs8SkPAExYNxtSjQJ1p0s4I4BYaAFJkZh8/3L4Twizz8UXKDjoiiHg7LuRkZHOGAAD/woMAMEEc2PQ7wrgA1eGgv9w6/y5gj/1l127dq3/jTfemDBjxoxpMTExM6VSqdsWHtusNtRmFOP0pu0o3ZGFhjPlsHaaGUCSQKH0hE3pcj4U7FqaT0T2of7lw/&#x2B;HlDsXYtYPb4JyUH/5pFsXIGp&#x2B;EioP5SFj405kf7gXYrGM07UJdA&#x2B;5gPYCLXJGzHoTDNZO1OWW8edUq3hhY7uHb6&#x2B;ztpVTuTtqmqAJ8YOEje0&#x2B;52dMrccO&#x2B;q1mMw&#x2B;oBUyMwMSb5yJyYRJzsqKg0I28NKG9sQWndx5C1v6jKM8qQOWZEvT0WDgVnjLlA&#x2B;/hy&#x2B;nMiMQSXn5QcaYI46Yl4vtvvIScQyewb9M3OPLFNlgZyKfSAApU8C4iIg80lFVzOj7tt09IIMLjY5C8aBamLJsP//BgSBV2pkRjZS3Ks/Ox670vICcmSM8oHGcvU4OCJ8Qu6WxrxxtP/hqb4zdi/vpVWHrfrVw/QDDBBBvaSLyPsvxarVbS1tZmCQgI4BkGqvF300CFQxG&#x2B;wZn5gfOqM/E7R9twlj0f/D1XwnkDP9dSUs/XUIXMExJikNnO3z/KxJPOzLE/f8Xfo/Kygm&#x2B;OwUy6OyK7Bk9raR0qDueifH827vjyl1BoVS7FCB3tuxNs4vD8CiKAQ7hHAgPgrAkMgFEF/iMR8xsL0D8Y3LuTgr/4uuuu85szZ07o3XffvTY4ODhJJpNp3HmMNOVXIeuTvSjecgrVGfkwNuuZsy3ndcCc3i9k&#x2B;69YI&#x2B;BLtdV97RcH1uTbadWii51Y7JlrgwlmkxF&#x2B;yeGIWzodCbfMR/ishPNmAao3P/H6t8j74ghqThUyIN4MOQNJ5/&#x2B;&#x2B;Rz9ANhsNMJr0kMmViJifgHGrp7HfmIGAhMhzjoNKVChL3lZRzzMe7VVN6KppQUdDI&#x2B;9I0dnQjO76Tu7kNBVWoof966xvhthDzn7NZt&#x2B;HMRjexJogKqVVb&#x2B;GOmFekPyaunY2Y5VMQMi0W8lHQI&#x2B;hu60DWvmMc&#x2B;BecyEJ1QQn/XTp2mUrptpxJQ2c3m28USJg3DTc99SBipiTw14mxsO&#x2B;Db5Cz7yjamlohlUlhZMDfPzwEEYnjETstCfNuWYWAyLPrPpU4FBzPwI5/fsLZDp3NrfCQSKD28rykTiUxFnrYOI9OmYBFd6zDtJXz4R0cIExCggk2eJ7q7rawh7W1tdWiVqvFUqnUg2r7xWLxFUPrHgzSh2r9N/i14egKDNz2cLcx8Dmth1ufeRMn/r6Z/5/Yerd&#x2B;8tP&#x2B;mv6&#x2B;78u91Ph0wys4&#x2B;c&#x2B;tUHlpeICTNGh6egOmIhJR7b0ypi4D0n5xJ2Y&#x2B;eUM/k2AoBsNQWX5XxxgRESEwAIQAgBAAcGPQ7&#x2B;jzrl73GMH/RRfwfMwU/GfNmqVNS0sLvuOOO5bGxcXNlcvl7lsUyuaNpsIanN64A5WHclGTUYSu6hZIJXKIGeinWq&#x2B;Bbb4Eu0LBP7t&#x2B;Mk8FVD4aLnwn9ZTz7DeJ51Eph6lDz4ChZOTXmU035m4DDwSodVok3bMAKXcuQdiMCeeJAFLZQEtxLfb/fhNyNh6Ame2LTK3kmgK0HVNXNywWCzzkHgifNgFxN8xG9LxkhM2c4JT2n/vpQex/9UO05NeA9DO769u58rvJ3A2xSGa/2dl3&#x2B;Y0q5eQcHhDhDAOR6JJfA3KkKJMiZcdJLImEW&#x2B;dj/HXTeH2lOmjk04TFaMLp3YeRsesIik5m8my6Sc/Oq1LOs9SXY40meqjHAG2QgfX8jhYSbZA/DJ1daK1p4E7r1OXzMX/9agaiF/LPkNDftrc&#x2B;QGNlDSbMmYY5N65AyPjIft&#x2B;sq7UDeUdPY8c/PuadAZqr6&#x2B;0ZepmMO6&#x2B;iMcgocUecOcxGfTeMzEn2YeB/5SN3YMUDt0Gp8RQmJMGuadPr9VbK9peXl3f7&#x2B;fnJCeyPpZDfWKy3rkD8UIEAR0D4YkUG&#x2B;/7PAwDPvokTfzsbALjt05&#x2B;xddh8TmeAmvQi/GPhc5CopWw9scBGIr9eSqgDdHzN7qhtsYvO0pTO5jipSob7D/wOKj8vzi5wdEyD922w7sFQAYG&#x2B;v0IAQAgACAGASwP6XQH9S9m2D7gKFPyp9cwTTzwRe8MNN8yYPHnyUrVaHejOY6Sjphm5nxxA4a6TqDqYhzbmbMvEck7xlzBHWaBcXV3W3daO5S8/gNTH1vBr7xnkA0NLB7ob23gGmjLnm278NV/gR2stoAw3ATmpTo7xS2Zg3tO3IDQ1rpdJcq5R8Cnr/b04/dFOWFpMbMU2I2RmHMYtmoSI2UmISZvcC9hdW1dDG/6x9Dk05lZALJHaHRWiOYouH42QnCKr0QwP5oBpw/0Rf/0MRKVN4vR&#x2B;XdTIs8L6jm5k7z&#x2B;GM4dPovBENkoz82Ds7OZMCC6g1xvYGNPj721XaDYaodZ68WATzZQEwrvbO7mInqOuENQB4OefvQ7vIH&#x2B;01DXi2Ne7sOvfn6CRgfhlG27BgtvXYOKcqeefAzbOCo9nYc/GL5F94Diaq2r5b0gVCs4UuFzXnjNrqF1ZtwEmkxGRiXFIXjAT1z9xL7z8vIWJSbBrwuj&#x2B;Y4CfWvYZLRaLjdr0UatjyvYz8C&#x2B;62tq8XShAHwiUHdH9L6bmf2AJALGRKPC67dm3cPxv3/QGAKbgtk/PMgD4/MvW/w9vexllezKh8PZESOp4hM&#x2B;ewNvmUitdfXsXsjbuwd5fb4Tcy17aRCyAJb&#x2B;5D9MfvQ5Wg9nhPjhS&#x2B;nf1OWfBj/DwcCEA4MAEDYBr3K4yBX8RRibsNyYK/vT3u9/9biQD/ZPnzp270tPTM1hMhc1uakYGFPK/Ooq8rUdQcSAXbYV1/DCobZ9G533Ze3sLdgkXCDYsdVFBfNHuW7ipbk8XZY9TEUCj8WEXdUQ/rZ8i/ARgeywWu9x/j710gJT1KaPgSLm3fyFn76l0Wu5gnPn0MEo2n0LE6kRMvWslJqydfc7nw2ZPROisCUj9/vW8/MQ/KYIB/4RhgX7az/rsUpz4YCtKv81ES3ktZEoVhcX7Z5CxHtN96v3k8GjD/DH&#x2B;ulREp6UgfG4CNKG&#x2B;I94&#x2B;AevcQ&#x2B;nIZWA39&#x2B;BJFKfnMPBs4YwdmVLBBegu6/3Mzrl/ZCj8QgIwf/0aJC2YwVvwUQnCq9/9CVqq69i&#x2B;yimFdI47RToPX//135i5bhm0vt5Y8727serh27H93U&#x2B;w6cU/4&#x2B;hXO5G4IBWL7rgeCXOnoSTjDA5/sQNHvtiOjuZWXuai8FQxcO3jFvNZnyPLgzEKGWoKy1CakYf0HQew/IHbMHXZPPiGBQkTlGBXpRHYpyy/TqeTNjc3m0NDQxV0P7hrTf9o3fPO&#x2B;tkPDAw6Ao&#x2B;u9AScaQU42wYFnGk9oEAs9Fa7GlW/S23rX&#x2B;b7X2XreltpHe/qNP&#x2B;/1iNiXgKCp8by7D/3EYwWHhSY/9xt6KhqRMZ7u/mcRoyqqiN5mHL/cofH6aqDgSPtAlfHJpiT5VZgAJy1a4UBcAnE/EYb9ANXmYI/ifmtW7cu4N57752&#x2B;cOHCNWq12l8qlbqtypOhpROF206g9EAmyndnoSGnAlYG5uRKJcQyqTBzXkOmjQqALjoQpm47HZ4Wbwk9lBJ0N3agZFcGp8MTaKU2ezTs&#x2B;Wf8ZPCNCYe&#x2B;rhXqAG&#x2B;Y9UY0F9XC3NbNM7YytQoiyTDo8z02GNhvi2RixK&#x2B;ciehVkxC/Yha0Ef4XdTyNBZXI&#x2B;GgXCr44ivqCchiaOqGUeXKwZbsMOhV9mX6ivHsGeXOKZfRS9liUwo4xYMSNiui&#x2B;pQx/9v7jyN53FIUns2Exmew1/Qz0u1MWjWr4v/vq8wiKCudq&#x2B;1SG8O0bm9Dd0Ymj1N6PHYuhWw&#x2B;pVAZxLy3fzMYSnUOal0jIb/z0ZKx9YgN8Qu1Bqvde&#x2B;D9sfn0jDxoQs0Hjq0NzdQNMBgNnGdhLOTzcv1zJw541M&#x2B;gNCImNxOrH7sKM1WnQBvgJk5RgV7wRvb&#x2B;jo4PX9UskEi7g5&#x2B;XlJSH1/mvxfLiivzsCuBdSMjDw&#x2B;eDP0VpUcfgMF/Cb&#x2B;vAq&#x2B;MeHYcsPX8fxXg2AaLY&#x2B;3f75z/tLAOjbZt7K14PT/Snoz0sAenrO&#x2B;Q0K/Btbu/GX1EfQ09XD16WgKbG47cOfcEHfoY7V0f&#x2B;HWxIQFhYmMAAcmMAAuFYiPe6t4D9aoH8gaB8M6ofK&#x2B;A9V3z/cOv9zKP5paWneDPSnrFy5cpWvr&#x2B;84BvrV7jpGqMa4eGc6yvZlIm/zETRmVTLsZYVcroJ8YG9vwa4pa86rQkNmmZ2Cbxd2sFPy2H/FIjHXfDB16iFhi3jEPKLdpyBsVjz8kyLhGezLdQKkajkHaW3lDag6VoCirceQ99VR2Cz2jL8r8EUChPR7PQYLbydpU9gQMmn88AMAbNNtVfXI/HAv8rYdQu3xEugbOqCQqXg3AS&#x2B;dr32lHquxbbNxYSS63&#x2B;jY5RoFYlelIm51KkJnxsNvQvioNBSgmveMXYcY&#x2B;M9C7sFT0Hd2susl4noJUpnaLUEvtfN759n/gdlogicD58yFRE1ROd9VmUKORXeuRUBEKA58sgVtDU0wdnUjeHwkpiybh&#x2B;mrFiE0LpqDfA4oOrtQV1KJxqoaiKUiWAxW3uaPHmKpmFPpbX2K/lfCvMZ2Uc6uHbUrbK6pxz9&#x2B;8gq2vLEJk5fOxcqHbodfWLAwWQl2RVlnZ6eFWveVlJR0M/9IRsA/KipKaH&#x2B;BczPZA913R0r/jkDz4Kz5YIbBeZCA/be1rB7fPPZnVB8vhMloQPLdi&#x2B;3rxMCM//lfY2uYyq6/06k/B9hSkNmDzbXkGxhaO6Fv6YCnry/aOup5aUFXXTMPOPDg&#x2B;xClDoP33VnHA8GEAIBgIwP&#x2B;goL/xYv6iWNiYpTf//73k1avXp0WERExVSaTebnr&#x2B;Ohh4KriaA6Kt6ajaNdJVB44w8CJFTIGjpReng4jrIJdW0bRebFCejZ&#x2B;3ddaz2qFiYFYpacC8WtnIfn2BYhZMgkS1bnt9eRauz9HGQDfuFD&#x2B;SLlzETI37sJXj7zG6deDOwtQaYGp2wCbhw3ekYGIT5uF&#x2B;KUzkXDzPHt9/pAY28YzFCf/uQVnvmWg/0AxOuqaIBXJOXvhspSu9PTYQT87D6SYHHddKs/2B0&#x2B;LRfDUcSNuI0hU/pKMXA72S9JzeE07tfGjftgEGtU6LzuJ0&#x2B;Y&#x2B;oJc7pj32bJBEKuPXmyj5tJ&#x2B;kA0GBHxUp75MuRLeeO43LH1yP6x69C2XZ&#x2B;Zw1ETEhtn9MEG21PLcQe977HKe2H0RtUTl/3TvQF7e89Bjkchmb19Q4czgdu//9OaywXlH3Yt&#x2B;1I3FGCl40VNTgiz&#x2B;9y8sZbvjBdzBhzlSExccIk5Zgbjt&#x2B;DQaDtbm52UQZf4VCIdZqtdLExEQvBhY9BBA3dFDAEeh11RLQVTDhnM8zsE7Mz8pDZ/gar9CoOTvK4zzUf34wgrc1ZXN137ZpPqYyPKL/12WWoj67DAVfH&#x2B;MaAaT6z7fL1nxDcwd6TNbz9ndgieDg4Iaj4xo4voYqfxBMCAAIoH90Qb&#x2B;jz18uBX9nDIBLquBPf9944425zFKjoqKms4VNyy6D2/agrc8q5dTt/G1HULYvC5Y2M3PAJVBqNNwJhw0C6BdswKA59zmBf5FSgtiFCVj5u0c4qL/Q2Sb59kU4/e&#x2B;dnG1CgNxkNKLHaIW5xwCvcD9ErUhG/KrZmHjjHKh8vYbcvyN//IwDQqqhr8jKReX&#x2B;PHRUN8HDKuIA2FPnw1sJjuW4pt&#x2B;x6E08yEEdFMatmMYfkfMTETgpxqGg3QVtnzldFWeKcebQSWTtO468I&#x2B;lob2ji9HipXA6Nt9Ze1mCnOLhVI047&#x2B;LdC6enJg41t9U088ENif5Ttp2Ogy9Td3gGlWoXQ2CheClBbVIawCeO4MB618yNns/h0DvZu/IqLGtaWVMJiMnMmgFqr4WUDVNMqkUh4uUBzfikPJFgs1pEzLSgTRcEX9nv0RCIdWjiQxih9lv6SIyy6mC4SvX246RhlSl90NLXgH8&#x2B;/Ai9/Hyy/71aseHA91zQQTDB3uM97enooy99FYL&#x2B;lpcUcGRmppGDd1VzTP5qgfzDAHQzAnWX3&#x2B;9r0inizWnBRv4GK&#x2B;4NBPK1HEiV1&#x2B;jGfJbA7qbMfGITg36PSUBLsY9tvyK1EXUYxSneeRsHWkzC2dvJ1mZIJNOeRaGCP0QKrt8Xl8Q4H5LsKlDj6vmBCAEAA/UMDfXdS8BcN8bkLVfAfiahf/3NavB5//PHYDRs2rAgNDU1ki1uYh4eH29ar1Z4uRtXJfBRtP4nCrSdgatSDQhRE75dq5b1&#x2B;pQ0QML9gQ5nYA9PuX4Wlv/nOxW&#x2B;DOQ0zHrsexbtOoq21HrqoYAQlRiM6bRIm3b4EmhDfYdW/U/vA7K/3Y8//bERHbTO7QSVcyE&#x2B;uVEOl9hrgOPSMjcPLHFtycIiBIPNUInJBEsYtm4LIeYkImRnPmRAjNaLFk3p/1t5j7HEUnU1t7F4m7QU5z/QPdJbcBgj0CkEOvP5rHtuA&#x2B;bdex7P8XW0daGdAllrxkTJ/0alsSKUSjJuaiAV3rMX4aclsrlL0H1fJ6Vx8&#x2B;od30Fxdy9sWUjBAxUCvXKngj77PEQOiu6Mbf3nsZ/3/p7Z&#x2B;fZ&#x2B;5WCMAb2K/aTGboAvw59eVgLjCU80DM05vHRLYMlugUCthNpn7AwEjOa903YlhQq0MP3j5r9j13heYsWYxrn/sbmiErgGCXQYzGo1WAvsM6NvMZrPNz89PplQqJf7&#x2B;/nLh7FyYddW2oC6nHBFzJ/ZrMDmivg8E5px&#x2B;z54bOvVoK6/nON4zzA9KNkdSIHSwWN7Z7djQJ/jXH0jofdCsRnMVb/NMIoHsOQVWaR5syqtCzakilOw6jbLdWWhlv8nnW6mYswu4BkB3N9&#x2B;8F9uPmMVTMO76qVAH6s4LXDgSRHTGfhh8DoYjpiiYEAAQQP/YgX5ngYCxUvAfLVE/EbWeufPOO0OffPLJVRERERN9fHzGsYnWbVXxWoprUHHkDM58fgj5W4/B1NrND0epVkOhVXMqt01A/IJdMPqx4ehrn2Pciqlcpf5ijUoGku9ciIApMZh06xJ4Bg4PrBCVvnDXCeR8sA9lp3PQfLoKSqUnA7/ePNM91uOaQBgJ63HFYy8VYtImIXxOAiLmJyFsTvzZLgkjsIrcQhSn56LgWAZObj/AM/2kj0BAkmjt7kx3JGfUZDZCz&#x2B;YfmUIKiUzOOxJQn3v/iBDOYPjk929jwowUTF25EKsfuQtNlTWQMGCr9fOxDzmLFU3Vddj5z09xcute1BVXwKA38iABsR0UKqXL4z8nMDLS4c&#x2B;cX7FUisTp07Dw9usxfuZk3kLxrWdf5oKLzoILJoMRT/z9RfiEBPBjJwr/Xx79KTpb2kdWAmLjlADO4qJHS00DPvv9m8jYeQjTr1uIRXeshV&#x2B;4oBEg2KW1jo4OM92DZWVl3ZTtl8lkopCQEKWQhb04y/5gL07/awcD/6XwjQnDnV/&#x2B;YjAGcDzfEsOJrZG7//s9VJ8qRN3pUq6DQkH1dW8/iYDEKC7EO3B&#x2B;drQpXv7fB6ZhD142l1TzWn6pSs78y1oUfH0U1ccKUHEgG&#x2B;01LXwu4owruZS5CTYYurog9hBDFxOAccumImrRJAQmR8E3PpSvm1RGCCcg3hHQd1b370gbQDAhACCA/rEF/cDFU/pHS8F/OPX9F/R32bJlvs8///yy2NjYxMDAwESJRKJw1zHSWdeC8oM5KNh6HPlfHEVHdSMXa5Myp1Tlpe3V/uqtrxLAv2AXM5kwh8FsMOGzDb/DAwdegVe4/wAw3MNvm&#x2B;HQ24lueONbzw7rNy1GE3I&#x2B;P4jiPSdRdTwPtcdKIGb/JDIZNFof2DzQX9c&#x2B;VuPaYjDz1n0kchg&#x2B;ayIH/OOWTUbkguSRBxXYsZCIXeHJLGTuPoLTOw&#x2B;is7Wd11BSFkehVl0RGh19/aS/8/Iz3KPMP3wKWXtPoLqoBO/94lUkL5yBwKgwzLttFXpMFugC7ar2vgNE7doaW/DSLY&#x2B;htrAMhm4DZAoZB/1q0ge4iOMfqWtIWf57fv0UZq9b2v9aa10Tb1tYcDTT&#x2B;Xgxmdlxl2PqigXo7uiAd6A/khbNwqHPtmE03VUpc75lCl9Us/P1&#x2B;avvYMc/PsG6J&#x2B;/DzOsXwzsoQJjABBsV66vpb29vN1O7PgL9KpVKRDX9vWBMQGEjsI3rX4BUrKKII5a//CDXrxl47gcHAvoy//q2Lnz1yP8h6/09nO3ENVLYe22VDdjy1Bu499sXzwfKveDZrvCDs1FSm63/NRLNbcyvwqYbfw2VvxaVR87wMjv6Li87Y/tH5W6U6RdJJLwrwOT7lyBkShzGrZhiD/DTemC2wtRp5D/SpzHgsCWhixaGA/8v1P4LAQAB9A/t51wNCv7DadvnCsw7e188&#x2B;PUlS5b4PPPMMwvHjRsXHxkZOd2d2/ZRRLYmvRjF208i56P9aCyvgsgo4mJRam9db42XvahLmBcFGw0jRXIad3t&#x2B;/T5m//AGNGSVo/pUAW8ZKZaJIdMqYTX0QKqTIW7pdIxbOg0S1YVlwinrW8jGdNH&#x2B;kyj85gQassvgYRJxh0aj9ebAsh/wj8m49mAA3Mj2yy54FDQpph/0R6WlnOOgXaxR9raAgf7sfcdweschNFRWA1Ybv5cpy&#x2B;3BgP&#x2B;VJMxJwSJS6/fy88HkJXMwY/VirmJ/9Mud2Py3/&#x2B;CVDU/hvpd&#x2B;jOkMFKu8NPw7TZW12LnxM&#x2B;TsPY77//cnCIoKw9ybVmLTi69B6&#x2B;/DM/CX8/g7m1uw9a1NiJ2cAP/IEFjZOM07egonNu/hY9HQ0QWpSsHpsQP3UalRY9ubm7Dl9Y3w9NHxTgZUO8sFtESjWz1GvyvrHY/GbgPefvY3bJ8/wKS02Vj&#x2B;wG0Ijo0UJjHBLmpc9db0d6vVajG17mP&#x2B;kcrLy0uqVCqFmv5Rsq0/egNKhYbPLaGzJiLxtvkOge9AE/G5Vo9/r3gelSfyuLo&#x2B;1d5bDWbINEoo5VIO2ssP5SAkNe7cbXAS0dmOPKRnIlX3llL16pbQZ2kNqmDfp&#x2B;w9Bd&#x2B;pAwDp3PBgOAzw9NUi4bZ5fF2MWpgMbWQgZwSY9QbO3Du7/2dhw3AEDAePQWdBAWedEAQTAgDXAvC/khX8hxsAuGQK/qmpqV7f&#x2B;973psyaNWsGW9Qmy&#x2B;Vyty2gpNrn&#x2B;swyZH&#x2B;2j4P&#x2B;9ppG3l9VopRBRY0H5L0goadHuJkEcz1j2AbUzg2zPRzPNojFyHxvF4q3nkRHdTPMJgO/nYzohNhDDt9xwTz6r/Lz4mJEjsxiMJ0LnNlPU2eKvB3HUPDZEdSfLmPbNUIhV0Ot1MKmtO9bz1jV9FNHAaOZg36qewxMikZkWjIi5iZi/OrpvM5/pNbOACVljvOPnsbxzbt55p87WAopF8Drv0huDPq5GBWvZxfbZ9Re4UHezYFdq788&#x2B;nPogvywdMPNWPqdm3HT0w9i3i0r8cK6h/DiTY/wUgBdgC8HwtS6sLm&#x2B;Acvuu5X3vBczIL3q4TuRc/AEcg&#x2B;c6G/1N1pGXQioLp9nskSi/jpbZ0bsgwJ2rf5w37OYdeMyxKWmIHnhLExfuYhrMqTvOIg9G79AV3sH1F6ac5zZro5Onk8jzQM6LmK2iESXVjqG6nZ1/r685ODbN97nYyzt3puw4LbV8AsLEuZAwYa0rq4uS2trq1kikYiI6k&#x2B;1/ETxDw4OVghnZ3StKb8KmZv28kA3Afi7Nv&#x2B;3M4xw3prw1cOvofpYIWQMqKt8NUi&#x2B;Mw1dDa049c52tlYp0GO1ofJoHg8ADNwOaaPom9p5UJ9APbHalDo1n8cpc2/ub9cHe2DBbIXZQKDeBP/YCERQyduiJETOT4ZfTChfsuxlcRQccKzgP5Sa/3AAvwD6hQCAAPovHvQ7&#x2B;vzlVvC/EKr/iBX8w8PD5T/84Q&#x2B;TV65cuZA9T/L09HRbj8iiN6MhrxxF20/h1Ltb0VZeC1OHETKFCjIpW4e1A4VcBBPMNWCjWn5yMAhgExihjDvVNvM2PsMUq6OsQXtVE8xmtg2VFN5U67c4FdMeWAm/8aE8IOXKTr25FSV7MxA6dTxvy5a/7RgqDudwx0Il9YScjW2FUs0zq2NWskKgnwF&#x2B;ymxQ7SR1OSBaf8iMOMSvmQmlr2bEP0HZ36L0MyhiYPfElj2oPFPMBeGk7NwTu&#x2B;LcpWD0j5tT83t6&#x2B;mmjFwKWaeoUDxoflMmmsdDZ3MqV96kWnXbbm4F&#x2B;n5BALNlwE&#x2B;JnTOb175JegK0L8kfS/FTsff8rlGSc4dulY49KisOT7/4W4RNi2Pi0oqO5DU0MvBLNXiwRj9YJgKGzmwcn/EKDeEaesl7dnZ1oqa7rLat33jJLqfFEZV4R3v/VGSjUanh6e/HM&#x2B;oL1azBpyRzMWrcUbz71EqoKSng3AgrokJGjbQflsjG93&#x2B;laUzcM0ifoaO3Ae7/8Iz7701u471fPYu6tq3jnBcEEG2iU3ScRv&#x2B;rqar1Op5NRq76AgABZYGCgMFguoe17aRMMDIgTjX7ZKw9yvabWsjoYW7uh8FZDE&#x2B;p3nnAozVVt5Q2oOJDDs/0UcH/gwO/hFerL3894bzcXCqUZzdxl6A/2U8Czb5bb9uN3OJWfjOr0ZWwupokw&#x2B;Y5F7Pu70JhXyZUAe9g6Tdsdt2w&#x2B;IhclIyaNzesRgexVtm5aLTAZDf1JhcGBiqHaEzqj8Q&#x2B;lBeCKRSCYkyXQHU6Qu0Rs9Ft3QpoQB3Fo6FgfvzuA/sHg3xmIB9xXwd9ZgOC8z40bN0750EMPTVi&#x2B;fPnMsLCwBF9f31h3rVejSGtraR2Kd55C&#x2B;qbtaDxRDj21ypIrucIqATVhohPsgsYUteFhYJ9oyoEpUYhfN4uoIqBC&#x2B;vzNx1B7qhh6BhIIjPFAwEBWANUK2sBbBZGoGaQ2aMOCEL04CSl3LEHEzImQqIb2DwkQ1eWXYMuTb6BwywnIZXKYTCZIxFLI2H55MKBkI29jDIc2nROiKYrlEvhEB3HqZczSyYhdNR1Kb8&#x2B;RO9QMyJZl5SF733FOgSdRO0N3FwNfCl63TQB6rBwXOv80fxCrwcCOmX5fPIiyPtjI6fT01vLsdVdLOw/IUGmCkTmUUxjoXf&#x2B;zJ9BSW4/cQ6fQzI6NAH/SwhmQM3BJWXOLxa56f/CzLcjccxQV2YU8EEK96xMXzGCAvIvT1RsqqtHd3sVLBwg8k1p&#x2B;e2MLe0/Ps0/osY3Cte7B9NWLEBgViinL5iEicTy6Wzux/Z8fY9OLf&#x2B;ZMBgpi0Dmh566U&#x2B;glcU32/2WhCcEwExqcm44Yn74c2wBcv3fwoKnKLeX2sWzl/pONhNPKOFXFsf1c9dAdS1ywWJsdr3Kimv7Oz01JXV2f09vaWMfNg/pEMEEr6L/hcMhBP/hvVwg/7O61d&#x2B;JX39dBofbmQ3pQHV6Ahp5ytyUUwdxoh81Jw9tma15&#x2B;wz4UDrPLwGfx71c9hY&#x2B;vYuJVTcduHz/fpg&#x2B;L9G36F/G&#x2B;P8Tlt4S/vwtynbuZzcUd9C6qP5qPg2&#x2B;M4&#x2B;ffNkOvUXCBw/Uc/Q/SSFL7&#x2B;ko5AQ3Ypsj7aD0NzJwKSIth7U&#x2B;AbE8J/12K1d73pX1sGrCGO1pOBrQsdlbMN9XzwNl1tg/4GBgbeS3EP9jD1/rU4&#x2B;Nv33Nr7sAx4PvDRM&#x2B;DvwIdtwN&#x2B;Bj/5dcnQeLqcJDIDLF/S41hX8h5P1H1UFf3r&#x2B;4osvpqSmpsbOmDFjmVarddsiSJoYuupbkf3hXk7xb8qqQkdjMyQimb2/tU435j3NBbvi5xyYDWa&#x2B;UPtNCMOke5bw2vWA5Gi7SFCvpT5&#x2B;PZryK3Dms8M49fZWtFXUM6dBximBBHKIsm&#x2B;VWKANDEDUnMmYdvdKRC1MgVwzPCo8MVjI2SjacxJFO09A1CWBp86uUyEdoOQ&#x2B;Vm37eI2kycJnCm14AEKnj0cMc57iV8&#x2B;EOlA74u3rO7pQkVOI7IMncOyrXagvq&#x2B;Tt2gg4U8ZZ461z6dxcMue0qwsrGOibtnw&#x2B;jn29G3ve/5KLDJLAoEgsdjSA&#x2B;Bh67LX/hkKjQmlmHk5t34&#x2B;8w&#x2B;noaGpDc10jV/MPiAzBvFuuY9dU0y/oR4GiPRu/xP6PvkFdSQUD8618YpYpFVCoVEhePBspC2ZwDQBq9ffZq&#x2B;/g0Kfb2PsytLLtUhBK5CHiWWpbz&#x2B;icHyoh0fn5ICoxjlPjK7IL8M7zr/CyBCpR0HhrUVtSidricjTXNkDf1sHPAe0zMSYGXif6P2XW6T3SN9j/wTfI2X&#x2B;cK/BPWjKPnat8SOFeAQAqDaPxR4yf/KOZvHvB&#x2B;p8&#x2B;hmUbbub0YcGuDaNxbDKZeqqqqvRSqVRE7fvCw8OVGo1GIpfLhZr&#x2B;i7CaE4U4/JfPUfj1Ccz/yW2Y9YMbhv3dzI27GDCzA3sSfD30ysccOYrEEt7q1VRrwOl/70BHXTNu&#x2B;ucz8Aw6W6XamFvB13cqMVL56/qKxrgbLPVU8MA9TbzGti4UbD6Ogi0nUMTL95p44FumVcPYoed0/rgV03i7QD5Xmi3wT4jE4p9HoYdtRMLcaUuPlQcQnVH6h2rH5wgCuaL9D/zMUN0BnG1fsEHnUmAADHDULjED4CoD/VeMgv&#x2B;PfvSj8XPmzBk3d&#x2B;7ctICAgATmrLntoqZv6kDxrnSc/Me3qMssRWdlM5/MZUold8oF1X7BLhrwtXchIDESkzcsQcIt86GLChzSMWzMLkfOpweYU7Ib9bnl8AzWIWJeElIfXoWg5HHDzmwQfbH40Gnkf3kERczpMDUZuDOjVGn4nTrW45ozIJhTQ2BSNy4IgUlRCJ87EYnsvGgjAkYsE9/d3omaojIUncrBwU&#x2B;2oJyBS6KbE/WdMu38Xr7Ma29HSxvWP/cIbnrmIf5/ytpve/MDZB88jq7Wdr6vvH1hz1mHijJDc25cgbm3rILWT4eAqDBU5pXgradfQsGxTK4SLZZIodJ6ctD/vb/9GlOXz&#x2B;dihr&#x2B;&#x2B;&#x2B;REGkomCLoPHgCnY1rdto4kDfAL7FDQZ7Tp/R34H9a/maRurlY8F7&#x2B;AA/O7gRxwYn951EFb2etzUZHR1dPDa/sOfb8eZw6cgpetIlHkXl5Ay60SHHao9obsEB3u4Q29C4vxU3PzUgxg3NWnUhQkFc6P1wGCwUpZfpVKJ9Xq9VafTSam&#x2B;n/4vnJ2RBNZs&#x2B;Piu3yLz/V3cBV39p8cw44nrh/39N2Y&#x2B;icYzVXbSnbWHiwDaRfgYiO8tp6P71djRjUkblmLdW0/2f3fHc&#x2B;/g0Kuf8fUl6a6FWPv6D/rf&#x2B;&#x2B;CWF5H31RHeWlWmVsDM5mcqKRApJJzdZLPauA6KSCXCAzt/h5Cpsf0BgMF&#x2B;gSPavaus/1AZemfbGo3tk/n7&#x2B;wsMAAcmMAAu/cIqKPhfWgX/8yj&#x2B;YmY33nhj4Nq1aycsWLBgYVhY2BT2ksxdxwiJrlQdL0D6O9tQfjgbHZWNfDImir9C7dkrl2oTwL9gFzWNmLv1fCGPu2461v39h9CE&#x2B;Tr8JAHipoJqdNQ0wyvMH75xIfBPisRC9pj6wArUZ5fBPzESmiCfYbX4ayioQG1WEW9Fmb&#x2B;V2lG2QOohZYDIE0qthge2xnJME72f6Jg9Fgs8g30ROi0WMcunYuKNc9j/vUcciKZsSHlOIXIPnuT0/oozRRwE02YpM0yg2F0WfjISp9v5r8/R3tyKhDnTOf174uwpPHDx6e/fxqmt&#x2B;zjtXkXXymav/adxtPfDr1FwPAurHl6PwOgIRKdMwDP/eRV/e&#x2B;IFZO&#x2B;3U0wp2NFQUYXq/BIeAEiYNw2zb1jOtymSSM8RJuWzG3NwuSCehflf7DekQ4jwjYqjTowTuaw/AMHLPxgAbm9s5oKEUpkMgSGB0Ab68kcHOxeTFs9BTXEF3nn6JTTVNkLlqeL0f4fOFQVDbGIeXHB3IG13wkXsmOVcwLDgWAYe/tMvkHpdmjCFXkVGQn5Go7Gnvr7eSBl&#x2B;hUIhIpo/A0hCunQUTSQVQ6HRwNSlv6BgcsnO0wz8V9pFZ9mcSEBdE6yFNtQfli4jatKLOIAnT5fey/jXTix5cUM/C6DHPpnBQyJCyfZ0NOSWo7uxA3lfHEHJngyI5fZ51djexec9qUrG9tEAo42tiX5aJN&#x2B;4CPOeuxU&#x2B;McHoaGiB3OssG4zmOY/&#x2B;VoFnA4fDqecf&#x2B;PnBn3HGFjivTaGDbTvL&#x2B;A/FPhBMCAC4I/B3dwX/4YD&#x2B;oQIAl0LBnz/S0tK8b7vttgmLFy&#x2B;eFx0dPdOd2/aZOw2oyylF&#x2B;rvbUXTgJNryGtBjtPIIr1yp4g7j2YlLmMAEuzgjCqFfQjhmPbEWk&#x2B;5dymv5BpuJjcWM93Yg&#x2B;4MDqD6RD31bJ9TeXgidEYeFv7gLvuPDoAnx5Y8hUAS6WzpQuOsk8r8&#x2B;jPxPj6GztZmBfgXP/Gp1fvZAVl&#x2B;0fizGNfOIzAYTB3eeAToETR3HyxUm3DSHHVfIyO9jBhhrCsuQdySd93Ivz2bnj4Ffcpoo008K/hQscUcnRMScRFKp3/b2h/j29U2YuSYNS75zMybOmYbH/vwCKhl43/Pe51ygj5w/39AgLLp7LRLnTUdwbBSnvPMAZmcXV8Q3m0z99HwqEZi/fg2WfucW/n8C9JFJcTjxze4B/QwGLFa9ASUPjHHy0cPj7KJFrarYMbz2yE85DT56aiIPTGx960O0NzRxUchlD96CyYtn48l3fot//eyPyNp/BFpfb5d0VVxBVFS6Dp5aLzYuOvHOj/8HnjotGw9ThYn0CjbK7lO2v7KyUu/r6ysnEcr4&#x2B;HhPoaD/Uk4rItj59hcQhGNz7PafvcPX0cCUaARNjkHS&#x2B;oUISImC2l/LtQFOvL4Zu1/4D3N4xfxetZhNqDqez4VpybyjAng2ny5tZ20r3p7zNJ&#x2B;bzF1GiBXS/k48pKliM/dArlOytXA2YpZPQfTCyfCPD0PVyUJsfeYtNJ6pwE3/eRYilbhfKNYV3d9ZUMAZiHcl8Nf3/8G/OfDzjrbtKhAgmBAAuNpAv6PPXwoFf2dt&#x2B;9xCwf&#x2B;pp56axED/rISEhDS2uLltSxpyJisO5yJj0y42aefxun6KvpLqqkzOdlt5VmhNiFoKNmLHr60Dscum46Z/Pg110PlU/daSWpTvy&#x2B;HdJGpyi2FpNkIXHQBNkC9vP0dMgL0vbsT0B69D2NwEqP28HP6OoaMTxTtPo3jHSWR/uB8dTU2QmGVcQVjrHcgcm76e7WNT009g1ao38wCDwkuFyNQkhM2MR9Kdi&#x2B;CfEDEs9oIrIxZBbWkFCk9k4uDHW1GRW8Az5bRdoswrvTzPaaPotvcy2y1S1Ke6e9rD49/uRcaeowyoj8fax&#x2B;/F1FULcecvn8Scm1Zyqnz0pIn9SvF0TMe&#x2B;2YXTOw5yxgMp&#x2B;PuGBHL9gPt&#x2B;&#x2B;2OkpM3m4n3U2aDgRAao6ip9&#x2B;wGunN/jNm1JbTxYQ8s2MQFoHqb62b5jikiI5er40ckTMOuGpfDy9e69/hZU5ZfAZOjmLIGrzejaqtkY7m7rxJ8f&#x2B;Rke/P1/YfLSucKEegVdP5PJZK2pqTGy5zYa3wEBAQoG&#x2B;jVU4y8AIve0isNnoAsPwvyn13NAThn&#x2B;gabQqTH32Vv4urrtx2/xMioP5go351f1f4YCB5Tl54wq9pezj0jpXy7pd757emwInzUBE2&#x2B;eh5i0FAQkRfWD5PbqRnx0&#x2B;2&#x2B;4b&#x2B;AzMYSvY44Avc3J64NBvzOw76puf&#x2B;D2HQUHnG1rcBBA8KGFAMC1AvoHg39XoB649Ar&#x2B;F1Lff8EK/kRd&#x2B;/GPf5yQlpY2Zdq0adfJZDI1uwzuWbdmI9GzCi7aUnEoB1Un8mBuM9lBP3OmFV7qs&#x2B;kwYcISbHQmJVj0RkTOT8QN7/zIIfjnHxOL4DMhFAt/fgcD996Qeinsdd8Ke40670HMwA71uR&#x2B;o8DvQsjbtxudP/wnmej1sph4oPD2hUfn0Z/f7wP8lB/1UK2k0c0V7pa8XgpKjETqDgf7b5yN4epxLBffhgX4LGipreC3/gY&#x2B;3oPBkFle7J2BLVG&#x2B;lRn3W4biC7mOi9RP1nqzvGEi34Pf3P4uJs6bwLP7cm1f2t4ai4//mb&#x2B;&#x2B;hNPMMKnILYWHnRa5Q4v7fPoeFt69BZ2sHgsdF4NS2/bx&#x2B;/pvX/o1cqplXyMCQh11TYCxuAVCWywJKxPW1o&#x2B;JCgn1UfAp&#x2B;sGNafPeNqC&#x2B;vQnVBCZqq6&#x2B;EfFowVD6xHctpMxKVOhrxXZZs6Xhz6fDuOfLkNRceyUV9RyTs3qBhQtrlNQGN0QSQFRVrrG/HW0y/jp5/8FYEx4cLc6sbWJ&#x2B;Tn5eUlbWlpMQcFBcnJPVWr1YKffwUY6dDc8t6PhwxQT75vKU6&#x2B;&#x2B;y1aCmr5utZZ19r/HrEGqHa/cPtJLppKLC&#x2B;T2QBdSBAUOhXayhv59lMfXYPk2xf23&#x2B;s8KEtlUOYeGDu77B2C5IrzQLij565KAAaD8r73B792IeJ9rtoFOmMWCCYEAC436HcF9K8mBX9XgYCLVvAPDAyUrV&#x2B;/PnzlypUps2bNIgX/CHcW82sra0DWp3tQ/O0pVJ8sQFdDG8RiCe/DLNHK0Y/6Bcwv2Cgb9a6PXJiCm997Birf87P2pPIrkUu42B0XvHNhfTWDYic12UGTYiEzMnAnE8FD2bswj9GgpiwHtXIjYTqinPvHhSJ66RSe6feLC4FEKR/x9qlNX97R0zj02VaUZOShrb6JMxkIHKk07lXTf8GLP7umKgb6m2rquRK8nMA5W9rsonU9yDl0CmeOpOP9X/8ffvnV2wiICuXifKe27eNdDCib30dxz9x9GLmHTkLn58tbC&#x2B;769&#x2B;e8DpWGQp/2wVg5Y1yrwGCCxlfX23rQwq&#x2B;lSa/n&#x2B;28XYpTxMqt1P7yPBwXI4e1sa4d/eAhnLvD7pEuP/R9vxvGvd6M4Kxt1hdWc1kvXXePr0xvg6rlq5xEa0xQUqi&#x2B;rwuY338d3XnpGmFzdzLq7u3nLvvb2djMp9hPYpwRJb9s&#x2B;wcbqXumxwdTRDblWfdHboHr7oUzf0olmNg&#x2B;Je/NdHoMCAFK1Ard8&#x2B;BOcemsL6jJKIVHIEJAcgfErpuPvU7/P5zqZTonxq6afB9QpQEvBAb9xYZh6/0okrZ/f387XFWXf2fuu6PfO2AGOAguuAghDbftKXZuFAIAA&#x2B;i8l6L8iFPzZQiadMmWK9uWXX14dFxc33c/PLxYj1ue&#x2B;dNaUX438LUdRvjcL5Udz0F7RyG4wGa/rV&#x2B;u0Qk2/YGMDgExmJNw42yH4b8guw4d3/w&#x2B;CEqOx5OUNvO2d0&#x2B;2QSr7VxrOoFoPZ7mzUNnMKIlEEVf5a1OeUMWdiBrI/2sfV3y919pscLRLxs&#x2B;jNkGmU8I0PQ9SCJCTevgCBk6L4vo0U9LTUNqDoVDYD/duRf/gU2hqbOUCUqRS87p0rJl8FTgWBYarRb2toxJnDp1GdV2IH7T22/vpSuqaz1i2DLsiffyd&#x2B;1mTc95sf4&#x2B;8//NVZ54o9cg6e4PrHVgLE7PsqLzubwIMEpMbwXBH4lzMn&#x2B;MHfPY9JS&#x2B;awY&#x2B;zkiv4E&#x2B;OtLq7iCPyn5E4OD9vGXqx/kn49KjIcuwBcrH76DBwA2/vo17Hz/YzRXNEAuVfB&#x2B;2xRQ4M4lHeM14lTycgBvDQ&#x2B;CLFi/BjGTJgoT7GW&#x2B;HiTkR9T&#x2B;4uLibuYTycg3HTdunKeQ7Rx7a6&#x2B;oR87HBzl9Pyx1PGY/dfNoX3BeJlp7ugRluzOR99VRNGSVci&#x2B;YApgE6A1tned8RanzxJwB&#x2B;0GlfFufepN3JaG5OX7tTCi06vMAO7EAqKvPnd&#x2B;8wAPqZPSaM5Dvqv7eGXi/kO86Gs&#x2B;DSwcGg35nrADBhADA5QL9QwH/4Sr4D1Xr7w4K/hei5C929rmpU6dqfvrTn86dPXv24oCAgDg2ybltNLu7sR05nx1ABQP8hZtPoq2yHjKxHCKZFJ5ab3s2dMDEJJhgl9pI7Ofk29sQuTAZfhPDzwHPh179ApXpuWjMLOc6FJPvWcqDAJ0NLegxMMDPgF8Xcxg629tgaTXCqDdSr1gYW7s48GkqqmGASQWLwcSzxOR8yL087RTxSzTG6R7qMVl5QEIil8I3NgQByTGY/J0lCJs9ETLPkct&#x2B;EOivLizFvg&#x2B;&#x2B;4SCxra6JK/gTcCQBw4FCflfLvUxlHlve2Ii0u2/EfS89g8r8YmTsPgxDRze77nqEJ8YhYfYUzL5xBdcKIKstrsDnf3zXDoIlZ685naPBzhhfPsfqXPGWWVZekvHwH3&#x2B;JSWmzcOTLnShJz&#x2B;Ht7XyCA6EL9MN1j97FAxp/ffwXvIyhs6UNXexRU1CGmoZS0GFteOlHmLx4Do58vh0gcXSPs4GOa3Eep3Pa1daOvRu/RHRyvNAa8DKY0Wi0knK/Xq/vkUqlHv7&#x2B;/vKEhAQNte0TAM7ls6OvfYW9v93EVyn/xLBR266py4j67FLkfXoIRdtOorW0jov1cseZ2Hge4G0ALT1m2CTO5ySap99IfRLdDW32njvso4t/fe85wHjg&#x2B;KGyP1pj&#x2B;8C0K6V9Z&#x2B;B&#x2B;8BrgLMPvLMA11HvOsvtC5l8IAFxO4C8o&#x2B;A&#x2B;/zv88Bf&#x2B;YmBjls88&#x2B;O&#x2B;W6665bERwcnMgWNiXcNNtv6jag8NvjKN6djuLt6WjMq4DIJoJMpYRG59MvdjZWomeCCXbOpM4cBMr0v3/Tr7D&#x2B;k5/Cf2JEP5TWhvogZEIsmgtruDbFjp/&#x2B;k3cGoBaApFxMY1YksmcDJFzgzMbr66l&#x2B;mtcFK&#x2B;QwtHb2U7/lnur&#x2B;PvGjCvrZbxGTgWoSKePuExuMsFkTkHxXGoKnjoNC5zni32hrbEFZxhns/eBrBgbz0VRRA5PRaKeIEz2e6ruvYlFOatdHte3f/O0/2PXe53j4Tz/HhhefgaevFgqloh/oGbr16Gjq4rX8n/zv66grqYJcpXB6TsbqXFnY&#x2B;JD0lqbQVEvijA&#x2B;/9jNMWToXbz71Ej74/V8RGByKqSvnIzQ&#x2B;BuNTU/hnfUIC8MDv/gsv3vAwrJ1dPDBGAoYTZk7Ciodu458h5fv5t13H9Q48IAAsUo4/8tVO3Prco1DrNMIke4mNz39Wq620tLRLq9VKm5ubTeHh4TzKplKpBL/dTYzU9bmAs42qg0YWGDO2daG5qIb5lieQ89EBdNY0o6u&#x2B;lZfhcf0SNl9T4N3U0cnn39g10xAyKQ6T71viYiCxda6qns9hcdfNwPznb4c2MsAV9hmyhn6gUr8rcD8csO7su67KAoZb8y8ExoQAwAUBeOXyxWMJ&#x2B;h19frRB/2BwP9oK/hcK9s/5O378ePWGDRvGr1&#x2B;/fmVQUNAEtVrt78H7p7ifUfaxfF828rcf4/1V606VwmoxQa5QQaXxGjA5CqBfsMtv1Ie4Ob8an9/3B2zY&#x2B;RtIVXIO6Bb&#x2B;8i5M&#x2B;e4K1BwrwNG3v0bJrlPo6bTYRdqYg8EFiIbI3Iokl0Z6g4CYzWLl4nFUj0htB0nIL&#x2B;XuxQz8x0PlqxlxS7Xuji6UnM7lNf2FxzN5RttkNEEikfBsv1KmHnMgezlBhogdt4I9qF3k7zc8A52/D6KTJ8LLT8cF&#x2B;&#x2B;QKOYozzqCrpZ0zBEj1XsbG0uU/Nx7w9PZCS20jp8Hqu7tw448exOx1y1CSnou2pmb892fvMNCfzME9d9bZdU7feQDHvtqNwpOZvNWdlc3XQZFhPDiQsmgGZxGUZeejrrQKJ7bsFSaSAee7q7kNGbsPYfYNy4XTcYmM2vW1traa2V9yJGw6nU7q6ekpoYy/cHbc8K4YhrisqwAi6fG0FtegiPmUOR/uQ0tJHQzNHbx0itZZWrep/M6g74JMqUTEgiRELUhG/PWpCJ46flgIxSc6BNO&#x2B;uxJznr3FpRiuK0r&#x2B;cMH0QEA&#x2B;EKy7Uup3xRZwtL3B23a0n0L2XwgAXAyAvxygfzDAdwXqgaHr&#x2B;F29N5wAwEgU/If86&#x2B;fnJ33sscfi7rnnnjW&#x2B;vr6R3t7e0e46OCjaWnn0DMr2Z7MJ&#x2B;hSqDp2B0aCHXKpkkzHVAquEiUYwtzWqka8&#x2B;Xoh3F/8X5j1zE2JXTuMiQV6hfvwRv242Kg7noGRnBtLf3Y6W0hpe80&#x2B;17kTpH4uxzX&#x2B;DAX&#x2B;z3sS7DygYyA&#x2B;dPh4pd6UhZGY8tOH&#x2B;I/4NavVWlVeEg59tx5lDJ1GdXwpjt54DfqlcCpVczZ20a/leJoq/Uq2Gvr0Lp3cehLXHColYArPZzEE/OY5Ktao3OHR595UYKb4hAfjVtn/ydn1VuUUoysjFuu9/h7/vHxGCp959pf/zWXuP4OiXu5Bz&#x2B;DjKsgr4taZjobp&#x2B;kU3MhR7rP/4W&#x2B;z782t7VgY19CiyQRgDN84LRyu0Bq9WCmoJS4VyMspGIH9X0FxUVdfv4&#x2B;EjFYrFHRESEUiQSCSnMMTZ9Uwf0DIB3VDdDG&#x2B;EPbVTAiDPJg5NCJgb6W4prkfn&#x2B;XlQw37Ihp4wHAvg8TBR8Ni&#x2B;Z9UaYjHqofbUInxaL6OWTMH7JdARPjx1W0KEfSIhE&#x2B;O6xVx3qAQ0XyA9H4M9R276Bn3fVMnDwNi4E6LvartAKUAgAjBbodwX0L5eY33Dfu&#x2B;wK/vScgf7oRx555Lrg4ODxfn5&#x2B;4&#x2B;Gm9H5Si646WYCKg7nI&#x2B;WI/qg6c4ZkjmUTOJ2aZQjmA4i9MLoK5fxCg9lQBPr7rfxEybRxSn1iL2GVToPD24uJ&#x2B;4bMT&#x2B;GPq/StQceQMFxrK&#x2B;M8OGFu7ebCA36WXYJhTbSIF2CjTofL2xLjlUzH5vmUISIqALipoxNsnBXfK4h75YjvSdxxAQ0UNOltaeVkDATzKHp9t2zd2nQvcemH0sLfGoxpTj975TeHhHkFOYofQSuJhr2Tl5Rs7//UJgmIikLpmMRZvuIkr1pN5&#x2B;miRfeA4jn&#x2B;9E/lHMlGYnm1vQciuPXUpQL&#x2B;Q37kBELFNjB42t1stVngH&#x2B;wvaLeeiGJ6RpGCaYKMANPV6a0tLi6mtrc1MGX4SPE5OTvYiNouHwF0eczv59hZUHcpD7eliNOaUc9o9Zd9jV01H6uNrEDQp5uIAFgP0xTtOY8oDy9FcUIP0/2xDyZYMdNY0Qd/SxddXsULGf8vE1iwS/JOqZYhOS0H4nIlIuHkeApKjRnRsFwP&#x2B;hwoGDEf8z9lrVF7oSuXfVZDB2XYd7atgQgDgagP9wBWi4E9/V61a5f&#x2B;DH/xg/tSpU&#x2B;f6&#x2B;PiME4vFbivm15hXibJ9WSjYcgwF3x6DpdsEiVgKmUoFuVI1gIYkUPwFu7Icd8p00t/Ko/moue8P8I4NQciM8ZiyYRl3bORaFTyDvTHxhtn8Eb92FrY&#x2B;/QZq04tG1NbovF1hwMpitHDwRWrDEXMTuXp/5NwE6GKCRiwuZjYYUZlfgqNf7kDOgRNoKK9GS10TpMwJI2Cr1nnZgaQQvBtyzNgGOV2Xd3dsvO68taGZjx1qpdpjteA/P/8j16QgvQZqURiVPAHf/f3z/Bq/&#x2B;/PfovBgJtRaL3j5eve36&#x2B;sT83O22ot6K9Cu5vZ&#x2B;F2s97LxSwEWwixvDvVn&#x2B;Li8vLwkD/2bK8lN9P7XuE87Q5TOr0YzNT/8dtk62NrE5gFrnWU0WXhZ18s0tyP3sAB5N/ys0IT4XNIeSUSChZOdp/DXlcc5y625o5UFvWo9IbI&#x2B;SS9Q&#x2B;kFqnhs&#x2B;fiPAZCQz0z0XwtPH2crzLCZqcZOqHU4PvqAxg8GectRIcjtCgo885ChAIsbRrOwBwqSn&#x2B;l1vB31m9/6VS8B/y7/333x9&#x2B;ww03TJo2bdpcX1/fKLlcrnXXBbmltA7Vx/KR/&#x2B;0R3r7PUN3Fj4SEzaSavpI7GwSsINiVPxN6QKZWcHDUUlyDuqwS5GzaC9&#x2B;4MEQtSkHSHYsQkBjBMxHRi1Nwy/s/wTeP/xmlezLYaxdPg6b2efQggTa1rwZBU2LZby3EuKWToY0MZA7SyJYgEoKrL6vG4c&#x2B;3Inv/CVTmFXFVdzpe6gGv1p4VC7T1CDfyFQk8rT1QajyxYP1qZO4&#x2B;jIIT2fxaEvgnbZbO1na0N7dgxYPr7UOdOc5P/OlFPL/sXsjVSgHMj9J6qVApkTB3mnAyLsDa29vNRPGnrCfV91PbPuYTiQMDA4XaErcZ22yO8bDy8jebyAarwcwFaGUaFW&#x2B;XZ2juwuFXP8Oy395/QfcLj6L2etSdtS2cvUS6KtSOT9/RAaVOg9CU8YhckIS41akIm5Poskb/cgYBXNXnD0eRfzDwH0q4z9F2HZUFOPstQQ/g2g0AjHW2390V/IdD9b&#x2B;YOv/&#x2B;Nn7z5s3TPfXUU7NTUlImh4eHT5VKpWp3HRxtFY2oyy7B6X9sQ9GeUzDUdbEJwgq5Ss2znSKBQiTY1RwHYOBILJJw58PGwFNDTjlqThXi1D&#x2B;2wjsqGKGpcZj&#x2B;yCoEpsRg3ds/xFvznoK&#x2B;sQMimXhYpQB9GVbKoFhNVih9PKGLDEDK3WmIXjqFt/CTKEdGBCJnurGiBke/2omsfce4qF9HUwvvYkDqyArqTDCWLegEu6RG2bH6kkrUFFZg9WP3wKDX48zBdJTnFHA2gG9YINLuXIsJs6f2fyd9&#x2B;wFYLWY2BgScNSpBGHbPJS&#x2B;cicDoMOFkDGF9Nf2lpaXdOp1ORkAkODhYQbX9wtlxx8Ftw8TrZkPj74ugyeN4Rr4htxyZ7&#x2B;3mgUaZlwoVB3M4U4Ay&#x2B;sNZY/0nhiPno/32LiU2e4cSs0kPhZeGd7EJnzcRk&#x2B;9ZxoPuHmL3bqvpjJrvKiDgDJy7EvkbbmcAVzoBjrYr2LURALic2f4LFfO7HAr&#x2B;oyrqFxISonjllVfmTZ48OSUqKmqqUqn0ddeBoW9sR01mMXI/P4Tcz/ZzgReRVcSpXgqN&#x2B;jylUcEEu&#x2B;qNFk2JGBJSGlbKOWCvyyhB7ckiZH6wG8HMEYpfPZPX5mdv2ssdIVd0Orpvetg2eqxUciBFyLTxSLp9EcLmTEBAQjjXzxjR7rLfry0ux&#x2B;HPt6PwRCbKsgvRXFvPA3bUwUDl5dWL&#x2B;W39xyfY1TJW7eJYx77ZiRNb92DdD&#x2B;7HqkfugE9QAK/778ua6Tu6kEmCf1/txPGvd7MxIbSrGy0jIcjrH7&#x2B;HnWuxcDIc&#x2B;Rh6vbW9vd3S2Nho9PLykjJ/SJSUlOQFCCX97m5ihRS3/PO58zx&#x2B;ouof&#x2B;8tXnDnXVt6A9qomeMcMT58m/vqZOP76ZnQ1tvKyotAZcQibHY&#x2B;J62YjfG7ilQmwnIj8OQLnzgIHzoIKjoIIw/XHXTEAhDKAayMA4DGCz19stv9Sivm5pYL/uHHjlM8&#x2B;&#x2B;&#x2B;yUlJSUuIkTJ87RarXh7jogqHVKdXoBirefQvb7e9FYVAGbCXawoNLwIxJAv2CC9baDY86OTC22C6RZelC&#x2B;Pwdle7OgCfJ13nqPfY/ojAT8icrvnxiJiTfNQeSCZJ7loHKCkRrV8Z/ath9Ze4&#x2B;iJCMPjRXVDAzKIJGIoPbyHHDvCqU6V7uRIj/R&#x2B;T/8zV&#x2B;x5c1NDOCrEBIbzdtGmvQGNjZqUV9WydtZ8o4Fgo2Kmbr1mLxsPm&#x2B;VKNjZOZOy/MXFxV0qlUpM4J9q&#x2B;jUajZr&#x2B;L5yhKwg8OKm1n3T3Yuz/0weQQcE7AxhaO10iiYHrDwn33fHZz9Be3WSn&#x2B;s&#x2B;Mu6qCZ858Zket/Ry97ygocKGfGRx4cLZfQgDg6g0AXCrgP1S2fzQo/iKMvYL/hdb587Z9Tz755MQZM2aMnzNnzhq2uAW6a0ib6kEb86pQuicdp/&#x2B;1C3VnimBpM0MqV0AuVwPyfqgAQfRbMMEcg3pyiKgVIM0Cxvauc8T5CID1mK1cwZ&#x2B;y&#x2B;rrIQEy8cTail0zmWQ6518iBV3tjCwf9p3ceQsnpM6gvr&#x2B;Kvk5if2tur/94VAnfXorMugkqrYYBfD2NXN&#x2B;pKq/mMTp0dyMEmoUfBRulcs2WeRMoM3Xrc/d9PCieEWVdXl6W5udkklUpFpOBPtfzsuUdISIhSODsjN9KLoW4T7mCBk6Jhgal/3XO03nTVtfE5ifZbpj034E3lBPS4mucHV8J7zsD/UC3&#x2B;nG3PUQDCFbNAsKs7AOAxgs96jAD4jxbF/1Ir&#x2B;F&#x2B;0qB8D&#x2B;ZKHHnooZvny5UmpqamL/Pz84twWr/TY0FpSi9yvDiHzvZ1oLqqBsanLniVkD5lWIWB9wQS7qJvLDrjoHuuxWmHuNkKmksMnNgQJt8zjbYoCk6OhDtKN&#x2B;Keaa&#x2B;pxYvM&#x2B;FJw4jdKMPFQXlPLMrkwph9JTdc4&#x2B;CXatj0s7Y4VUaJRUYysEdC&#x2B;Jd2UyGKHx1uK7r/4MAZGh1zToN5lMPdXV1QZS8KcECIn5BQUFCQITo2iFm49j9y/&#x2B;g5jlUzD1wRXQRQVelv0gAcCOmmbkf34USni6hBvt1Y0QSUScgaSLCLx2podBgn7DEQR0FShwBeiH0hAY&#x2B;HrfZ11pFQh25QcALhb8Xw7gPxIBvzFT8BczW7Vqld&#x2B;jjz46OykpaWpERMQM9wX9NPE2oHRXBo6/sxlNZ6rQWdsMqUTBBaMUOs3ZLKFwjwsm2EWBLBL&#x2B;4u0wFVJogn0Rv3Ymxi2bgtDUeCj9Rl5f3dHcxjP9uQdPIP/IadSWVvIe7HIG&#x2B;km9nXpiC2wdwYYap4KNvnNvNrH7XirFD//xCsZNSbjmzgEp9jPgb62qqtL7&#x2B;PjIJBKJx8SJEzUedhMGyShbXVYpvnrkNQa8m1BxLBc5Hx/ATf9&#x2B;hpeSjcX5pgB3WxnzKXdnIvvDvWjIruAt&#x2B;&#x2B;y&#x2B;ZG/r0EFTDekCtJXU8yB5J5oRvXDSNTtfOHrNVXtAV4KBzsD/hbQJHO57QgDg6gX/F0L3Hw7wdxQIEA0RBBBdwPPRUPAfivp/noL/ggULvB977LFpKSkpyePHj5/HFjq3pbLpmzpQtj8L6e9vR&#x2B;X&#x2B;fHTUNkFss4v5qbXaAQJgwo0tmGAX6whZDRb&#x2B;3DPYG3F3pyJm6RSEzZoATejIdT672jqQve8Yf5w5nI7KvGJOr5TJ5VzQzQOCNodggl2&#x2B;eIoNnS1t0AX54/HXXrimwL/ZbO6pqKjQi0Si/2fvO&#x2B;CjKtOvz/SZ9N57SEhCEnrvvbhKExDsfV3XvtZ17Z/rusW6uur&#x2B;de3rWlBRQUGlSEd6D6EEkpBeZzJ9vvd5ZiYkYVIgQJLhHn6Xmdy5c&#x2B;e2t5ynnEdmMpnscXFx2vT0dD&#x2B;tVivl9J9HlO87jg&#x2B;nPop6CqcXA4AuKADVR0rwwbQ/YfrLtyJn4bjz9LADlflFKNyUh72frUHxr4egL69hQVwyeivUKlj0RjhsdohpZrMSffqSaiy5&#x2B;SUYa/UcGZc1fBR0oRe36GhHvO5taQN4MhS0BDsF2qgk4Ok4JAOAdxkAzpb8t&#x2B;X17ylh/edE1G/EiBFBs2bNSpkzZ860hISE/iqVyq/bDsoNZhz8diP2fik66E35qDxRDJioBrQOPr5&#x2B;Tg&#x2B;hRBYkSDhrkHYGK/hb7fCLDEbKzL5ImToQiaP7nJMwTAol3rduG3auXI8DG7ejYHceh/crxISKxNpIc8BdPlBqxRIkdM3k3WIycWrF8NlTMf/h3yE6Nd7rz5s8/SdPnjRS2iOV7wsNDVWTAcDPz08pEYfzj/riSvxv7jMwVNbDLyoYETmJyF&#x2B;2FeoAHawGIxZf83fED81AUAv1/SM/bkdYZgL8Y0LO&#x2B;rd/fvI97PpwjTiGCh77KJSfSL5DrhDE3yTYkQzhWfGIzk3FwFumsbAfjVFHft6JJbe8gppjJZCrlQiID8PcDx&#x2B;QbiZaV/dvq0RfayUF29q&#x2B;mR3HA9mX2q53GgBkZ7hNW&#x2B;S/PQE/oHVF/rY&#x2B;O18efqATCv4DBw70nzZtWvyCBQsmpqamDhUDXgjOrnTi&#x2B;SckJiuOb9yHbf/5Hie2HUTl7kJXaLAOWqUvoGY/ISS6IEHCmYMHU5sdFqOZJzR&#x2B;USFI&#x2B;80QxA/PRPyw3gjpHY/Ojp8kHLZn1Ubs37ADR3buQ97mXU6CoVRCywKDMmfv45CMdxIkdCWsZgv01bWI75OGG//6MLJGDvTqCbTBYLBSeH9FRYVZp9Mp1Gq1IigoSBUREaGRnoYLi02vfYvyvCLIVQrkXjkO4564Cque&#x2B;ggbX13CHniTwYQdH/2EsY8uava9f066FYlp2QjLSIBvZDBmvPxbKHXqM/rt0iMFqCssY9FBmSD&#x2B;JCqqUCgR0icWsblpyL12IhJH9mm2X9IH2PDS16g9UcZjmEqjxtXfP4Og5EjpZnowBrSm0t/a3x3ZV0eMBi0NAxJ6vgHgXJD/s/H6dzS0v718/o6W6&#x2B;usgn/j&#x2B;/j4eM2UKVOirr/&#x2B;&#x2B;jG5ublj/P3947rrzaWw49L9x7Dj/R9x5JedqNhzHGa9EWq1lvOBZTJ5s5JfEiRIOBPW7xwQrQ0m9rhrgvyQdskQDu9PHJeD0LSYTv8EKYaTh3/36s3Yu34rju3cz&#x2B;JICpWSS7iRoF/TQV9qxhIkdFV/IPoCixVW0WaDYyIw49ZFmHDdXITFeieRaWhosFFY/9GjR/VhYWHcEVF4P3n7pYeh67BTzPdUYlzQBvliwM3TmGxP/PN1OL5uH4q2HoLWX4cT6/afPtbAjNrjFajKL4FMKce0F24&#x2B;K4JqofFQkP&#x2B;Q1BjEjxqF9BlD0PvSYVCola2Oo3azhWfYMQN7YfrLv2VRXAlok4yfKZlvzYjQXiRAy/dSJID3GADOB/nvSHj/2eTudzaM/6zF/Oh19uzZUQ888MDUjIyMYYGBgfEyYs/dcQ5CCv5HT2LXx6uQ9/NmlG47BlOlgYX8qMSYb5BGygeWIKFTbcwOi94M6gFIK6PXtEFInTIACaP6ILJvUrMSf2cDEgrM27IL&#x2B;9dt5bz&#x2B;/G17oa&#x2B;t45x&#x2B;lUYFtTZQasMSJHSTSTlpfJgE6VGKMTYyOQG9h&#x2B;TgN3dci4gE71P5dyv3U24/KfdFRESoMzMzA9RqtVwiBl2PvO82o&#x2B;JYEdRKLfrfM6sZkc6cOwIFa/dA7auFqc542nflgrooxHhGIfgKMc7IziKY1T8qFH1vmIjUcQOQOWckVL4dCwCJHdYbg&#x2B;&#x2B;4FCnjcqH0kYJGOmII8ETi2yoT2JqAYHvGgqbbSbh4DAAdIf&#x2B;thfyfaS5/R1T5zzvJb/k6bdq00Ntuu23YmDFjZvj6&#x2B;kaqVCqf7nqzao6XYfdnq1hxtWhzHupPVnH&#x2B;lVqjgzbQ9xR5kQiDBAlnTvptdvbs2S02aEMCkP6bvkgYkYW4kZkc5i9TdI70U8jwoV9349C2Pdj3yxYc2LgDhrp6KJRKQfjVXDpMIv0SJHSPCTilz1nNZpgMRgRGhCA1MxUj50zDiDlT4RcU2E0TAc&#x2B;yb7Ja7QUFBQ1iDqSsqamxREVFaYj8Szn93Q9f/fZF&#x2B;PoHsAbN2CeuavZZYGIE7CS&#x2B;J4YPlVZ12ncNqIW5xgAoBCG02nE24WSTH7/hjNMGyOAw&#x2B;pEFHNUm4cwNAe0ZCDwZBFqS/9ZKDbZmaJDQ8w0AsvNM/luq&#x2B;Xc0b/9My/Ghk2S/WYj/xIkTQxYsWJAxe/bsy/39/aM0Gk1Qd72BdjEJyV&#x2B;&#x2B;DXnfbsLub1aj/pgg/TIF1L466AL80JgQLEGChLMi/aReTORcE&#x2B;CDpHF9kTQ2m739MYPTO99&#x2B;xf6P7NiHA5t3YPdK0YbXbBLEwspRPFrRhn0CTumISgOvBAldOtsW/YGNQ/xNhgaurhGXkYKxCy5FzoThCE&#x2B;Ihkqt9prTpfD&#x2B;2tpaS11dnZVC&#x2B;gX5VwQGBiojIyMl92w3Rf73W2Esq2fPfda80adpzjhsDte4Y0NgUniLDx244qlHYa4woGj7YVjqGkge/szJj059Fk1LJpH/c2AMoDlCU1LvVvdvrTpAUyNAy/ct5x2tCRFK6LkGgDMxErSV2w&#x2B;0nd/fVV79jm6rGDx4cIAg/Mnz5s2bHhsbm63T6UK6800xic752Opd2Pnuj9j96RoW7lPrdPANCnTSfSmvX4KEsyP9ou2Qer/VaGbSHzc8k5X7ifTHj8zsdHg/pQ8c35&#x2B;P/espr38T9q79FQ119fwZkX61VuMcwOGQmq8ECd0ApMNhNhpZcyO6VwJGz5uBzJGDkdinF0foeEu/p9frreLVcejQIcrpZyaXkpLiK&#x2B;X09wwc37SPBWGphB7l0rdE&#x2B;b4C8bwqYG0wI3pAWksGifF/urpxjCKtqLMh8xK61gjQ8v2Z5Ps33cZTuT&#x2B;pIoD3GAA64v1vz/PfHvmXtUHsgXMYqo9WvPntGQPeeOON4aNGjRqSmJjYj0L8e8LDdWLzAax6/EMWdDHVGaAN8mus8y15CSVIOMtJvpgUOew2yOUKRPZNRuIYp6efXinPv7Mozj/G6v17127hvP7qknI2JmgE4ffx9&#x2B;NeSQrxlyChiydGVD7T7mChTQrzJ89kZHIcRsyajP6TRyOhTxqX9fMWmEwmW2lpqZnK9SmVSll4eLg6JycnQKFQSDn9PcyAU3eigr3&#x2B;RPKLtx1q9jmlBOz5dA3rQNXVVSBz9og22oAYl/x9pIvagw0BrQkCtvdZW9u3picgoecZAM7GUNBe2H9H8/rPhSdf3s42itb288c//jFzzpw5o9LS0ob6&#x2B;flFioe5R4zm&#x2B;tJq/PK3T7HrPz&#x2B;hodogSImKPZRSnW8JEs5mxgT28pO3QyYm9DEDeiF2cDriRmQi/ZLBUPvrOj0hKz50DPnb9nC5vm0rfkFFYakgDzIoNWr4Bvo3bid5&#x2B;yVI6NoJs43C&#x2B;03OnH6tID&#x2B;RKfHIHTcc4xddioikOPb&#x2B;ewvsdrsjPz9fHxAQoKqsrDTFxcX5BAcHqyinX3oaeu4z7BcTzOMJzQ33L16PsgcKEJ6ZgPKDJ7D8wbdRfbgE5voGjPrdPPhFBUsXzUufg45u09ESgG1pCkjwLgOAJ6&#x2B;/J0PAmZL/dsPwO0D8Fa181poxgLdXCMyfPz/mzjvvnChI/6CgoKA4sapHjeYnNuzHpwv/jKqjxdD4&#x2B;ELlo24kMRIkSOgwK4fNQhN9CxPxsPQ4JI7NQcqUAUid1A8q3853C2XHi1jBf9eqTdixfC1qyiudKToaDXwCJDFOCRK6Dem32jgfuqFeD52fLyKT4zFq3jT0nzRKkP54TsnxFlRXV1tcZftsFovFIeZBKsrrj4yMDJCehi4YiuwOGKvqUXXkJGIGpZ2TfSYM64OVpg/g4xsEu9WKD6Y&#x2B;isicZJTuPYbqYyWQKxXoM280Jj1/g3QDLiJDQMuQ/raIflvefkkHwPsNAO0ZATpK/lsL/T8Tz/2ZrDttvzfddFPCNddcMzo1NTUrPDy8t0ql8u2JN4NU/b&#x2B;8/u&#x2B;oOVYGn6AgJ&#x2B;uXuIMECR2darFyP&#x2B;U9ylRKhKRGIX5YJpIn9UXa9CHQBne&#x2B;W6gqLmNP/85VG7Ht&#x2B;zWoLq0Q5MICjU4niIUP51dKYXMSJHQPkKgnCflpfLQIiY3CmPkzkDNuGOIzU6HWeo&#x2B;nnwT8qAM8evSoITAwUEV9EHn7KdS/p5zD998vQ2xsHLKzs73qGdz2wXKsf34xEkZmnTMDAKWspU8bgkNLtkIdoIOhohZ5yzbDWbFahl5TBuHyTx6SOoCLZebjIvDtVQtwb9t0Xct0RGn&#x2B;4j0GANlZrO8s&#x2B;e8ssW/6eavbTpgwIeSRRx6ZlJiYmJySkjJaLpf3aGPM7k9WY8nNLzHh1wX6SQ1QgoQO9nA2szOkV6FQIDQthvP6kyf0Q&#x2B;9Lh8InIrDTP0Ge/hP7D2Pf&#x2B;m349buVqCgqcZEKHdQ6NeRyXbP2KrVdCRK6oCsg/TrR9EwNRib&#x2B;lNMfkRiLQdPHYMglE5GUm8E5094C8vJXVVVZKisrzeThp9J9WVlZASTk1xO9ds8&#x2B;&#x2B;yymTp3qdQaAEjF2lB88joSRfdpicDDVGFBzvBx&#x2B;0cHwCQtod9yb8/b9&#x2B;PCSx1Gy6yjsDjt8QoMQMzQdKRP6YtCt06UO4WLq&#x2B;86gTKAnbQD3dna7vVWDgYSeZwDoiHGgvSgAT8YAT&#x2B;S/tXD9tkj9Gb3v1auX7vnnnx&#x2B;blpbWOz09fbRarfb3hoeoMr8IX934AnsvVTqN1OAkSGgHJHREZftkoq0EpUQjIicR6TMGI3PuKGgDnZ74zqCmrBIn9h3C9h/XYfPSVagqLmWFcLVWDaVKDVWwWhLykyChG0x8qcSmxWyGpcEEhVrJJfsGXzIefSeMQEJWGlfb8BaQcn9eXp6ecvirq6vN8fHxuoCAAJ/ultNPfeLy5csxatQo&#x2B;PicEpkrKChAVFQU1B7KKI4dO5Y/6zH3Qjx3lYeLUbzlEHpfOgQqP89pJApBE1QatdNA5QHGaj1WPvURClbtRNXhEgQkhmPsHxcia96oNn9fFxaAK756DCfW72fi5hsRhPhhGZCrFFLHcBGjLVG/1owAbRkSpBQA7zIAyFp5D3gu&#x2B;Qd4Lu/XFvlXtPG&#x2B;Jbn3tDRul5yc7PO73/0ua9q0aaOSkpIGiIEuxtseoh8feQ8OqwMqH40U8i9BQiuwW22c10&#x2B;GsoDYEET2T0Xa1IHImDUc/jEhnSb9hjo9ju7Yiz2//Ioty1aj&#x2B;OARWG02qFQqMYFT8SSu5SArQYKEC0/6bVYrkx6jaLNqHx1CY8Ixcu50DJoxDhGJcfAJ8POa86Xwfsrrp/MmBf&#x2B;IiAiN6JPkMTEx3TKHwW534Pbbb0NNTS2ysrIaDQAPPvgAPvvsc7EuA&#x2B;LYodXq8Nhjj2PHju34/PPPsXr1anz55Vc95r5UHCrCa31uhVGpx2NF30B1lvv57vevY&#x2B;OHXyE4MIrHsPLdBVh271uIHZyGwKS2C1aRwF/G7OFSpyDhNMLe3hylve2kVADvNAC0ZhTw5O339B5oO9ffE&#x2B;GXt/N3M4NARkaG71VXXdVrxowZRPr7BQUFpci81AxVuOkgjv603VmHVWpsEiQ0n0za7LCbLRzS6x8Viqh&#x2B;KUgan4usOSMQ3KvztkBjvQEFe/Owb91WbFjyI4rzjsJiMkFBpF&#x2B;rgUYhl5T7JUjoDhDjo9VqE21WD62vDwIjQzHt5isw&#x2B;DcTENMrkcX9vAVE9EnBv6CgoMHf35/nmdHR0dq4uLgeoVZ40003IScnt9HTbxJ96sKFC&#x2B;En7tEzzzyD0NBQWCxWrFixHNXVNRg4cCBefvkVpKam9ph7ZLNYQAHTKQP7Qx1wdqX0tr&#x2B;3Ars/WYWhV83EmEcXYtdHP2Pd85&#x2B;hvrgS5QcK2zUASJDQFsF3awOc3pU6PBoCWhoFJO&#x2B;/dxoAZB00BshaIf2tvbYk/x01AMgphO3uu&#x2B;/uLUj/0MzMzNFE&#x2B;i&#x2B;GB2jDi4s5dFGulKrySJDgZP0OWIxmnvDrQv0RNSIT0QPS0Pfq8QjNiG81lLKjMNTWoyjvGPK37sa6L79H4YEjMNTUQSkmq0q1Cjp/P48DpQQJEi7sLEUm/pmNJk6/ofz98Pho5E64FCPnTkNSTkazqJyeDsrpJ29/UVGRMSQkRKVUKuVZWVn&#x2B;Micu&#x2B;PGYzWaPofqeYLVaoFQ6feBy0T/37z8A77zzNm688SbuQysqyun8sH//Afztb3/D3Lnz8Prrr6F3794YOnQYIiMjcfDgAezatQs5OTk94n6FJEfj1k0vIzg5Cvqyap74Uhi&#x2B;TCHv2DUzmLH275858/nf/wOvSx6fizXPfiL2IcibzSb1ARI6bQRo77PWUgak&#x2B;Y/3GQDaK/HX1metqf17UvlvSf4VrbzK//CHP/SaPHlyTr9&#x2B;/caFh4f3lTllTC8K1B4vw/GN&#x2B;0m9SGpJEi5qUD4llexz2O3QBvkhrn8qT4ayrxiDkLRYyBWdayNU87v48DHsW/srfvl0GcpPFKG2otpF&#x2B;pXwDQqQBjsJErrBhJVC&#x2B;6kvMJtMYmiUI6ZXgjOnf9wwpPTPdub0e4Fjivobm81Gyv16jUYjr62ttVJOf1pami8J&#x2B;nXVMW3duhWvvfYq/u//3ml1u/r6eixZsoS9&#x2B;lu2bME999yNf/3rDfTp4xS6y8s7iJdeehHifPDjjyuwePFiGAwG3Hvvfbjjjrt4m6effqZxf4888jAKCwtx3XXX9Zj7V7a3ANve&#x2B;wFlO4&#x2B;jrqgCMpUCgXFhGHjrDGTNHenp4p5mNCnYuQdJObmnjC71RsjEZjTehWcnSh2ChHPev7aMCmgr1F9KA&#x2B;i5BgDZWX6nLdG/lloAreXvn0b03euVAjfddFP8mDFjUkeNGjUpOjp6iFjlczE&#x2B;PJX5J1FfVMnhxhIkXHSkn3L6qT63WDT&#x2B;OkSmJyFlYj/kLBqHkN5xUOk6592zWiwoOXIC&#x2B;9dvw4avV6BgTx7qqqohlytYzM830L/ZxFeCBAldMitlb6fNaodRkESlGA&#x2B;Do8Mx/LKJHN4fnZoEv2DvKWGv1&#x2B;ut5eXlZpVKJTOZTPbQ0FC1QqGQCbLcpfMg6gNfffUVfPjh&#x2B;5g/f2Fbx4/Zs2dyzj4ZAF555WXccMONWLnyZxbx2759K77&#x2B;&#x2B;mscPpwvPl&#x2B;EuXPn4P77H8S4ceNaDfG/&#x2B;uqrkZmZ1ahC3p1h1hux7Z0fsOqZj1FWcgw6&#x2B;EPr48vHXrhvP9JnDmn&#x2B;eMvlnELW1IhtrKrHrv&#x2B;uEgRCDUNZTeP6vZ//AqNNj0HzLkFgQoTUN0g4p&#x2B;S/6asnUcC2ygVK6FkGgI6Q/Lb&#x2B;bq1KQFtGgFa9/ldeeWXU2LFjk2fOnHllSEhItiD9vhf7w2MjjydnkUkNTMJFQvopp18sNqMZ2hB/BMeFIXF0NrIXjkNk3ySofTuna0Wkv6ygGIe27sK6L35A/tY90NfUcQtT6zTwofB&#x2B;GtAkwi9BQtf2BeQBt1rRUOfM6Q8IDcK4RZdi1LzpiE5JhK&#x2B;XkX6z2WwvLCw0&#x2B;vn5KahUnyD&#x2B;GvL8d8XxlJeXQ8zDIJc7f/7QoUN47LE/8T358sslbarxv/TSC7j88nl44403sXnzZmi1GkHeM3D77b/Da6&#x2B;9hqqqKuTmZuO7735AUFCgeJ/b7vEQ&#x2B;efJpbx7R0M2lNfh/emP4cSWfYjsnYght92OpLE52PPJGuz88CdERiajz&#x2B;VjmjzkYp5ntPJ1peXA1xtwePl2nNiwH6U7j8DXNxANVfX4dP5zbATb88VaxPftg0v/dYfUQUg4r31vU&#x2B;Iv4eIxALQ0BnTEEOApEqClIeA0r//48eOD5s&#x2B;fnz5jxozfxMTEjBek3196ZE6B8puValL&#x2B;t&#x2B;NUcQUJErxssKHFYoPVZIZKp0VwajRSJ/VDzpXjEZYZ32nSTzh5&#x2B;Dj2b9iKtZ//gBMH8mGoqmEFfwoX1glyAXkT0i8NeBIkdM2EQ0w4LWYLzA0NTPbCk&#x2B;Lwm9unIGvEQKT078OGAG8B5fQbjUbbsWPHDIJsq&#x2B;ncMzMz/cnb35XHZbVa8cknH&#x2B;Pmm29tzPGfOnUypk&#x2B;fjldffa3N71Lo/&#x2B;7de8R2/4ROp8OhQ/l455138P33P3A&#x2B;/4IFCzB06FBkZGRCnKfXPb&#x2B;/PP8pjm/ZA5VCgz4LxrBwH6Wt/fSn92CpN2HeJw/DLzK4cfvKQ0XY&#x2B;9Ea1q/Yv3g9dr73E&#x2B;r1VWLSLIdPUAACIkJRdaQE2z79QZAJJTJmDMes/9zrFIWWIOE89sNuQ0BL77/k&#x2B;fdOA4DsDIwALdMA5G28b1TyVyuVipSkJN1Djz6aO3jw4CHp6ekLBOkPlNitZ4RnJcA/OhR1J8qkKyTB61i/TUz0bRYr5GLyE5oWi9ihvZGzcCxiBqdDE9C5iT5FEVQUliB/&#x2B;x6s&#x2B;d93OL43D5XFZUwqaLKl0mqhljexbkukX4KELploUhskET&#x2B;L2cwCn&#x2B;GJsRhyyXjkjB&#x2B;GjKH9oNZpveZ8Bbkm5X4DvafwflLuF8TYX6vVKrrLhNpisWDv3j2Nf9fW1uLo0aPYsWMnTp4sQVTU6crzRqMR4hzw1VdfYtWqlejbNwfXX389h/b/5z/vsZd/9&#x2B;7duOKKK3r0/TPV6FnRv7V7pS&#x2B;tcVWFcWDDy1&#x2B;hfH8B/GPDuJrTzHfvRa/pg9ijf3jFNpRsP4wDSzZBXya&#x2B;I3bXUFsPta8OycP7IXlCLvpfOxmaID9sfvUbmOsNiMhJQubsEdAE&#x2B;kodh4QL2j83fS8JAHqnAaA1st/ae09VAOQt3jeLCJg7bnzokw8&#x2B;eGNCbs4lmoiIMOnxaBsqHw0yZg3Dpn9&#x2B;IyUBSOj5nF9M7imf32a2cr5jQHw4ogemou9VExA/MhM6CumVdWb/dtRVViPv111Y9/lyHNmxD6XHC5lUKNRK6MTkqumQJQ1gEiR0zaSS03wE0WwQxIZENoMiwzF4xjgMnTkRMWnJCAwL8ZrzFUTfRsr9Op1OUVNTY42KitLQ&#x2B;oCAANWFJv3U59ntNigU7U1NTx2Xj48P/va3f2Dlyp&#x2B;wcOF8fPPNd/D1bU5Ci4oKkZKSimnTpiM9PR2XX345pk&#x2B;/BP7&#x2B;/li0aBFuvvlG3Hbb7T3y/pEHvmzvMex4/0dB6E/ALzwIs969D/4xpz&#x2B;jfeaPEoQ/BJV5hcj/YRv2f7WBI9vSpg9BYHwYlj/4Dk6s24eC9XtI4BFWmOHvF4LgjEj0XTgJ6ZcMRkBCRDN9m3FPXil1GhK6tL929x2eDAIS2rh23eECtTLIyDz83RbRl7f4u2lJP3mTdZ5y/Hnx1WpVeqNRtvxfb86cdOvNj0uPR0cGn5N4d/xDMFbrpYshoeeRfsptZAV/M4tZ&#x2B;oQGIJnC&#x2B;xeORXifRATEhnb6N0it//i&#x2B;Q1j72VLs37AdZQWFLB5IJcBUapUrvF&#x2B;6FxIkdN0kxJnJZrdZYajVQ&#x2B;OjRUh0OIZeNgn9Jo1ATC9B&#x2B;sO9h/S7S/ZVVlaaqVyfVquVU&#x2B;k&#x2B;Qaa71Cn0j3/8nRX4X3/9jbaOHffff5/Y9sXTyvzNnz8PJ06cwM8/r4RGw3YMJrI//PADpwgQfvhhGV588UV8/fU32LZtK2644QYEBgbil1/W9owxy&#x2B;5A7YlylOw&#x2B;in2frsGBZZtRX1oBm90KFTRiOFFg&#x2B;ANzMPm5G9rcz1uD70LJzqMc4Ual/&#x2B;xWQfcbjLDACH//UAQmhYtxcDwyZo5AaFo05Cqp1LOE7j&#x2B;faxkBQK8KheIa8dYiFrPr1erh1f3e5lqsTd43XexNXpsujiavTZfGw/N0vF0Jb9EAaC8yoEMVAAT5p&#x2B;/Ij5mMZR6eLKf4loRmoBqy6ZcOxebXvoEmwFcKVb6QT76jnY6Qt5PxhIE7RQopt9tPdZC0Xi47Nftt7flu57d6ItjDJ0i/XKmET4g/YodnoN&#x2B;1kxCZm4TA&#x2B;PBOt/U6Qfrzt&#x2B;3Fui&#x2B;W8WvVyVIY6w1Q6TRQa7UcYXAqvF96nCVI6JJuVLRzFvKrbxCTRDlCYsIx&#x2B;YZ5yB49GKkDsptV2ujpE2MS8qMQ//z8fH1ERISaiHFaWpofCfp1h/B&#x2B;k8mIgoJjuOKKRWcw9XOipKQEhYUnOMyfzqWlGN/PP/8oSH4ANm7ciPfeexdr1vwCpej7&#x2B;/TJxssvv4JRo0b1jHHLasMPD/wbe/67BlXFJ6GUq6FUqREUE4Vxj1&#x2B;Jg99sxOEV21G4/gAseiNULfRpGirrULBmD/YuXoeyPQXQBvtyykDVoSIofFWIzknlKgAkBEgpnnKVQuokJPSo/txtBPBUGUBCzzQAyM6A/Lck/jIPxL9to4Cvj8zDk9XcEOCAJH7vwoj75mL7f5bDYjSxaJkUduPh2XERcgeXjLIz8SYCzh5oQcrlMjnn5lEpHtF18WeQNSfz3KmJiQ1NWMWcDTKlgkvREYl1CALvJPpyyBQytupT/jqHl2vV/Mr3R6eFucEkPpdDKdZTSSACeaJpQmi32DgHnW6hXfzNngGxjo7XfczuJiaTuQwMVCKIKwWdWsfnK77rth1wJ9zF6vV0na1GCx&#x2B;DTpD&#x2B;mDE5yF4whsP7g5KjXMaQswep9VOpvo1fr8Cetb&#x2B;i4sRJmAwNUIprq1Ap4RsU0MwqLUGChAs/QSRwTr9YqE&#x2B;gkn2jF1yCfhNGoPew/vAJ8POa87VYLHYK7zcYDDYxtjgopz87OztArSZNv&#x2B;41M1arNXjssSe4HF9HhtTKykou1bd06VJ88cUXqK6uQr9&#x2B;/QWhfxmqJqWJScyP9n3ttdcgKCgI77zzLvz8nIYdSh8YP358j7mf6/&#x2B;xGGtf&#x2B;AwKqBCWEAeLwQSryYKZ/3c3UqcMQGh6LPKXb0P5wUIc&#x2B;GoDsheNg6muAUdX7ULx1kM48sM2FG8/DL2&#x2B;BjG9UzHvs0fE&#x2B;G5F8bZ8RPZNRvSAXhJhkuAVfbwE7zEAtEb00Q7h96QF0DICwJ0C0LhOECF5myOP2xJAbE561hCUFIE57z&#x2B;Axdf&#x2B;jfMmKZTa6wlOI6mXCW7tqv1rdziduXZn5I/d5nCRZrd33cH8V&#x2B;2jhs1kEwRcxYRe5aflfan9dU4CrlFBF&#x2B;QHS4MZ2kAfvpYaf1/ntRVkUiW&#x2B;T88dlYWzmm1sDFD5agSZN4vv&#x2B;fDP2wTZV2jUnFtOpFehUvD3QQYCOS1ObwJ5wonw28R&#x2B;&#x2B;JEWX6btaBu71Q4T58Cq2JhgFhMJmVLOOfI2cWwcOi/W05kZq/Tceuj75nqnUYF&#x2B;1xll4HzPJgJxrHZa5zKgycXkjK4anYPbgEBGjFOWA3TKcMDnaHHm9fuGByCqXyqyrxiLlIl9mfTT9ekMiOAX5R3FL18sw4ENO1B86BiMegN7E1VaNXT&#x2B;p3JRJdIvQULXTAipHyLxOJNom9S/kKc/Z&#x2B;xQjJo3A3EZqQiKCPWa87VarfajR48a/P39lRUVFebY2FhdcHCwinL6u/t9&#x2B;vDDD9hDbxHjCinyN&#x2B;07aSHPPg0HeXmHMHXqFJSVlSItLR233vpbTJw4kfP7m5J/Nx588CEm/2Rgl8t75qRt18crseKhdxCWFIdh98xGSK8YfPf71&#x2B;AXHYz4EZnOa0hGd6pUoTdi6V3/wo4Pf0JATCg2/nsJGw2sMEGr9kPqyP647K07uYoNIap/qtRRSLggcLZB&#x2B;QXrUyR4hwGgNSNAW69tef9b&#x2B;1whBhrZGT1ZUnoAiwFe/f3T&#x2B;L/R9/Nki8inV6QDuEgokze701tPq4gQk2eBOjMi5XSuXPpGTC50pIIrngddkL94tUMXEsi78osOgsPqgDbYT7zaoQnUMdkHhyzKePAmQkx/KzWCuJudvwHywpMwnSscz&#x2B;2F50gChZx/mztVOh5BeJ2RAjJXdIGDj0nmOGW3sNudz6vTKw&#x2B;XgULe&#x2B;AjL3IRbJmvcnhsJRQa4hPLIoECGD4fJxsdFBJt&#x2B;k7xqMo4ecLAysHMyYuL69rYGC3sjbCYL59zT9awuKIXSTwtTtZ7X0XUhjwZdJ4pkoGOjc1OSUQnOCSBcx&#x2B;2pg6dtHOK3yathM1m5VGXU0BTkLhqLmKEZCEmN7nSJIlIDP7rzAH75bCmO7T6I43sPoaFez/eKQvx1fj5emTYhQUIPYv2U/A2b6GMa6urZiBkSFY6BV83EwGljXKTfe3R&#x2B;qVxfVVWVpb6&#x2B;3kr9pSD7Sl9fX2VkZGSPKVGQn5&#x2B;PDz74AJMnT8E333zdzACwd&#x2B;9eKkHYOLVLSkrCjBnTBemfjF69ejXm&#x2B;7cGEvujyILs7OzTBALPFVasWI74&#x2B;Hj07p1xzvdN4&#x2B;a65z9nhf3xT1&#x2B;N3KsmoHTXMViNZp5PkCGfxkpS7acx0WowiTGpFvu/24DI/kk8HIVlxKH3JUPQ79rJHCnAcw8JEi4gKErnnnvuwdVXX4Nx48ZdMEOABO8wALRlEEAL4t/SCAC0kf/f9LM2IwBam2w0pgZcvMaAuGGZuOyNO/HVTf9gz7DGT9dDSJAzB57tFUSmbS4dD7qVcqciNFU8UAhS7hMeIIipAj5h/lz/XR3owxEPRPrl4nOlmIho/LX8HSLkcrWikaiSR52c20RQ3WTV7XV35ys5XNED5noTHxaRbbgIO4f0t4T51NNNnu6zh&#x2B;00owccLVoZefFdrYkItpt8E2F3GxyUanVjGoDaX9uMoMtc5N0hJuZKMfmwkmeexfeULCJJW1oMZpgNDbDUG9mIoC&#x2B;rYgOAobSWr0N9aTUbNGxi4sPXw&#x2B;Ek/A6ZQ6x23iu1IOBROUnoc8VYJI3N4YlPZyc79Dwf35eHDV&#x2B;twIGNO1C4/zBqK6uh1pKQn5pzhR1uYyAk8i9BQleBiFBDnZ7ToPxDAjHuysuQO24YUvtnIcBL1PvdOf3i1ZGXl6cPCQkhq6YjOTnZV6lU9sgJyKZNG5noBwT4M5F2Q5wn1q9fjz59&#x2B;vDfFMlBOftXXXX1Ge3/vfc&#x2B;gLhOHdr2559/wvjxE85o/0899RQLDT788CPnnjgdOYmKg4VQinkIRbERKI2PnvHKvCJsef1bNgas&#x2B;&#x2B;unbLCf/sKtKNiwGza9FTFD03HpS3cidlAalDqN1EFIuKDYt28vMjIyeS5YU1ODr776Gvv378Mvv6yTLo5kAOgwsW/t89bC/NvTA2jp/VectQHAbQRo&#x2B;nqRGgJISM0nJAArHn8bZTuPQxPo1z2yJNhp7PQou4k2edDdPI08RDSgUnkbbWiAeFXBNzyIw/LJkKELC2DvLoXt060lD7jbi&#x2B;70oLuIvcsbz4SfvNcNtuakurUJXUvGKGtKxmVn31I60/pkaP2Y0Dyk/ZQ2gKNt7uu6Dmw0cOkCUPSAJsCV6hDoC5m8ySSNDAtWe2M0gr6ylktE1RVVsHGkobwW&#x2B;oo6mI16&#x2B;AYHIXlCXySPy0Vk3xROi&#x2B;gMyMBQfPgYfv1uNXat3oTj&#x2B;/JRW14JlUbFz0tAaJCU0y9BQld2624jpNks&#x2B;gAz97mk1j9s1mQMmDoGaQOzvYb0E6hkX1lZmbm6utqiUqlkQUFB6pycnAAi/bIeHu9K&#x2B;fs33XQTtm/fjssuu6xxfW1tLUcE0Gdbt/6KBx98APfd94cz3n9HyT/h22&#x2B;/8WgAOHjwIBsnNBrtaakEY8eORXh4xHm5NvrSahgNYoxTK3msJJAXn0r61RZWYPnDb8MOG/xCQjHpuesw8OZpGOa4zDkNlUth0BK6BvX19Zg2bSpmzZqNZ5/9Mwtvkh/ob3/7uzO6VYJkADiHxoH2PP8dEQWUdygFoINoVF2/SIwBFJLee9YwJmDr/vE5Nr/&#x2B;LddR5jD5CwgmZC6PPpVcgyuHkITvyBusFURTJ4i&#x2B;hgi&#x2B;GFADEyN4e9/wQB4waRvyWLN3XvRTjTnyrM3nYNLaNs91nH&#x2B;ijp7bemVNDWVwRToQ6bbZ2/y6NsCXt6VQfso18IvKYbViv8hgjs6g&#x2B;9sZEIEoPHAEm7/9GXm/7mLSX1Vcyqr9FN3gFywJ&#x2B;UmQ0NWkn9qe1WyBqcHIYqWRiXHoP3U0&#x2B;o4fhuR&#x2B;WQiO9J7wfhLvI&#x2B;V&#x2B;yukvLy83CwKqoxD/7p7TT&#x2B;X6SKgvNja2cR0JzTad&#x2B;BO5Jw/hJ5/8F2vXrucQYQrTv/TSmY3b6HQ6HDt2TBDs0Th8&#x2B;DAWLVokSMX083rsf/nLXymtgqsKNDUK3HLLzUhNTeVzorHiL395XhxbAZYs&#x2B;Qo//LAcn332&#x2B;Xk5HjJG291Reu4652JMmvzc9Vj6hzfhMNuRPL4vBt12CcLS49wNRSpcJaFLQf00Vff4738/RllZGSZNmoQJEyZg5MhR0sWRDADnzBjQkUoAntZ5MgTIRcfe&#x2B;cQUV8/LYc&#x2B;cP&#x2B;4SgrtIeuSg5AhMef5GBCdHYv0Li1FfVAk1C6KdH9LEuemkWk&#x2B;ifKSMr1JybjqF7lMtdyL5umBfBKfFcii&#x2B;b1jAKQE6pZJr4PJ3bTY&#x2B;xLYIvkT7LvwgAhYntHK6gDbED&#x2B;GZCQhICEdgXFinhfzMRhMr9m/6xkn6D23ZhdqKKiYaKo0k5CdBQjdg/c7oLQrvZ20RMcZEhWPU/BkYIIh/St8srxLyIw8/hfiTir8g0rawsDCNIKPyqKiogJ5w/AUFBXjkkYewZ89evPrqa2LCPwLbt2/Dzp27cMUVV2DXrl2CLH&#x2B;K7777DuXlZcjK6oM5c&#x2B;YI4v8bpKf3bmYkIPG&#x2B;119/kwUCn3vueQwfPvysjqm0tBTLl3&#x2B;PadNmoKKiAn5&#x2B;foiJifG47VNPPcmpB3/9698ajdVpaWl48cWXccstN7JeARkIZs68TBx/BXJzc/D888&#x2B;zCOF5nem2QOLYXNy05gUxX7E0RgZIkNAVIIPfyZMnue2PGTOG2w1pbyxf/iN8ff1E23kB99xzNz799DPpYkkGgHPeHZ4J4W8aEdA0AoBGHZndbj&#x2B;3LL1FCTQHl1fz/vAXElsbfu8c9L5sODa&#x2B;&#x2B;CXWvbEYKocGar/O6xJxnr7NGc7vzPvWwDciBHJBBoOTosT7QGiD/KATZFHt7&#x2B;MqS6dgot8sMoDU&#x2B;juVOy/hvJF&#x2B;h1NrgIw5VKs4rHcse/79okPYsNOp50fc&#x2B;7qqGuRv3Y2Dm3di83crcfLwcdYf0PjooNJqWMlfJonUSJDQtX2B3QFDXR1XK9H6&#x2B;2Li1bPRb/IoJOdmIDQ20mvOkwi/zWZzkIJ/YGCgit7HxcXp1Gp1j&#x2B;uE3njjdSxYsJDJwLJl32HEiOEwm834179ex9tv/xvV1TUIDAzAjTfehIEDBzKpb0sQbNiwobx0BkRA/vzn57B37x4m62RwiIm57LTtNm3ahKKiQo42cEebkPeyuroa3333La677gY8&#x2B;uij&#x2B;PLLL/mYBw8ejJSUVBw4cAD79&#x2B;9HRkbGBb3WlJZIiwQJXQWDwYCbbrqBU2OSk1MwevToRsNZTk4uvy5adCW2bNnM7VD0bxg6dJh04SQDQIfJvqyN9e2lBbQk/HK0EQFwLlMATjME0AuR/0bRQHh9eHhIr2hMf/U2xI7IwL5P1&#x2B;LAdxsFAwOXSZNzzXlH29fM5d13k0LKvSNST158/2gK/Q7kUoRKrZaNC&#x2B;TZtwmiz7u121l13gmr1OJ7wGSfozGoPKKvBmF9kxGcGgX/mNBz4uGoLa9C4cHDKDt&#x2B;EjWl5bCIZ0OpUmPYZZNYyd9QXYeaskqUF56E2WAUxKMeVovZWdJRBhZ85MdSLpNCQSRIOC/DpIxFN80NRu7zKe1m5NxpGDZzElL6ZyEkKsJrzpW8&#x2B;&#x2B;TtLykpMfn5&#x2B;Sl0Op2iT58&#x2B;AYJYXvCUfrrWNpsVSuWZk0nyllP5PQrx/&#x2B;tf/4J58xZwKP/u3buxfftWvqdDhgxFamov8TpYEP4RTPybF1NynNeyXSQcOGLEMCbrb7zxJvLyDrLwIB1XUzz//HO4994/4D//eQdbt25l0v/xxx&#x2B;jpqYas2fP4bB/tVrNxgs3Hn30jzh27Ciuu&#x2B;76C24AkCChK0BtndJ31GoNR77cfvvvuQJGWJjn9CtKA1i9&#x2B;hd89tlneOyxx7B06TKpCoBkADgjI0Bb69sK/W9te48aAOckBaCDxgD&#x2B;VZcwnbdHBeQuGo&#x2B;cheOw939rsPavn6N07xGYBOlS&#x2B;/qyqF6jirpLpI&#x2B;8v0S8VH4aFhaksnp&#x2B;UUGC7EdBFxEINXlptUon4TdZ&#x2B;RpajGbnTZaS33oQ6bc7IzrEPaeojZC0aATGhyMgPoz/7uSsFnWV1ZzLX1lcipryKq4FLpcrOIeSxPzcGh0&#x2B;gf4Ij49pJCAWkwnGegMqikpQU1qBuqpaVBaepDrb/Ly5yQoZsWQtonwkSJDQccLPOf0Wi&#x2B;i/TSwQGp4QjRFzpiB3/DCkDcpFSLR3kH43yT148GC9j4&#x2B;PorKy0pyQkOCTmprq4&#x2B;fnp&#x2B;pKHT8S7Dp&#x2B;vIDD8c&#x2B;UCNx//x9w5ZVXYvHixQgNDcW33y7BLbfchPLycrzzzru8HeXxDx8&#x2B;BL/73R2n7ePAgf2IjIzicP/zhczMLFYhp2tMKv9vvfUme&#x2B;xffPElTJo0mbf54IP3sWLFChQVFaGiohIfffQB7rrrbhYgpPKEVInA0z0i7&#x2B;b5Jv4OOJ0ZpwR3JUg4f7DbbXj55VcEqU/HhAkTTyu1&#x2B;dpr/8QXX3zB&#x2B;fzPPPNMY17/v//9FubOnYvg4FOimxRNQwKe1113jXjdJtp5sET&#x2B;JQPAOTUGeDICeDIItAz7By5UBEBroIZgtzeSIZl7nZdO9vosGIPes0egcPMB7PzwJxz4fD17Y9UqrbNTUMmg8dXBPyYGgYmRrCOgDfKFykfLSv1c9o1U/Nm7L8hYE8&#x2B;&#x2B;7GIj/g5PZrCm5SgdrG3gnnyeKlXpqorgFhSSNdnGbUBxb293tKhK0Plj5tQNK0V12KHx90FIrxgEJYYjKCmSKwF0ejJbXYvCA&#x2B;TpL2byTkSeDEXkuScxv5aTck4JsTfKLDXm/6vEoBcsyAdFJdCpm/QNqCopQ31FNQrzj8JQU8&#x2B;RAqQjQBNhldopHimTDFASJLQ5DthdOf0mvZHbTlBECIZeNpHV&#x2B;9MF6Q&#x2B;OCoO3hMfV1dVZq6qqzOTWFyTUEhMToyUvP4X4d5djfPvt/0NOTk4zA8DOnTt4PXm2SaW/KagcH6l6071MTk7G739/O/btO4D4&#x2B;BjExMRj5sxZmDHjEvG9fpwffNddd4ptft9iH1asW/cL8vMPYdasOef1/IKDg/l13bp1WLNmNd544y288847TFgoR/mjjz5kMcKIiAiuGHDttddhyJAhfN7t9edZWVnnd5intiL&#x2B;BSVHQXUOUiglSGgPFNVDBjCaHlG4fksDwLhx4zBv3nyEh4c3W0&#x2B;VMsrKypsZAI4cyceBAwcREBAo2tW1nH4jQTIAnEuDgCdvf0dLADZ7f0EiAFoerIvwy5oYA1zsxCu92VQZIHFkHyQMz8KIe&#x2B;Zg&#x2B;3s/ouDnXc7Q/qhgBMWFwScqiEv1kWgfk0Xx3mr1/nx99og14fLuagRk/Gh8Pqg8Hq1zRY1QigTlyttJvJDUf&#x2B;WnyD1cHgNaR9eSxBGZ8FpsLKDHk3GbnasbyCglw&#x2B;rcP&#x2B;9DXG&#x2B;qiEDX3ibWUx4ufUaCfHJ6Lmkbm1Pg0lmuz/nM8v5cYfJNVfPtVE1BrKYc/pD0GISkRLFmAwn7dW6G5EBDfQMK846g9NgJVJ8UpN9g4PUk8kg5/We2O4ezrKOA2WDj86STUeu0iE5NhLxXMnoNyoHFbEF9VQ2qistQVVqGiuMnYajTc2QLKMJA6YwwkEoxSZDgBJH9hpp6KDVqaH20GDF3CoZcOgGJWemISIrzpgm0VcBRUFBgIAV/6lOio6M1pOLfHY&#x2B;XvN79&#x2B;/dvRgBmzJiB&#x2B;fPnobKy6rTtibRTyC8Z7W&#x2B;99bdYtmwp/vrX59G3b1&#x2B;MGDGSjQN0zp9//hmee&#x2B;45pKQkY/ToMY3fJ02Ab775RpCFUlb69/X1Pa/nRykKROzJE/nkk09jz57dgqwcwI8//oj16zciMzNDrH8KEydORFpaercy4oZnJOKq/z2FhNHZ8A0LlDoRCecNJG5J7SI3ty/&#x2B;8If7OWffx&#x2B;f09EvK7SeNj//9739YuHAhG3SrqqrYINCyxF9OTl/Rzn7itCAJkgHgXBJ/T6S/PSMAWjEEoMlr18Ht/XdVDxC0yiGInlcyCCJGoWmxmPj0NezNL993HCV7jqKusAKGslrI1YqeHSrUxGPuJIGCDCpkjcSU0x1cpN91r5l0cxh6g5lJv6mmjsm9SRBcIvicGmF1aiKY6xr4M6OYUJNCvqXeyJ&#x2B;p/XQw1uq5mgEReHp1VqQgYq4QBN4ZSqjSqkC&#x2B;BaveIrZTcuSFuaGBt1WL9zYxSaPce6vRuR8lGQPEcSp1GvFeSbtj3QVapw32Y4JP4o/aYF9xTA2s88CRGuL3ybgTlh6LgPhwBCaEwy8yqNPGLX11LYoOHUPlSUHAi0rRIMg3DURKcS2UKtW562nc5QoFeeFKEe4OVAx0wVHhCI2N4vOkEGZKFagqLuFIgZKjhbA0mGA2mdgQQ2k&#x2B;PDhK9gAJFwmoLyPST9EzBP/QIIyYNRk5E4ajV98shCXEeM25Uk4/eftPnDjREBwcrBJtXUY5/WwE7OZhQaoW/SXlwH/55VcYNGiQq5yXqdELSIr6&#x2B;/btQ0ZGpssYkI9bbvktFixYcNq979u3H&#x2B;666y7On2/qRSQDAO2XlMNvu&#x2B;13p3kYOzS8sm6BjY0NbuPS&#x2B;vXrWGOgJQk5cuQw6urq2dAxePBAlJSUcMTDE088yZ7&#x2B;wYOHdNt7E0yGcrFIkNBZUOQOtRu1&#x2B;vSSyTR3omobFC1DBoD58xfg2WefZQHMqKgo1ghRKE7RRmq7d999JxvvKIKGqntUVVXiyiuvarZfiqqhRYJkADjXpN/T&#x2B;o6IAnoyCshdjaB7ME5WHRME2MGx2u4Wyuu8EURAI/slIyI3CdXHSnD8l73Ql9XAVGtgcks52902z9oB1/E5Pfbs/Kb8cKo8QIRR3DaL0chGgIYyPZRaJfQnq9kj31BZy&#x2B;F9&#x2B;pJqcQ3UaKiqEzMZMeGqMzi95hYbrCazc4JjsrJeAnnvG4mpw31JnNEiTbMAnKTTFd5PQnZKubNMIhkDxPGS157C8KnOPT1m9Hy5DQVOw4Tc6eGH8/wcrnKWMtePuOe0ZBzgCANxXGp/LZ8XlSYKiAtD8oS&#x2B;SJk0ALGD0&#x2B;Ab2fkcT6MgEsWHjqKisARlJ4phqNGLQ3HwJJCekwvZOux0kS1WjojgDkRco5DIMITGRPD9oGMlYcHq0gqcPFyAiuJSmAwNzjKT1LxdWgQSJHgT4afOh6K1LA1GWATRC44Ox&#x2B;BLxiN7zBBkjx6EYC8S8iO1/iNHjhhE/yMT5N9CYf3p6el&#x2B;YlKs7MmpQCTwNXHiJOzduxdffPEZxowZy4ub8G/YsJ5J/cqVK3HVVVdg6dIfPO6HyufRctrkU/TXI0eO5CgDigA4U2zYsAHvvvsui/N99NHHvI6IyiWXzMDRowWNIf&#x2B;k4E9pDC&#x2B;88A/Wb9m8ebMgKFezKCARfyldS4K3g7z6Wq0zdWTx4s8RExPHz39LkJGPDGVHj8owZ85cXkfbUalOMgB8/vkXSE9P48gfav9vvvkm7/eGG65DZmYm5s6dgylTpvG2EiQDwIU2CrT08LdG/OVouyxgNzxDF6NjcuY4lRrghYMXEcng5CgEJUYy&#x2B;T&#x2B;xcT/K9x4XhLjB6X3WqrtuYus6ProP9Eoeeg6lVypg1hthNZhhs1pgrDHAZjSj9ni5mCDaoS&#x2B;u5FtorhPbGJ3b2Ew2FzG381NHnnki0AqV3Hl75afuL73nOpVqZ1glvZ61oUXV5LvKc0CXxbESASaBIoosIHIbO6Q3Uib3Q&#x2B;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&#x2B;XMK&#x2B;SYSTOH6DmfdQu4YnZUe5I3ecybiTZ9GB9i731FDRJeTXTtdC6srTcAX8cMzkTgmGylTBoj3Gc570xnSL/afv20Pdq/aiGO7DnKZPvIcqkk/QLzSNVVqNZzKIHNFP1D5R7tLk6CrSbRb&#x2B;4COiRae9IoJqtbPF2HxcZxqYRTnVHy4AOUnSlBRdJJTGuj4VWq1M0pDck5J6M6gLDXRL5IYJhlBKYVowJTRGHn5dMRnpiKmV5LXnKog/VaTyWQvKioyajQauVKplFOYf2xsrM4bzo&#x2B;8&#x2B;iT6V1FRgby8Q0hMTMBjjz2OwYMHYdiwEY0eRALl&#x2B;d922&#x2B;1sJFi8&#x2B;MvTBALPBPv37&#x2B;Pwf6of3tFxgUKPKYSZPJvXX389ExISH6NyffHx8c2OlYwMX3zx5TlNJaRr9MQTj7NS&#x2B;j//&#x2B;brUD0jo1qC28u233&#x2B;L55/&#x2B;KmJhYrvbREoWFhRB9GWbOnNk4x6TKIPSsR0Q4hf5I2PPFF19EamoqrrnmZYwZMxrSJKUHcyxHN/A0eSA0beXxyz28Nl0UTV5bLsomr00XVdPXp556qv&#x2B;f/vSnx3rMXRSDUKPWu5eX1iBveVV&#x2B;MUr3FKD6yEkYquu5lFtnyabTiOLgOu&#x2B;cs06h8WJSoS&#x2B;t4Tx7s8EkfreI8&#x2B;8NFbUw1TY4w1wFAZa5QvFlrtxu9taTe1rehNl7kUOXvHtk3FD7atkwEzUg1entH5XN&#x2B;f&#x2B;dAUUSHNy8A/nb9&#x2B;Hgxu3Yt24r6qprIBfXkzxUJFJIYfb&#x2B;wYFsAAoIDYZvoD/8QgLFawB8A/yg8fPhyR5XOaCsBle1ge5WPknmjiJxtVlDbT2nCdSUVKCkoFA82&#x2B;LZM5pZK0KpUkKChG7x3LoU/MkgR72bj2h3AyaPQr/JI5Gc2xtRKYneMdYIkKffbDbbDx8&#x2B;rA8NDdXQOirbRwr&#x2B;XW2IXb16FRNnUug&#x2B;G9DkvqDgGAvxLVnyNRoajLy/KVOmYNSo0RgxYsQ58ZS3h9GjRwoS/RrnHLd3vH5&#x2B;p8RiqYzfLbfciuuuuxZ79&#x2B;5BcfFJNlo89dQzGD9&#x2B;/Hk9ZiJF33&#x2B;/DIMGDebKAbfeeqsgSZFS5yChW4IMZbGx0di&#x2B;fSd27NiOJ598Aps3/9psm//&#x2B;92NcccVCniutWrWKS/xt2bKZS/h98813rAVCiImJQlHRyZ42Zl1DU1exmF2vVg&#x2B;v7vc212Jt8r7pYm/y2nRxNHltujQOKR7GmC69Lt46q2wt/L&#x2B;lQQEeXi98GcDOgvKI2RDgqh5AOefeGhVAOdbpsbw0VNbhxIYDqDxyEibxnppSY032NomX7BT5EtuTB8tS6wzNry0sE0slzLUGJv8NVfVOBXyzxfU9J6l0q&#x2B;8rtW2Enzs8tvkeOBMGXxua9JOXL6Z/KmIF8U&#x2B;bMQipk/q7FPI7QfoFQT&#x2B;&#x2B;9xAOCMK//ed1gvjvYI8iVYqgUnz&#x2B;QYGndZa1FU5V6srCEmdkBUVZiMUnyJ&#x2B;97L6BfgiLjYIu0Bd&#x2B;QUFinY5Vx&#x2B;n4ycNORh67q5Skuzb3Bb&#x2B;sXAaNRgwbX2Otrw9S&#x2B;2eJY1GgQa9HxYmTqCwuQcG&#x2B;Q6gnnQhKf1GrpJxVCRec8NMAY7XYOGrFarbCPyQQI2ZPRfbowegzZjDC471HyI9y&#x2B;km5n4g/GQCI8GdmZgYIMizvLkJ&#x2B;JOT18ssv4ddff&#x2B;XSe0093kuXfofp02e0&#x2B;X1S9ibVfsrvz83NZXX&#x2B;m2&#x2B;&#x2B;RUzuY85KjO9sQYJ8x44dY689gSoPbNu27bTwZApbtlotmDp1Gvbs2YP//e8TDuuPj4/F7t27cfnlczFs2HAW8qM85vON0NBQLFp0JadKUJQElUG86qqrpc5CQreEO92G0gCorVO0T1FRIUcDuLF9&#x2B;zb88MMPOHr0CIv50fZkBLzvvj9wH0H46qsvMW7ceOmCegm8xQDgKRWgJdFv7XunpQf0OANAoyFA7ma4LP7mkPGJyLw1KkAX4s8klELuKw8WomDtfpgEcSSyyuXtXF5guHLF5a7we4vJgoayWhir65jkVx09Kb5ngKGqFjaj1ZnPSmSXQ/SdpL&#x2B;znu0ex/nF80NGDxLzo/D60IwEJI3PRsrE/kiZ1I&#x2B;rDHSW/JJ6/77127B3zSbsWr2Zw9/JsKLWauAb7N9oO/FkJVUolR4NFfrqGtSL&#x2B;1hy1IIjuw7wsat1usZIAV2AL4cla3y08Anwg4qiR8RvWt2pA3Z715hsZE0rDDjra8emJSGudyrnTxfszRdLHkoLCkFPtVwp5dpJOL&#x2B;k353TT6KVVtEXUJQNhfcPmjEOmcMHIILU&#x2B;73EGEWh/cePH2/w8fFRVFdXmwUR1tE1CAgIUHVHgxuRXBLpIkMAqW/fcMONvP5f/3oNixcvPs0AwP2b6NsoFHjNmtV4993/4PDhQ3jllX9iwYKFF5T0NwXVBae8/aqqaq4bbjAYBOG4B2&#x2B;//R/06dPH1f/bmewvXeosM3jkyBFOFyAv/7vvvs&#x2B;l/dyRAURwli//Ac888&#x2B;wFMZQ&#x2B;&#x2B;OD94nquQWhoiNRpSLggIBFLKqfXVnROeXk5wsKaa1NQH/Hf//5XtPcr2OB24MCBZgaAuXMvxy233ISMjCzxXD&#x2B;MMWPGNP4GtcuXX34Zr732TzYSnC0oooDKB3ZVfyPBOw0AQMcSUdrSA2AKDW9IaHGVm3NHBDgEqZA5Jce98iFW6TSI7JuCsKwE1BZWoOJAIUp2HGHDAOfUkwK/6MBqT5Sj6tBJNLiIv1nvLKsnJ2OBm&#x2B;h3I0G5C8/6nSH4VHFAKSaKoemxiB2UjuSJ/djQQmX&#x2B;OrV7QbBPHDyMIzv2Y/fqTdi5coMg6zVMvLU&#x2B;PvDx93UJ4OHsAic4MsPZpTnvu7MGI3mOygtPovxEMQtCUYQBedupRGFUagL8ggJYW4AIjlqrdVYzcJVZdLh0Ni74rRC/azFb2BhAwly9BvRBSr9MlBw&#x2B;ji3fr2LxQLU0iEo4xyMop8mIRV&#x2B;v57SmgLBgFvHrN3EEknIzENc7xWtO12g02mpra61VVVUUFioT5F/u7&#x2B;&#x2B;vEOQ/oCuOh/qmjopokVAf5eveeeddzQwAvXqlcwh8S9AEnr5DpIBK933wwUe4&#x2B;uqrMGfO5V06Gffz82WjhM1VWpVqiFNKw0033Yi///0fHNr/&#x2B;uuvs51J3BsWLyMhswEDBnosY0ZCZL179z6n5J/6YooyWLv2F/Tr148jDQgkgkaRCeRRJU0EpVLFhhmp1rmE84WGhgbMn3&#x2B;5IOErPFbWcPcNM2ZMw7ffLuX25MaUKVPx9ttvc7uhPsDWpJwxgaJn1q7dwAKfLUHfmTuXomyGij4m7ayO/cCB/ZwuEx&#x2B;fgMjIbpMuc1GrLXuLCGBHDAGeIgLaEgfs&#x2B;fM5lzwu/2e1guIBZG5vqhdGBZDHPjgpkpfo/imsE7D30zU4&#x2B;N0m1BdXcmi1W02fUgm4ZByp6V/kgut2Ltdl4lzz0NRoRA3shcw5I5A6uX&#x2B;nPf2EEwcO49jug9i6bA12rFzPqvcUXUBh&#x2B;RofHefAN3r5z9W9cNYwdD7q9E/lfN6VMjUTeqMYSCnMvqqknNMCSLMhIDSI85mphF9oXBRrCtDxURoCweIqxXjB7484XrPRxObJqNRETLh6NjZ98xPKC4qc2hUSJHRmnHB5&#x2B;w21zpx&#x2B;rWjzw2dNwoApY9FrYDaikuO73YjYWtpOW&#x2B;k89Jler7dSiH9eXl69mBxrLBaLPTU11VcQb3lXevr379/PnnB3KHx7WL16NbKyMrnsncHQ0Lh&#x2B;0qRJHren7erq6tgAQKTgnnvuwh133NEsp/58gryW5CmfN2&#x2B;ex3OkMYDSAaqrq5iY7NixDbNnzxJEfwAuu&#x2B;wyViIn9X6uktIGAgODeGkKOu8dO3Z4VD3vqGGGIitojBg/fkKze3bppb/Bv//9FodNBweHYtasWXj11X9KnYqE8wJKOSksPCHavL7VbcjhQXjkkQfx1ltv8/NLBizK8SfRSsLYsWNZ56MlPJF/njeJuSGludBytti&#x2B;fTtqa2s5mmfWrNk9ifx7LUO4GDQA2iL&#x2B;8ED8ZT02BaDNO610VROUcd1yQSocJGTkrekBvhFBSBZLRFYCwtJjsX/JRhRtyYO5voEjBijs2&#x2B;Fl4nxnRCotNvb0E4EMSopEVL8U9JoyABlzR0LXSU8/XdOywmLkb92DXSs3YvuP61BbWsGi/FSyT6vTQibIv5v0X1AhFBdB4Mk&#x2B;6QY0SSWoLqtEdUkFivKOcIg9GQb8AgMQlhCNsLhohCfEdq0Ynx0wG43w8ffjmurrvvge1SfLObVFgoQzYPw8DFAuv7nBCLvNCo2Y&#x2B;A2eMQ6544Yic&#x2B;QgxPRKPE/NrzlBb4&#x2B;wt/ZZR9a7&#x2B;xWr1crK/fX19eKt1REZGanJzs4OUKvVcrlc3i3G&#x2B;quvvhLLljUPrSXDH&#x2B;W7Z2RksABqU1BZr9mz57AQ3sKFi9rdv15fjxde&#x2B;AfS09Px&#x2B;eefcRju9dffcEHObfHiL/Dcc89hyJAhTJRbGgDIq9nQYGDCT5EKJOT38cefsNdx4kSnQWPlyp/w1VdfCVLzyBn//vvvv9fhCgOtkZ&#x2B;XXnqFjRRNKwmQMYAiAp555mlByoowb958TJ48WepfJJw3UC4&#x2B;edBJN6Nv334ccXLjjddz1E9KSoqLxPuyaB9FCjz77LPYsmWTWH7liRk9o4RFixY10w25EKAIBBIUpGOvqqpCcHBwd7u8jovNCNDTDABtefzbIvltGQZa29Z7IUiMzCV&#x2B;RukBcpooKb3TFuQbGYShd8/CkDtn4sjPO7HlrW9xbOUuNJTVceg/iapx4sdFYAjgnH6bgysZBMSGIbJvMtKnD0Lv2cPhHxPS6SZQW16JQ7/uxu7Vm5n0lxw57nzctCpofH24ykJbef1d3hmKdsHigDY75zxTOC4JRFIUAJFuRTfIuyeCYxKkLTAsBGHxUagoLJEMABI69Ny4c/otRhMT/8CIUAyaPhUZw/oha/QgRCXFtxpR0rS9doSwt/a&#x2B;tbbf3nebvrY8p5bv3aT/6NGjBl9fX2VFRYVJkE6fwMBAFS1d6ekngrtu3bpmnnryzldUlJ8W/v/ll1&#x2B;Kyf0NePzxx3H33fc0&#x2B;&#x2B;yzzz7H2rVrmYDecsst7f5ueHgE8vIOsieQSOojjzx61uewYsWKViMNWoI0CjZs2ID//OddZGZmuu8Nk2o3KPc/LS2dQ4zHjBnLnvqmBg8yglB5v9/85tKzOl7SO7juuuvP6Dt0rei43HnUdLy33347nnjiCY6a2Lx5U6NSemJiPD788L8cwSFBwtngww8/xLBhw7i8Xmv9BqWgTJo0mQ1/JJR52WUz8fTTT/Jzd&#x2B;edv8enn37O5TG/&#x2B;&#x2B;5bjhAqLS3FP//5CgYMGCSe2ycxZ84c0jTh/QUFXXjyTb9NhgdKIaA2PnDgoAtN7ltT5He0Qfi9mhn0FNYnOwffb8tQgIvNENAsPcDmVCF3uMKDZAqFF56vDCkT&#x2B;/JCOgEbX1qMHYt/huFYrTh/O1S&#x2B;Ot7G20CefqpBT/n3RPrDsxKQODYHWfNGISQlqtMiXtWl5Ti2O4/L9W3&#x2B;9ieUFhTDLn6PPf1&#x2B;Ps5r6q6G0E27Usp7Jm8bpUKodRqExUUhPrMXQmIiWRdARTmqVrdAX9dDrVHDWG9AVVEplApJDFBCq6yfdWDsghib9A2wCjIWGB6CnHFD0X/SSPQRpD8iMa5VMt6SqHsi8S23a0ne2yL9LT9rbfvWIoVabkPifQ0NDXa9Xi&#x2B;6PKuNBPxI1C8mJiawu9ySEydOsBBWUwJNQ7FC0XwqRjXt33773/jmm28FWX/oNAMAhZ1nZWVx3m5HQESWCAJNws/G8/fwww8JAv4b1h1YuvRbjwaAxx9/DE8&#x2B;&#x2B;RTnILvz88kAQHn&#x2B;iYmJfE7ffLMEN9xwQyMBqaqqxPvvv886BI8//oTH36bzJFHAMzXcuJ/FZ5/9M44fP97mtnTMDz74AP785&#x2B;eY7N955x1c1u&#x2B;NN97k60VGmi1bNrJIGqUqnDhRyJEMVDlh4cKFEvmX0GlyHB0d5XmOJZ69mTMvRX29HqtWjcAll8zAhx9&#x2B;xJ8R0X/vvQ8Eme7PaTbl5WVspBo4cAAeeOBBbqdxcfHd4hzJwEntkaJoampqpJsuGQDOi0FAdhbbNjMOeGUKQNst89SEkUqkwebMoPbSUoIBsaGY/JebMPy&#x2B;y3F4xTbs&#x2B;2ItDny/ATDIWBOAdQF6MMiLTdUMyJPtExaAyH7JSJs2iPP6A&#x2B;LCWP&#x2B;gM6gpq0DB3kPY&#x2B;dN6bFjyI&#x2B;oqqjivX6PTMjmV&#x2B;2jPfU7/ub5GHP1iZw8/EfzgqDDEZ6UJ8h&#x2B;JgLAQKFUqJvxkHOiq3P/TOivSrRBt1VhXjy3fr0H5iZOeqyFIkCC67YY6PfcFatEuB0wbjYFTRiN1YA7iScjPA0lvjZTL2tjWLZTZnoffk4GgowSuNZDRjnL6xXYO8vYHBQWpqHRfUlKSj0ql6pZhMRSC/9vf3sZebSK2ns6Pzuuhhx7ACy&#x2B;8yJ7xljnthBtvvOmMfzsiIuKsj/vtt/9PEI9LsHfvfkFUoj1uEx0dw/XGieATqafc40OH8vDWW29x&#x2B;bDS0gpERkbg3nvva/wOnRt52tu2Y5058X/vvffE75Ww1z47O4cNJm1FAVAYNfWttBC5evjhR3Drrbdy2sG2bVuxbNl3bKQxmy245prrMHToEEnNXMI5w7Rp0/DSSy8Koj&#x2B;T27wb1IbuuusOFrZ8&#x2B;OFH2dCUktKrWZsYM2YUk&#x2B;ovv1yMv/zlL&#x2B;jff0CncvXPJxISEjFx4niuVDJhwsQum/51cN3ZbCMZALqJgcBTnr&#x2B;nz4CLLQWgtYtGhN8ZAipzWCxsBOAnnsrpeZshQJyOX2QQcq8cj&#x2B;wFY3Do&#x2B;y3IW7IZB5duRu3xcjYCkFZAT9EJ4LJ9RjNPHnVBfogdnI6E0TnoM28UwrLiO33/qETf8f35rN6/cclPXKOevIqkpE/58v7Bgc0IQbe8RvTP5vT2K8QzTSHQ8ZmpXMOcPKNKEvtzh0mfZ9LfVoh0U8h5UirnR5DKG5YVFGLf&#x2B;q1cPUGpUkGCBGffLWss2UeGP4V4NnLHD0P/KaOQPjgXSdm9mxP0s2ijLcPxPZF9T89ye3n/7e3PTQLd74nkl5eXm8RiVqvVMvL09&#x2B;nTJ0CQN1l3H6coH/7NN99gL/KSJd&#x2B;KCXECC9s5JUkULOBF&#x2B;bp79uxmT5&#x2B;fnz/GjRvb5cdNtb8ph//AgYNcRtATfvvb36KsrJRD/v/4x4exY8dO5OUdQlJSIkaMGIXhw0dw6b5m/dt50CCqrKzEF198jrvvvlsQdC3/3VrJNHqmnnzycXFuQ3HHHXfyus8//5QjFkg3gUKrqRwhkf4ZMy5hPQYJEs41vv76axbHW7FiOT788GOEhobyevLob9q0STyTi1kgc//&#x2B;BjYiup/D&#x2B;&#x2B;9/EMePF/B2NopkVam7Lfl39/OkWUKRNmdiDD5HpP9Mib/XJwZ7WxUA2Vlsf9q6iy4CwNOFUqlk5D2iBmqzWB0UpigTEyxvjAggApt&#x2B;yVBeRh4twYYXvkTBhj0o&#x2B;vUw11xX6Zwkt7sRW5ro28xW1nHQBPgirG8yksb1RfaisQgXpF&#x2B;pUXdq/4a6ehQfKsDetVuw&#x2B;dufWc3fWGfgUom0&#x2B;AT6dY2Q35mNOmxFp&#x2B;OTy&#x2B;TwDw1EbHoKwhNiEBIdySH/HDFBoohmS5cMii0HSBmLTcmI1cFYr0d1STlHXJQdL&#x2B;JIC3HAEvm/gEYjmWuIaPq&#x2B;ozMOWTv7bW2fDtfco&#x2B;VnzdZT32y1wmo0wdhghH9IEAZMG4s&#x2B;IwZyTn9sWlKzCBG7q5ylJ4LedH3LFICOhPK3lrffnmGgLaLfrK&#x2B;z20m5X09l&#x2B;srKysxJSUk6Pz8/n67K6ac629SvnEk5K1LBnjNnLi699BLOcQ8Kcnr2yWtOp/zCC3/H5s1bUFh4HHfddQ/vf/369YJ8Xtvl7SAgwJ&#x2B;FuyhM2a0k7gaJ&#x2B;FGOMpEW0hr44x8f4TBkUsS/7bbbMXXqlHPuKdfr9axY7unek7jYV199jZUrf&#x2B;Z&#x2B;lEL4TSbPffvBgwfYIHPXXfdylYLRo0cjMDCAyw9SusNDDz0iiP&#x2B;M00QYJUg4l8jPz&#x2B;dUldtuu42f27lzL&#x2B;f1FJESGRnFgn5HjhzBqlVr&#x2B;JmfOnUqf37ppZdy&#x2B;kp2dhY&#x2B;&#x2B;eTTbn2O9957D0c1jRkzhitl1NfXc2nPCz6kt07uO5r37zX6ABdD/KjsDLaTuSYjF70BgC&#x2B;IyzqvUKtkRDIdzhzoU&#x2B;kBXlhBgBTxp710K2wmK3Z9vBKbX1&#x2B;CkwePwFqtZ6VsOavAd127J9LvsJKCvwW6UH8Ep0QhY&#x2B;ZwZM8XE5dkQWh9O6fsSgTz5JEC/LpsNX5duhonDxfAaGjggYi8/UT62yMDXc/5Hc6ICKuFCRAJ5sVl9UKoIPxBEaGsTUDh/XYP4f2evJztEffG9uJBpMwTuTltPUXYiGdKqVJzSoLZYGLSf2zvQVQWlsJQWyfIgPWUCrX84sn7P1PSfTZEviUZb0qym27X9PtN1zk89AfObR2t9hQtv9fals0JP1mnZUzkqYwlCfkFhAUje9xQ5E4Yjn7jRyAqpbmQn6eInPbC/jvSttvbZ2vpAq0ZvZq&#x2B;ut/X1tZaxMLK/XV1dZaoqCgtefz79evXpTn9NFknD/ff//5Cm9tR&#x2B;TnyPLsF7/LzD2Hhwiuwdu0a9oDV19exmv9nn33GhJbCzYcPH86e64kTJ/I1cHulzydIlI8EB8k77/Y8tgT1/9XVNQgJCeaIpKYoLi5GSUkJH7u7n/voo4&#x2B;ZTJ8vvPLKy7z/kSNPL&#x2B;1HfeRzz/0ZS5cuxT/&#x2B;8QJ7TLXa5gYIykGm&#x2B;6LXG5Ca2kvcg0/FuioWJ/v3v9&#x2B;BwVDHuf0Uki1BwvkGRc5cccVChIm5ytGjRxvXh4WF45Zbbmahz/vuu4&#x2B;rAFD76tMnmz8nRf3bbruVxQMpUqU7oKDgGH7&#x2B;eSWuvba54ZL6CIrMISNoSkoyjMaGC20AcLTxt6MNkt&#x2B;eYKBkAPBiw4AENBMG5PQAEnqTKZUyLqvmhUJkCo0S/a6bhOwrxqB4x2Hs&#x2B;d9K7P54NeqKK6HSaKDUqi/YsdCEmATqbEYL1H5aBKbFImViLnKvnoSw3rFQdZL0k1DTiX2HsX/9r1i/eDkK846ioa4eCpWSPR8&#x2B;/t1f4MgZ1gwWOqPKDr5B/ogjT39iDIIjw5uQfkGwjabmRM&#x2B;Dt7I14u5JhbwlcfGUP&#x2B;1xvyT&#x2B;JSahDiL9DRaUHCnEkd37UV9ejTox2abjJTKnEIS/pcf/XBHjjuyvOXlGI7Vt6cFua91pZLYNYt6ad9wTQW&#x2B;5z5ZE2r2&#x2B;re&#x2B;15on3tH1rBL2j6z197ujAnIIMQ4aaen6vUmuQPWYwBk4dg9T&#x2B;2Ujpl9n4nNHz7XB5&#x2B;j21kfa85W158lszaLX8rGW7aE0U0FNEgDun/8iRI4bAwECl6JscCQkJOq1W69PVfQx5/f/&#x2B;97/hxx9X4Omn/x97iD2B1Lc/&#x2B;uhDznuncnZRUU5xL/LqUcj/Tz/9yHnmjzzyR/asz5u3AH/846McYk8K8xcaRIYpx58INRH30tJiXHnlNQgPD2vchryQbs9/aGhYs&#x2B;9T2LJb4Z8MCU888bggASfO2/HSePX998tYEd0Ttm/fxscxb948LF&#x2B;&#x2B;nIlRywoLO3bs4GMeMGAA1qxZy/nTzkgMB4dUP/DA/Xj&#x2B;&#x2B;b9KEz8JFwRU4YJK&#x2B;v1/9q4DsKmyaz9Jm3Tv0g20Ze&#x2B;9NwICbhnyOVAcn3uLv7i3OD63OBFFFMUFirKRvaHsTQsU2tK9m47k/u85GSTpvTcps9Sc74ukyU1y53vf5znnPA&#x2B;NHUY7sWF6Pn/&#x2B;fLz22mtcFeQcNAaREGXXrt1swpt1CdLJ8PPzlwXidD1QBZJz247cPYPGALLsJPKNbAiff/5ZcR0d4xYFmkNShRBdb0QiUhCRQRU8F2Oq6ATq3XUH8NgAXiJAXuMC5Cst7yEE3N3hOp2GHd3EpJRUpqkyQKPXX3Lb4c6EmIB&#x2B;416t&#x2B;dHt9tHY&#x2B;9saHPprCzK3HjL72vv7OLgHnAZItU8oyY2TzH6ZmuoamKpqWI&#x2B;AMv0Jfdqgww2DENejBXyC/WW3xR27Lp5EVVYJwHkCBzfvxNpfFuDEwVTuKydA6qXzQkBIkEW8v36PewSS6SZJvfJ&#x2B;gQFIbtkWMUkJCI2OFKDfTFxQbzSBfkUA5ma2UynLqZY5lVNSp3YSjUaLyrJy5KRnIn3vYeRnZqNM3ByN4pjTthDwJ9DvDBSdAbE90FUD23LAWG0Z59es361xek0NzLp6Lve7at/t7ve7AuNKf0sK93npItz7&#x2B;VoWY2tFaTkPCHo/P/S8cija9OkqQH877uu3XQMWS1el8c1VeX6t31Upx69L9YCr37K&#x2B;XlFRYRQgtPrkyZMGMRH1FmBfKyaIwdwOc5Ga&#x2B;qn/e9eu3WzNZY17772Hy/Y//fRzdOvWTfZzmzZtxFNPPcV9uJRZLi8vQ2rqEbaLW758OQ4dOoT27duhVavWuOWWibj66qsv1kTYFpT1J7cBshn75ZefsGXLFt72Tz/9jIFzXl4eP&#x2B;Li4lFSUsz&#x2B;4/ZBInl//vkHK/xTGfLLL79y3ufwdM6ToKBc0H6mjCpVV9x88y18njm3asyb9ztatGjBIOfHH2cLgPWK2O7tfL7OmfMj75OOHTt5JnueOG9BYH/v3r1YuHABX3tU4k8E4L333mdbhkgBEsu788675OenYr5GtoBnGsuX/4Pu3buyuCCBd7quiLzs0aMHCgoKxfVzE06ezFD8PLUF3XXXnWIML8fw4SP4NXIc&#x2B;eOPPzFq1EhUVxuxatUK8R0nkZ9fwHoGFKNGjRK/eUHJTqkOAL8uegGXNDHQUCoANG4u4wH553CPE4jhNgDKUFdVQfLykrQmk0Zzgfvl6qos7Qocy02e6d9G7ZpgULsb0feJMdj6xQIcWZyCY&#x2B;t2o7qkElq9F7yZBJFka4nUyAAbaUD96gLwU7afBuOghEi0HN0Dra7phZguzbnkX&#x2B;Ni29UUuyk7npeRjUNbdmLdr4uQvu8w&#x2B;8iTvz1lzcnrvt739MPcBkHZKFrF4IhQxDZrgoj4GITHRME/NIiBJfdGX4SeftlLxVK6r/Ui0G9AflYuThw4jOyjJ1FeVILqKmpVMC/jpdfVAuhqgNgdMCwHuF2BZ6kOQFguQ16X8vbze9eX6vD&#x2B;xT3nWW/FaES1oRKVFZXwCwrg0v52/bqzoF&#x2B;Tdi1t179RMlkUWutusefO&#x2B;OgOmeXOd6pVwxw&#x2B;fLiUwH5hYWF148aN/Vq2bBlAgn71QchvwoQJ3MNuJQB27NjO5bY///yL4mdI2X/ixFswduwYPPfci3j99de4DJZK5IPE2Erl6qTeT/27FyPTrzieikk/qXKTt/1vv83Fhg3rcffd/2UATa/v3LmDCY&#x2B;QkBCe8A8a5ChKeOutk1hF3yDOW8q8d&#x2B;7c&#x2B;TxfJ1qEh0fw8WjcuAlnF&#x2B;1JFGqfSE1NZeKlV6/eDKKc7RKPHj2GJ554QgAUA5MdX3/9Lff&#x2B;U0yZ8gwLqp3PeYgnGl5QhRARSgkJCYrL0Hm1aNECrkCZM2cOl8uTO8eAAQPx7rvvo3379g6ClfR80qRJ523evG3bVhw6dECMVy/wa7T&#x2B;s2Z9x7oYb7/9DjIyMlW/45133ubtpZYmiv379yMnJwdLlixm8nDatI&#x2B;5PYF0NO68879ITm7Gy3Xu3OVCHx4Jyr37kgvg32CjobsAnA8iwRO178gCAOvN2glmMoDuhJy90TjZlLmTqVYrPXVVVmpdXqnv2tXn5H7feaJL7gC9H74WvR68BhlbD2LlS7ORtTMVhSezodf7mW0ENaeBvUaNfrSozpsECCSgGBQXgaYD2qPjzYMR1SERQbERLifd1tdMFtFG64NvOOK7C7KysXv1Fqz9ZSEyDqWh4FQutOJ97ukPduzpd78UXL3cWwmAunruDFT5PS6vN6GGMv3iFKN1jm&#x2B;VjPC4KEQ1iTMTF7St1fUE9GvMW0AtFHQcqgSYKy7Mx7Hdh5B9/CTKiooZ5BHgJ2s/b4vtpFRHAO0O4HU7S26zbZRqWX&#x2B;6JMsa/D1Tc17mBTzGwGxHWW2oQkVZOQLDgtG6dxd0GNwbnS7rg8atmtmE/EySZBPyq3W&#x2B;uNCucCWy56paQK6VRak1RmmcLS0trcnLy6uiEn8q7Y&#x2B;MjNTTcmTbV5&#x2B;ONoHcv/9eIIDtbbbXVqxYgaysTDzyyMN48cWXbAJ&#x2B;1iAhvBdeeB6dOnXCV19NF8B5HiIjI9CuXVs8/vgTGDFixDnP9BNZ5HUW7Xc0&#x2B;acs&#x2B;MaNG9muj3qMP/10GjZs2MgT&#x2B;TfeeANDhgxm1W7K5lGYXQscNQCIJFm/fiNnI&#x2B;uyjVTKXxdxPcrUk20giQrq9TrbufX&#x2B;&#x2B;&#x2B;9x9pGAFFVaUHY/Ly9fbFsrLjsmEOVcxvzYY4/h5Zdf4kqM1157Uyzb3OHc9fZ2b7/SOhBoot8gDYe4uFh2FPBEw4zCwkLs3r2LrwOytLMPIs3IvePzz7/AoEGDHd4jvQ9y9Ni6dTOuuOJKhIWFYODAQWyR2bx5czGehCneI8h&#x2B;8nwRztQm88QTk1lI8OGHH0FwcAhPAciqNCmpmTif41gfY&#x2B;zYcTLEoRHTp0/HzJnfcStB06aJ4vm3TAZ06tSBK5zocx06tGd3gn/&#x2B;&#x2B;Qfjx48T1&#x2B;v7XE10kQgApYccIeDqezwEQAOd7XniDAcUcefk4gCjmOBpaMJaWSmB7JloEiuTrbYXqVID3XK910rvq/VzKwIfuBbBqjXJ1WoQ36MV/jPveRRn5mPzV/OxZ9Zq5KdlcJaC/LfhrZUZXiQWoDNWCtDvpUFAZCjie7ZEp4lDEdutBYLjIhzbChR6Z50n5taJGQng5Z7MxMEtu7Fp3hIcTtmDopx8riwg1Xu/QH/&#x2B;fnvA7wzGlUC5PeBTK093fl&#x2B;tX10WtPJ5YW6DoHWldW6a3ARRTeMRmRAtgFIogyGqBqiqo2XfufQidz7/td4k6KflFosCARiO7TmI/KwclOYX8nqaKwE0XHFxsUKy7FtxjZqreCznstYi7GnLMpPOh/gfTdS5LYEdCjRsV3apj5IyPIfK&#x2B;5LqMvbLKj23/yamEwSOLxeTQmph0fn6oEWPDugxejCSO5vL&#x2B;63XMp3jJNKm1ouvRNKogXKlSiEl9X53qgzkXiPQL4CqlJGRUREQEOBFgn4JCQm&#x2B;AijW27kHW6mSO4jddt1xx11o1ixZTIzvZgBAtlyUEbfGmjWrOdP16KOPcSk8lcVTLyxl0c5H0Dnxf/83mbNq1v575/1P5baxsbEMVj766ANERDTCjTfeaFvm1VdfZfC&#x2B;dOlSAUhCeTJPwJqy5j/9NEe818emX&#x2B;B8j3GO4OBgt9edMvJfffWV&#x2B;J2e6N69h1vjFWkUzJ49mwHURx9NY&#x2B;IjJiaW3ycANXbs9UxAEDEzYsRIDB48mCsVyAGAwtmFgKoxpk//Gi&#x2B;88AKXYLdo8eAZHYetW7fiwQfvZ62HRx99GJ988qlnIngJB7Xw2BM4ZMtJANw6Xr766itYt24tH2d7AoCqf4hEos/edtutrCthXwmwatVqzoJT5Q9pgPz&#x2B;&#x2B;1wGye6c/&#x2B;czqDImLe2IGL9WiTFrO6ZNm8YVATfcMIGvsX79&#x2B;uDnn&#x2B;c4EAA09tC1RlamRIhMmnQroqKimSS98cabuAKI2hKcyT2qLBg2bBiPixfrto/auTjpHAH7S5IQ&#x2B;LcSAP8KkF9VWoFT29NQUVIGv5AABMSEISwxxgFcnq/w0uk0lh2tMYkbvmS2VtBIlLGwAlWniaM1g&#x2B;0uSJebpCplrOQm0GoATy2jVmtSLPZnSEIkhr14G3rdczXS1&#x2B;3Fztn/4MiCFBgKi&#x2B;Hj7wctZSwEWK2pqCTxRPgE&#x2B;SNpUEe0Hd8fTfq1QVhSrO24sOifxavbedLuMHHXOE7qCwTQTN2xH&#x2B;vnLcaBDTtQmJ3LAMNb5w1fMaGl/X4603v6UpAD8sp90sql4WfTh22/b40M&#x2B;rXQ6fWIb5mE6KTGiIyPQVBEqE3hn7LqdbmK7Y&#x2B;9Wj&#x2B;0Rib7rZY9pUoKEsEkZeyaqhrkZ&#x2B;awoCIRMMW5BagW5z6DZnJRuOig3ywmSRoEvuKcbNSkGTskkKVjWEwUqsoruLqCbvBEYBBJYSgpRVlRKWso0PlUVlDM40mlwcCZaWprUCJIlEC2dRe64lXUPu/O99ofKqXfkgPxcu&#x2B;praPzbzkvz99DhJs4bw3c0y9xuxCV9XcY2BOJndqgTd9u8HIC/XUdA9XePxOCU&#x2B;l1NbFLS0bUWF5ebjx27FhZWFgY90W1a9cu6GL29CsFTWLDw8NtQFHpXAkMDMCVV16NBQsSucSfsr0TJ060Aw6buEqJes2t/bqUVTtfQUCcMomUwZcD2A88cB8L223dup3L4ancmI4NEQBZWVk8Wd&#x2B;1a5fYnr&#x2B;RnJzMYIbA8NVXX3NelbmpsuCJJx5n14M77rjDrc&#x2B;89tqr3FdMRMV995lt0kiU0CrCSMr9tA2PPfY4VwLYH0u1qBb3GfosqZK7G1TmTf3atJ/oVN64cQM2bNjEz48fP85kiycu3Xj33Xfx448/2f4mh46//vob3333Hf/93//ejYceerjWcaZz&#x2B;r333kPr1m3w668/sxClIwGwkgmAtm3bcbZ/yZJF7DJxIYKqk4hAa9u2LYYMGVrrfRL&#x2B;zMo6hTVr1oh1HMXg3VpZNGLE5WLbZ/I9yUr&#x2B;bd68mVuC6Bok0oAcisi&#x2B;kIA9tTDQQ&#x2B;4eQpVRF3H4lwP6rgQA3SUFLllbQE8FQAONlOmLsOnDP1CcVYCK0mJxUwyAT0gAorskos9D1yG&#x2B;d6uz9ol3e7Liw17r3B5AgoFUFeCl12sYkFpmyO4MDEpA3hXYVwYoktskgT0AlAONVvIiKCYcba/vj1ZX9saxtXuwe/ZKpC7bgYLUk/CPCEHS4I5od8NAxHRJRkSLeC4T50k/QWIZ9W7nybV1ELauQ3FeAfat24YNfyxl4JmdnsGgk0C/XgA7aPSnRybJuRxcvrT5Qpd0my37anh1fP39uew5IiEG4bFRCI2KZPBERIa1vN92PKBO6qjpPcgtI6f&#x2B;r0Qi0A1Sw6C/GiV5hTix/whyjp9EYW4e27MRIaDRel3kTL9ZJJGqJGgfBoYEI751M0Q1iWWRRD0RUw6EkoZFPcXCJLPF7gN0ThJ5wee3OPfKCs0EwIkDachMTYOhpJzbGaxjiStw7wyU7ZdzBuxK78kBd/vflcOxSsvZv&#x2B;bO52TZZIX3rUJ&#x2B;1M9fXVXJ6v1t&#x2B;3cVj&#x2B;5oP6gXkgXw97aUd1I5tzPoPxekj9q57y5hpvY5K7FEDwE0S8V1oSEl/7i4ON82bdoEivDW1NPGaJq07969k0X9kpKS&#x2B;bXp07/CyJEjLSDbvNo1NUYWlfvjj3n455/lnPWiib59RESE48CBAw6v6c&#x2B;jMC7dB4hgePvtN7ln3T6o/5bs7RYtWsJA5aqrrmQ7wU8//RRjxlzP2UrKbE6adLsAKY3FhP&#x2B;6OmXw3QkiIeictm8JICAxY8YMLg2&#x2B;4YYbFIE69fRT1pFaMMg2LCkpURyTUfjggw&#x2B;xdes2vPHG69xqZ/38jz/&#x2B;KADONyy8WJeg5ev6GTr&#x2B;N974H&#x2B;7L/uKLr7g8&#x2B;uuvv0bTpk0RH5&#x2B;AvLxcz&#x2B;SzngdpclBljPx5a8C&#x2B;fXvRpk1b/ptaery9T9/DyVJy&#x2B;/btOHUqi7PnVB1HdpNEBBExSNoUNA7Yi4eaz9HZXJGSnn5CXK9Pso2f1TbzfEd5eYUYJ97CI488KksA9O9vtuscO3Ysj&#x2B;9hYWGsr0HnNJGMpAdAbS7Wa5kqIGi8IHcNqj769ddfxTjTWLWdpx7cAkxwnf2HCpBvkI4AHgKgAUZWyhH8cc9HPLmnzLPe24&#x2B;zk9WZ&#x2B;Sg4noWD8zYivk9rjHznv4jv1eqCrJPVm1pjKSU2VVVLGp23xlRTI2n1eo2kMPF0BvJ18ZtWmrieiZq70nLOr1ufkyhg8pBODPgLUrNwZMk2NO7fFpEtGzv0fJucQL9sLy4dR7v1L8kvQtqu/Vj1459IF6Cf&#x2B;vqp15/U&#x2B;/UCiHnr/OFe3/LFG8c4G20Bpz7&#x2B;vohp1gTRTeO5xD/Q4jVN5f/U949qdVszbmSoY0uI0nOyW7NpEDiRPJTt1np7o6ayCoXZeTi&#x2B;7xDyMrOZACBFf3M23Fy5oAQk6wKSlcrLlbLW5s&#x2B;Z&#x2B;8RN1QTYgaCIMCS0bo7I&#x2B;CgmVMgOkQgXEoQ0if1rlNVeqLHcMWvM73KrgPmcpGNF3xGdmIDy0i4sInlw03ZkHkln0klryRyoAWdXoFvtdbll1LLvauRDXX/H1fs23Q2rkJ&#x2B;YeNG&#x2B;at6tHToM6YVOQ/ogsX0r2/lB5zZNIJ0nSUpWk64AujvEpisCzJ5UtR/P5EgyUu/Pzs42WEF/fHy8L5X7t2jRIuBSuE8SiKe&#x2B;VysYKC4u5hJfym7RbiD1648//ggLFy5kUEBl5H369BVA9CP07OlYuhsbGwc/P98Ltu6U1aOqAyonJtBx99332N7766&#x2B;/2InA19cP&#x2B;/fvE4B/H/9dVFTImevJkyfj8stHqoqVnW1QWX3z5i1s3uRUbUCl8kuXkup4d9nPWDUNCGDdc889fL4RadCoURSef/557qEeMWI4hg4dxgQDEWYHDx7EypUrOft/IYKUy8l&#x2B;cOXKVewKQUDIKtJGtokmkwmeqL9BBM2YMdfhuuvG8HXgHCROR9U9VgKA/iWSjMYGK0mWl5fD1TLUFvTXX/OZcJsyZYo4N4Jw6NBBPkcjIxs5fC9ZgJKiPlUIkTXe&#x2B;TpfqbKG9Dzat&#x2B;9gy&#x2B;ITOUnkg7W1gYjDWbNmiWtyJ1cEURsCXWtEtpH2SWRkOAuYkpYBjY10/dmTmSTkN2XK/7FmCPX/0zW6ffuOS&#x2B;Hwm&#x2B;BaB0CpUkCJBPC4AHii/kR5fgnm3vYegxESq&#x2B;N2agEOa6jfXDynjJNWTNQzNhzEj9e9ir6Tx6DnA1faMtEXhAzw9tZYha2oD9lkMDAxAM6qeln6v91XoHYlfKUE6F19/kxArW2SbDqdSQ9vFiseVzhMdJwn1M6TeQactn5LCeUl5UjbsQ8b5i3BwS27kJV6nEGnt68P9L56&#x2B;NiX99fTcUmyCB5KJiN8/PwYRDZqEs9CfiFREZxxJlBkqqkWAFVS9Gc/vYWSbTOVNAjkNA007vYOaGDp2ffijFkxZfoPpCL7WAaKc/MEwDNwZp1Av5dOZwO2agDd&#x2B;rcckJfLcrsCrubfM/8oESZ00/cPDUZCqySxb&#x2B;ME6I&#x2B;Gf3AAV1gYq42orDCo0EGSgz2Fs8gcvcATXPEo59/SIia5MR/HY7sOIG3nfuScyGT7QvO5febg/pILsU0VYvJFrRPURtFuQHe07dedwX&#x2B;rXl1s2RGjyQz65a79upCO7pKd7n7WWUhUiTil0n4q8c/JyakU26ShR2RkpC4pKcn/Ujtkd955J1JSUmyl5DTBJ/BvJjeqMHXq6ywsR4CVyv2HDLmMQZ5ckPgbieVdqEwX2fJR6wJl9P7&#x2B;&#x2B;2/2ArfeL8jHfuDAAQgKCsaaNWvxv/&#x2B;9jfz8fLbqmzHjmwuyfj/99JMA7S/Y/n7ooQc4k3rs2FFZAoBsxEhbhMavvn37chUGVQC0a9eaiZr//e89AfyH2kAYkTGff/4Znn32WfHeuxfsnCEBQtrnJ0&#x2B;ewBVXjMLPP/9me49aCuqTu4Mn5EgmE5M4paXFsu8T4P/666/w1FNTbK999NGH7DZBGfsNGzZgzpyfuIqABEEJWP/44xx2nlCr&#x2B;Jk69U2uuCGNAVLJLyoqEmNJo7PaFgLyJSUlbFlpjfz8PBa3JI0S&#x2B;xgwYAB&#x2B;&#x2B;WUOX1tU5bR48WKudvjvf&#x2B;/CihWrOLu/YMFCHjdmzvyGbVCtcdNNN3HPvzVI0PSrr75khxOyOv3rrwXc2nAJgH97YO/8N9wkBuBikn1JzW48BEADi/2/rUPuwRPsG009iTTb9gkNRPtR3aAL9EP&#x2B;4QykLk3hSX5FfjG2z1yMbndefkEJAPvQ&#x2B;flZWwMkFh2rrNJIBCCcVHiV7O7sn8tlu&#x2B;T0AeQm3O6oWKtN1p2Xt3&#x2B;fAL&#x2B;7E35Whrd8l0EAfCrvT1myBoe27saptHRUlJRCJyY/VEUQGBZyTm371ITRXL1nD2qtz63vGQV4pn99/HwFYGyCsJhGnO0PFf&#x2B;y7oElI12DakWxQTn3gdrL2Y&#x2B;/8svL6RvUOgY6L1t7QUl&#x2B;ITIOHkN2&#x2B;kkUZedxVpcy6ERgOZf3u5NhlgPwZwqKqbycQb9YFz9xbcc2T0Jss8YIi20kQGgQg36qsDCUljkxEXBPP8HBq5IVPGyv0csmI1VxVPMxTOzYWvx2IlKWrUbmoWNM7HnpdA12nDVfowIolpbzcaAWiNZ9uqDdoF5o3787WnbvYDtnjXaZfqUxqi4kmhJ56NyT766Kv9qYZzKZJAL9Yv1NR44cKYuOjtaTgj&#x2B;V91vGqktCT4cy5ZQxf/TRxwV4NE/Ujx49ivvuuwezZv2ApUuXsEo1Cfx16dIVDzxwPwM9AqLOAnJykZiYzH3q7pLEZxuUkaRSeLIPIzFCe3E&#x2B;AjGl4pp/6aWXuYyXHvv27WMrwnNF5LrahsrKKodlHnjgIezatQOPPfYoZ/LJCtE&#x2B;6FiQqJ91X19zzTVin5IuQW3HBWvcdtskzl527NjxgpxD1tJxPz9v3pfUOkHCfyRoSC0kpBNB1RieqL9BhN6DDz4oQO9K22vU007n5u2338mCkqQLQgCdAD3515OC/&#x2B;OPP8YCmVR1QuX7JOLn4&#x2B;PLLQHuXM9EAFNv/DPPTOHKGGsSqK5B60UkGRFNr776Mvr06YdRo0bZ3iei4ptvZtrmnNZxoV&#x2B;/AdyqQgQEnce0/rQtzz77DBMBVDmwZcsmLFjwF1q0aMkVDdYgYT/7CAgIwC&#x2B;//MrVD0SEUVvM8OHD6/uht4J&#x2B;OcAPuOcK0OBsAj0EQAOLoyt3scgXg3&#x2B;YS&#x2B;5HvncX2o4z9/lQ2W/a8h3YP3cddnz7D5oNI2LA9&#x2B;KuNJX3U1UAVQBQabihUqqprpK0Xt5ajcVKTQ3Eq6lUy0183bHEUpv41OUz9u/LqW&#x2B;fLmMHZ8ZL8oqQmZqOLX/9g8Mpu5G&#x2B;5zAqystZQI4yq5TdJQBqbteWFIXL7J/LiaHJAXW1rHRd&#x2B;q05Gy1uLiT7qNN7IyapCSLiohEtwGl4TJSlO0HijLTb4oAKdnbKYF4e8EtyY7tYT2qfoJ59kmcn8T7qcS88lYv8zFMs3EY0gpe4rry8L&#x2B;6QSW0TVEVBN3advy&#x2B;admiJ6KSmYr9Gwj8kyAzMxftUHWJD6hqNe0Y3GjngL/MBqfa5TVoIOl8deowaipx26Ww7SYKILHxYLzCiveaFxg3GAwrEn4krP9idQizaqndnFvDrMKgnmnfvCB&#x2B;zHSq/r1amLwek3Cn9lyM/7ccWtfYkpfJ&#x2B;uc8R8E9PT6&#x2B;orKysEZNDowCRfgJoBfn5&#x2B;XlptdqLdkCphJeE2Mi&#x2B;zeW9UIBKGoeoV5xK&#x2B;yMiIrk8lvpWCwoKWa1/y5YtAuRfLiboXujdux8&#x2B;//xL/uz7739Qp/VyJ5tHQmBk/XUugmznrrrqagYozpZj1L&#x2B;7cOEi3m5qFXj99Vcxb94fLAR4NkEkFu2zZs1aCNDdQZ1EdXILGDNmDD8om3/DDePwySef4KabbrFb5&#x2B;M28EzbRFlXEl9TAv8URBZQxcb5jFOnTvGxpfPkySef4GwpXStPPjkZDz/8KPbu3SsA5BYmAIiM8YgA1v/o338gPvvsU&#x2B;s4J66Nudw2U1hYxK0nhw4dwowZ07F&#x2B;/XosX/6PWKYGN988kUX0SMWejrWSG4bqvVv81owZ33LlzpkGtZ1Q9c&#x2B;HH36E77&#x2B;fJa6PcAcCgOLvv/9ivQ&#x2B;qYrDqmdCYl52djQ8&#x2B;&#x2B;AAvvfQSvvnmG6xcuUKcv3vYBjAgwJftSum7wsLCXW4fjT9EeNJ&#x2B;a9WqzaVw2OUy&#x2B;yaZ96A6oZT/&#x2B;5IlBTwEQAOLUzvTbP3iVSUV6HjzZTbwzzdmAaibXd6NH&#x2B;Et4hHWLA71JYmjsSh/af39NN4kiEVkQIUBJm&#x2B;tpPHWaaxA2RlUq014XbUOuOOb7TyBVvO&#x2B;VprEuyrNpWOWn12AVbP/xF&#x2B;fzkL20ZMM6KicOED8S6CfP2P9VyGz7AzwlZaT&#x2B;1tNFM1Vv7VZYd7EJc5ULhYRH4PoxMaIahrHvedEXtQYazjTXwtgusJjcthN9rlU6/skSLWHaI2ZGKA2GQL0BKhLC4uRIUB/XkYWA9fy4hIuSSXtiouayZbMfruUyad9HBASjLiWTdGoMe3XRggIDeHN5QoKBztETd1vTS5uaRbjCdt&#x2B;1Tj9BosNihMoJjkRIdGNsG3hKqTvPyz2sc4sEiiZnJgGtZXQwLmaQ/nkcF4eKq8p/U7tE8t6LRktApRUkUPVN8mdWwvA3xvtBehv0bUDV7bQp&#x2B;j8dlZ&#x2B;d9ey1B1dEqXP2k8w3WklcB6PrH3LYt1NBPrF5E5bUFBQlZiY6C&#x2B;W8Q4JCdHXl3vE9ddfz&#x2B;DRVRDwf&#x2B;qpJ3kySxn9d955l8tjp037GJmZWSyER5UAJKBHGXICp5TZOnLkyDlfZ7PH9oPct36mBAALvhYX8&#x2B;SelPupT57syRo3TuBSXPu4/fY7HOzvrr32Orb2cxYurEuQev/zzz&#x2B;HtLQ07n9XCnH&#x2B;iHVq7HD9nAbTWVxqbBUItI8tWzZzmxWBbWrNGDdurM3m73wGgTzK3HfocLqKgMqqybfc19eHe6FJsJDaKXbs2Mnvk8PCzp07xb8PiHuEZKtmIIV4XQOuemooER4exhlvup7o2iwsLGBv&#x2B;gkTbsD999/PRBdlwEkng6wyidgh8H&#x2B;2QaD6bMA/BRFezz33LF/Xffv2w6ZNGxzeJ4HSmTNnMuCnMn8rAUBjH71H2f7hw4fxOd66dWuMHTue22qo2uHmm2&#x2B;p07oMHjyEKwt0uksCRprgWAWgBv4lF6&#x2B;fKQHhIQA8cX6jIq/YNoWtMJWg58NXKS7b&#x2B;5Hr2Iu&#x2B;PobW21tjJix05BqAKoPB5E2yZjTYeHvXFspTAONyAF6tLLYWIQH5LJrSJE1tEq9WWUCPsKgIXHHvTWjdqxMWf/Mr9q7ZzLZrpDavV1BMdgXw6z7RrNvCRu7ZN3FLQpgA&#x2B;qQw36hpAiLio1mbgLLRtAzZyDlgOWfg7w7u07iF26BkcGAmmGAmIwRAIF2FzCPHuLWiMCsPZSXF0Gq0Zv0MN8p&#x2B;6z72axSAq&#x2B;MG2Fv20T4mIoh67aMSExAp9iuBflq&#x2B;WoDSGkMVK/bDSS/BWe/AuQVCSS9B6TVJ5qDI/Qavd3UViwX2vm4E4nYn4vCW3cjPyoZevGaxo4B8Nl5yn41waxnlSj67vW23rXZbJrajsrySNRP8gwLQvFt7Vu9v2aOjuD67sI0iA01xbhOgUSMR5cYpNbtSpfFMjpxUawNQIiHtlxGTwioq6S8qKqoWf5uCgoII8HsJ8B9SH&#x2B;8Lu3fvcVCWp4k8AXe&#x2B;91VUcGaKJzbiHtGuXQf2tD52LI37dk&#x2B;cSOdJeLdu3bl3nMTc7NXAyQObXAGmTfvsnKwrjTGrV6/GBx&#x2B;8x3Z91MfuHBs2rBeT&#x2B;M247777HPps7YPaE8iObNu2rcjLy&#x2B;fs&#x2B;/33P8hkiFzlgXXSbwUdtL3ukxWVTAiRgKCVHFq8eBGmTn2DlfhnzpzFwFguaJynHuKdO3exg4JZSPEkExYERkhvgc4/Eiy8/vqxDp8l5fFbb53IGc2nn56CO&#x2B;6486z3/9GjadzvrVSdQQr&#x2B;n3/&#x2B;OYvB2RMAlBGmc4l0FXr16imO3/sYP36CTbWdiIDExCRuERk/fjy3YFA0a9bMMwG9RIJIqq1btyIuLg6LFi1mHQ0aD4noIvcMOqZdu3Y9o0z/&#x2B;QzK0r/55hvIzc3hCqBHH33E4X2qcCLBT3K3&#x2B;OSTj/HDDz&#x2B;wewkRbEQKEkH36KOPsSUhtSKcbVwi4B8K4N&#x2B;E2u4AJrju/3f1&#x2B;tmSBR4CwBNnFmT1V1lcwdPbalQirmtzxWWpd9fbT1/vt0nr46PxFQ&#x2B;&#x2B;YsWNuaK4xOTjo9cSESBZRAPVJt&#x2B;uALm7Jf1qCvJKlQLuEA72k3LyZCfxMCorzs04hX&#x2B;&#x2B;m4fVc&#x2B;YjTzynGZVeTL7qw02JMqIElBslxCBUAP/oJvGIbBwrgLOee6IZ9FdUqmIy3ifQyOI4BmSSxh0sp/rd9D2UKaN1ZY/ysnIc23UQp46dREGWOdNvtlf0Mperu2Qh3L3XyLEXcoTA6eWpvJzEOkl0kMBybJsmiEqKF/s4FgFhwWKGDct&#x2B;NVhs&#x2B;&#x2B;R3rFzLg3Vf2Osq1F5r16&#x2B;5&#x2B;zmqqqDzOqlLG8S3SMTa3xcjKzUdPv4&#x2B;ZkcQ6cxEdCVFGqU24yN3FCTZo2H5rBgPK0srWDuB9B2Su7ZFx0G90Iaux95dbKrK1eJ9Av1KwFwJkDuTBHJg312xP7nX7AX8lMY8WoYU&#x2B;0mtX0wGyyMiInQk6teyZcsAAUC1l0JLv3VbKHtH2TBS8qfe3kmTbsV3381GUVEBZ8qpR/Xll19hC7/MzFMs4HbZZcPExF6&#x2B;bJzErrTaW87Zen777TcsqDVx4m0saCcH8Kk1YcOGjQgODuKediuQpm2k5SlTR2Jj1Lc7bNhlmD9/gdjWRudlv9K5QareBA7i4swEwMaNG8V63YqVK1ejVStHx6CXXnqRAbBVMd2L7ULNhBhlG8kbnKotJMmI7t17sXI6CfnFxcXX&#x2B;u2JE29l0ELAq1&#x2B;//udke6gvmcqdnXuYrUGCaJTFdNZuIOeCKVOeYmGz9es3sDYE9Yx//PHHFoLgDwfhNU9cIgjQbgxu2bIVdu7cwaQOaTlQLz/phFBrEAn61ecYMeJyrlwZN268GOtKOLtvbZ9JTU3jMYeuP7IjpDZRc5XQbVzJQqJ91vvYvyzkwL8a8FezDGww4SEAGlhEtWuK4hO5dT5PC49mo7K4DPpAPwQnRMJLXz9PDa2fH/yJDKipkYzVNaguK5d0Af5a2IFid7NszssqAXp33le60TiDAecqBPvlOfNrlGxl/pFx0Rj/1N0YNul67Fm9BSlLViNl6Vr2Ydf56u3U1s92TKqbKly1oYqF5tr07YrYZk3NNxQNuO&#x2B;52laGbp9jldxS3ncW7FMT/1NS97c&#x2B;9yKBMjGBFv9FaVExZ/rzM04hj8r7C4p4skvl/14sNqmRGeM1LsZ8tXIDpQy/8/sS36BJMI9IHd8AfzRp1xKRAvBTT39wowgmBWhdqe&#x2B;ct1CjzkvIAnReRcnlkVYTelR6X&#x2B;kzVneCqooqePno0efa4di1chPS9x2BSQBom12gDDXiqkhE/khIqjyRHAXD147Yt4bycr7uCHi17NkR7fp1Q&#x2B;s&#x2B;XQXw78YZZckCNimj63yNu0siOl/rSmr7rsYrpXHGlW4JZflPnTplKCoqqqL&#x2B;/ujoaJ/27dsH&#x2B;fj4aC/Ve505Y7ePe1tjYmJY6O7KK0dxGXZq6mG2i6OeXbq2brrpZu7hJksrpbBmct2NEydOsK2XUtn3rFnf4eGHH&#x2B;NMvVyQeNwzzzzLfeSUZbYSAKWlpXy&#x2B;Uea6XJybc&#x2B;f&#x2B;gVGjRuL11988b&#x2B;CfgoA79fhfccVo22vvvPM2CwoaDBW1yA3K6lP5MBEABQX5WLVqNT&#x2B;n1yjDStUZEyb8B2PHjlPt5acICgrC6NFXnNPtad26FVd5MGFtsQykSgzr8SIi4p9/lnEPM2WC6TwiwmPt2tUMnm655SbExyfg&#x2B;&#x2B;9nMylAy1B4wP&#x2B;lF3R&#x2B;UiLA6iLRu3dvPtaUFX/rrbeZaHvttVfx6quv1/ttocz/smXLuJImMbEJtwOlpqbiyJFUzJv3O7cwkE6BmXi8FR06tGenon87/4PabQBKGX/7z0ioe6b/kiEJPARAA4vYLs1x6O9N0IibnA4&#x2B;yDt0EhEt4l1&#x2B;bvs3S7DmwzkIiYxGWLNodJ40HMlDO8E/sv5VgmqovlCvN1uv6bxhrKyUKKsoidc1dlkWJQEsNSLAGZzLfZfchPtMfOhdLc&#x2B;AQ6xiaFQkBowdhb7XjsCOFRuwY9l6pCxexR701Fft4&#x2B;/vAkK5es39ZQm4tOnbGe0G9jTb41VWo0a8Jl8uLsmq&#x2B;mtqjaDm5Vwp9DtntjX2r1n0I3TeOrPDRXGZAP2HkHsyk73qS/MLzQSSWGcSydTCy8V47Q7h614lmPOe5p5&#x2B;skMkZwR/P8S3SkJMUmMG/oFh5gkK9dNXW7LM5tNBUyegfvpcdnzNWfTR/rmSJaGSRaHzdzsSXqdfp2oAsqvsNnowYpLjsemvFTxJ8SbbJElSpVvcOTLu3m2toN9kUeUnUoUqapp364BWvTqhDYF&#x2B;8fAPDOCjRoQWgSI1nRAlcVIlAO&#x2B;OdoiaU4DSsnLjFGX5jx07VibAlVdubm4l9fSHh4f7CTCmv0TE&#x2B;&#x2B;VJYAvZS4KAVOKdnJzMPbEkYLVmzRrce&#x2B;/9DPytk30Cqu&#x2B;&#x2B;&#x2B;w6rz1v70882SCvg9ddfx/Tp0xWXIeu9J598nC3uiICwDyqNf/PNqQJgv8Oq46RTYA0CIwT8iQAggoH8uTt16nTeBebMrUcmh7Hm6quvFr/blHvyv//&#x2B;B/To0ZOVyD/7bJpYr7ksmkYExokTxwXAPiy290nuJyaRMn//8&#x2B;sMSYTOW2&#x2B;9o/g&#x2B;VRRYyTayPqN93bdvH7HuX9haRcgBgvq7KYs6d&#x2B;5c7gunUv633nqLxeLoGHh7e6bJl3rs2LGD/eutYwKRd9YxcP36dUz2UM9/cnJSvd&#x2B;WTp06s80mXWckhnr77ZNYjT8pqTkuu2wotwnQOOdzTtsYL/kwQTnT78oJwB09gEuyMsAzsjWwaNyvDVv60dno7xWEbdMXYfjU211&#x2B;LqJlLKQSCXkF6cg9dBwHFm1CWHwjjHz/PrQd07debisN4F56vcaLlLdraqQqIgIqq/iGT20D8DpdamwvkGUvfqU0sVcT71MCAkoTcqX3lEgAB1BBGWKphqq/&#x2B;e&#x2B;uw/qhi3hc9eAtWPD5bOxbvxVHt&#x2B;9ncUcqYddoNS7ISA3cb2FyWlb8P7RRBAugUZl0dY1REaA7v&#x2B;YI3tXfd/WdthFdAnvRExEkWbLkGQfTcCrtBLdMkIUffZ5Avzf1qmk0slumgXtd6dYaA9drJrOuYv0I1FOWmQBmoxZxiG6agMgmsQgKC2VSgsiUKqqgcALfcsKM7hZ9uBJ9dPW8Lss5nseO5yERHvRo3LqFOHdM2L5sLR8vncWS7bzePTVm8UwSSSTbPr&#x2B;gACS2a4l2A7qj/cBebN&#x2B;n1&#x2B;l5ZmCsOQ36nQlD&#x2B;7&#x2B;dlfTPRuhPGYy5ZxloP45RL39FRUWNwWAwCRBZExUVpSflfgEeQxvC/Y2yt7///jv3727duoWBvlVYi4D&#x2B;tm3bbeCbfNr//HM&#x2B;C1&#x2B;Rvdcbb0w9Z&#x2B;uxcOECHDlyWHWZ&#x2B;fP/EkD4Q0ye/ARnjamHnsA9lR6/8sorLD533333QhwrpKTssH2Osv&#x2B;UjSTBLyr1PXjwANasWXdBBOacM4VUOkwagyScRi0UX375FWf509KOsntCQUEBevXqxdlGEhokMobiXIJ/6/ltf&#x2B;&#x2B;cPfsHAd5nqRIAer0vj52kiE6cESmgT5p0G3bt2oWKijIWM1y7dg23ilC1wOTJT6Jfv77scnARjS48cR6CFP6XLFnMZfDk6ECtNz/8MNs2powbd4PF&#x2B;q5&#x2B;HneqFLSek0RsWUlQ2p6EhHhxjd4uztvkOlcx/YvCuQLAmQhQIgaULAMbRHgIgAYWTQe2R2iTaBQczYIuyA97Zq/C0JcnuizpD02MQdNB7dk5oDS7kNsISk8W4vc7xA3W9Djaju1bT&#x2B;y8FCYu3t4aHwtTX2OoNFWWlZn0Op2XSaORtL4&#x2B;GiWgrQS&#x2B;XQFzpUm&#x2B;O6rfruwLlaoNGERaJkOkrH/zi4/AUFGOTX8sx/If5iI1ZS&#x2B;qDZWsSk49zI5fLSmCX2di4LQgmlOPManQhwZZsosmG9ngUDPgZCMIp9ftgaPz&#x2B;1bXOney0CwwSB73ZeU4tfcIck9moSAzG8W5&#x2B;WI9zfvIy06gRqlA3/E9jQtgXzfQD6sdHK2vALrRyU0QnZjAzgjBkeG8jjXVRhbzk5x8s51BtrvEkpLbxOn37Y&#x2B;D4&#x2B;fMPbwml84YziScWnbaeTkiOBI7tGbSY/vytSjIymV9hvOEZsT1YGABSmqXaWIB/R0E6Kf2Fb0lQ0KAi0CY2rXprgWosy2f0jKujpU7Pf/W7Cb19NPflO0XYJh7&#x2B;ps1a&#x2B;av1&#x2B;u9LuVMPwWJXUVGni57J9D8&#x2B;eefolOnrnjxxZdw5ZVX8X4goTkCodYgADp16lvi3wAumaXHuQwi8lwBcvLkfvvtd9jPnvr4Bw78Ddu2beNS84kTb8H//d8ULt2lUnn7ygTSMygpKRZg&#x2B;3O0bduePbetGesLMU92PmcoK962LVknFvF2k2vCpEm3C7ARzL3HpH5PsXHjBgHKZ&#x2B;L55188p2v0559/cN&#x2B;z/T6g/UZtA2oRJsYYUvHv0aM3xo8fxx7o1Ot99913IT&#x2B;/ABER4awRQBlVUkT3RMON/v0HiDFgNN57713W05g69U307m0WdezevQc/6nNQlUK/fv34OWX2ScOAYvz4G/jhCdccCuTL/01ugn/n6WKDIAM8BEADjCs&#x2B;ux&#x2B;f9X0QgSFhMBSWYdtXi9DjPvX&#x2B;uthuLXDLoldQUVCG8rwibPpoPnbPXsn2Yr9OfAtevk&#x2B;j1VW9eNnDi7YivHkcwpvF1s&#x2B;T2tdH66XX8YVZWVoqGfILTPoAfy/odA5Isi5Cf3KAXB7zuR4PXPUNy9kN2mdAzD7jZvcGKqMeNOFK9LhyCE4cSMWGP5di3S8Lud9d5&#x2B;vLomvmFKhjBl5jN8JpVMYxB6JA/KdIAGy2aiQBRpPx9Ncq9IFbwbs9gLc&#x2B;r0UESHajqkoWmvbD4W17kJueiXwB&#x2B;stLSrnMnKoBapf3K2/TWcJ7hduMiUXiqFZA7&#x2B;eLxi0SERkfg/C4KIRFRzFpQplwEkjkegKNeaPVdCnc0ZRQA961zzU72ker4QoJyvwZSkshrhvehyZLdYd6FYxk154gyayDo7OB9V9S1g&#x2B;JjkTPq4ZhzU9/oTAnl1shzh7vayzq/RVMDtWIbUjuRJZ9vdCiewd0GNKLS8bpOFOWv9JgUNy/zgSh2rFRu/5dtfzUdQyyXf81Naa8vLwqASYNYkKoCQ0N9e7UqVPQpSLk525Qqev99z9gt&#x2B;0mATRTuKecFLtJnZ4s20i5feHCRbblqLe3Z8&#x2B;e549wdtFTW1paghUrVnBVAmX8iYigUv9x48Zxr3uHDh14OSrtd47AwEDMmDETM2d&#x2B;jRMnMlBeXnHO15&#x2B;8zilbT6SfVXSQgsRQKbtIpARVH/zww/dcPl1UVCiA/l247rrrmfigaopNmzYxcWaN&#x2B;Ph4jBw5&#x2B;pyu5&#x2B;7du/H119Nr6QOY1ccdrw06H&#x2B;yBPBEttFxeXg5XLxw6dJDJC8r2kuUb9Uk3pGvFE8oRGRmB99//EMuWLcWAAf3FY1C9X2e6R61atZKtQ&#x2B;fP/8NGAJBDBWmceKLOBIBcBQDgvu2fqwniJUcGeAiABhgJfdogplUzFKfnsIXcjm&#x2B;Xovs9o2XKw&#x2B;1OBB9zNsM/Mpgfoz66B0lDO2Hurf/jCcGP176CF4zzeZkTG/bjpxteRZ/J16Hrfy5HaHJ0vdsHGku9lG9wsNbbp1IykWhgebmkpZmbr6/FEs6RDDgT8S2l99T&#x2B;dQZWahUJauDA2s9cJUAnlVJTL3OLru0xeMJV2LxgBXYtX49961Kg0XnBh9wDqEJCkhQpTbWRzNo/XZxXiF0rN7JLAVUZVBuqHfgFa/m3c9bZcVudt9MNgUAnUOQXFISqyqOoFkDaUFYBX39fs7r8RQiuiKg2C8RROwIJI0YnNUZU4ziERkWAzAxIZK7aySNesmM8zgQIukM4Ob5v3td0WPhcEP&#x2B;SoCNpJBzfewi56ScRFBGOXlcPs5EA1p5g595gd&#x2B;gUR7rJ8T1jTTUCQgLR86qhSFmyhokcb33dS5ytQn7V1D4hwAitd2LH1qza36JnJ7Qf0B3BAizS2pOmQgUBFhWC5ExF/ZQIPCVCT&#x2B;6alyMYHLklk5SWllbm7&#x2B;/vVVBQUCnAjL8AwvTQaRoYknnyycncX3748BHba1RO37Rpok1QjmyuqC&#x2B;&#x2B;S5cuXIauZPd2LuL48WOsG0Eq2tZz2HmXEximkvK5c80tCgT4W7dug&#x2B;HDL2dve&#x2B;rndzcou/7PPyuQmJjo0jucxO2oasCV0J59UBb8ssuG45lnnsGiRYvE&#x2B;m7migRSD3/88cdYUJHcE0ibYMyYsbjppht531NkZJxkf3Ta1oULF5&#x2B;edyQ05se5DNo25x78igpDrX1PrQj33HM3/vjjT&#x2B;zZs5vJi&#x2B;&#x2B;/nyX2SYjYf5EYNGgwPv/8C660oN5pT/z7gsYIelwqQeMIjSmU8Z89e7a4BieKv8vZTUOn8/Ic0DMjAOQqAJwJACVyAJBvCbgkwb&#x2B;HAGjA0feJ6/HHXe/BNzQYGVsO4e&#x2B;Hp2HEm3dC5y8vDJKVkort3y9GZX4FQppGofnl3dHm&#x2B;r5Y88Yc5OxPh9FUjaOrdiFxYAfO/FcXGbD82ZnI3nMcE354ljNudEvWeNU/tVFv0gMQgyiVy6KyCmUlpTV6vc5L0nppNAQ6FPr9zzTT747dYF1sCpUAh3MPslHcLAgEx7dqhiatm2PkXROw/tfFSFm2Bgc2pqAkrxh6P58zAlrW0HprsXfNVhbXa927K&#x2B;KaNeH&#x2B;NMq2UvZbiQRxBXJcZVYdQJ94RCXGIaFlIvKzcnAkZQ&#x2B;yUo/DUFIGI5Wye3ud98wOazMYjXzeU3k/ifg1Skowg/7oCFYcJlKAe/pl1Qac7xtK4FqjArBduQ&#x2B;c/ry1JYIV4cU65R3P4IqRvJNZLJBotGT8i3IK4eu/Dp0u68sVFbSNrqvdzowYp/UgN4l&#x2B;40Zjw7wlyDl6QlyreteuERbQT1aU1NPvI87phDbN0bZvV3QY3Aet&#x2B;3Rmb3iSpqT2iorycod&#x2B;E3dF9tTGBLkKDCUwr0bgyZX12y9XWlpaQ339YiJYQ9laKvEX/2qSk5NDG&#x2B;q9iwTwKEN&#x2B;&#x2B;PBhrFq1Art372LP9hkzZjBYtcZHH31s1nu5AMTfjBnT0b17TxYPo3Ji63VFpMCiRQv5sWnTZpw6lcVl5gT6qcyfhMfOZCyi4//zz7&#x2B;6ZdlFgP3dd99zIADy8vJ4311&#x2B;&#x2B;SjZfnwSCnv22Wf4s7R&#x2B;c&#x2B;b8jOeee4HL6kkQj8qKyQ2gXbv2tT4bHByKrl27YPToKxEbe36rAAn821dbUEaUqkIo02/dr5QpXbduLbXAsAgaAfyyslI8//wLGDJkCFq0aMkVIZ7wxKUU1PYSFhbGz0lEdOjQgXwtEOH5wQcfenaQ&#x2B;vgpiftmWmZm5oGFCxcucyIAjFAv&#x2B;3fV/3/JA38PAdDAo8N/BiF711Gs&#x2B;/BX&#x2B;Iub&#x2B;qaP5&#x2B;P4qj0Y/uYdaD7S0Qc5e&#x2B;9xzJnwGnIPHheTKTMgXv/2bwhoFgZtpdmnXS9uoCc3HGACQDKaLdT8AoNgLKvC5s/mY&#x2B;cP/8A/OAgtru2NLrcOc&#x2B;i/ri&#x2B;hpaoAP18E&#x2B;fl6k3NAjXiU5hYZAwICvSUBPNhJQGXS7q6DgNznXREMcllCV4BFVv2bgVEVqsXfdMwuu/V6DLrxahzbvR&#x2B;/vzcDJw&#x2B;mMfDzDfDl9gEq/5ZMJrf3If2m3t8HOcep/H4RmrZvKcBvE0TERcMnwI8rEggUq5EY1nHTvlrAcRk1czjLCCwAq6GmAkERoeg2chAqikuRk34SBzftFCA2jwkJq8DcObypMFCWxDbq/fwQLQB/uNhu6ukPi27E10RNTTX3/ZOg3&#x2B;lV1sjcQzRu3Ec0cM&#x2B;FQO5viYGR1kKGUMtBodgvJ/YfQW56Fkry8rkigSoBCGQwKaQB/5u2az/KiorQVexXv8BAcTxrLNuvbPmn5i4gt6z1kBMJQNUp3UcPxtIZv3AWn8Qs7etU7C0fqyoMTKpQaW9cyyS07d&#x2B;dS/zb9e8hzmmzZR&#x2B;D/oqK09eN5Ydd6XOoaRi40w7kSuzP&#x2B;ZqVEyal5wT66Xl6enpZSEiItwCZJurpp8z/v&#x2B;HeRYD1llsmsto8AdmhQ4cw4Fu3bgOXmTuN6RdknSg7TmC/b9/eeOCBhzhDT2JygwYNRGZmBivHX3nllaxJQBP0sw0m7Nz06yaxQXtAUFRUjOuuu4bBPOknDBgw0GF5ujZIlJD8wX18fNG9e3d07NiR35s5cxZvm1qQDsOdd/73vOxnKtsnIkMpS79r126sXr2Kzwe6fr755hv8&#x2B;ONsdiIghX9SRSewRMfjX&#x2B;p37okGElbwT/Hqq6/xdUrtTqNHj&#x2B;JWHU/UBv3l5eV5hw8f3rJhw4Yt99xzzzoL2K&#x2B;RAf0mhYf9JM36mhwJoDzx8tgAeuJih04AvJEf3A2NAAApXy2EX3Agcvem45ebpqLttf0Q270FEnq1QmzX5tj6&#x2B;d/IOZiOwNBw9ug2kf1VmQEVO9PhKyZjWhYQ9EJJRn6tiW3mpiNIW7IDRoO57/nAoo3YNXM5hr99B39/fQ0vHx&#x2B;Nl94H&#x2B;sBAr2qDwWQoKZEko0mjDwrUkoWiRpLctvZTIgzkCAFXft1KIMSd8mPn90knwMhWghokd2qHR76eKkByJvat24aFX/6IrCPHUVpYIo57oPs&#x2B;sZbVIHBNv5O2fR/SduxHcHgomnfvgNjmifATQIxEAgkoy7vPSwrgXnIT3J4OI22jeOh8dEho3RzxLZKQdTQdWYeO49jeQ1xqrhETwTOeDEpgUE8V8DrO9MchIiGGxfwiYqN41bnfXKwDES82xKtRXnczCFY6D&#x2B;xBgFRLC8GVkCIJ6jHwF/9Sr31RZjaO7z2MglM5KC8otpTJe3M7kN4uK2bfjkCOCRmHjqHSsBR9rxvONpMmo1EWwMuuj4qWg8OylucE6AMF6Oh59TDs&#x2B;mc9ik7lwtvPx&#x2B;a5QC0e9Pu0Tcmd2qJ5t/ZI7tIWXYcP4HFNK5ajLKBBplfaNREFVZCvJOonR8Sp6XcoXevWv8X6m0pKSqozMjLKBXDzpr7&#x2B;Tp06BXuxPsO/s1GZFK3Xrl3PPfSDBw&#x2B;5gEJ4jlFYWCBAaRiD5ZtvvhUffvgBvvxyOjp37sIEwH/&#x2B;cyP3ll&#x2B;s0DsJ/M6f/ydGjhyJhx9&#x2B;DAEB/g5VEqdOncKYMdfh6NFjmDHjGz4HiciwkhauwP&#x2B;ZEqeuTmGyVZw69XWUlpbh448/YcG&#x2B;nJwcPgeoCoDWn&#x2B;wU4&#x2B;PjuJWCABCV/f/vf&#x2B;9g&#x2B;PDh7OVuJTE84YmGFnT9kP6GJ2oPL6Wlpfmpqak7d&#x2B;zYsfeZZ55ZS8S5Heg32oF/d7L/SvoA7k9KXb/nIQA8cWFixNu3I6JFHJZN&#x2B;cYMmCqNSJmxBNu/XQK/qBDctvRNZO1LhZfGrABOJd5d77oCOgHi8g9n4OiyHZzNpOx4RWFRre&#x2B;vLquERlwuPkH&#x2B;qCwug97HH&#x2B;nr9&#x2B;O7YU9j3M9P16o2qF&#x2B;jKos5afT&#x2B;/hox45ZMAsRVVVSYasrK4e3rK96gPmmt&#x2B;55rkO/7dQf4y4EUNfLAlVK4A5nAAMPcN9mosZhA3dSYrQT3b0jh0uuUpetQVV5GrRJcTi25ub30fdZ2gpKCImxbtBpBm3cgplkTJHVsg5BGEazIbySVe8mdMnHNGY&#x2B;b7JBgAeAxyU0R1zwRTTq0RGbqcZzYd0SsXyGTHN6WMnh74Otcbs6WcSzkZwbUkQmxaNTUbNtHYn40&#x2B;aSqCcpGw5Jh5q&#x2B;UVdpXBsbObgnOrgf2z9Ws&#x2B;KyAn67R6qpKFGZbM/2ZKBXHhQC2F7&#x2B;v4WMMB&#x2B;tFGVAr/ucT6IeinFykLF7NFRY&#x2B;AkhQyb3c7ysRGK5K&#x2B;e0/SuA9Nqkx/IMCsOGPpSjIyGISib6wadsWaN2vKzoO7o2WPTsjOCyE79BcDVBhUOzDd0dM0fmaUSP71L5PqUXH1XUqJi5ler1eI8B/VUJCgl&#x2B;bNm0CBOjRaTzqZByU8XfO&#x2B;qsFEUF5ebmIi3PvM1RhMGPG12jRogXb2xHhQtlxazk9ZcvN2eV&#x2B;fCxHjRqFX36ZI/7ui7///vuctxpRy83ZZq7Xrl3LegkmkxF//vmnAPedbb35VBpPff2ffvq5TYjw22&#x2B;/wZQpT5&#x2B;X4/fll19g3LjxqvoENHZTiX7v3n1x&#x2B;eWX8/5fvnw5MjIyMXbsGPY4JyHAH374Adu3p2DWrB/QqlUr9OnTmzUWqGKE3CLuuON2Jg8uFlHkCU944sJEcXFxbnZ29vGFCxeunjp1akpWVlaFGDtrVAC/Ow&#x2B;1vn&#x2B;l9oBLCvB7CIB/G3MoQAEJAPqG&#x2B;mPb9MU4tmIXtDovLv2uKqxA1rbDaNqrAw4v2QqCBgHRYeg7eSyCYs3CQ3PGvo6D8zeabQRlyi2pz7np4I647LVbkbZsO9a8&#x2B;TPrAFD2d&#x2B;kzM9CkX1vog&#x2B;r/DVnsDw37xfv6aqrLyiRTdY1kKC4x6bx1Xho/X0ZhGri2WXP1ujve3u4ACLXvUyIcbO4BAtwGhoeg9zXD0XXkQBzashvrf1&#x2B;EPas3I10AR7/AAOj0erOeg5tkAPXdU5QWFuPg5p04vucwEwHxLZO4P56yOFRyzvaBGnko6EhwuLYOlAOdBMcZqIrlIuKjERkfi5bdO&#x2B;Lwtt3ctkDaBQTeiQiwtx&#x2B;g76BqCRMLKvoiqkmcAP4xiBT/RsTFwFuc/9T6Qt9dg5paK1MLvNuBfWcA7/wZtfeUnpt7&#x2B;r34&#x2B;iaChez0Thw0l/cX5xeYqxEkcFuCzkencp&#x2B;SnDiY0ytPxzT9QCoMFZXoPmoQ/EMCmRzR2HwjXD93JhbMx8hCmtgTEOKfirIy&#x2B;Ab6o8uwvjiwaQeadW2PLkP7ok2/bggJC0WNyWyZSD3iGmjcKtF3BebVrpm6Kvg7X4tyv0uWfaTeTy/V1NQYGzVq5CM&#x2B;IwlAE&#x2B;q5W51ZEOj3sVg6fvDB&#x2B;wwOr7nGPQLg77/ns83csWPHqfUCQUGBmDbtUwH0zWr2s2Z9h4EDB9rA&#x2B;fTpX3GvvDNhdC6C/OhJ4&#x2B;Dxxx&#x2B;3Ce6dSezduxsjRgxnErOgIB9LliyzvUeaBKSdQEFCfw88cL8A0a3OiQ0eiZYlJiaxswHtm3379uKZZ57mknylIAtOup6J5Lnjjjts&#x2B;7ldu3ZMbNL3rFmzDqdO5eD666/jdW/fvr0MGa1F165dPeDfE55ooCHG50IB&#x2B;k&#x2B;uWLFiw0cffZSyffv2Qjhm&#x2B;eUerkgApez/mVgCeggAT9TPaD9hMFpf2xf7fluPjR/NY3tAcgk4vHQbLn/7Lqx962eeihefyMXJTQfR&#x2B;pre/Dl9oC&#x2B;XOHspZPIqDeUY&#x2B;PR4xHVrzo/A2DD8NvEd&#x2B;AmwkLvnOPIOn0Rsl&#x2B;YOn2F1caNkJhXqYZ5LFxDAa&#x2B;VVXaNBRbkAtUVGmojoAvy9qD1AkkFtdbEMrItyuzvlymolynLghJaiPnXqZ6esMHmit&#x2B;3bDdnHT2D1T39h66LVyDxyDJXFpZz59XLqN5NkerNtRArb8HmjSkzKj&#x2B;7cj/S9hzh7Htc8CTHNGsM/OJiPv8nOekp9XziCaFcfsQfVpAzPx1Gv4x5xAvhFOfnYv3E7so4c5fe9LGr3pIdAZEFE42iuHiDLPgLYpCVgqqHKEKO6Jp8d8DVJjvuEj4&#x2B;lusEd8Cy/byWe5HJPvzhmRETQtpCeQ87xDM7611SRtaCW9Te8vXXymN9Zh1BS2uHm93zF8c/PyMLWhSvRb8xorhCy14ywt06s9Zy2WwNFIoC2jo4JERhENgVHhiE8Jgo9rhiCCc8&#x2B;CL/gAP4OqkAiWzLZ73CDkHNHuE/uuTsK/a6qcuhvAXBqSME/IyOjIiAggFhUKSEhwTcoKEjnuTOdXcybNw8///wTZ4VpX7/55pssFuhukCXcjTfejKuuuhI&#x2B;PnpcccWVbLtljZUrV3BZekxMLJebz5v3h/j33bNeb6o8oMjOPsWVBxTr12/kTPc999xbt0mcGBO2bdvKln2UOScxvKSkJFa&#x2B;nzRpklj3GNnPUZ889Ra3adP6nByLl19&#x2B;GePHj0fnzp3579TUVM7mW0UIyUpQr/dxAOl///0XGjduwqQBERIk5vfjjz/iyJFUFvsjF4QlS5awpSN9D1Vr0Odp3e2DfsfeLtITnvDEJR&#x2B;SwWAoy8rKylizZs3WadOmbVu/fn2eG6BfiQSQIwLsWwIA10KAUkMB/x4C4F8W3r56dLhxENqN64f81Czk7D2OGkMV/BsFY8CUG7DmzV&#x2B;g9dJg2VMzGGRUlRlwYuMBS5m3kk&#x2B;8CYExp22K2o7pzwRD/qEs7pte&#x2B;eIPmDDveX6vIrcYW79ehLSlO6DRAwHhoWw12H7CQLFuPvVvf&#x2B;kE2tEFIyQwUEugp6yg0FhdVAy9v79W6&#x2B;ujYds5Fwr3ctl9V9ZhahUAzt8rl3FU8oiX&#x2B;5eIGC5lhzljPubJu3H5XROwa9VGLPjsB1bXL8kvho&#x2B;/72l1fckZyNXOKnMvOlcQABlHjovvSUdQRBiSOrTmrHpQeAhn1Y3Vp4kAK&#x2B;C19qNLdkDYiiTrApytrxHAr6wxZ&#x2B;1DyX/&#x2B;yqHiWBbj6J4DXCYf1SQeUU3jOeOvFeCZdDCo759t&#x2B;zRO4Nnyi/a/J7cvnNcBMvvKvgRfciKWJesPa83e3FQWTIJ5BVk5SN93RPybzer91B9P16xG6w2dXv0a4l&#x2B;TqTqopVXocHuTWPsg70QWDm3dhbZ9u7DTguRQvqA53dAv189gf/6Ka4bIJxMfDw2LOEbER3GVSFyLRPMma83e5IbScsVrx9V1pka8uSP0ZxXos/9dd0r6rZ8l1f6qqioTlfhHRkbyANqxY8dAUvD3lPefu6De&#x2B;0mTzJnjanFeUSWAO8KAJOiXkpKCuXN/Yz/7QYOG4Lnnnqu1HClxP/jgA5g27RPxW014WWdburoGaRrcdddd&#x2B;PbbbzFs2GV4770PGDiXlRXjt9/mom3bti6/g7LmBJbXr1/HJOX999/HIoTUmvDuu&#x2B;&#x2B;yPoGrIKG9Pn36nNNjQdaN1iDLPaqqqKqqRklJEesM0PtPP/2Mw3bceOMEtGzZSuyXnSwwSL3OU6ZMsa2b1WmgpKSELf6uuupqz4nvCU800BBjc2VmZuaJxYsXb/jggw9Sdu/eXawA5s8G&#x2B;J9J9h9OZABkyIBLihDwEAD/wiCQE9kqgR/W6Hb3KOz7bS3b&#x2B;lHW/sdxr3BvP2Ud9QG&#x2B;MFUb3fpushnsdONlWPTUdFaLP7xgC0qyChAUE4Y5417HoRVboffyYaBAWeAd3y/HTvHo&#x2B;9gYNB/VvV7uLwFaGOwHRkZoKVtprDRIJQUFRj&#x2B;93ltD2Qxrz&#x2B;YZghB3QUldgY6cyrgzyWAfNVU1/CCrwN5XDUPXEQORmrIHO1dswIof/uCMM4VfgL9jBrmWYL9jLz/Z5NGfpflF2LF8nfh&#x2B;XyYbWnTvYCmv13G5KkxSrRHVESzLPXdcWlIE2maEawX1/qFBrB5PLSzeOh1rFVBWXRLAQCMr5GeDd6fBue27lXvpZfcR7MGyZCcIYCFPtIz6ObNHJe8leQU4eSANp46d5OeVFQL0a0m9X2NzOlCio&#x2B;US/kqGg84f1titKh2j/eu2ijHBhJa9O9dmEBT6Gay/T9c6VZzQOUlEUKPGMWjUJI7JFyr7N4st1vDnjZAfa&#x2B;oi6Cf3WWcCwZ3KAXvwL0fKOb9//PjxMsr2FxYWViUnJ/t36tQpkET92IHEE&#x2B;c8mjRpwiX84eFh6NCho2oVFPXzE2hesWIF&#x2B;8QfOnSQs89UUj558mTZz0ycOJGBMgnS3X77HWwveaZBGfBPPvkECxYswFtvvcW/TVfIAw/cx9UH4eERGDp0qOp3rF69GmvXrsHixYtYm2DEiBFMXAwbNhy9evXGxeSWyHWgxkK0UjRqFMXgXy/GjptvvhnTp0/nDL599O7dG506dUZUVBQefPAh9OvXT3Ef0/e//77H/swTnmhoIe6fpvT09KMpKSn7X3jhhdX79&#x2B;8vrqysrJEB/K7&#x2B;liMB3O3/l2RIADi95g7g97gAeOLSCur5J9G&#x2B;Fc/PQto/O1FVUg6trxa&#x2B;wYEwlJTXqVS/yaD2qKgpgZ93AMqrS3B87V6ENo7EwRWbERQcbi5hNpiBFvVVpy3biRPrD2LIazejz0PXyjd61wciQAT5lIuHQF46yctolMrLyqWq6mrJNyjQS2ttD5ABQmqAxB5I2D9Xy3g6AxY1MUF3gJAD2DFKqCS1eAFCW/bshNa9u6LvdZdj&#x2B;9J12Pz3clb9J7BMtn82wSrJCTHKZJOppJ5L7gUYzDx8DLknMhES1QiNWycjoVUSfIIC2YHCvj2gVnVBLW85Sd1vTm5cNkni/&#x2B;Y2BFqG2hWsmWyN8/GzAnN7kAtnCXynbT99wtRW&#x2B;5Pk7w8sOKj3hlaj5fUqKSwSoD&#x2B;VdQtKcvNhKDdXaZh7&#x2B;n0cwLXzcyhQ08rkisI56njyc2vB7rXiGm4Uxm0SJovLg8aZ57BsL&#x2B;k9GKurBOiXEBgeisi4KEQlNUZMYjz86FiL9&#x2B;k7TosLukdUyV0zCterW9eAGjHninQToNKYnZ1toMx&#x2B;eXl5NQn5EWDs0KFDoOeucn6DyKT//e9tcQwMmDZtms0Kz8vr9LSGMv2UJd&#x2B;wYT3b5aWlpXG/OVlqvfLKq&#x2B;jRowdn9Ek74IEHHpQR4NNgwoT/nPW6kqr9lClPsfXeV19NZ50CirVr12HFin8wefITePXV12tVF5gs7TY0Fn/66TQ8/fQU/vvOO&#x2B;/i7W3fvgMudkEJXQ&#x2B;nTmUhNzdX3BZ1dq&#x2B;T&#x2B;4CGCQtqS6DqjKysUw6fJU2CmTO/YxFAT3jCE/&#x2B;eqBFx6tSpzL179x768MMP161atSqnuLi4GvKZeyWwf7aEgFwFgPPrcAH4XQ6RHgLAE/U&#x2B;qCLg&#x2B;u8nc2tAVsoRBDeJQvaONPz56Mfw9w&#x2B;SxeXe0CNTLBvR8rToEmX&#x2B;JRJKo8yhVoeio1kwFJTATy/mxGJCQLZtfhFBaHV1b36&#x2B;Z85qBmXLp3yLlqN6OnxXfQ0fPz&#x2B;eKQYHBmpK8/ONmqoqU0VpqaTT6bVeAf4ayU75TQncK4ESpZJ9V2CkLvZm9v/aVwrYD1lmgFbFfxLgi2&#x2B;VjKG3XMv94FsXr8a&#x2B;tVtRkl8Eva&#x2B;egenpcnjzf2qVlluF8TTmzDUBw/yTYuKYfhJHdx1ATHJjJLRuhuCIMLO9XrWRlaxlNsgRgDsMs3ZoXFKBx7Uy1nbLyJWvS85wXTpd/g4llT&#x2B;577A3RpTEftMxIUZAuPBULoswFp3KQ2F2Ltv40T4l0sTqtqB0V7lQdxjSFtizehMS2jRnLQCzvsHpXzdaAb1GK45jCMJikhBFDgqJCQL0B/Dy1JJRZais87nqrqWm9T1ZcsvN71e7rgTQF8NWtTEnJ6dSAB5JAH5tdHS0LjQ01N9zF7lwQboQfn7&#x2B;bMP34osvcIafDmF1dRU2btyIBQv&#x2B;YoC9b99&#x2B;xMZGY&#x2B;jQYfjww49sInX2QQD0fAFpGl&#x2B;JoKDz6PPPp3O23xrU404CfP36DUBKylZcc801NkFDipMnTyIwMJA9wWn7brrpJm6Refvtd84LkCfChAisusTMmd9yyX55eRlee&#x2B;01sS990L59R7G/h5jFX6tr&#x2B;D0S&#x2B;YuKalTr8x7w7wlP/DuClPpLSkqKU1JSds&#x2B;aNWvLd999d4zupVBW7ZcT83MF/E0qoF9JB0DODlBNC0Du&#x2B;SUXHgLAEw5BImPRHZP4QRHQKBihjRrBUFQOQ3l5reV1/r7Y9PGfaH/DQNtrmSmp8JJ0ZmBAQK6qBqUZBdB4m3szCViO/OAetLmuD4Mjv7AgbPxwHvcHfzvyady35RP4hl86CbTA8HAmA/SVlaaqwiKpPC&#x2B;/RqvVaH2Cg82igWehQq5mb2YlFJyXVQNLSlUHamJmGmuWnI63mLz2H38F&#x2B;o0dhYObd2D1T39j54r1KM0rRo2xmogRG&#x2B;CVVNCpZPleDYsGeqFAgN/8jGyk7dqPhJbJiG3WFKExjeDjq&#x2B;eecUlGAVCyF9uTHEv&#x2B;NYpQ&#x2B;XQHv2NZvJwpnn23/&#x2B;lXnEG8sqZe7Vw7bTO5TZAtH5XEF&#x2B;Xmc3l/XkYWirLzYCgr5/fpoavjRPwcwwHIlf3Q&#x2B;FCYU4CDm3agebf2Am2ZKzboGNG2BYQEIaJVDGsqxLdMZLBCWhCk9WAP&#x2B;l318auV67uT9Ze7ttTE&#x2B;9SuG3oI8MVCfgcPHiyNiYnRiYmMqX379oEC4Gg85f0XJqxEpfUYEdlEVnxLlixmazt6nQT7nn32GRQXlyAiIhL9&#x2B;/fD1Klvcv&#x2B;5mjbA3Xffc07XlazrAgIC2f6O1pMy42lpR/Gf/4zHhx9&#x2B;jIQEc/tdYWEhPvroI3zxxZdcBZCdnc2989bYvn07uncnK90wPPbY47jllpvx0EMPn5f9m5GRgczMDPF7Pdz&#x2B;DBEGkZGRnMX/4ovPWH&#x2B;gWbNkjBgxkgka6tcfPHgwZs/&#x2B;CTEx0WK5mZ4T2ROe&#x2B;HeN26bS0tKSVatWbf755593/vTTTycs5f1GO7CtBtSV&#x2B;vnViACTCzJAUnmuVOrvKudyyZEAHgLAE6oR1T4R9&#x2B;6ehmMrd&#x2B;HEhv213vfSe&#x2B;HEmr1Y&#x2B;twMdL5xuHgBWP3WT/DXBzM0kow10IcEoCyrAFqauJkkdhZoObo7Zz4JZAx/63YcW7Ubp3akojQ9Hwsnf4FrvnjEbENHk4xSA/KPZLAIWkBkKEIToy2frV&#x2B;h8/HR6qKj4FtdramuqJAE4DFW5udLviEhJMvOoE6Syba761Puijioa/myuw4F9q/RZNZYXsHPm3frwA/KXKcsWYMVs/9A6ra98PbRsao&#x2B;ldPKOSbIDkRky6cTx7qiCoe27MSR7fsQHh2J5C5tGUz6BvhxxQD9vvz3aeyE&#x2B;eRhvzOgV1Jx0TgRCRqVkd8t&#x2B;pfK58W5TFUSlB0vKyziFoisoydRTOX9ArSw5ZXYX/qzyobJCjK4uE9p6vC99K&#x2B;WNSC2LVrNxze2eVP4BfojpllTRIvjFJOUwK0h9mJ/JqP6b6g5WCj13qt9l7vnu5Ilpz0xceLEiXKarIgJTE3Tpk39unXrFuTv7&#x2B;9FJf&#x2B;eu8OFDVKVJ0V7yojzeCtANdn1pacf40ohyjxTD310dDRnyvv27eeWIOC5Jiluu20iDh8&#x2B;zHaCJMZHWfA33piKO&#x2B;44xOJ/1PP/yy&#x2B;/8euzZ//ALQw333wjK&#x2B;QTmLb/ri1bNvF1R6TAW2&#x2B;9yf3x1LZwPuKxxx7Fgw8&#x2B;6PDa8uVL8eWXX4l1fgD9&#x2B;vXn18jBIDw83HbtEGFw8OBBJgPWrVvPFn60nkePHsV7771vvlc0b4annvo/rsLwhCc80fCjuLi4cO/evQc///zzdfPnz8/Izc01OIFtuYe7RIDce65eV8r6q4n/KWX81SZLHgLAEw0nAqJC0XbcALS6urZisKnGhKDGEVj16mxs&#x2B;3QxfEN8UXA0G77BAdzfTxAqNDEGRkM126NpxcPLR&#x2B;BhP8fs5pBXJ2L26BfgE&#x2B;iH3T&#x2B;txMApExDePA5F6Tn48473kZFyGAZTmZh4xCKiUwI6/ucybhfQ&#x2B;evr3f7y0uk09NAFGCVff3&#x2B;psrzMVFlRYfKmFu7gYI1k3xfuBkhxByC5&#x2B;tvV5&#x2B;0Vz&#x2B;WAmVwLg7V3m0r2h902Br2vGY5dqzZh64IV2LJwJSpKyuDj52suX9e4NzQSscM97uI38rOykfd3NgJDgwTQTERyxzYICAs2j9g1NU7l55LqCGxfk6BGtPD2KYF9y3FTylQ7fzcBfsqYk64B6WicOEhCfidQkpOPilKzroaXAChmIT93gbg9cJeT/JPbA86f08hQHkrtEubtITBCgL6aHCO8tIgTgD8oMgzdRg5CVNNY&#x2B;AcFgWw/SJGcev9RYzx9x7T0MTufW2oVL&#x2B;6IXcqdv650NNR6/i0l0KaTJ09WCJCvLSwsrExMTPQTQNM7NDRU7xHvP/&#x2B;hNtb9&#x2B;usvbNNXWWnAsmXLBDhdxr3lJJ53yy23wN8/AD/9NMehD/1CB6374MFD8PLLr7LWgPU1Avb0WLZsOfr27YNFixaJbbkCa9asFUD5CLp27S4A&#x2B;BMOFnlEXnTt2g333nuPDWjPmPHNeVt3qgCwL//Py8vn/frww4842IpShQVZFR45cpgt&#x2B;7Zu3SKWLcDcub&#x2B;zXZ81qL2BgsQK//vfO5kUIKcCT3jCEw0zioqKCtPS0o598cUXa1asWJG5b9&#x2B;&#x2B;EjdAf12JACVgb3SDNFCrAHD&#x2B;F1CWUbrky/89BIAn6gZsfWqfLpUCyAx/axJ&#x2B;v&#x2B;9dVBSUoLq8Ar4hAvybyL&#x2B;7Co3aNUXT/m1RJcCgVGPikm9TtanW98R3bwG/yGDxeQPKy0pwYtN&#x2B;&#x2B;IUGYu7Ed3BsxW54B/hAp/FF4Ykc5B45gf1zN6D1qF64evqjCIgKqZ/7y8tL4xUYoNEHBkBbUmLSVlVLJbl5Rq1ep9X7&#x2B;Go1AhxrLH3UaoKAagBIaRLqLoByF2A5/12rKqCsgq0Ce111GXqOHoIDm1KwYd5S7F61GZmpx1lp38fXx65vX1IHvZQ1J0Es8TtlRSXi&#x2B;7bjxP7DiGwcj4TWSYhNamJTl7e3bHNYN43Fss&#x2B;F8rt1n8mJLroLOG3HnFoatF68TqUFZiG/vIxTnOknQoSWJzE9skB0BNxq&#x2B;v1K7ynRHBq71gRHYkSjaOdp/WZH/wQiLyosbQlk1UfODZ0v64t2g3oiMCxYXOM1LPZlbRFRIkaU9qFa64kiQaNQpeIqo69EtpHwUE1NjYn&#x2B;FcfNGBwc7B0SEqJt2bJlqGfUv7Dx9dfTWaCPlOGdg2zipk37mK&#x2B;vkJBQBtIvvfQyZ9mtffMXAvwbDAbFvnU6/8gtYOnSJWyLZx0fd&#x2B;xIwYoVK7F27VpUVVWwar8ZTD/LQNke&#x2B;NsHldCXietPnIusXXA&#x2B;t0/n1K72zTdfY&#x2B;PGzdyuQK&#x2B;TpR9VX1DlzxVXjBLL6zFgwADWI6DjpaQdQLaGs2Z9j9DQMHHcQjwnuSc80XBCKhchxua9P//887aVK1dmbN26tVAGTDuDb7nyf0kF1EtnSQq4Uv&#x2B;XA/smuJ/992gAeOLfF0ZUo/nIHrj2w0dZCyDv0Anu96Vy/xox8RkwZTx8gv0R26UZDFXlCPIPQ1VJBQqPZiM0Mer0xIkyv756JgB8NH7I2Z1O8mc4smI7/MNCqR4SEoE9&#x2B;m6yQBMgas/81Qh&#x2B;uRGu&#x2B;Pj&#x2B;er&#x2B;fAoKC&#x2B;FrziwjXFmRmVRsrKiRqD/AJDfHy0us1sIBdJZCiBojUwJE7GVI1cCYHrJWAMmWIrb3grXp3FY8uyD&#x2B;ZjeWzfsf&#x2B;DSk4sm2PWRjSR2dXmiuXgXbEugSq6VEpzo30PQeYCEhokYSIJnHsHe8X5M/2hVZROrsVttPhkywihJZ9bJIcMLbLfe7U6C9ZFA1p92gsPf30uZICKu8/zg4HhadyLF72GnZA8OYJsrNKgKQA90/DeA1caQs4UgMy3gmKVEKt7xMbZKyqYtcBIm0iG8egR49O6DCwBzoP78/q/VTeX22oFNtW4RKkK2XalYC6mjim8/cqkTBq1pfW3xFzlhrxt3T8&#x2B;PHy8PBw76qqKmOrVq0CBLDTajyp/rMOUtunjPCjjz5Wp8&#x2B;RzR3tfisBQEQa9chfdtlleOSRRziLPm7cOPTu3aeWYv65iMzMTM5UBwcHy75P6zN69OX47be5DGizsrLw3HPP4PnnX2KFf4r8/HzccMMNWLx4MTZv3oSFCxdh27ZtYvkQcS31xFdfzbAJAbZp00Z1fWicvPHGG8/pNtI2kCsBWfb17z8AJSUlbLHnHIcPH8KBAwc40z979mx2Q6B&#x2B;/nbt2qJp0yYYM2YckpOTbd95yy034fvvZ8v&#x2B;ZmJikuei8IQnGkiI&#x2B;2XVPhFz587dNm/evLSUlJRiyGfUjaidbTfCvVYAyQ0QbzzDz6ll/t0R/rvks/8eAsAT52ZCIUBfzweuRPNR3bD&#x2B;3d9RnJ4rQEQNmg7pgLZjzX2DES0TEB4XjfKCMgYie35ehX6TxzpO9i2lwgQQy0uKcXjBZs4yMPgXD31wADrd0psB16ndR3FoxWbEdDJPLNZ9/BtyUo4hpHEjxHRuhuThXaAPqJ/qwmGxMToBQqQag0GqLC6WSnJyqn18fb29goK0lGmFUx&#x2B;yOx7mSsSBkvq5K4LBHV0BNdBWVWG2rQuJisCYJ&#x2B;/mv7ctWoWVP87HsV0HOKtPWXC9rw&#x2B;Dccd6APl1IjE5rZee300/mIb0A0eQtnMvkju1Q1hcFEIiw832c9Qe4ATwaxVwyaFhudZ42WU0vC4EQGgSTcJ9WQL0Z6efREFWNiostpl0LMk28nSOX3JJH0sy5IA6eFenod1xCmCRR3F8uHy/upoV&#x2B;7v16Ig2fbqi87B&#x2B;CIoI5TaFyrIK23FVIqLUXpM7n&#x2B;QIKnct&#x2B;pTOTSU7TKPRKOXk5BgKCgqqxDKmqKgofceOHQOpp98zip/byM3N4dJvOWKAesgp601gnnQ9rBqKBCKjo6PQrFlzB7BaWVnBy1L/PwHo8xnUv3/DDRM4iy8X5eXlGDt2PIN/iu3bU3D8&#x2B;HE888xTmDlzFoPlOXN&#x2B;ZoB/zTVXi&#x2B;XC0atXTwGMv&#x2B;d1P9&#x2B;K919//TWX7atVCsybNxc//DBLAHozsTB58uP47LMvbNdhYWEBV1vs3bsPV1wxGhER4UwUUGWG9dg&#x2B;9NAjXIVhf5zIYeHfGmWnChEQ7SkY8kQDnueLSE1NPfzXX39t/e677/aLMaLYouCvJKhncvGeUmWA2vNz9TgT8K80jZLceM9DAHiigYQcaBQTB&#x2B;rZv2La/WzzRY//Z&#x2B;86wJq62vCbhISQsDeyFFBRUXHvUfcetdVOW23V2mFbbf07rHbaPezSOlqtW6tW6164wIkLByAiyN4bQhLIf7&#x2B;DYAhZCDjvy3Mfkrtyx7nnnvcb72chrR4S&#x2B;Pi697C090zY2Nkh7PtNaNK3LRp1asqW3Tx2&#x2B;Za3lPYv4J7EMmReTWQ51BWdjwa9P5yATq9W5BCWciQr7JtN8Onein1POHkFF1cdhBiWTF/APsADrZ/tjY4vDIXc3eG&#x2B;u4TkZRRbWdEEsZ2dSJWfr1EWF5cV5Rdq5M5OFgISxTPiSTWXoBu&#x2B;haZD3I0JFVb&#x2B;N0TWKucTGaeJCHO3MYPQpl935Gdk4siGXTi1/SCSIq9DaiNnBJM8y1XbQzsmQFCDPJNHnRQn8zKycW7/UaYb4NbYE37tWsHexRlirg2UKVXQlGlqlDc0ixlrqhNxoUDIRClJrJBIf3FeAZKvxbHKBXQMRXn5FaSfOwfdkn318QbQ1G/bY9eENBxIWJMG7x4BPmjSujmadmyDjkP6wtHTlbU/ZUlpRWTHLb0Hc9qTOYTdnNQSXUE&#x2B;cw0PuqQ/Pj6&#x2B;WC6XU06/giOeMhcXFytHR0cx7&#x2B;lvOBDZpdB8UoInjzohPj6OkWIimL6&#x2B;jZlCPhFiyie/di2aecyzsjLxwQcf3h6gWFhg9uz37soxU6g&#x2B;heI7O7sYXIdC4F999TWO6F&#x2B;Hv78/fvnlZ&#x2B;7765g69SU8&#x2B;eQ4pKSkMo/6K6&#x2B;8whH/rujRowe3jc1dOX4yrHzwwXsYO3YMHBwcq4j5tGnTMHnyJHTu3IWF73fr1p2lIFR6/Wk7RmK5e/Xhhx8gg&#x2B;uf09JS0b59eyxdupTdy4CAAHZvdu/exe1TUI38V94nqrrwyAyBuPFISU4hK3lsIRVj98zFGLd6Nv/g83jYSH/ZTQ5c33xmxYoVVyIiIvK5/k0Fwzn0ZdAf/m9OKkBtjQO12c5Uzr&#x2B;5IoCmCP8DBd4AwOMO&#x2B;L8AJepCCFX6mw&#x2B;R9krirg3fHq0w/PvpOPDBCghKVVg5eA76f/UCnJt649C81VCXKFlov0qphB03mMi2Trm9T26s3v7lIVXfLW1keOyz51GmUrPv/l2DcWbVLlhJbFCuLEdmxE3sf385ov45hef3fg4rh/u3rKClVCriJkZWJBJJeWlBgbpMbCEQlpULxfZ2gipCbCJf2lRJQEPh1IYIovZnUwTPFKEjIk517SVSCVwbe2PC&#x2B;9PR5&#x2B;mRuHzkFI5v2ctKCpaVcwNwjixQ7r9Gp6yfIYhuhQGrOIKacPU6UmITYO/qDO9AfzQK8GXVA4jIMqOUVt16gaYyvF5giCWzXxaJLDjiz/TtUFxQiJTr8chMSEZOSib7XkH6RTVI/z19PmFA&#x2B;5&#x2B;yFjiSQxELtJaLjycCOgahTd9uCOrTGY4eLqxEJ6VTKIpK9JJtc4xCxrbR184MCSmakwqjb35&#x2B;fr66pKRERYJ&#x2B;HKlRubm5SThiJwgMDHTge&#x2B;&#x2B;6YfPmzSzvm1TgSYCvMgRcFwkJCRg//gm8&#x2B;OKkqhJ7Nja22Lp1G/77bxs&#x2B;//wzNGrUCBcuRODcubMc8ZYxwkkl&#x2B;3TJ5d0CkeN27TqYzFOnsP7//vuPEesjR44wYwAp&#x2B;FMEzaeffsoIs76Q&#x2B;oYCheqXlpbC0lLKEfeMKvJPoPleXp5o0sSPwnaZgYMiKQiUqhAbex2enhWpC5TrTxEO06e/yu4x6Q5UplmQ7sHHH3&#x2B;M7du3ITz83CPR1lPPx7Jxg52va41lhak5WDfmMzj6uaPTq8MRtT2M7xx4PBTgxqFqrv9O4Pr6E&#x2B;Hh4UlbtmxJpjK4ZhL72qxjLlkvu4NtaiP4pyv6Z07ov75hF28A4PHww29QMLpNGYurm8OQXZzCPTnlZm1Hef7dZo5F&#x2B;qU4nP1rLyNku15bBKHEAuUqFcQyaUU4sqYIDk0boTi7AAnHrkBUqSKvb9AmrmjCTUd2xvDM1yB3tkNhWjYi1hxCfmIWksOj8ffAD/Dcjs8gd6sY2JH1/n4sI0iigdZOTiJuQm5mlkrIXZP8pORyS2trkVhmJRTQddBU5rNrjIY7GyJJhtTX9ZE9fdsa87jqMy7okjoimDSpNEo4e7pXVA8YMxAXQ47j&#x2B;NZ9iDkdgdyMbI64y24J6gnNEkCkHHxSpyeCm3EziZH02AuXYW1vC3f/xnBwc66qSMAUrQVa7eBWTj99p99khgKqYMEdb15mFrKS0pCZlILslAyU5BeiXFPOrSe&#x2B;pd5vnHQbWq4d1i8w8BbRzULQp5RgbL&#x2B;V15&#x2B;894riEu68RRzJd0Xbgd3RuncXBA/oCVsn&#x2B;4qc/lIlivOLTBj&#x2B;THv0a9O2ynVKYmqLOeoTdjTksKd1Kaef2srNmzeLnJycLDjiU8aRU5mcA&#x2B;/orx9Q5Mu0aVOwbt16jhw2x7Zt21hevj7MnfsRRo8ei8zMzKp7RCrzoaHHEBYWhq1b/0PTpgH44ov5GDp0KPr06cPu75Ytmxlpbd26dYOfT1JSEiO8TZs2rZpHteoLCvINtjNqY4GBLXDo0CHm8Z47dx574o4fD2W6APcCJCxIIf/9&#x2B;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&#x2B;kNO2cndo0oIqNUK6ffGMk2NlA25PU3VlLSmNifofai27YoYiY3N1eZmppawhEUga2trahdu3bWlpaWIp70N8BgwcKCKbr37z&#x2B;AeZOpjB2F7Xfo0IEjjk5V65GQH603atQobNq0GUuXLkFISAiOHTvK0gEov75Lly6MTP/4449V233xxee4cOE8uHt4V86HIhHkcpmOAcCdpQLoA3nayfBB3n1XV1dGimfOnMWd50h89tnnDXKMpDGwZcu/rPReWNhxjuDbcNenfbV1nn32ORZ9kJ&#x2B;fx6IXWBnOGvdOxF3r7zF37hwW6k86C5R6QWkKlbn9rq5uRo&#x2B;Foj4eJYxaNhPJpyNxZVMoWo7roTMGckKzEV1QWlDCjUm8IbaTIjHsKry6t&#x2B;A7Ch4PDLKzszO5/pqE/K5y5D8xLy9PiTvz5t8J&#x2B;a9t2oA55N6c0n61If/mDMn4MoA8Hj14dWnOptqCwveH/v4qWjzZC&#x2B;eW7sbN0CtQFimgLlbCs3NzPPbp84zQkxigra8TlHkKxndD5v6NJzd8oHefZTQAiktn&#x2B;eYiSwkcGrth1JI3UJSWg6TT0bhx&#x2B;DwSjl&#x2B;FX/9gCMVCHP95Cw59uQZ&#x2B;A4IxeP4UvWF&#x2B;hhCzJxxnFu1E4BPdETSuNxMebLAHVCIRNgrwt6QyZVYFBZqizAx1CYRU9spCbGsjKNcmmGboBBhTTze2jqkIA1OEy1hkAHnWykoUbJ5f2xZ4&#x2B;YcPkZOSwdIC9izdwMLuFfmFFVEBlPuvMdHj3lpYIRpYUR6MiG4JaUwIBchMSmOGBYtbqQYaQcU1FAiETARPyM2nY6JoADIoiGqQfo1BWq8xOg&#x2B;3NP2rmwwMK/PriwFAjXmCW0kiqtJS9hyQx9/VtxF8g5qj3cAeaPNYN&#x2B;bpF4nFLKefnhF1Qc2cflNpJfrWN2boqW3EgD6Ff935dF/Iyy&#x2B;TyQQc&#x2B;S/19fW1atWqlYzP6b9Lxl9bO0aQqeTbl19&#x2B;wTzhFLq/atWaKoG7v/9egUuXIvDTTz8ykk&#x2B;EmWrYr1ixkiOvwQZD/ImQ0j4qNQMaCpWe/Oeee65Gfr6bmxsj3SoyTGoJ6e3evRvR0VHMAHDgwAHuGK2RkZGBmTPfYvPoGjQELly4gDVrVuOTTz7B8eNhLFpC33NIlQjIQ0&#x2B;GAO3qCBS1MW7cOMye/S4T7rt5Mx6DBw9GixYtq0on8oDea3rok5XI48YUgaO71TAAEDy7tsDutxZy/dLrcAnwRszecN4AwOO&#x2B;R3JycuLFixevbdmyJYLr11KoEg7M9&#x2B;ab6/G/E0OBof3X1quvS/D15fprE3595N9Y6L&#x2B;5hP&#x2B;&#x2B;NwzwBgAe9wQ0APPr3xZN&#x2B;rZGZlQSClIyGfHyaO/PDAQEaw9HdHl9DA68vxwSaykit4Th0rojCHqqd4397XzjN1zecJSROImtFbw6NIfPYy3g3MIbSaejSLedI&#x2B;5nmAGAILW2RlFiHiLWHIZ/7/Zsn1kxKbD3dYXM2dbosYuEFkg6eQ03Qi/i6I/r8V78hoZ/UC0shBYODpA7OIgKcnPV6oLCsoK0tHILsVgktbEV4VYqhADGxf&#x2B;MkTxDZM0UsTdlTDCHDFZ&#x2B;VypKmQfbwcMF3R8fgqDenXHzcjRObg/B2d1HUJCTywT/yBNfGb5vmiRXpJ&#x2B;IhBW6FJTrW7mY6QDcyvenQxBbSNlnUbWu0TgBr0naBQaMBMYiyQD95QqMvE80RGbUrGQfaRw4ebnDv10rtO7bhYX4u/o0YmRHrVRCVarirq1S7z3QDrvXbQ/alR4MEXN9RiN9xp7aGKG0j4fC&#x2B;/Pz81WUh8g9B&#x2B;UuLi4S7r&#x2B;gRYsWfE5/HUgwefFrq0pPXuD09DR89913eP31N1j5u4kTn&#x2B;VI8X5GiPfv388&#x2B;kwAg5ZA/99zzLCeeBP9MQTuKoCExZMhgLF&#x2B;&#x2B;glUWeOutN/HZZ18wZfsTJ45j06ZNOHLkEEe2j&#x2B;Ovv1ZUlSslj79KpcSvv/6CefPmstB5Sh8YOXIU&#x2B;vTp22DH2qZNW4wYMZx9fu&#x2B;997Fy5Urs27efu/avV9078viHh59hBguNpqwaseeeGVZCsUOHjujRoyff8KHXbqt3&#x2B;fDfXoVQZAHn5p5sVtKpKGZc9e0ZxL57tPODIrcIaRdj4dMrCClnr/PXlcd9iZycnOywsLCzISEhMVwfciM9PV2BuuXv14c3vq4EvzZE31AEgKkSf4bIP58CwINHXUHK6i4tvdmkD93feRynfvuPldkRy62w792lcG/XhHsp314/Zlc4Ti/dDkuxnHl4lfkluHzjCM79sw/WcnsWui3mCGPG5YTq73&#x2B;xCNZWdkg&#x2B;c41VEMiIToDETobXzi3kfsuId0SggYRbbgkpFGlFFd2J8O5dMxt7ewtuRA0btVqTn56uLsnMLFdz5FZmLbMQSqUCwa1SgqYIubbAn7nOU&#x2B;3cbFPaAeYaFiqrCVStw0hrORtsyWyt0ap3Z7Ts0Qk9Hh&#x2B;MK2Hcvd5&#x2B;CCmx8WwEJ5VLb52HLsEWGCDVWn22oHKtSqJqgGxXDRY11fdL5yIwRNK1fldT0WYM2gQEuutoLdBoagxUyctfWljMymHauzkhqFdnJuLXtn8PluPP8v5VqgqRQiMGIH0Cj4bSQnQNOcZSQ8wt12fMqFRUVKSm30hMTCyysbERcfPKAwMDrbjPYr7XrDtIhI/quhNJv33doec5qA5SwV&#x2B;0aCFH&#x2B;ifC0dEJoaFHOZKpwJQpU2BnZ4PAwFbc8j8YMa4kz/cK5P3&#x2B;4IP38c0331bNI3HCq1evIDo6miPQlvj33y3UxpjqPf1v27YtXnvtdXh6elc7fvLw5&#x2B;fnY/Hixez8yIhIkQ3jx0&#x2B;40wE5mwyJKFbCwcEeubl57PNff/2JvXv3sHSK6OhI7liWorCwkAn5tWrVilUfePbZidXfFdwxzpgxg2/wWog/cgm&#x2B;vYNMDEwAz04V0Y3hi3eiw9Rh3P/dEFlbwLtzINKv3sT13eFVIrQO/u5MD4AHj/vFxMX1DUWhoaGnuenG6tWrY2JjY4tQe29&#x2B;fXjky&#x2B;6A0NeW&#x2B;NeW8N8J&#x2B;cfDQPp5AwCPBwpDF0zD&#x2B;scrcixJGHD5Y7PRZHgwGndpi/aTOVK49RispDYQcERfrVBC7mrHQrfpM6UWEIRiMQqyM3Xf8Sz8O2bvWShyCpjwW0lGAYozcmEnd7tFRjUVA2K9ZLa8YgBwj8a55AV1bNRIrHF316SlpCgt1GXl2YlJaitbG7HExkZYaQgwpgmgTeaMeXkr5xnTDahvIlhJdmkiNO3UBoFd26H3hBE4vnkPzh8IQ/yVaKgUKljKpRDS&#x2B;ZZrqow0d9ZXa2p6h/QaBjR6CLyOsUDXFiAw93Aqt60siShgVQ5IqI&#x2B;MIy6&#x2B;jeDDkf6ADq3QadhjcOBIP&#x2B;X0U94/aRuYui&#x2B;1/W7IkGPKcGBMj0I3SoD&#x2B;k3CfQqEoi4&#x2B;PL3JwcBCRJ5MjXtYSiUTIh/fXH4gofvzxJ3jhhRerzV&#x2B;/fi22bt3KyDwJyukDlYxzdnbkyOcf2LVrFyPJPXv2xieffIq&#x2B;fftCJpPdN&#x2B;eZl5eLFSuWsxB4ynUn4yVFGVCKgY&#x2B;PDzNgTJ06Fbt378Xs2f9jte65dmdwf3R&#x2B;Z8&#x2B;eqxZiX1tQFQXaDzcgR0JCPL755juj69vbOzCjy7JlS5kS/9q169k&#x2B;3nlnJr788kvuHuzE1atXMXPm2ywtw5AoIw8gNz4dh&#x2B;atQnF6nlEDQNa1ZOTGpcJ/YHtkXE3A4U/WonHftvDu1gJHvliPlRfmIPVCLPJzsuDaxBcOTdyhUZcj6Kk&#x2B;/EXmcU&#x2B;hVCoVp0&#x2B;fPn/q1KnYZcuWXb18&#x2B;XI&#x2B;7iws/048/nX5b07OvjHib2weoF/pXwPDXn5T4ZqmBpcPhJGANwDwuO/RdHhnDP/tNRz9aj0KkrJRmqvAxWUhOLV0G7w7NoPGoiKSoEypZhxr1OI34dqmMVIv3sCF5ftwfe85RqKUylK9&#x2B;y/JLkAZ1UPnXuL02AqlFU7Gk79sRQy3rbWzHZzaeKLL1NHGIwNuoSg1B6qSUth6u&#x2B;gth1jfEAiFAndPT3ZgUmcnZMTFqywgsCgsLiq3dXMTa7hBui7ZMue/NnRV2XVJnjESacjwYJIG6xBGighQQwV7VycMe/U5DJ4yAWf3heLw6q2IvXgVxbmFkFhJmHik0S5YYKyLFsC0yIABm4HGxGtC17agqcn3BZXHICDhSxXK1CpG/l283OET1Axt&#x2B;nZB24G9YOfswKoQqG7l9JcVqs263vrC741VbzDXWGNuCoj2epRLTr&#x2B;TkJBQRP85cqlo3ry5LDg4WM4RMTFHLnnS3wAgIknXW/vylnL935IlSxghJs&#x2B;5NmJiYrB3725Gfkk478qVAAQE&#x2B;OPnn39B9&#x2B;497qk4HHm/SbyOSLIuSKV/xYoVLF3hySefZHoFVMeea2NVnveIiAgW9u/iYp6OS13I/44dO5gxYt&#x2B;&#x2B;ffjjj0V4913TdeMpdYJSLii8n3L3v/jiCya8SIaYPXt2o2fPnkyAsHPnzkzxn0r5PcoozsiD1MG6xns3evtJbH7uW2iEGozfMMfoPtIj4rBv9jJMP/87pDYyiLjxwPK&#x2B;s7n3rAjFWfncGCQDbu390GnASHR4eQgsbWXw6BDAdyw87k2bLy4uvHTpUuSZM2di//rrrytnz57N48ZrZag/xf76Iv8NTfJNefrNDfE3R/X/oYgC4A0APO57kJhbh2lDmeBg2A&#x2B;bcXFNCCyEYliUSRB/PBJBI3oiYvlBbnAmgTK/FDZeTrD1cmZTYVImbuy/wPV8aqYPYIBAw69vG8i9nREfcomRsGNf/YMDc5cDqopScWqNCjcPXsWoJTMgFOt/bHLj05heQcLxKywE28raBv6Pd0D3V8dxx3J38lulcrnIu1VLkVKpLLfIzkbOjbhSsb2tUCKRWljY2lTROk35baVofWHhd0Ly9O3PlGFBd7k&#x2B;D7EuOVWr1LfumwBdRvZH28e6IS0uEeG7DuHwhu0oyMhhuf2WMpn&#x2B;bHyNMS6v0Rulr2UaMGo/MJbRDwPbaasG0LlRbrZaUQpnbw/4tmqKoN5d0KZfN7g19mLXgSIBmJCfUmX0ehoqpaeb6699/fWp8WuX6zOm3q9vf/qMQ&#x2B;Tlz8zMLOWWabhzVXl4eEhtbGyE7dq1k/O9XcNDn3FnxozXsWjRYlaaj&#x2B;43GQkqc8wpPP77779nyvFr1qxFjx497otScEVFhZg8eRJHjiXYsGFjNe/9tWvXwA2KERYWiv379&#x2B;H06dNo1SoIP/20AIMGDWLrUBlDEgEkLYC7Ysi&#x2B;VW2A0gkoXSI3N7fGOpTLT/n6BKVSgePHT&#x2B;D69VhmpJgz5wO4uzfCY4/1Y95/2k9tNRweVuQnZuLoVxsQd/Aihi6YCr&#x2B;Bt0UZs6&#x2B;nYOOEr9DznSfQ4ZWhTFvIEKjii52PC8q5fvjPXu&#x2B;gKD0XxTkFkLvZQmJlhSE/TIVr28Zw9PPgxgEi/sLzuCfg&#x2B;ucSro&#x2B;LOXr06JU1a9ZEhYaGZtcDob/bAny1Veg3RfyNfTYn5B/1RP4fGOMAbwDg8cDALdgPIxe/iabDOuPajlPIjExE4smr6DR9GOTO9lBkF0FkJcbutxfjmW0fQ2hpgbykbEbqjMHW0xGjV74DazcH5kG4ceACQr/eAEuqpSxnBeMhUkmYF4E8AVQ&#x2B;UB&#x2B;92/n674jYfhjtxg9k1QGoRND59fux4YnP8VLo9yxK4W6BwqYl7u5CB3d3ZKamKsvyC9RZN7LKpdZyCytrG5HQSlqR9KsTym2uJoA&#x2B;oqhPU0CfR9lQiThjHmu96QNlGiiKipm3x7uFP5u6PzEUFw&#x2B;dxIX9obh05FSF/oPYAiKxRVWOc216b2PqL6Z6fXPfAmVEuAqLWTi1vaszWrZuisBu7dFhcC&#x2B;4eHuQpYMRfgrvN6ShUBfvvLFlxqpBGDPw6Cr3k4Af91mTlpZWQgr&#x2B;5NH08vKytLe350n/PYaKIzskfDdmzFhGlOnztGnTqsrNkXjcuXMXYGtr21CDWfzzz0ZMmPBUNeV9U6BjfeaZZ7Fw4e9YseJvJuhXif79&#x2B;7G227ixLytF6O/P9Q/ePswoMGfOHGYsWLt2LTuvumSXUBQLtXF9kQFqtYott7SsIOmkt&#x2B;Du7sayyQICmqGwML/a&#x2B;vHx8Rg2bCiWLl3GNAq2b/8PFy9e5M6hCYKCglh0xoABA3n1fj1QK1RIv3gDQU/3hmfXwGrLkk5fRUFxFpxbejMdIW2EfrMRrZ7sxba/tvM04g5dRPKZGBZ5VZSZBxtPJwz&#x2B;aApajukBmYsd9w7ng5J43BtwfYma6xeijxw5cnnr1q3Xdu3alY76Uew3R8yvvj37uIN5d0L2a&#x2B;P1r8vw74EEbwDg8WA1WKmYKfbTVJJVgJKcikFU37nPYtNL30BubcfUeteO&#x2B;QQW3EApOfway&#x2B;M3Jvkrc7arqjxAL/mbYVdQmJsHuZ0t0wWgUGybRo7c7wmQEZWIMwt3VvMUE&#x2B;hYroecwxML/8e8DBFrQtB8dFe0e2kQjn69Hku7zMQzOz&#x2B;G3NX&#x2B;rl8zZ3d3icbNTWOvUJSn3ohTKXNzy9V5gEQut5DI5ILKMnjGwvf1kU1ztQCMEUpjZNSc32EEkxtkl1LYMrdvZ0839J84Fj3HDUH47sO4evwsIg6fRH5GDisrKeHahLkVDhoKFSJ9aig54kOvE3t3F7TgCH9Q704sp19mb8NEK2md0pLSap57Y/n4&#x2B;owq5lxnQ9sYK/2oez6669GxlpaWqlUqlebGjRuFLi4uFtx65e3atbPmSJ6QD&#x2B;&#x2B;/h33oLbJK9y0qKhJhYWEsBeCpp8azHPlOnbqgSZMm1Y2k9Uj&#x2B;qcQelbTz8/NnIesUhk9h&#x2B;o8/Pq6aAYDa0kcfzcG0aa9w5L26SCx5z0ngLyzsBLj2hZSUpGrLP/74YwwePASenp5V85KTk7Bq1Ur2uXXr1ujVqzczDtYFlFLg4&#x2B;PL9qeLv/76C46ODhg37smqeXbcO6WwsOjWPaj&#x2B;CFClgeefn8gMIa1bt2LVBWbOnMVU/GUy3k5mDI4BHnjx0DcVqVPF1VP9JFIreAUGYv1TX8CzXTMMX/h6Vfniq5vDcHFlCCP7BdlZ0Cg1cGnmg06vPsE0AGi/2mVgefC4m&#x2B;D6ShV5&#x2B;i9duhTLkf6r69atS7oV3l8f&#x2B;fu1FeerrXifqWV1DeM3Re7LYTy8vzZef3PJ/wNlIOANADweWFg52bCJ0G7SIOTGpeHMol0oyshFzP5wli9uZSGHWG5GmKQWwUm/HA/RLWU/MgC0HNcdvec8jfRLcdj/wXIUJmZBJJVU2zzxRCTk7vaM/BNCPlmFnW8uhG//1hj921uI2RnOhAxfPPT1XdEF0EPSBJZWViLfli1E3DulPC0hQanKztEUZ&#x2B;dA5uAgtrC6XT3AWG12Q&#x2B;Hg&#x2B;oimsRxzUznqhgwGRnPTuf8qFhav4q6xEN0fH4yuYwYgMfIG9i//B/GXryHuYiQsZVaw4Ab&#x2B;JBrYUMaACgORoBpJpmOrDN13cHNC8y5t0apXR3QY0he2zvbg7g9H&#x2B;BUo44h/mUptknwbIuyGDAGGjDmmojN0DT&#x2B;GDBC3iVZysVqtLi8oKCj19/e36tSpk5zU&#x2B;0Ui3n12P4BE4&#x2B;g5JsG406dPMUX7Nm3a4LnnJjKBuoYOiefaB6ZOncL91mNMUT81NZWRaN1wdiphl5CQyNrWwoULMX36dDY/MzMTU6a8hKioKDz2WF&#x2B;mA3DwYEi1bSdPfqnG77q5uWP&#x2B;/C/rlMdfw3gsk&#x2B;HQoRCmK0AifNqg8yMVfm34&#x2B;jZmkQFqdVmNfH3K4ffw8MC7776DOXPm1tk48bDi5IJt6DJjZA1hXkoJu7LxGLJiktDr/dvVGZqP6Qb/IR0QMm8VTv28DVue&#x2B;xZvXFvKlg2YPwl/D/6ACfl1nvEi/Pu3g1sbP&#x2B;Zo4MHjXoDrm8s50h8dFxeX8tVXX4UeOXIkywzSX58ef3P/A3Xz8NcmnN&#x2B;QiN&#x2B;dfAcMe/3rQv4fOPBvGB4PB7ixwGOfPo&#x2B;mwzshfNEuZEZWlPxzDGiE6P9OmUwD0EZxRn5VeR9rDwf0/GACXFr6sKlR5&#x2B;ZY2e99Vo1AG2UlSsgcb3vJJBzJHLN0Fq5uPYZNL3yLFw5&#x2B;hR8aP4fr&#x2B;86h6dCO9/RSkQfWy8&#x2B;PjbbzsrNV6THXFSKJxEIoFgtkbq4WRFxZVb1y42XeDHntzdUAMCfiQF/ZQmNkuOolWlYOpaKUzfMO9MPE&#x2B;e&#x2B;gJL8QV4&#x2B;fZ8YAMgQoue9WtnIm7nS7HKBAq63czvoX6LwHbq9Rub7g1toVxL9yf2pG&#x2B;Cl8vxhOjdzh09IfLXt0RPDAniynnwQL6TgpiqGksMiIfUpj9vXQGDHimFrPkJGmXEczQnse6U2kp6eXkPe2qKhI6evra8WROQsnJydrvmO6P8ANJlnIPJWRO3/&#x2B;HJo180dZmRq//74Q7dt3gLu7O&#x2B;5WoQVrazl3PPF4//332XcbG2smdEfPijaJJnJNIn4EEs3z9vZCeHg4Nm7ciKFDh2L48BE4duwYhg0bzvQJTIEMHfWNX375mSPy3jXIP4GiKXSFZ2k9MnRQCcIWLVpWW0YpACtXruDuTwTfYG9BkVfEhPjIICqyFCOWe3/umr0IwZMGMPE9XZz46V9kxSaj65ujIZZJWfRfYVoOUs5eR2FyNkfsJazdVw2A5ZZwbOaJaacWmOco4MGjAUBlbhMSEm5GRUXF/f3332dXrVqVAPNz8msj2lcX8m8st/9OSP&#x2B;dePhNGQFgBvEHTKv83wn5f&#x2B;CMBLwBgMdDBa8ugfDiSHppfgkjY3lx6QhftxuW5TKzn0&#x2B;hSFC1pqWdNey8bnvEHBq7od3LgxD6zaZq27h3bApV/u0SbGUKFYqy8tDrf0/h52YvMSHDkb&#x2B;&#x2B;iZN/bDVqAChXl93VCAE7R0exXWdHsaKkpCw7KVmdHRWtFllbC20c7CVCOUeOtbzrxoipvpryhtbRJpLmeq2Nic/p27c2wVWWKtlyK45odB7xGFr17IjEyBgc27gT4XuOoCg3HxKZJSTcoFxTDr3vCo0&#x2B;ixObr9H6fOselpdV5Otzg09bF0f4dm6Kph3boOPQ3nD3b8yOhSIBWGk/jvxrdIi1uddMn&#x2B;FDH&#x2B;E3RyPA3NSMymuan59PoRaanJwcpVAoLLOyshJyJFLi7OzMxyrfRXz22WeYOHEifH199S4/efIE1qxZg4MHDyAvL495&#x2B;r/77gcm9teokWe9HgsZhJRcmyZya7TPsbNnpfgqRfvkcusa3m7d3PoJEyZw03i0bNkSr7/&#x2B;OnfOLzADwcsvT7mXg3Z8/fU3aNKkoqIAqfz7&#x2B;Hijdes27Pu&#x2B;fXuZsWXGjLewZcsm7N27DwUF&#x2B;dx5OzL1/g4dOrD1yPBB6QmzZs3E22&#x2B;/wzdqLRz84G8Wedfj/SfRdEhHXN1ynHs/CqAqKq1mAChXleHAh8uZgF/C8asI&#x2B;34LnDliH739FJJORSM9Jp5153aNXND1zTEVbYzbJuy7f9C4TxBP/nncdXDPvSqbw9mzZ6/s3r376oIFC66hdt58cz3&#x2B;dxruD5jO9zdF&#x2B;mtrANDdti7efWM5/PXt9X8gIwR4AwCPhw8cmbG0qxgciAO9MGDOJMTuPY&#x2B;clOTq/M0AnAK9kXQ&#x2B;BhJIaVRb49GmcEFdDUD7xq6M1CkLSiCxsWJihDtf&#x2B;w0aSTnkLnZsneaju2DXrEVGD33v&#x2B;8vY/ru8OuquXjKplZWoUYC/yM3XR5N4M0FRXlCoykpKKrd2cLCQ2tmJBJVhs2YIypkrOqdPdV5Xwd6UUcHQvvQRWlYuj7yMUgmadW6LgA5B6Pv8aITvOoqIkOOIjYiElVzGdAIEFqJqlRKq036d/l5QYbgpLa4or2bjZM8If8seHdBpeF8m7CcSiyvaR4miVqJ8hhT79RF9Q6ReN23DUGqGsXQB&#x2B;kxCfhwx06SkpBRx5M2CG8CUBQUFWXNETEgpJvdaW&#x2B;FRQ0lJMUJCDrJyfh9&#x2B;eLu0GZFMoVDE7vu8eXNZyDyFqJMCPnmrGwohISEs571SPFC77eTn53PEv6IfJE&#x2B;8g4M9E&#x2B;SjMoIaTTkTwKRJ&#x2B;xzICECl/AiUH7979x6OOPdq8EgFMuDR9TP9mhHA1tYO586dQ6dOnVhZPhLrIwMApTWQov&#x2B;yZUuxffsOlgoQFNQa77zzDosAIINGZUQCGTlWrVrFIgaeeeYZvmFroTgzj1XVsW1U0Q4CBrZD6OKNUOQUsui8SpCAX&#x2B;i3/6Dza6OYsf3o/PUcwSqFSq2Eo7s7gp8biHYTB6BRp2bMcJBy5hoOzvkb8WGX8NLR72t9XLEHzzPDQq/3xvM3iUdtjIblWVlZmRcvXozinvmzK1asiNcJ7zfHm1/bMn3mkH/APJG/&#x2B;srlN0b074TkG/Ls3wnxfyTIP28A4PHQg8IG&#x2B;857luUExuwOZ6SOyv6pihSs5I&#x2B;&#x2B;Uj5N&#x2B;rfFxXUHKgYg2flQFZey2sLaBgZ9j7x7cFNcWHMQnaYNZ4TwxQNf4cySnShMv13uycbLAWkXYuHW1q9mL1KuQdyBiwg9/w/OLd2LJgOC0emVEXD0c79710ssFvj6&#x2B;1lxZFUjy81Vx0dHlzgoSqVlErFAam0tFEmlFVX09JTsM0RCDeXvm&#x2B;PJNuSZNjXPGCkmYlFWUsbm&#x2B;bZqDr&#x2B;2rZhwIEUEUOWAm1euQ1FQCEt5hVaA9r2u8tZTGyotrcjX5&#x2B;61jaMdGrdtgda9OqHDUCL9TpDKZSy8n3n6dUr26Xr1Tc3XXqbPyGHqXpgxMNFreCCQcn9RUZFKoVCoSbm/devWcgcHBzFP&#x2B;OtKNMuxY8d2HD16lCOG7zKSawrUditJtJWVDBs2bMCff/5ZnZzExnKE0xY&#x2B;Pj7YuHETC/2/cOF8g5L/srJyTJ8&#x2B;DevXb6g2/9ixo/j999&#x2B;QmZmFtWvXMZJL7dPd3QM5OTlVNkUPj0bVQvSzsrKr1O4pjH7btq3YuvW/Br0f586d567Xekbmx4593Oi6dN8o9YB7LvDll19g5crVaNu2LU6dOomJE4/izJlwJvj38stTERjYghF&#x2B;iliohERSPUrif/97jxkealMF4VFAp1dH4NKmw1Xvaf/BHbi27YjMmASm6l&#x2B;JK/&#x2B;GQgkFTi/ZjuZDuyDxdDRaPDEQTYd0gnf3lrCiYiNa/aJzSx90e2cc2qT11/suNgWKLCxMyb7rEXs8HkxkZGSk3bx5M4nrr8/88ssvUWRMR&#x2B;29&#x2B;bXx&#x2B;BvaVoPal/HTmDFPl9Df61x&#x2B;Y6H&#x2B;hta9EzL/QA&#x2B;CeAMAj0fDECCxQPNRXaq&#x2B;Bz3ZB&#x2B;eW7WE141XK0mpPcfORXWHn5gJViZLlDV5efwRdZ46tWi4UkKeqZhnADpMHY9Xjc9Fx6jBW8o/y6Lu&#x2B;ORbrx392&#x2B;4ETWyIrJlXvoKO8VIX81CzI5LbIvJKApHPRuLB6P1qM6o5WT/SG5y3vxV25XhYWAntnZzFNiuLispuxsYqi67FCSzs7kdzZSSKkwTkNqG4RRU09RAaYS/L1EV1jofC6EQba81WlSibKZ&#x2B;vsiBGvT8SAyeMRfeIc9ixbj7T4JGQlpUEqs2KaEHRPy24J&#x2B;VFagZOHK9z8vBHYpS06DnsMLj6NGOmnSADyalKJQmPh&#x2B;&#x2B;ZeF&#x2B;3jNqXSr7ue7md9JF93PyTgl5ycXCKVSgUcSSsNCAiw8vT0lHLkTaK97d3KGX9YQQJ33377Dbp06VpDmC4nJ5uVj9MmjYQ//1zKCP6XX37NEeJ/cfjwYfTo0aPaOjt37mQEljzqpLY/fforHGHd1aDnQsdLbUI3z/7xx8eie/fuLL&#x2B;90njBDKE21ti9ezc6d&#x2B;7Cthk6dFi19nTmzCnk5eXD2toaX301n5UorG&#x2B;EhYWyCIRKxMffYBEMdEymsHjxYpbDT8dMJfuGDx&#x2B;G/Pw87ppbcIS/Gd5&#x2B;&#x2B;2088cSTVWkOJvtb7ho0hEbBgw6vrs1RUlaAmJ2n4dLCGxYyCXsfUp6/NlxbNEb/DyfBvU0T9p6nqjxUws8QxDJL&#x2B;A0IvuPjatKvLdPzWTloDsb89TbsfF35m8WjGrKzs7OSOGzbtu3cokWLriYmJpbAdE5&#x2B;bfL261O931RY/70m/UDdvf3Glj1SxJ83APB4pNFv/kR0mDYEsXvPITMysdrg09rVHh1fG4nQrzdAZCVByMerWY5/495BbHlpUYne579J/2B4BQdi5ZAP0Wv2BFjZWzPSWJJZWLVOQVo2bBvpHxTmJWRAkVsIsYUlhBwhkApkUOcocWrRdoT/sQfOwV7oP&#x2B;8FtBjd/a5eK6lMJmoWFCQncpielFSacSOuSCgQWEjt7SysXFyYtLvgljFAA5jl9TdEhk3lvBsSCTRFpI0ZCIi4aFQqKh7AETER2vTvhsDu7ZAen4wroWcQsnobslPSocxTwNbZAf7cwL9tv&#x2B;5o2787nDnST0SLpReo1CjKK9CrX2BKMNGYnoG5qv7mXGdDx1FQUEAl&#x2B;8qKiorUlJtob28v5iZh69atHYxdW917x8N8&#x2B;Pr6MGJO4eKOjo5V8//7bxtmz34Xfn5&#x2B;TKCPllE5u/HjJzCCSTn9AwYMYnXhg4Pb4vXX36i2XxLKI6V/Kt23efMmzJr1DkdKAxv0XCgNgZ4D7WYSGnqMhb5zA2H069eP5f1T1QHKlU9ISMDJkyexf/8&#x2B;hIQcQdOmTavtr3HjJtz5jodEImZEet68T&#x2B;p0fEqlkvvNm6z0ILXTtWvX4sqVy9UMAGRkoKgEysmvRGlpKRPu027blFJRWqrAU09NYGkYHTt2YuSfqhT07z&#x2B;gwasoPIyg6LeLKw8g/VI8en0woSrijiL4mvXrirN/7UG3mY8zu3vTYdz1Ts6qtn2P2eOqfTdG/usDadxxlinL0KRfG9j5uDINAkpLkLna8TfzUW3DHAoLC/O5vi1p3759F37//fdL0dHRRbhzb765IoB1Jf2GyvcBtVPtN0T074T0GyL4prz9psg9T/x5AwCPRx00oLNv7Ib2U4ewwUc17sJ97vXek7iwYi&#x2B;K0/OZovymZ77CyMUzUK4uR8SaEP0PEzdYmbj3c/zZezYi94WhxbjuEIktWBgiIXb/ORQkZMGzc3O92&#x2B;fGp3FElOtfROWwaeQEqb0MqefjIBFbsbJEGRfisHfWkrtuANC&#x2B;Zm5eXpaunp6SwoL8svTYG8r0y1cEUkcHkcxabiG2tWXqicZU/HVJuTZxNJQDb0yZ3lgpQu1l5hoSWHpAcRnLI/UI8IVXcz&#x2B;0HdATN85eQnpCMrqM7A&#x2B;Xxl4sCoQJ&#x2B;VFOvwHybW7VBFOGDGPq/frSJAzl9uvur7i4WE2DlqSkpGKO7FNOv7pZs2ZUsk/GkTmBIcOJqe88zEdKSgrGjh2Ny5evVs2jvPf33vsAmzZtxPz5XzBy/OGHH7FlL730EvOId&#x2B;rUEUePHgN3v2rsc8qUqXjzzTeYMv6uXbvRtm3tPJ1Egs31XBsDkWsyPrz11gxmgBg4sD&#x2B;SklLg6uqCL774EiLuGSssLIK7u1uNbcnwsX37diaYp1su707w7rvv4ty5cGzY8A&#x2B;reHDw4P4ann7ueUCXLh3h4uKGL7/8Cr1798Ybb7zBXb82ePHFSdi5cwczzpw/fx7e3j5o3jwQgwYN4u7fWBapwMMgMTLZR4T&#x2B;sBGHP1nHEWk19867gef3fc4qACSHX4eglErz3sSqoR9h6M&#x2B;vsOg5uZt9gx1vaUEJLG2sjK7TfERnNqVFxLHxAokNkpFiwj9zWLQhj0cHJSUlRRzpT9i8efOpBQsWXE5NTS2F&#x2B;d78u&#x2B;HxN0fRvzak39jnOyX9pubVlvQbI/53QuL5MoA8eDyUxgBhzcEJ5Rz2nvsMNrzwBazlDtxgpBjrnvgUEgsrJuQmMaAabGkrx6RD32DH679iy8vfod3EQegwbTCLIgj7biMChnRkUQH6kHczk2Og5UyduMljbTDou5dxfsU&#x2B;nP/7ILIiExjhldrc&#x2B;4EmCb7Z2NpZWLdta1FaVFQWcy2muCwnT5qfkVVu4&#x2B;IstpDJhUSgGdE0kreub772gNGYZ1yf0r2&#x2B;7Y0NSo0NTMnoQxNH8eHk4QLX0QPJzcndGxVH&#x2B;kv1km9jUQ36BsTG/td2gG3KAKH1WZOZmVmanZ1dypH8cmdnZ4s2bdrI7ezsLLS3qTSuVB47T/LrH9euReOjj&#x2B;awCICMjAyOeLqw&#x2B;USWSRV/yxYR/vlnEwuPJ&#x2B;E4wq5dOzFq1GgmPkeTPgwePBhHj4ayfHttYT1zsGvXDu5eCzFkyFCj62VnZ6GgoLCq&#x2B;oBIZMHaCOWwFxYWICLiEs6cOYPNm/9hBo2IiAiMGDGS7bddu2CTInu0n0o1/fqAvb09FIoS7n/FNSM9hIKC6qVcSbBvwoSnWNt///33EBoahoAAf3z55XwsX76cO&#x2B;dMdOjQCZMmTeKml9g&#x2B;eRiHsrAEmyd&#x2B;h6E/ToWdr5vedXLj05F2Pg6vXvgNN49dwe43/8C&#x2B;//2JpJNRSA6/hmKuPbk3bcxS4ujd6BTgzoz39Y2s6CQc&#x2B;mwV&#x2B;n38gkEDgFqh5CYVpPZyJvi7csAHmHJmAYv&#x2B;igu5iKL0XNh68REgDztUHG7cuBF78uTJq3PmzDmZmJio0CPmdy88/rVV9Dcl6mfIAFAfCv53k/TzxJ83APDgYT6CJw5AQUImTv22HQUp2UwQrrgkH3IHOxY1YAg0OBj&#x2B;62vY9fYf2PzSNxByf8WpBXBt7Yf&#x2B;n000uF1mVEIFWeOIp3MLH1ZNoPProxD84iAknYpExPrDyIi4qc30kBWZhMubj7LydY7&#x2B;HvDsGnjXRANpwC&#x2B;1thYFtQu2oeNOSUwsvX7pcr6Ps7O12spKILWzFQlviVoZq0VfSTirEXADVQB0IwfMyYvXNR4YWt8Q1NzgjiZDpQYNEXFj882NEjBqpNCKgNB3bpWfSbmfvPy3cvoVjRs3lrm5uVlx5F98y55jMGVD&#x2B;xh4z3/9gTz/33//PebOnYtTp04hMvIq8ywfPnwI//67BenpGfj000&#x2B;qidFduHAB7733P&#x2B;zZs8/k/iuNCbUiQFlZmDFjBhYvXlJj2YkTxxmRp2gECpEfOHAAevTohR9&#x2B;&#x2B;IHpF5AGAHnQly5dwtrlkiWLWRj/5MmT8eeff8HZ2YWlAzQUoqOjWFlDQ574/v374dChEEilFcSuUaNGyM29Lc5KkT/bt/&#x2B;HefM&#x2B;ZroKffr0YfNnz/4fvv32a5aO8NRTT8Pb2/uRb7tMPNdCZNCQXa3v4NoCpdRZOVc3VpGwbvyxy3Br5Yu1w&#x2B;aiz7zncHnDMcQfjoCySIGD3/wNeydXeHdvgbbP9of/4PbIuHITrq186v186F1&#x2B;kzuW9U99DrmjHavoY7Cd7TiJc3/uw5Mb3odIKmbnseX579G4b2sIRSL27ubxkBqzlMrS5OTkpLNnz0ZzfffJ8PDwvNLSUjVq582vjcfflBHAlCHgTkX9ajMB5uX4wwxDAFC3vP76Iv0PPfHnDQA8eJiBXh8&#x2B;habDu&#x2B;DMwu3MQ2Aht0Sz4Z1x4P2/ACMESGpvjbF/zUJefDoyLt&#x2B;E1NmGDXaM1RvOiksGZdGLJRbIvBKPnOspcOBIvcRaiib9gtG4TxtkRiVyg4wybvAlwtklu3H0yw3Ijk&#x2B;FSCBiAxm5pwOGfjsVrZ7ufVevE5HBRt7eljQV5eWpr0VGFeXcjBdZu7hKrF1dxEKJmHkW9ZXWM0WODRFp3fQAbbKq6&#x2B;E3ZkQwRLh1ybc&#x2B;wq1rYNAX0aB7XMauobHzNmWA0D43UhkuLCykSSkWizWU0y&#x2B;TyQRBQUGO5pJ4Q97/O4lSeJhARJnyx3v1uvNnjMr3EUlfuXIlZDIrTJz4PFQqNdMFmDHjTRZ&#x2B;TiSV2hx58Sn8fMqUKXjttddYCHtDIC8vDwqFosb9JrHBV199jY3xrl&#x2B;/gZ9&#x2B;&#x2B;gFz587D/v37ceDAfly7dg2bNm1iInbbtm1jAniHDh1hkQwNSfq1QZoHdnb2Bg0AHh4VVQcop5&#x2B;qC5RzfaW26B4ZLyg9ge4DKftHRFxm83/&#x2B;&#x2B;Rfm7X/33dn8y5BD&#x2B;OLdLNydSDKF49cwDijVTICvskQfRcSNWPQGcm&#x2B;kQdLk9rvv1K//4cqmUNaPFGbmYev0n1CQnQUrSxs0G9mZe&#x2B;d2hFfnFnAO9IbQosLQUJewf9LWiTt4ESnnrqP3R09XhemXZBdg7zvLcGntIbSfNhS9P5hg1LAhsbbC9T3h2PbSAvgP6gCZsy2uHz6LmMNn4NOxFTPa83i4SD/XL&#x2B;Zu3rz5yPbt269zU6qZ5Nxcxf76FvMzl/SjDuQfZiwDzPP&#x2B;6yP9hgwHPOnnDQA8eNxduAc3wfBFr7PQPxobl5WosP3tXyFSW0BgadwLSurA5ioE58WmQY1SyEQ2uLjmEKL&#x2B;O4lOr41Az/fGV3lcXFpWeECKaeDy7jJWqUBma83KcGnUZShOzsGWl75H3LEIDPhqsslcxoaA3M7Oom3nTrZl3EElxcSUJkVFK2QSsUTm4mJh5egoYkKBBjzdhsi8ueUEDX2vjQJ/bfLxDa1vLEdfn7GhLsdduQ7l9NOixMTEYgcHBwvyTrRq1UrOwaJCoM1w2gPvzTcf69evR0pKskEDQFRUJBO6CwhoCj&#x2B;/JowEy2Tyal75w4ePsBJ5jRp5YPLkl1imzPDhw9GiRYsKIlVWhvHjn8DChX&#x2B;w8oCtWgVxnxey8P&#x2B;GArURXSV6CpPftGkzE&#x2B;ybPPlFVut&#x2B;//4DEIslTOSPGxizNIDp019FUFAQmjdvXqNyQX2jUqRPu3JCv379mTCfIdC9IKE&#x2B;2pYMAPQcWFvfNk6Q0N&#x2B;zzz7L/j/11FNMyC8uLg6//PITdz&#x2B;v8Y2e2IJKjZthl9l/8szrImZXOE4u2Ir06HiMWTqLCeSx&#x2B;XvPYh9Hsqec/AG5cWm4tP4IrnHrJp66wkbcErklGvdqi&#x2B;ajusK3Zyu4BvkaNa7fCU4v3IEzi3ax1L3u7z5RZQBIPhuDI3&#x2B;tRa8XJ2DoT9OqbUPGAXWxEjZeTizqITs2FWnnbkDqYMOdw2GcX78P1o5O6PHGONj4OCJofB9YOdrwDeUBB4ng5nOdxd69e0&#x2B;sWbPm8u7du9NUZJ29M0JvqixfXUg/YDgqAKhdfn9dST9QNwV/4O6K&#x2B;T2ypJ83APDgUUuw/FariipoJPY3&#x2B;PMpzBNy80QEytUajqDXfcAS/MIgSO1skBweA1VBKVMZPvTJakRtP4nB302BDzc4qkTi8asozS&#x2B;BpZ2MebMo596tfVOUZOUi50YawrnBDg1yBn8/hdWsvxfXixugC30DA608/PzKC3Jy1AmRkYqchCShnYebRCy3FkrkMnbRNFrl6AyJ85maZ7B3N7C9sVD32nw29bvGDAemSL4pg8Otkn0ajqQpU1NTizliI7C2thYGBwcz0q99nKYiHrTPy1RKwKNuMIiLu4HWrVsbvF/cwBF//fUncnIqQsxJjX/hwkVVYeWEqVOn4JNPPmG14q2sahJmpbIUH3/8WZXRgEh2Zb69uUhPT2fGBysr/UbAK1euMBFBItLkGdfX1sLCwjhi/Bx3DjbMCEGGCUtLCRYvXgR//6aYP/8r9O/f/67Vr6ffpVSIWbMqqiRUgqIUfv31V2zcuJEJ9Olrr4WFhSwKgKoR0Pn27du3ajkZBd5///2q76GhoZg8&#x2B;QX8/vuiWusoPKwgI/SoJTOgLlGxd6A2SAF/ywvfQZFbBKVKgZzrycwAUJpfjPhDEUiLuI6VQ&#x2B;ciPz4DqXHXIYYU7SYNhHsrf3j3agkvA8K49QUq7UvVA9x1yu/m3kiFiBsGx&#x2B;w5i6ubQxE4pnuVJtCOV3&#x2B;ForAEgcO7sOVJp6KQnZIMG0dn9HjnCWakaDd5EJwDvfjG8RAgMzMznetbIn/55ZfjHOlPvxXeb64gn7ke/7qQf2Me/voi/drrAw1bts8c0m&#x2B;M&#x2B;POknzcA8OBx19ktur/zOLq9PYblBCpy8iFzqXv5ny5vjELn10YigSP3oV9twM2wq9xgS4nkM9ewesTHGPjtJHScMoytm3U1AULyYhBZU6vR97PnWQhjdnQy1o7&#x2B;hAkURawKQf/5L0JsZXlPL5dEIhE6ublJHFxcxPmZmerrsbEFopQ0S4GNXOjg5mYpIgJEY65bZQSNEVRjRgJt8mpOmHptvP&#x2B;mjA7GDAz60hG0j9NQLr8uKnUS6H9ycnKxSCTS5OfnK729vaXk6Xd0dBQLKlBtP6bIurGICt1zMZQe8TCBSruFh59l/wcOHFRjOYWZUxqAoWtJZfk6deqEp59&#x2B;iiPNrTgi&#x2B;TJ69epVbb0OHToaPQYyCrRuHVSn8/j555/wzDPPomXLVjWWvfPOTBw/HoZt23aw0pcTJozHTz8toDOoMhhcvnwJf/65jOkSkFefhAq/&#x2B;eY7dk1IpHDRoj&#x2B;4zwMbpH69SqVCUVEh7O0dqrXFhIREPPnkeDRp0kR74I7Tp0&#x2B;z60VREvPnf4nVq1chODiYVUI4cuQINx1mxouxY8ew1AW6P4aMOARS/l&#x2B;6dBm6du0OHrffeyKxmCPN6Sz67Kktc6qMy&#x2B;mXbkJqJ4e6VAm1SsnK555ZuINFsqVfioPU3haxh8/Cs0Mgxrw1E406N4N3txZ37dBZVAEHij4IGNKBHSuBUutGfjkDSWGRLJe/zXNn0W3WODg1awSfnkE4Nn8DIneEQia3g9zLHkPeeAUtx3XnlvOk/2Eh/TExMXEc6T/G9RPpiYmJJaifEP66hvsbU&#x2B;83ZhC4k1D/h570a7QGNXy0I28A4MGj7uMhkRDNR3Wr330KBfDp0RLeW&#x2B;ci8UQUNk74knlVKL//8CerEDiyG6zdHZCXmMU8MkSaxdZW6PzGKObx92jvzwSTrqw7guK8IoR&#x2B;sxF95z13X1wvKi1n7&#x2B;oq7uDqal&#x2B;mVmnirsWURF26lOXt6GQrcrAXSm3tRAIxnZOmBlGuJL6m6tpXkm1j4fXGSLcpZX9D1QwMGQVMCRSa0juo/F9SUlKWl5dXqlAoaGCidnFxkZLXtU2bNg66BNRccm6ud1&#x2B;fCODD8hKlGvVEYO3sbhvwzp49i48&#x2B;&#x2B;pCV4tMHWpe7H&#x2B;wzedFPnjyBSZMmcwQ5HRcuXMTRo0eYkN/MmTMxffpr1ULVGxqUv04EnrzWISGH8b//va/3Xg4bNpzl9VOlgJSUVBw8GMK2JU/46tVrmADhuXPnMWHCBPz&#x2B;&#x2B;0KWY0/l&#x2B;oj4JyZmYv36tXB0dGoQ8h8fH4dXXnkFI0aMwGuvvV6tzX322efYt28v0x2oLIG4ZMkfrGQg6SdUph9ERl7BokXkvRcgNjYOPj7erPRgQUEe0wro3t04saf0gF69&#x2B;vAvOT04v2YfLm07hMj/BqLF6Ir3n0fHAFa1ZvWYeZBYWrFytVnpybCVOcElyBv9v5gEoViIRh2bGayg09CgigQbnvocz2z&#x2B;GIFjK&#x2B;4/Cef2em8CsqKSsHr4xzi2eCMa927DDACdpg9HQtgVNHfoysR47bxdmB4PjwcXXP9XXlBQkH/69OmIdevWnTt06FBaTExMIepHsd8UqS&#x2B;rJdmvD9Jv7LM54n3Gvusj&#x2B;PdL2b5qpJ8HbwDgwePBMS5wA3jKsxyzfCYrNWRpJ0dRaj4iVh9Ct1ljUZSWw&#x2B;poU6k6u0aO1WoPd31rLE4v2w4bOweEfbsJ3WeOu&#x2B;/EiUQWYoF/ixYyv8BAWXZamiry8pUCQcx1sYOnp0Tm7CQWSi3Zq8kQib5TD78p0l0b4UFD1QgqDQyGflefUUHf71Xm9KekpJTI5XIht89yjvRYcQRUrEvodAm8oTz/2gj4PQqW8nXr1mLTpn&#x2B;4aUtVWbdOnTpj48ZNLA/c0HWpvDZnz4Zj/vzPcfNmAiuhl5SUxNTo5879GOPGjbur50Je86eeGo/vv/&#x2B;BI8fNWai&#x2B;SqWstg4dn5eXF8uZrzQYZGVloEOHDrCxsYVEImZ5/qNHj2aRDBTeL5FYardJfPPN1yxEnqaGMRSKWLlASj3QRVRUFDMM/PjjT1UGAEpNIP0BSrUgjz/hhRcmY&#x2B;nSpXjxxZfwxx9LmDYB7/mpOwqSs5AeHg97Dw8c/34zHAMa4dyS3VApVIg7cB4SqZQJ/9l6OzAC3bhvW2bQprK6DYGorSfg1S0QclfTAoGbnv4Gcns79g4lAwCl2mVcimPh/Ykno5B3Mx1SWKPJoGC2fmFKDiI2H8L/kjbAyonP7X&#x2B;QoVAois&#x2B;fP39pw4YNZ7ds2RIfFxdXjPpV7K9PIT9TYf2PAum/I&#x2B;LPk37eAMCDxwOHcnV5ldqxNnx7ByFwTDfEHrzAKgjseGchMwBQ3WGIODKnKodNo2rC7nAL8oWLnw&#x2B;KUnNYV39xTQg6Tht2fxo6uEG5k7u7uKuLi11pSUn59YhLJXERl4odbe1kYicHoczBXgSBsLJ3r0HWjYWkG/Pm68tzN1XSz9Bv1UU0UNcgoVQqy8jLf/PmzSLK5ydRMgrv5z6LBCYYjDnifoZC&#x2B;s01qjzoIKK&#x2B;YcM6Rm6lHFmhUP42bdpUq&#x2B;lO1/yPPxYhMTERM2fOYqXviDj/889GvPnmW&#x2B;w6Vebmjx8/AWvXrsWWLZuYmF&#x2B;fPn0ZGW0IzziVC/Tx8WGigJSeQCXttH&#x2B;HPlOpOiL/BPLu5&#x2B;cXME99JT7//FP88stvuH49hoXGr1mzFlevXmH6BESoFy9eytIWiEzrA3nYSRmfxPQMaQvUFVRq75lnnmbnqH1fKFpj1qyZ&#x2B;Omnn1glBMrjpzQGitggQwZVZqBoBUJ0dDR&#x2B;/HEBux48ao/r&#x2B;86hcR&#x2B;uHUtu5/qTB315v/fh168tbJOykHQiEiv6/g&#x2B;qohIUlOTAs3lzDPpuCrw6N4NrmyY1dALqG8WZ&#x2B;Vj/5Od4Yd&#x2B;XVQaA4ow8yKjkoE5XGPr1P5Day9DjvSdx8qdt2PHq77i28xSyE1JQVq6GS2NvdJ05FoGjukDuYocbIRew&#x2B;81FkFhKefL/gELFIZIDR/jPrFix4lpsbGwRzPfM14fHvz5Jv6F55hgAzBX20/fd1Dye9PMGAB48eNQFBSlZOPLjGgyc8zKkjvLbg3qxBYJfHIjL20OZR1&#x2B;FYkRvP10VRkk9X6U4oTaoXvK1uHRmNLhx8CKCXxgIC6n4vj1/jrwIZBzJbd2tq3V&#x2B;Xp4qPyu7LCYiotAyXihx9vGxEttYC4RisUDbEGBOOL6pnH5ThNwY0TdkJDAVgq8vtYBy&#x2B;snDzxFShZ&#x2B;fn1Xr1q3lDg4OYkqbMCTKp4&#x2B;wmxI3NGQk0N2/PmHAhwGrV6/EBx98yLz7zz8/EVlZmRyh/LnaOqmpadiwYT38/Pzx0kuTOaJ8lJXho5r3L744iZXt69y5c8VzW1AAhaIE585daNBrRJ73Z599GoGBLbB16zbuHN7HnDkfwcXldoURCvsnr/mSJYsxZcpUWFjUfN6pTN&#x2B;VK1cRFxfLnYc1qzwwe/bsKo2Cbt1MpzRR6klDi/4tXboEQUGtMXLkqKp5f/&#x2B;9HE2aNKZnhRH83377FZGRUUwcsW/fPszjX1l2cPHiP7Bly7/8i0UL&#x2B;//3FwZ8PakmUSpSIPt6CtxaN2HE&#x2B;b&#x2B;pP&#x2B;PUku0Y&#x2B;u00dH/ndhRLyukYZFyPR0ZUHJz8veDUzBMagQaBI4fCq3tzFjpvaSu7a&#x2B;cTu&#x2B;8cslTJUJeqq&#x2B;Ytf&#x2B;w9&#x2B;A8KxsBvXq5Ikas0aBw8i9zrabi86ShENpY4tnAD3Lnnu8sro5jwX6NOTWFlX1FCkozxN/adR9a1ZIxd8Q7fcB4w0n&#x2B;Rw969ey&#x2B;tXr06hkORlpjf/eDxr424H2A61N/YZ5708&#x2B;ANADx43O8oSsrB0V82IGlfNAZ8OwkBQ26LhKkUSqg1payblAvtEXf4AtMB0JQbFqaz83Zjng0JR0oyLscz7839bADQhq2dnZgmzyaNpVnJKcro6Kg8ZVSUha27m6W9h4dEZCllVaIqw/G1w/L1efkNEWVz5tXmPWMqgkAblNPPkf1SIv3cZ6Wnp6eVXC4XBwcHWxsj8LpE35hAX13JuzkCgvc7qG1oq7hTKPjTT0/A119/BW5wCE9P7xrbkHjeG2/MYCrxw4YNZfOIUO/Zs4cp63fr1h0tWrRk83/66UdGUhv6OhHhJi2BsWPHsvOhCIaSEgVSU1OZN7wSFJ5PAnh0vNRhODhUk4jAjBlvIj4&#x2B;Hh9&#x2B;OIeF/RtKc7hn/WBRERYs&#x2B;Ak3btyASGRRZQC4ePECFi78Hbm5uazqiZ9fALp06YzvvvuepQBUGiRWrFiOL7&#x2B;cj2nTXnlkQ/61&#x2B;4vwxbtZOTvPzs1wcfVBdH59BGy9Xaqtf/zHLdj/0V/o&#x2B;&#x2B;FzaPVET1zZeAxP/DUbR79aX80AQM9S8wFd0KhLMzQb2QUiit5q4d1gIrPXdpxmxNxQeL/fgGBYwx55iRkV580Rd9dWvjj84zr49e&#x2B;ApsMr3qHqUhUg0kDmZAvPTs3g3bcVHHzd4RbUGLZeNds/ReKRqG6HaUO5a&#x2B;UMHvc96VfGcli/fv3x06dPp27fvj0NdffmG1Pqr08Pf0ORfu39PBSknyf&#x2B;vAGAB4&#x2B;HEtlJqbAVuCA9Mh5rx3&#x2B;GVo/3RJPH2kJTpkHYd5thJbZBuYYjuly/qcgthkugFxvwGBriSqytuDU1zKNDHp4ypeqBuyY0iHX2bCShSVFcXB514WJxzMWIQidrG7mtp4dYbGMj1CXcup55fYKAuuvrI&#x2B;2G0gX0HaO5ooBE&#x2B;jmUZ2ZmKjgypyFCxxF/SycnJ2tDx2DI&#x2B;28sykBfqoI&#x2B;nQJD&#x2B;zL3d&#x2B;5nUA33gwcPICkpGR999FHV/McfH8emZcuW4uWXp2DVqpW6g0lERESwXPNFixZyBHRk1TKFQgEPD49biviZWLlyBVuXRPPqYRBr1KtOy8i7XSlWSAR57tyPWBj8f//tYHn9hNGjx3LntIp9dnNzrSZuSHjvvffv6/v2&#x2B;&#x2B;&#x2B;/sgiL6dNfxbx5HzH9gZCQg9x1vshSH0gUkMT5SMFfn7hiy5YtMHXqK8yA86hBkVeE079tR68PJlTNO79yP6KOncCzyz9mHvErm0LR9a0x1baL2R2OnrMm4PgPm1hqmYWVBPnJ2ci/mYGEE5Hw7hrI1vPt3QpN&#x2B;rdt0HM4v3w/U&#x2B;x3D/bDgTnL0e2tsWj7wgC961LlHYo6SDodhfaTB0FVokTwpIGI2nYCmdcS0RQVBgAymI385U3YeDhAZClm4r2mQGV17XxdDfcvhy4i5WwMus18nB&#x2B;83AOo1WpVEoe1a9cePXXqVPKWLVtSUHtv/p0o9d&#x2B;Jh9&#x2B;cXH5zSvWZ493nST8P3gDAg8eDBN9uLeHewQ/Jp69BqBIg4u8QXOAGbxYWlqwyAIkrUeh7YXk&#x2B;vLs0ZwOZ8rIyNqgrSM7R02neFqEjD4iyQPFAXx&#x2B;pTCZs262rNUd4ytPi4pTRkZF5co3A0tbbUyKzs7cQWEpYRQSBHpJvjNwbIriGFPt119WNQtDdB5F&#x2B;8vJfv3690NHRUUQqxIGBgdZWVlYiSnug7QwRcEMefFNknf7r1i43VE7R2O8YmvcgIDz8DI4fP37LE17z3p44cZwpx&#x2B;/Y8V81sTkqFUcedVL2f&#x2B;KJJ5nHnPDKK1PRo0dPVgKw4r6XMT2BWbNmsbrydQHl9ufl5bGSesZAv00l78g4ERp6DAsXLsKff/6JAwf2o3fv3ggLO46NGzegX79&#x2B;bP2hQ4c9cPft0KHDKCwsxK&#x2B;//sp0Bkh7gUQZX3vtNQwaNNjk9p06dWHTo4bUC7FYN&#x2B;ZTqJWqagYA8pKncO8Ut2B/jjDbI2ZPeDUDQELYVVjay9Bx&#x2B;jDEhZxn0QI07frwd4gFUhSn5d0mxeKGHS5mXk3Alkk/MDI/5MepSLsQh&#x2B;Ks/BrrKYsUKMnMZwQ9cFgPxB0&#x2B;z&#x2B;Zvn/Urrvx9FLml6QgY3EHruEVw8Hev12PNik5C9o2UCkrDa0veFdC7MzU1NeXAgQNn//3338ht27Ylq1Sq&#x2B;srfL0P95PObCuu/01J9pkL6TQn7wQxDAGC4bB9P&#x2B;nkDAA8ePBoCNo2c8eLBr1g4ZviS3ciLS&#x2B;NIv5zp3wlFIkYwlSUl8Gjij2ajuyIrKhHlSjUTaSpIzqyxvzL2XrxNeMrK1A/FdbK0tBT6NG8udWvcWKIoKCy7cOJ4YeL1WHi4OFuLnV2EVrY2QlSSVhNVAAyRY33zdQ0HhsoDVm7DDVRKKPcwNzdX6ePjY9mmTRs5qfdbWFgIDP2eOaTfnNJ9xsr1mUP6H0RQWb5Tp06y&#x2B;u4ymZx5&#x2B;ceNe4Ij6fE11qWSdoMGDYGfXxPu/KsbSkgY8Isv5jMvPxHunJwcfPLJJxwxPYTIyMVV65GRYMGCBXd8vH/&#x2B;uYwEH/HKK9Px5pszMHfuXJPbkCAepS3Q9NVXX7Nw&#x2B;N69&#x2B;&#x2B;Czzz5hx0hjLVL3J20AQt&#x2B;&#x2B;jz0Q946uw7Vr0SyUPyDAn50n5f937NiJXeeGEht8kFCmUCLt8k1Yu9lXC1unfj7s&#x2B;02s2otn1&#x2B;bo9&#x2B;nEatsF9G&#x2B;PA58uR1JoJKxd7ZCXkAFVcSmbEo9fRchHK5F88Qau75sKmYMtRiwaBv&#x2B;B7ZmuzPGft1TTo2loWLvbo9mQDmjcpzV7r3l3D0TujbQa60VuCkXsofMYvXQmfLq2QPzpCDY/Jz4VTYd3QvPR3VgZv4aE38B2uBl6BauHzcXIP96ArY8LP4hpIMTGxl4PDw&#x2B;PWr9&#x2B;/eWQkJD07OzsUpjnmTfH419f5B8wP6y/vki/sWUw0xBgDuk3Rex50s8bAHjw4FGnh5EbdJH3hrwXIXNXIu1CLBQFJSgtKGYhiVI7a4xY&#x2B;AZTKRbLLKsIpCK7EEpuPe1Sf3kJ6RChQgSJIgiEukTvAfdckCGApt4jRtinJiUpinJylVfOny&#x2B;2kVpaefgHyCR2tgKQQjq9U8x4rxgrDVj5X1&#x2B;of&#x2B;V8jsSUZ2RksOLwBQUFpb6&#x2B;vjLu&#x2B;CTt2rWz0WdsMObx117PHNJvrmCfuZEE5ggZ3m84d&#x2B;4sZs9&#x2B;F1u3/scMAJVRGa&#x2B;&#x2B;Oh3bt&#x2B;&#x2B;sti7lie/atYvl81O5O11QqHklKDSf1OcpzL6&#x2B;QNeWSg8&#x2B;&#x2B;&#x2B;yz7HtmZhZLLTAFDw9Pptj/0ksv44UXJiIsLJTblwB9&#x2B;vTGsGHDmZAfEebK&#x2B;8a1vwfi3p0/fx5//PEHlixZgh9&#x2B;&#x2B;KlBKig8yKAUrt/bvAZ1USm6zBqFnu&#x2B;Or1p2&#x2B;NPVOPD5Cgz46EU89unzNbb17BoI1&#x2B;a&#x2B;uHH4Aizt5SgKv449s5Yi48pNxBw5DTtnF3SbMQqZkYkVRiY/N4itLRG79xxSw2&#x2B;wEn53C1IHG7SZOADxhyPQdmJ/jmS3x7UdZ2qs594&#x2B;AEe/3gh1qRI2nk5oMahCuPLJZe/BlvuOu9BvZVyKR0lWPjy4Y6FjKFeVMaOKpZ2Mb7D1AK5vTj18&#x2B;PDZPXv2XNuwYUMC905VwXxBPnMV&#x2B;&#x2B;sq5qe5h6S/Nt9rQ/r1/TeH&#x2B;POknzcA8ODBo67w6BCAp7fNQ258GqtVTP&#x2B;tXR2ZV8OzS0WJL6oC0HJcd1zddBwiKzHOLttTFdpJA5HcmBQIb5VwEkkkTBOgEpTnGbpgI5xb&#x2B;iBwYNcGq9F8t&#x2B;Du6SmFpycatwi0SoyKKo2NvZGjuHRJ6ObjI7d1dxOLLCuMJdBD4I2JB&#x2B;oj0Nrzi4qK1BxBLOcGJ0q1Wl0mk8mETk5O4tatWzvqGhBqI8qnL5VAN6Rfn5HCFHk3lfuvz&#x2B;jxoBgB2rYNxoEDB2FtfdveQtdMLq&#x2B;hqcgiAEhMb/DgwWjTxnhOMxkD6uLpN3R/&#x2B;/cfgH79KnKbmzTxRUZGRo31qGTf66/PYJ7&#x2B;kydPYuXKv&#x2B;Hh4Ya3334bXbt2w9dff4N27dojICDggX5&#x2B;SZjxu&#x2B;&#x2B;&#x2B;NdrGH2UQufTp1RItn&#x2B;gFn24tqi2L2nKcGXoVOUUozS&#x2B;CpW11jz2Jv7oFNmGe/&#x2B;Yju&#x2B;Dsmt0IW/QPbOwcEfzkAPbO8O7eEmVKdYWdVFOOi7vDEfLparQY0x2CO70n3L6KMvOYsdoQyGhNivtSh9vH3Ih794XM&#x2B;Zt99usfjPA/dtXYjqoP2Pu4chdGw6IG2jxXkfKiT9CvLri28zSLhtD3fmw2oguaDuvEvZszmKZA9I6TOL98H55Y9x73vuWH1XdCBPPz83P37dt3IjQ0NG7dunVxqampijoSelO5/PXl4TeVy6&#x2B;vPF995fHzpJ8HbwDgweNhAg0qHPw82GQIVHM5/thVqBVKHP9&#x2B;Mxp1bAqfnq1w4&#x2B;AFJF24BpmdLeuirRysYaGt1Mz1v5H/HUf0uwvw7NLP4BzoxYwLMiODtQcBlFPv27Kl1Kt5c8v87BxVZHh4yeWTJ/PdXF3lDl5elhZyueBW&#x2B;YBqpN&#x2B;cfP/K9YqLiymXQpOYmFj0f/auAjyKq&#x2B;2euLu7kBBCQoAQggR3glO8paVAkRYKpf1K&#x2B;1Wghb&#x2B;0X0tpSxV3l1DcLYEQosTd3d3DP/eGhM1mNQRL7uHZJ7Nju7PM3Jlz3vc9r6ampnxNTU0dR8DU1dTU5GR4NhDmxC8s8i/KZFDQ/gSJBcIMA4UJC6K&#x2B;0&#x2B;uCEydOICwsDOvXr6dR/fT0VMyaNQexsbHUOd7IyKjVNocOHW6u5W8vFBUVcp/3iKbk84PU9xNDwgkTJkJRsbFlJzHnIy0EScReV1ePZivwora2hpL&#x2B;u3dnITExgXtfR6P&#x2B;Awd6oE8fN3Tt2rXDjHX8RoUMLUEi99P2fEynSzMKWizr8dZwqFzWQsDOi0i9H4l&#x2B;qyZT4k6mC&#x2B;IyaBeAzJB4dJ8&#x2B;CL0Xj0VGUCwsBnRHt2ke0LF&#x2B;munCS1r7fzQNDlP6Q1WI&#x2B;75E10NSNrwWbMaC2/8Tuo7fn&#x2B;eRH5sOz63Lm1vZKqor0wh&#x2B;WWYhvZcJIt/E0LYkLY&#x2B;KE4Ja4LbL9ZyYjauf7oKVrzMUFXjE85o6er8l7Q5Jd54d/VZj2aM/UFteifgrgSjPLmzVZYFBOHJycrL9/f252/SDxF27dsVy99VKSN&#x2B;CT1KBQFLyD0hm8ifOwE/SqH97kH5BBP95mPkx0s8EAAYGhpf&#x2B;4GxthAl/LMfp&#x2B;T&#x2B;hIq&#x2B;WmkC5vueJqNM&#x2B;UFRVoWSujiMOxj1tW2QAkNx/RXkV6Kmaw/fX09TQSMlADRO2vI/uMwa99r8LEQJ0DPQVB4wbq1haUlKXGB5eFRPyqEJHSUVFw8RQQc3ISF6GOIjzlAcIuj/xzuMeVKpIpL&#x2B;ysrLW0NBQ0cHBQU1HR0dBFHEXldovbY0/77aSdAAQNJ/3s0Xdj1/VyP/t27cwdOiwFvNISvzevbupAEDKAIgD/u7de2gXAILdu3e32k97k3&#x2B;CsrJy&#x2B;vnu7u5QVm5Zs04c&#x2B;w8cOIjJk6e0eI4iJncE5C9/BwAFBUX85z&#x2B;fYuvWrVi79jNqgGdhYcEGvU6M0rRcnFv1F&#x2B;aefOoXMeizWfQVtOcqvN79GeeWbIX/XxeQHhBDu8SQsjHrUT3g/v4EGo2fdewLiT5LlPAsCYgAEXXnPoqTc6hZHyHO8ZcD0GWsK63vJ9Aw1cWFz/7gvmc9Bn48HSEHbnL3ojSUZRVAzahRfHCePaR5n9UlFQg9eAvhJ&#x2B;7S9oDECPd5Id0vmootFTnFLe6d0ed8EbL3Ovc7/hdyCvKoq6yG19s/w2qoMzXkbWrNyyAcxcXFhSEhIRH37t1L&#x2B;PHHHx8VFBTUoH1T&#x2B;NvTyE8aJ39B64malsS8j5F&#x2B;BiYAMDAwtIbjG4OQ4h0On19O0a4APt8fg7yyAvdSpO/luYeU7jM96LyWgzNHChWIcVI27Y9cllGIy2u3UwEg3T8Wj2vrYT6g22v/&#x2B;2hoasq7DBig3sXFpa4kO6c&#x2B;KiKiNCUmFhZWVppKRoayiioqMiBprk8isE2Rfo6UPc7Ozq4gaclFRUVVlpaWqrq6uqRln6aw9nyCovG8ac3i0u8lNQCUlpzzbiduH68q&#x2B;Sfu/Nu3b6NEmUTBm&#x2B;aR9PemFniffroWt2/fhouLCzZt&#x2B;h6Ojo4wMHgx0TjykyUkJGL16lX4&#x2B;&#x2B;9tLZb17NkTR48e5RMhnpYqEAGA13egCcnJydi8&#x2B;Wdw5x4b6Do5iNnfueV/IPVhFIoSs6BtbUQJManlTw&#x2B;IQ9L1EOqdQDq&#x2B;5MenUyM9ktrfd6kn1Ix1Xvg1TXwL5KGIqsIyKgAcnvINYi89xLiflmLAx9Noyz7jXl1g7tgN/nsvIOaCHwpy06Ekpw6naYOobw0Bb5s9QrArcktQmpaPIV/NbV7neUDHxhjFhbnc75sKbdunHQQUVJQRfe4Bzi7dii5jXGnWXMw1P0RduwfLXs58QjtDE8rKykojIiKib9y4EXHgwIHY8PDwkmcg9NJG/Nub9AubJ4kA8Kw1/i&#x2B;K9LeJ&#x2B;DPSzwQABgaGF4iR3y8krQIQccIbRSlZ3MMiRzof16CquhLDPp9LaxUFkhbIwrCHOWYd&#x2B;hyHJn&#x2B;DnEdJODhuHVIDI1BbUgVbz96YsGUFtEX0Q35doKamJq9mayNvbGOtlJacXFWamVX16L5vuYmunoahna2ynIqKTGVlZV1VVVV9Xl5eFTFQU1ZWltPU1JTjiKQeL6mXhnALIv&#x2B;8ZFxUyj7vZ4oz&#x2B;hNF7JuECF4jQ0GZBJIe3/NAeXk5TZMfNGgwdHR0Wi0n5Ia09HvzzXnYt28/UlJSuL/7cOfOXVy82GjyRyLtjhyhILXxL7qenNTwjxs3rrnkID09DWZmjcIEcbnfsuVnrF79ET2OzMxMZGRkYsCAgXS5lZUVdb3nxfnz57Ft2z9466232ADXyUE8AIjbvHFPG5qa7vfHeWhbGyJ47zU6ZlfUlEBRQRldRrhSAZdE2bWtjJ7Pd6mrR9ih2zB1t4d&#x2B;t9YZKdFnH9Bov2lfByjJqyJozzU4zR6M7OBEzOTuM7c2HESvBaNwYt4PyAlNQmFmFiz7ONFt&#x2B;34wEQ6e/WDcy/apUGb8dCwgxrdDvp4D91WToKyl9szHQUoIhIkIhk5WqEQJciNTYT&#x2B;xLxrqG2hnnrzINKhqa9Df/uHec1DX0kW/JZOgbqrDHdcYqOhpsBP2Cbhxr4Yj/RHXrl0LO336dPy9e/cK8XxM&#x2B;9qL7Itq3weIT/UXNd1W0i9uHiP9DEwAYGDotBexkgLG/LQIPd8ZidADN5Edmoi6yloYOVth&#x2B;DfzRTDVxocq0sLIdfFYXP54O2Ku&#x2B;MGklx2twYw5/RA5gf/Byugd9DM6AgjJtbC2Voa1Nax7uijF&#x2B;gdUJUZEFpZUVdabdumiUlVVVefk5KROyD9HImX4ibQ09fLiXP0ljbbzRu55ybywbgLCvgMvwRcmJrys6P/69esQFRWF1NRUvP/&#x2B;By1&#x2B;N&#x2B;LCTxz7Q0JCaLu/adOm0rrxqVOn4aOP1tB2d/n5eZg9eyY2bfrhpZjJ9erVm6b&#x2B;d&#x2B;vWDRERkVizZhUuXbpCl5HvvmnTJpqp4O19Fz4&#x2B;PlBSUsbChe/S4/vggxUtjnfNmo&#x2B;wb99eXL58tVWbQobXkAiVV9GaeB1rYyioSd&#x2B;ZIfF6MOKu&#x2B;UPDUhtl2cW4v&#x2B;UU6hpqoaKpATP3rrAe2RP249xg3r/9M7Yec8Q3LzodBt0byX4oR/6PvfN/mPr7mlYCQPQZX&#x2B;yc&#x2B;glcp46lZng6XUyQ7hdFPWZIrX5OeDLdV0F8OlLvRVCRwuXtEei3YjLUDLUlNs9rIv&#x2B;1FVX0PqVtYyyQyDfU1kFGXq7VmEayCPaM/gxq&#x2B;tqYdfTzVqQ942EsLTHQVTJBwu1gqBpqIvlOGOIvBaAgIxOq6pr0O8vIy1Ixg5TYMTSCu39WkEh/QEBAgpeXV8ylS5dyGhoa6oWQ9WeJ&#x2B;LeV/DPSz9r2MTABgIGh44A85Bi72MD4BxvugbOS1lkS/koegMQM4o0DAW0r2ABNK33MOfklChMysW/Uf5GfnI7rn&#x2B;3G2C1L6HrFSTkozS6Eae8ukH3N3Y5VVVXlew4ZrO5QVVWfn5fXoKDYWJzKT4hFRcvb6uwv6P&#x2B;hidhLIjoIExH4BQJ&#x2B;CPqMlw2Stk/S4M&#x2B;c&#x2B;bfVdy4pKaFRfyIOkOj5nj37aGs&#x2B;0vJOnju3b9y4iT/&#x2B;&#x2B;B07d&#x2B;7AqFFjqLN/e4CQdpJl4ObmJnY9krFAShM&#x2B;&#x2B;GA5rdsnnQXi4&#x2B;NRWlrG/Y3DP//8DQ0NdUrsPTw8sGjRe/D0HA9NTS16vLyGfuQ9KRk4fdpL7GczvPog6fpHZ3yH/Lh0zD39NWxGtOw6kRkYh/irQTB0toYeR5jJOEzS50naPBFnCYiZXw2qELL7JhynDUR5fhGsB7rAZf4Iat5KDGOfF7JDk3Dpw3&#x2B;w4M4P9L2FhyO09AxgPaJHq3XvbDyCocvnot&#x2B;Hk6lgbOpqh8zgeChyx1GWU4Rr/7cb8jIK3D1JAQvv/gQ9e7M2CSIEJMvg/PI/YO7hhD6LSLbDk/Gw4XGzGEAMEHsvHEPb67YYb749iLqKGpj1sUdFXnELASDp5iPsHPExVsfspSUUcZceIubiAygpq1IPhZHr3kW3Sf1h0qcLO7mfgBu760ikPy4uLmPjxo33goKCSvBi2vS1hexLUssvSas&#x2B;SYi&#x2B;NMZ&#x2B;jPQzMAGAgYHhWZQAtKkOkUR6yC1BVkWO1pdq2xhRN&#x2B;PK/FL6UEQQ7XUfF1b9g4r8YmjZGmDa9o9h3Nu22dTpdQWJ9mtoaspVVVUJJe2iiL4wwUDUtoKmJRUUxJUCCCL/khgItgUVFRXk9xMbdScp8o8eBWPkyNGtlu3evRNLly6nzySxsXEIDg7CrFmzG29Q8vIYOnQoR57XwN29H7S1nzqT//zzZjx44As7O3ssW7YcS5YsbfMxqKqqtvitiOhgbW3NkfAdIv8ffvvtVzg5OWPu3LnUnf&#x2B;LL/5LTfvIb9y/vzsl9yRrYcuWX9C9uxPNEBDX537BgnfZONaBBmQLj&#x2B;4Y9OkMWA9zabX06Nz/o8Z3ysrqUNVXpzX8ykYaWPbgj&#x2B;Z1jN3sMe/AOmhZGsHYxRoKqsovrHVr4PZLiLzr0/xet4sJfaXei4SB41NvCpLOX1tbjf6rpiD&#x2B;RhC9l3QZ74b0hzFweXsk5LnvTI7v2pe7aQRft4vxM32vgG0XoaCmjIrsQlSXVkJZuzEr4Oj0DdQ40HnuMHj/fBxdJ/eDFp8rf9zVQHwY03hdFyZmI&#x2B;l2KPVMINCyNICVuxMiT/nAedZQ5EQlosfMUej1zkjunmgIFR2W4k&#x2B;ZbUNDPUf44znen7hnz57gM2fOZEpA0tsj4t/WVH9xTv7SuPaLi&#x2B;6LM/aDBEIAxMxnpJ&#x2B;BCQAMDAxSD&#x2B;loqKvlSL&#x2B;Acb2hsT6SPGAqaamgqqgc5aXFqCwsw9mlv6E8twSycrLICUvF2eW/wX5CX1rH2We&#x2B;J2yGurzej&#x2B;pSRvMFZQTwk3NBRoHiWv4JI&#x2B;qSEndx3gPCOhFIg&#x2B;LiItqf/uFDf8yYMUPs&#x2B;qQ&#x2B;/9tvN1ABgETzCREmIO3tSKSdEGfyfcLDwzBq1OhmAUBNTQ2ff/5fgft8&#x2B;&#x2B;0FWLlyFRQU2n4bi46OxtWrV7FixdM0fJKN8MUXX7TqOCDodzY1NcXGjd9CX1&#x2B;PHkdaWho1Aly6dBmN8JOMBCICECGDoWOiNKsQUSd9aA07P4iQOn7LEmocF3/ZH3bjW/qxDPpoJpLuhCLxWjAdY/UdLGA3sQ9H8p9GrS36d6Ov54386DT4/HQS6ka6GLGxsXSMiMHcSEG9B8ixEBj2sMKj/dfhuuhptg0pcyiMy8I/rquQXhGN/2V4w2qwM4Z&#x2B;PY8uVzfWRsxZP9px5lnJP4H1sB54&#x2B;Oc56m&#x2B;T6htJSyBI2Vvkufuora&#x2B;Fw9QBqCmppGa2/Kjnxpxzy3/nJh4j7MRdOM0c3CwAkLKF4RvepqL3oLUz4TRrMFR0GeknqK6ursrNzc3x9fUNP3fuXPTevXuT0L6mfe1l5gcIzwYApEv1l5T0i1oGSBb9F0T6RQkBjPQzMAGAgYFBCqIrKws1Ix1k1yWiur5C&#x2B;E2ACgQcSZR9jKgzvqitrKZOzO4rJsF&#x2B;vBuuf7EXIXuuIy8tFTEnHuC/Rac7hjwiIMIuiTggyGWfv4RAXEq/sNICUdvyf7Y0AoG0GQFbt/7KkfM52L9/L4KDQ6ChoSGRAODq6oqLFy8hOTkJ69d/zb2&#x2B;xcOHfjhwYD8l4YToT5/&#x2B;Bj78cBVGjRol0XchpFtaENHi6NHDmDNnHvURuHbtKmpqqlusQ9L5u3Z1wPffb8L8&#x2B;W/T2n3yO/n63qfGfWSa7Cc2NhYBAQHcdCHefPMt9OvnjnPnztNsCJINwNBxkXovipZa6dga4/b/HUZuWAr1YBGUfVVZWI5zH/yBurJqvHF4LR0786PSqFdLdkgiMvxjUJZbhEV3fqLmevJKii/kGEipQWVROTTNGq&#x2B;jW&#x2B;sOIDMoHl3G9mlex7xfVyhBFblRKc0CgI6dCRKuB&#x2B;NxQwO9l9D1&#x2B;ndD/w&#x2B;nwG/rWSzYuglqJtpPBIQRqK2oRvqDaBq1772ofUp0yHd58&#x2B;IGBO6/jEOT12HGwc/gON0Dqtx4NGnrCiioKEFOWQGFpGOCbUvBwXPLMvw55X3oyBnDZmhP9Hx7ZIvlQbuuwqBbo4FnZyf/9fX1dVkcgoKConbt2hV0&#x2B;vTpDEgezZfGtO9Zzfwev0TSz7svCFkuTBQQRfoF/WWkn4EJAAwMDG0DIfGT/1qFpJshyItNa7zR19Shrq5GCGGURVl6HrdOPTVqGvjJdGiY6tHaym2DV0FTQx/KGqodTygRQ9xFkWdxBoD864kSHYQRfmH7EOYnIEjokAbE2X7Dho0c&#x2B;d&#x2B;PpKQkKCoq4tQpr&#x2B;bl3MMhRo8e1aLF3ZOHSPp9SJq9jo4udcEfN24sjYpPmjSJmv4RIz9CyJ83zp8/h6&#x2B;&#x2B;&#x2B;gojRoyin1dRUYlu3RxarUfq9QnB9/I6TevxL126RJ38d&#x2B;7chX///RcXL15EdnYWR/r7YceOXdDU1MaAAf1figEhw4vHne8OI/q8L0Z&#x2B;/TZy4hNRW1xDW/UJQkFMGjzWvIHY8w9x&#x2B;aNtiD5zH1FevijNzedYQz10LU0xcsM7sBzs9EKP4cHWf&#x2B;Hz02msjPybtrObtGMV6iprWpBeHXsz6NqYUmO8Bm78T74bgciTd2kZggzfuU5KAhbe3wwjZ&#x2B;uWgpqqEgZ8PB3Oc4ZARb99rnFFNRX60tDRgaqOFrze2Yz7W7zQdaI7zVpoFAkMEX3RDzYje7XYtqK4DJYWPTB282K6PjEoJN4BKd5hCNlzDX5Hz2LZla2d&#x2B;vxOS0tLTUhISOXGev8dO3YkQrpovrRt&#x2B;qQl/4Doen9JTP0kEQD4129L2772JP2iiD8j/QxMAGBgYBAPVX1NdJ85uPm2od/dHFomhqguLxdIFOlDFffAJ6cgD6UnLsyWg5xQjmKoQQsd6TYiLrLOH93nFQQkIeqCSLskJoGivgv/euJKCNriB2BgYEgj&#x2B;bm52ZT4k/R3W9tGB&#x2B;ywsFC8887biIqKbiUAREVF0ii6lpY2FQHMzMywYsWHHAkfAV1d3RfaeYAY7JGWewYGjXXBenq6tCRh0qTJzetkZ&#x2B;fQVP6AgEB07WqHmJhYjB/vid9&#x2B;&#x2B;w0TJoxHt25OmDp1CkaPHkuN&#x2B;lh6fycAd63kRWdAz8GUnq/mbl0Rcv4abbtXmJaNiFAflKbnQUVHvdWm&#x2B;XEZCDp4BbUFVSjNKIBvdCLMezrQNPZe74yC5ZAeHJlVeuGH5DC5P81YIOSfkmpuujSzEOc&#x2B;&#x2B;BOzjn1OI/eZHPEnGQn&#x2B;f19ARX4pqmpKoamvD4/lnq32R7wOdGyFp/drmOm303/FY5RlFNLWe8Tkz3a0K&#x2B;Iu&#x2B;&#x2B;PMh7/QGv766jrIKcnDpKcdUr0jW20fe8UPM4&#x2B;shcVAxxb/v6RVYdzlQDhPHAIzd4dOdXo3cMjJyclOTU1NP3HiROCuXbvi8vLyqiFdNL8tbfrELQckM/kTZ&#x2B;AnadSfkX4GJgAwMDB0AjzhXrbDe2Gx7y8IPngZj&#x2B;vrAQU51NVUo4GbJqme1sN7Qk5ejtZ6NtTUAWpNd8q6jvVzSGD2Jylpl7a9nrjyAkHzxLXzE2cKKA1IxJ8Q4fLyMgwaNKjFsrq6emp0p6/f&#x2B;iHf19eXpvcTEFf/7t2dMXPmzOfy/3fu3FlK8ImBnyB06dIFyspKzWINad3H/zxE9lFVVYlvv11PswTc3d2pcGFnZ4dvvvmG/gbkt2DoHLj9zUEk3Q5DRUEJlj78DTLc2Gg7qjcUNqgg&#x2B;1EinKcNgfeuk0i9GwlDJ&#x2B;vmMbWmtJI60qvqayE9MBqGXa1pdH3oyrnw&#x2B;M8MyCq83Mcvg&#x2B;6W9EXKEfSepLzHXw7Ao&#x2B;PXoLpUE2WZ&#x2B;Yg46w0VLXXIysvDflwfWI10gcvsYVAz0m61P1Hkvz1RXVyBv3t/gO5veGDCXytoJ4SHf2ag94xRtOuC9/&#x2B;OY&#x2B;hXc6FtbgSZx60zcqqLKlAQn8ltZ0Y7KJSk5SHdN5p6GywJ/A2KqspQ1FDp8Oc1N&#x2B;41FHJITExM3r59u8/p06fTcnJyqiB9NF/aiP&#x2B;zGvpJ4uQvLuoviOiLM&#x2B;8T9V4QwX8eDv6M9DMwAYCBgaF9oWWpj6Gfv9n83qSPPRKvPEJFfSk0THWpu7LPjhM0dbTJ3Kn5abeDkn9R0X9eEi1KFBBmvCfMGFBQpF7ITV3izAFphAhRIIZ2N2/eaDW/V69e9CUI165do5kDCQnx2LRpE0f&#x2B;Zz&#x2B;3/0MTExMYGhoKXa6iokJd&#x2B;KurG&#x2B;v&#x2B;6&#x2B;vroK7eMmpbUVFOsxYUFBSxatVHlPyfOXMGNTU1mDJlKhsoOhlIxhOJ0I/64cNm930DJ0vY9HXBwx3nMe/Mt9DVMUFaYBRcMY6a5hGQnvdEALAd3QsrArZDw0wP2/uuht2YPs9M/gmBjTrtw43ZhnCaNUQ8AahvQPjxu9Tgtcebw5vHAVKWELTvCoZ8Phe&#x2B;v3ohKyQRirIquL/tJFTUNdFj1nA4zx0Mw&#x2B;42lDC/Crj1zSGY9e0K/20Xod/NAo7TB8L71&#x2B;OwH94XuREpsBvf6L9h5t4V3aYNaLW91aAeOPz2epjY20FZTRW5kWnck/BjfJx8oEVLwI7K&#x2B;0s4JCQkJB07dszvzz//jCkuLq6B5JH5Z434t4XsS1PL3yCA0Isi/ZLW&#x2B;L9M0t8m4s9IPwMTABgYGNqEN/avRVZwPBJvh9Bo1thfliDukj/ubDjEPShpQllLlab/owPcZsS19xNFrCU1CJTmPf8yUen74gQEaUUDgtLSEmhoaLYWibS0aN97aUAc/8ePHw95eTmMG&#x2B;eJ6dOnPfP/F3Hqz8vLo6n8vG31TExMcfr0KWrKJ&#x2B;TXpK0EyfZN&#x2B;&#x2B;EXLqZOnYYePXpg0KDBNL3fz&#x2B;8BPvhgOQICgtig0AnRf/VU&#x2B;irLLEADR6RJFxRlHXVKQmOv&#x2B;kNJUwV2I3qjvKKoxXYlqTnUVM&#x2B;ohzWtMz8y5VsaVSflV8&#x2B;KE7M3oSA5E65vj5VIAIg9748j876FrpExTFztoGmhj7zwFDw6cANRp3wRdy6AXguyCjIYtr5RBCbk2ZCvnv9Fg3jTEN&#x2B;ZZnEupxgP/vTCUr&#x2B;tqKuqRdhxb2ia66MOtUi69QjWo3ui55sj6LrWpCuNAEuOXm&#x2B;OROTxuyjNKOTGuWo4TO6HnvNHdGjyX1lZWU7a9t29ezfys88&#x2B;e1haWlqHtkfzRbXpa0/SL0ktvyRRf2HRfWlJv7h5jPQzMAGAgYHh9Qd58CK1kLz1kFN2f4SDnuvw74pfaaRLW8cIdTU1Hfp3kEQc4I/y896HBUX/hdXoCyPyosi/MJFA0P4keT4ICgrCkiWL8f77K/Duuy170pMouKOjo1S/30cfraFRdmL017t372c2yiMmgitWvE/9BzZs&#x2B;L9mAYAc29mz/&#x2B;K3336FoqISLTOoqGjsckGi&#x2B;E0oKCjAnTu3MXr0GFhYWMDVtU&#x2B;L/ZN55EVAWvt9/PEabN&#x2B;&#x2B;E0ZGRmxQ6CQozymive15DeS8Fv2MYV/PR0NtHUL2X0fSzVDIaDRecxYDHGkvet5rkLSUO/rG/yHZOwzJfuGQb1DAiO/eaZda&#x2B;Ck7VtEsAgMnK4lI9MU1f2PO4a/x76JfEbD9EvJjMpB8&#x2B;xEqyothYGsFNRMd2I3qDZf5I6Fra/LKJHb5/3WeZiwQ0ST9YQzubDxCj2fnoI8hJ69AjQWNetnAc&#x2B;MHsPd0o2ILMbmlEDLMaJjrYeHdzShOzaXp/upmL9aH5AWS/ookDr6&#x2B;vtE//vhjQHR0dHlDQ0M9pKvFl6Ze/1kj/M9K&#x2B;kVNM9LPwMAEAAYGhraAOCWbcw&#x2B;60/Z&#x2B;jEiv&#x2B;7Rn9c0Ne6FCTN9e83uQsPR8SUi/JPsTJgTw77stmQiCBAjyys/Pp9F6aUsAdHV10KtXb3zzzXrMn/8W5LkH7SYQ4z9SRy8NNDU1ORL9SZv&#x2B;XyIiIqDAER17&#x2B;67N80ibvpEjR&#x2B;HddxdCWVm5eX5MTAw17ps9ew727dtLBYBdu3aggTtvR44ciVOnTnLE/w7i4xOwcOG7OHbsBMaMGdNiH/ywtLTEhQuXaJtCho6N6rJKxF8IQPdZg3Bs5ibIKcjCepgLSjMLUJlfijS/GBp5L8sqRFVNOdT0ddBjZGP0nUTLNc0NWuyPpKcP/3Y&#x2B;HvzxL&#x2B;yG98Gwr9&#x2B;CWV/7dvmuRr26oKq4HIEcmXd9b1yLZel&#x2B;0c2iLfFvubf5FCryiqGqp0lFiVu/HIKWnj6teSedBzw&#x2B;foNmdDUT55cI/oh/4M7LSLkXQWv1U&#x2B;&#x2B;FU9Lu8dEMZIcmoaqwDA4T3KHbxRRDvpCurIh0sHlVShram/QXFBTkHzp06PbZs2cT7t69W4Bnr9&#x2B;vl4DQt4Xsi3L0F2fqJ0wAaA9jv1ee9DPiz9Auz72vwjkk4KFUhm&#x2B;6ScuV5XlP/so9mW56yYl4yQt5KTz5q/hkWuHLL7/suWHDhrXs9GBgeIr8mHRcWPU35v27jnYDIFgt0wdG6tZQ0VbH6tS9r&#x2B;2xlZWVNdeFizPVEyYGCJsW1kZQHPEXFCmXpJQgIiIc//57BsHBwRwRPgAlJSWxxD86Ohp6enrNJn5xcbGYM2cu/Pz8WnwPkgHwogzwSFvBr7/&#x2B;Aj/88BM8PVu7jn/&#x2B;&#x2B;We0hWBTtP7AgQNYsuQ9jB8/jv7epFPBmTNeWLlyBT1&#x2B;0sVg8OAhePPNN2lLQ1bPz1CUlIP62lro2Zsh/MhdHFv4HT5PO46b6w8g7OQdOE4YiPzYdCT7hENRTZG7FuRg6GzFke6xsBjoDB1b8VkhpRn5UNHVhLyyQrt&#x2B;d1ILf2P9XqyO2Q1de9Pm&#x2B;X86L8OoTe&#x2B;ioqgc4YduIfFGCGTkZVFVUQZFBRU4zhiIfiun0KyFZyLr1bWoLqlo7iLAi4SrQbAd3bvFvNyoVOQ8SqI1&#x2B;4LEhoC/LyCZI/uDP52JNP9oJN0MQ&#x2B;y5ByguyOUYaC2cxw5Hr3dHwnn2UNTX1HKfXw9FDWUmXFVXV3Kkv4Aj/L7cGBju4&#x2B;NT&#x2B;CTSL4qcS1q/3xbyL04IEJfyLynxF&#x2B;fmL4mxHyQQAiBmPiP9rxPpfYWyfV72fyfLAGBgYJAIGQ/jEHbpFvYOr4Tz3GEoTsmGFvRpuyirIc4d9uYgLnWfdx1BrQCF1euLWod3nrQt/YqLizFs2Ah4eAxqQf4bSDTw3j0a1SZReTU1dZDnRLKOp&#x2B;dYfPXVeixYsIAj/rO49Xxp9J9fhHiR7vceHh7YtWsP3Nz6tlq2dOli3LlzFxMnTmwWAFxcemDx4sU0xb9790ZyQ7Z1cemJhQsXYdKkSTR7oHG&#x2B;G7ugGRCw/SJCD9zE6uQ9NCKuZ2mG43M2UYJZlV0G7&#x2B;3HYWxhAyMXKwz6dBZtHUdqzqWBhqmeROtVFZYjaPcVDFgj3iOjtryaI8iPoKKlgdsbj2DytpXIDE5ARV4JChOycGLuDygvL4K2gSH6fjCBdi2IOeeH4uQcDPnvXCpiPCtiL/oj6t/7mLprTYv5NWVVuPv90VYCwI1v9iPqxD2YD&#x2B;gKl9kj4LbMk0b2m1CeW4yQA9eRcCUQFQVlqKgt4kj/UAwaPQcmvW1hNbQH9V8gkFNUoK/OCuLgn5mZmfHw4cOIzZs3P7h7927&#x2B;MxD6trTnk/QvIFmdvzSt&#x2B;iRN6ZfEuE8a0i9MOGCkn&#x2B;G1BBMAGBgYJILj9AGY8r/VuPjffxDnEwA57p&#x2B;ykjrKq4tph4COSP4lEQfI/VlYej8/4efvHMBPsIV9B0nT&#x2B;MkyQvxjY2Opmz3vuqS93aJFC6lLPon0k9T4FStWYvbs2TSdPjIyEvHx8cjKysJ//vMJJc0vE&#x2B;R7ZmdnIyEhoUXZwaFDB&#x2B;Ho6MSReHd6HOQ7e3mdxo0b15GcnEJFij///JOu6&#x2B;19F/PmzcP06dPZBdwBUVtWjVTfCJj27QplLcFlGsUpuYi54Af7sW7QtmkZsTfpZYsHv3jhxKzvOeJaiYqsYuREJ0FFRR1dJrnCcYoHrDy6c9uZQFZett2/P/lukad8YD/Rndbk3/nuKHrMGwp1Y126vK66FvJKrYnuuQ9&#x2B;RxeOYBNjwoTLgTg1/ydKyCvKiqFragxVYy249B0B18Vjqekf6UZg79mXRu3llNqHOJMU&#x2B;i6jXeH/9wV0mzIA6iaN5qAF8RnIjUlDfW1dc6YYGQLj/vWnNffyikq4tPofaFrowWHyU5f&#x2B;IV/NRWVhGaIv&#x2B;qLPkvGwGNgd5u5dUVtVg8qC8mby35mRkZGR7u3tHbxz585H/v7&#x2B;JPBf/YyEvi0Rf2ki/JK69rcX6efdF4QsFyYKiCL9EEH8GelnYAIAAwNDBx4sVBQx8D9vQMvGEBFHvVGQkIm6imq4DB6JbtM9OtSxSkLEeeeJS&#x2B;8XlfIvrp2gKNM8YSaAJIo/evRY9Oz51MSMRMKPHTtOI/vl5eUYMWIkJf8EHh6D4e//kHoGXL9&#x2B;s4Wz/stCSUkJNeD7/PPPmwWA&#x2B;vp6fP/9JmpQSASN06e9EB0dQQUBCwsrrFjxIXdcw6lvQVFREfbs2Y0TJ06xi7cDojy3BPtHfYb8lAyM/99ympbfhIbaeo5MlkLNUBt&#x2B;v/8L31/OIHzAHbx16Vu6vIgj3nEcYY4950d73AcfvwYFBWUYuVtj2icfQ8/RHNpWRu2etk/P65Q8aFo2ZhEkXAvEyY/&#x2B;B5Ofu6D38rGoyC&#x2B;mpJ8gKzgBB8Z/ifG/Lmvh9J8bnor7e71gYmGD2ooaVJWXIYT7/pauTtB37I/BX82Blok&#x2B;FDVb97JvL/Lf9Bvf&#x2B;voA6uvqqRjQJABomupz8&#x2B;pQlJjdXGcf8Pd5WA/tAdO&#x2B;9lBQU0ZJci6qSypb75O7vmfsW0sFHYLLa7Yj7MhtMsDh4/T9ne4cJ6n83DhWyJH&#x2B;oP3794dwf3OzsrKqnpHQCyPvbSH/QPu075OE6EtTx/&#x2B;8Sb8o4s9IPwMTABgYGDoenGYMRvfpg2hLJtJHXcNYt0UqZ0ch//zRe36jPb6bt1CDP1GfIyj1v2l/pAUdIf9NLetaPMhzBL0p84B/f&#x2B;fPn6f97okXACHMZB/EOT8lJRk7d&#x2B;7gCPII/Prr1hbt/D75ZA0OHDgEXV3dV&#x2B;L/gPgX/P77VkyY4Inw8HAMHz6C&#x2B;hKQ7x8aGo6NG7&#x2B;lLQlJTf&#x2B;yZUvh6TmB/l5NOHLkED79dC2&#x2B;/fZbZuDXQSErJwOHqQNhM9yFmpPyIvlOKG6uO4CFd3&#x2B;kqeULbn&#x2B;P029uxiWOUBYn5aIoIQOZMYn0OrIc4ILJq1dBt4sZDJwsmqPWzwsXP/4HiipKGPndAtp6TgayGPO/xZBVkEMdqpEblkLFh2OzN8LY1Q5XPtnRQgDIi0qFqpI65FWUMe6XZcjwj&#x2B;bWs4fj1AG0tj700C1c2vsPtw9DTNr24XM7DiVNNUz8ewUMe1hToYUMRb5bTmHAmulQUFBEUVI29SYg94m4K4HIj0lDeVYBUoKiUIsqGPd6mtVTWVBKPRjCjt7BoLUzm&#x2B;cb97aFgaNFsyDQGUDS&#x2B;8s4&#x2B;Pn5hRw&#x2B;fDjwxIkTacXFxTUQHs1/loi/tORfXIRfkjp&#x2B;SQUARvoZGJgAwMDA8EqRZFkZqBlrd7zjEhG9F1f/L0wIEJW&#x2B;L6hdXxOys7M4InsYH330MRUBmtYjpCUtLRXGxsbctHyLbffv34/U1BRq4Ldt2z84evQo7t69jZs3b6GsrBRvvDETP/30E62FJ54AxPyQkGrS817a9n7PC&#x2B;R77d69kyP/E&#x2B;hvsG/fPvj4&#x2B;CAhIZ6aEH766X8wc&#x2B;Ys2NvbUxFAEDw9J8LKygYDBgxgF2sHhYquBoZ/8xbuc6STtCQlNeJN9sGFHPmM9wlATlgyjbjf/9mLZgQ8&#x2B;OcMZBXlYO3ughGziZDpQXvdv0gH/NqKKoScuIqEmyGw8nDCgAVTKcHPj0qDrLoc4i8GwqiXLfI4wjz&#x2B;l/dxftnv1A3fdVFjhoNpXzssubcVel1MoKSlRk31eOH/93koaqpC39HiuR6Hto0hffn87zj6LJ2ArKA4XPj4TzjPGcZ9N1ME7riM5NvhCD1yC8XJ2airr4G6vi7cl06EhbsjDHlaGF5Y/gf8jp2Hy9hhLTwTes4f2Wl4fyWH0NDQcI70&#x2B;x84cCAxLy&#x2B;vGu3j2C9JJJ9/PUA6Z39pSb&#x2B;oaUnM&#x2B;0S9F0Twn4eDPyP9DEwAYGBgYOgo5F8U2RdF6PkzB6TJCOBfl2x/7do1SvBJKnxTFJtEuU&#x2B;ePIGPPlqNcePGcSR/R/NnkZT3JUsWU&#x2B;JcWlqKuLg4fPXVF5g0aTLee&#x2B;89jBkzljr9X716BePHe9LMgD///IO65wcFBb8y/w9E7Lh&#x2B;/Qa8vLygrq5BMxXI8W/YsJFG/El2gzgQk0NG/jsYQ2p4jNsbDqPfikk0ck7gu&#x2B;UMLn&#x2B;xA/oWFlh0/ycoqqugKDELtaWVUJJXo23l6qpqEHbiNgwdrOAwqR/cP5oMg66WUFBTeinHMfiz2XCcMhAJ14Lx6NhNTN/5H3r96tgaw8qlB1KCwuGaOxZVKMORyd9ARk4GmQFxwBMBQMvSkL6E4c0LG2i51vOqmSdeCWGH79CSi4rcEpxb&#x2B;zuKknPR571xkOUeKUvT86DNHcvDXedQJ1MHAzNzOL7hAduRvWA3tg&#x2B;0rFp/98FfzYVpv64c4R/Vqc5p0rbP398/&#x2B;OLFi&#x2B;EHDx5MyMzMrKytrW0QQ87bI&#x2B;Lfltp&#x2B;cWn9nYH0t4n4M9LPwAQABgYGhtdICOCdx38PF0buhWUBCGsHKGi/JAoeEhJCI9wk4t&#x2B;0DSH5u3fvxtatv9PUd5IWb2fX2Fv8zp3bsLd3oNt&#x2B;990mBAQE0NT5rl2fps8eOnQIly9foinzBGvWfIxFixY3u&#x2B;O/TDx69Ii2YnRycsLSpctga2tLo/yka4GyMmv31dmRei8Cvr96YeATl/yGunok3gzG7H1fIOrsfXh/fxwFsekoSMhG2qNIqKlqQNfBHFP3rAE4Mhyy&#x2B;yqtQTftbf9yhK2qWkR53YPT7CGwGuxMa&#x2B;GJK//NdfvpsRBC7ThhAHz2n4RhL2sMWzEfZVmFUFRXpvX2koKs/zyR7h&#x2B;Lf5f/AkVVJdhP7IueU0fjwZ9eyAqMp&#x2B;UMj2VlYTPUhfvuBeg6qR&#x2B;6T/OAmpHobDHSlaA9OhO8DqiqqqqMioqK3r9//wNfX9&#x2B;se/fuFaLt0XxRqfsvgvQD0kX9hRF9aUm/uHmM9DMwMAGAgYGBoW2kXxLCL2498p602nv8uAE1NbVCTf94xQBC&#x2B;mfNmgUbG1sa/SaknkTsSUnAtm3bYWpqSjMB8vLyqQBAlg8c6IGHDx82k2VB7fNmzpyJOXPmPCULioowMDB4Jf4PfvrpR5ql0LdvX6xcuZKdlAwtQGrG3w/7C4oaKs0CQE15FUKP3qZ18fkRt1EjWw1d7toYvvZNOM8eBiWODGdnFyL6rC/8tp7D4vs/t420FZVDWVMVkJVpTQvEJPkE7bqK3gtH49qnOxGw4xIsPZyoSd5V7r39ODekh0Qj8dYjKgDoOprCbbon3W709wtpucChCevgwVMX/6JQkpaPe5tPUgv/cb8sbZ6vY20MAycrnHv/d&#x2B;j&#x2B;YkZr&#x2B;9W0tZEZGg&#x2B;nmYOhY2UIsz52cHl7BDtpn6C6uroqOTk5Ze/evXcI6b9x40YeJI/mv4iIvyT1/tKQflHTjPQzMDABgIGBgeH1EQLEufgL2p4Y8d28eQNpaWmYPv0NGm3nzwZoqskn6zahSxc7HDiwH6tWrabrpaam4sSJ49i1axdMTEyQlJSIXr16Nn8uaYknDq9CpF8Y/vlnm0Tp/QydEySy3RTdJr3uicmdupEOgg5fgbahEZT11bHw7GboO5ihprQKsZcCkB2aCHVjHaTdj4L9eDfodTOX&#x2B;nNrK6pxcNLX6L&#x2B;S1OoPpvOyQ5NQxH2HgG0XMXnHKqibPDXPrC6pQOq9SNiN64PCuEwcX7QJloOdaGeB2soaVHHLY876ojgjBwG7L9JxwHnuULqtWd&#x2B;uNGpOELL3Gm6uP4D6x7U0hf5FIvHGI2o&#x2B;mBkUiwqUYcxPixF3wR&#x2B;FSTmIPOmN4vhcKnwUxmfQdn0DPpoGTQsDatjH8OS8qa2tITX9HOGPPX78eMydO3fyias/nq1&#x2B;vz0j/tI4&#x2B;rcX6efdT4cg/Yz4MzABgIGBgaEDkH/&#x2B;tHxhJn2ituEF9xCITz75GB9&#x2B;uLq5pR9Zl2QFEMJPov1btmxBUVEhvvnm22Zh4PbtW1i/fh0GDhxIST9p09evXz9q3JeUlERr/ZWVVdBRnj0Y&#x2B;WcQB0JKPT6dgchTPnB5awTGcsTUbbknGqrrcPd/x2Hm3ljucnDCOpRmFkJNXxOLH2yBzYheqCmtgHxb2uBx1xfpfFJfU0v9BbRtjBHh5YPg7VfQZUzvVh1QYs/74fTin/FpxhGo6KrBYYQbTr75PVR1NOn1LycvS0UJc/du6P3OWDhM7gdN80bxTtP8aTZOzwWjuPd6UDXUemG/7&#x2B;OGBlz7717c33wKFgO6YZHPFpxd/AsOeq5D&#x2B;oMYlJTkQk1NE2auDhj&#x2B;3QJoWxpQ4i9F85MOjwgODx48iD506FAEifSLIf3PGvEXJwJI08ZPGlM/YQKAqOi&#x2B;uBp/SCAEQMx8RvoZGJgAwMDAwCAd&#x2B;ed9L8j9XxjRF5QF0PTX2dkZ589f4si6EjXxayL/x48fh6trbxQXl&#x2B;Ds2X9RXl5GBYDi4mLyEMnNO0vqRTFlymS4uPSk2QMffbSGpvhXVFQwwszQqVCUlAP/gxcx9Kt59P2Nr/Zj8vYPaXr&#x2B;mUVbYOz6tK3c6B8WQlFLFRomjY7yshzpVtZRb9tDkqoS8qLTkOoTidhzfph&#x2B;aC36LZ&#x2B;EPu&#x2B;MgSZHgIk5IS8MHK2grKmGYzP&#x2B;D7JycsiLSEdRVh4UFZVgPrgb7V7gPGcoeswbDjlF4Y9gCtzndp3c/7n9nkG7rsBxugeUtZ&#x2B;2yXz453l4/3AEBl2tqD9B4PaLtOwh8VYwbbXo6j4WrgvHQM/BnHaCYWgkgunp6WlXrlzxv3z5cjw3bmdUVlbWof0c&#x2B;9vbzE&#x2B;ck780rfokTelvb9IvbB&#x2B;M9DMwSPrc&#x2B;yqczwLSZmX4ppskdlme9&#x2B;Sv3JPpppeciJc8z4u8V3gy3fRX8cm0wpdfftlzw4YNa9npwcDQOUAINWkxJ0n7PmHu/oLKAJrq/wmp//XXX/DVV19Tl3s5OVlYWlpw79fh&#x2B;PFj2LTpe5run5ubQ937MzMzMXToMAwePBju7v3h4tKjWTyQtFsBA0NHQkN9AyrzS6FmqIV8jpD/1u09mPXviky/eCgZqGGJzy/Q7WLS7p9LIv/Be6&#x2B;itqIWLm8Nh6qeZvOy&#x2B;KuB0DI3gLatEQpiM5F4IwQx5/yQFZSA0rw8yCrIw7SHHYZ9M5&#x2B;uo2dnxpH&#x2B;9m85WJqR36J9XvO4llsERU21VpkPpDvCF0rDMf6b5Rj69bzm3/fQpHVwnjmEChPEnDAvPh3lKMJq7z0wH9iNjTVPx92GPA7nz5&#x2B;/d/v27aSTJ0&#x2B;mlZaW1rSR0Asj6/XtQPoBydP6nzfphxRCgCjSDxHEn5F&#x2B;Bmn55sscR17q57MMAAH/J&#x2B;wnYGDo3DcI/hIA/vm85n380X/e9YjJXlpaKtatW4fq6iqyBp1HMHLkKBQXFyEgIBCLFy9EYWEhzRZ4442Z6NfPHUOGDKXlAU2fR8oFBN28mAjA0BlA2tqpPUmHJxHoYV/NxcN/LsF2TC9u&#x2B;k3aRk9akLR2Y1dbyCkIfxSSU1RAn/c8KWnOiUiBqq5mc4ji6ic7YehsjaricuoJkBmVwC2SgWlPe0zathKaVgYw6WULGdn2aclHWhqS78pbdpAbnoKg3VdonT4/js/7gTryD/liDvUeUNZqjPbXV9XCvGs3Wq7QJAA8rm9AWUEhFDSUacmDzcheSH0QhfT7UbDwcGQPho2R/tR79&#x2B;6F3r9/P&#x2B;XAgQOJeXl51ZDckE/SiP&#x2B;zkH9Rhn4vgvRL8769SL8o4s9IPwNDJxMAHrfxwmcXPQNDJyb&#x2B;gqYFrSMqA6Dp2YFE/v38/PD333/h008/xRdffEHFgIyMdJw6dQoPH/ph7drPaOs74vRP1j169Fjz/ppMAcV9JntWYeiMGLZ&#x2B;PiXmaobakFOS/lGGtNjzWrIZi25vhpx2y/KA7JBEpPtFo8ebw2kqPkFGQCwOeH6NxT4/I&#x2B;q0NzKDEqkpXsqjCCgoKMKybw8M/c8cOM0ZCgNHS8grt7/h5oFxX1Eh5O3rm5rn&#x2B;W&#x2B;7gHTfKIHruy2dAD1bE&#x2B;67x8Hvj3MY&#x2B;X9vI/LUPWQFJ6I8pxj6PKZ9RFTQtTWlkX8iABCfAscpA&#x2B;irMyM3Nzf74cOH4d7e3vE///xzFDde16F9UvifNd1fHNmXpJZfUgGAdx1G&#x2B;hkYmADQKUQBBgaGTi4MND0b8GcDiMoEICAt995/fxmuX7&#x2B;JkJBgTJo0ERoa6lBSUsaCBe/SnvfklZmZgfj4eLoNbyeAJkFBmCcBi/4zdNrrUlYGmhb6bd6epOtnRsajLKMQyjwCQMj&#x2B;Gzjz3s&#x2B;ol6uDnacb5FUUUVVQhpgzD1BeVIiDnl8hOzkJClCCiasdhsydA&#x2B;shztDrat6inv55ICciGVoWLdt2kpKEOspJW8Nx6gDIyssh9V4Ede/P9I9FWlgUZCALAxtLuC31bF6XCAuO4wfi4eHzqCuvgryacqc9t4qKigqDg4PDr1y5Enn48OGEpKSkijYQemki/uIi/&#x2B;IM/Z4X6ZfEvE/Ue0HP3s/DwZ&#x2B;RfgaGTigAiCL2j6XcDwMDA0MLEi/Je14iTkz6yHRkZARSU5Pxzz/bafu9sWPHQlNTC3PnzkWPHj0QHR2D7OxsbN36Gw4c2Id1674VKDzwfy5xEmfEn4FBOBrq6pETlgTjnrYQZlGvZWmA0tp8FKXkQL97YySctPx7tPcaRv&#x2B;4CKVJ&#x2B;Xj4&#x2B;zkUJWXTiHl2VCIMrCxQW1&#x2B;D0V8uhP34vjSCrtJGc8G2oCv3maQMoMW8ie7w23YOdZU1VKxoQkVuMepq6qBppgfz/t1gN84N8ZcC4Pb2BDjNGASroT3o8RITwyZDP6thTujS07Uzkv/HhPSHh4fHXLp0KfzMmTNJoaGhJWhfx/72NPKTxslf0Hqipl8X0t&#x2B;m53ZG&#x2B;hkYOo4AIC2Rl2TAYWBg6ExPf3yEWpCjvyjS3TSfEP39&#x2B;/fB1tYWVlbWOH/&#x2B;AgwNjWBkZAgzs8Ye5KSN37p1X&#x2B;P&#x2B;fV8sX/4&#x2B;HBwcsHLlKsycObNV9F9YzT8DA4NwlKTl4ei0jXg/7C8oCCGzuvZmUIUGEq4HcOS4T/N2tRzBVlHXQJ1ONa59sxf1dTXQ4q7h/qumov&#x2B;KKdTFn7xeBtQMtHHv51OYcfTpPMPu1pBXVEBeTDqMe9o0z88MioeqvhYVAMg4QgSC7rMGY/KOVXR57CV/eL29GQu9N0OvqymdR1r6Td6&#x2B;stOcJ6WlpSWPHj0Kv3//fvyvv/4alpaWVgnJI/PtEfFvT9IvbJ4kAsCz1PiLm8dIPwMDEwBeSUGg1brczZINFgwMnQiCCL4kEXb&#x2B;dWpra3HlyhXars/CwoK&#x2B;6JNWQwPtMtA0PXCgBxYsWAgjIyNoaGg0zxf2nCKuDSEDQ2dG1BlfFCVmwt7TnSOzZoi/GoS8pDSUZhW26gzQUFuPioJSmq5vaGmN2PP&#x2B;MB/gjCiv&#x2B;8gKjKOmevE&#x2B;gVCAMtwWj4fjGx4w7&#x2B;/QokzgZeD0ss2IOepHr//rX&#x2B;ylRoR50emYffy/0HEwRklKbgsBoL6mHqGHb9GsANK&#x2B;MPLcPUzcuoJHOLDCkK/mQs1As8XnmPbt2qHPFW4crgoMDAyNjo5O37hx48O4uLhyPJtjf3tH/KVp3weIT/UXNc1IPwMDEwBeW3Iv0477YmBg6MQgzwyyfI7dwsi3ILGALN&#x2B;&#x2B;fQctAyDmfoK2V1VVhafnhGbSLyjqL&#x2B;zZhd&#x2B;LgIGBAfD7/SySboXAaeYQ&#x2B;l5JXYW68Zem57cSAK79dw9S70Xi3dv/g1EPG8RdDMCxeRtRU10JLQNDTD/4KdL8olCakofhG&#x2B;ZTM7wXjYbaOtpCsAlJNx8h71Eq1Aw16KPKje/2oxIl8Jg3gy43sLeEgZNFi31YDuqOw1PXw/&#x2B;vCygvL4THihlwXzGpeTkpgei3cnKnOD9qa2trojgEBwcnbt&#x2B;&#x2B;PeTu3bsFePZoviin/vaM8DPSz4g/AwMTAKQg8cIGImEpT83rsgwABobOLQKIS/kXBiIekBeJ9oty7a&#x2B;rqxMoJIgSF8SJAwwMnRU93xpO0/c1zPToe/MB3VCLGkSc9IbVEOcW62pZ6OPevQik3o&#x2B;kGQMZQTGwHe6KHvOG0Zp&#x2B;HRtjbnoobYsH2RcntJHafkL6a0orcXHFn/D8awWUNFQav7OVISb&#x2B;toKm/wcfvgb7YW5wnjMEvd8ZTZe7zBkBHduWQgfJcBix4W0qHpDfY9Da2Z3qnKisrCzPyMjI8vb2fnTmzJmY06dPZ0L6aH5bnPrbEuGXpJZfklZ9khB9adz8GelnYGACwCtH9GUkEAKkMQdkAwgDA0Mrcz9e4s3vxt9kyMe7Ponqi9o3/z4FLeftLNCW0gQGhs4Ewx7WqCkqR2ZAHEz62FFnfKOuNsh4GNtq3X4fTkFuRArKMvPR571xsBvfh5L&#x2B;VteqnOwLfZLx/fUM9OxMYT3MBfHXQ&#x2B;D32xn0XDAKEce8Ef2vL7JDk1CWXwDHiQMw8&#x2B;gXUFB9avhnMcBR4O4Hfz6bvjoLSKQ/jcODBw8it2/fHnTjxo08tJ9jfz3ap55fXFp/W137n9XNHxIIARAzn5F&#x2B;BgYmALxQwg8JBhdJ1UqWAcDA0InJv7CWf02lAfxCAP9fYYRewAOMQOFBWIs/RvwZGJ6C9LY35cg&#x2B;AYl&#x2B;19XXIfzYHSoAKGqowH50H8RdDGq1HYm0ZwTGw2FSf8gqyAkk/y8K97ecolkI&#x2B;t3MabcB35&#x2B;9MGX3KmiY6uLB1n/x4PezqKmqQm15VWPN/tdz0Gv&#x2B;qBbkv3Fw6NznQnx8fFxsbGzqzp07A06cOJGO9jftaw/yD0ie1t9epF/UMkCy6L8g0i9KCGCkn4GBCQAvVAh43EZR4LGYQY6BgaGTQBBZ550nSCAQRM4FkXhpjQZFCQsMDB0NsRce0nR9RXUVoesUJmZzhN0IOSGJODL1WywP&#x2B;YM68iuoKFKzu4hTPpBTUkDvRWNg0a87imKzm7cldfV5UWnw/uE44h8GYF6fdS/0&#x2B;C6t2oZxvy5pMS/hdjBiLj&#x2B;E55blUFBWQklePo69sQlVVeWwHuCM4rw8eG5aRo35iJeBvLIiO1EIG&#x2B;eQnp6elpSUlHbo0KHAffv2JVVWVtZBMkM&#x2B;aUz7ntXM7/FLJP3SvAfEt/IDxEf7GelnYGACwAsVBUQRe3FpS2Dkn4GBQRJhQJJnEd6MAf7yAEEEXxT5FyZKMDB0JFTml&#x2B;L4zO&#x2B;wMnZHKwGgIq8EqvqaqK&#x2B;pw54Rn2LO8S9RlluMmvIqhB2&#x2B;jfK8YqTcDUd5VhG3Ti3ObfidtstzfGMgLQ1oQm1lDW6uP4iIU3fQd54n1Ay1n8uxlGUV0u9KTPaaEHbkNnx/O41xvyyhIYzHDQ0ozy6GrpUp7mw9jLxRqSjMzIRVXxcqZNiNdUXfDyZCXlGee6/EThBQw9T6vLy8nKioqMS///77vpeXV8YT0v&#x2B;82vRJS/4B0fX&#x2B;4tL8H0soAADS1fE/b9Ivivgz0s/AwASAlyIISEL2W/1lJQAMDJ2P4Asz/yPv5eTkWqX&#x2B;SyIW8NbyS1siIIlQwMDQEZDiE87dgGVQnJwDDVO95vkl6XnYP&#x2B;5LzL&#x2B;0EepGOjBx7YILq/9Cz/mjoaCoiHMfboWymgbqqms40uwG53lDEHncB47TB9L98O5LSVMVk/5ZiX4rJsGY24&#x2B;MtAZ/3HVaWVgKRTUVyCkqCM1FvPrZTsSe98Pq&#x2B;L1I9Y2CaV97hB29AzkFBUR63UNZZgGSboUi/WEMilOyYdWzB2oqqjD620VwXTQOqnoaNIuBgY6lDYWFhQUxMTEJe/bsecAT6Zcmmt&#x2B;WNn3ilgOSmfyJM/CTNOrfHqQfEsxjpJ&#x2B;BgQkArw3Zl8YbQJL6KJYJwMDQySAq7Z&#x2B;/LaAowi5ter&#x2B;wEgFBGQQMDB0FtRXV1PFeTkGOvte1N4eKrjoK47NgzmNoJ88RbRLhv/n1QZi52UO2QRaJPiGI9wmGmoYWuk33gJW7M2xGuMC4dyOpd541hPsr2MCPZBJYD3eR&#x2B;HuWcmRdw0SXTteUV&#x2B;PQpG&#x2B;grKGGNy99K3SbwWvnwG5cX2SHJeHwpPUw7GmN7EeJtEzh/Pt/oCy3gLb&#x2B;1DY2RP810zBwzRu0jEGekf7mIbaYQ2RkZOz169fDv/zyyxC8/DZ9bWnfJ6mpn6hpScz7pCH9wkQARvoZGJgA8NoKAZIQd1EDZPNylgHAwMDAn/YvKDNAkDfAswgPrO6foTPg7NKtqCosRZfRrui9cAwMHM2hoqOO4vR8ury&#x2B;uo4j0IlIfxADPRtTBO65iAe7vOiyAUvegLqRNrqM7Q3LgU6tQgDCyH9bcHDC11gW&#x2B;HvjwxJH0En2QENdvchtNM31oM8dT86jJKgZaiE3NBl9l05A8N5rtK1g77dHo9e7Y2HQ3ZJG&#x2B;xmeiC2lpcUxMTHxBw4ceODl5ZWSlJRUAckj888a8W9v0i9sniQCwLPW&#x2B;L8o0t8m4s9IPwMDEwBepCggaiBk0X8GBkb2BZJ63mXiHP35o//8ooCg/QnbjySlAQwMLxOkpl6WI7Tx14I5Iu4IZY7AS4KqgjKEXb2N&#x2B;uw6xF7yR&#x2B;xFf8w&#x2B;&#x2B;QWNzKf6hCNknw4eHbyJDL8YFBXlQFFGCc4zh0PX1gg2I3rBdnTvF3J8hQlZyAiLQeq9SFhwx0c6BjjPHUafELJDEmHU06bVNpX5JShMzoGpqx0MXawx89jnODzlW4zZvJgaE2qa6dNMB7Drmg53HOkvycnJyd27d&#x2B;&#x2B;dc&#x2B;fOJQUFBZXg&#x2B;bTpa0/SL6x9HyA&#x2B;1V/UdFtJv7h5jPQzMDB0GAGgaWAT1xFA1ADIv07zQMwyABgYOqcIwEvS&#x2B;Wv5xRFyQcsFRfT5fQSECQeM/DO8yog86Y17P55EVUk5R&#x2B;C/hImOncD1SMRcVl6u&#x2B;X1&#x2B;XAZcPIehurAC8qpKKErOhv/fF2Dv2Re7xn2M0LO3oSyvBqMe1nAdOxY2w3rBbkyfF9/qjvs8FRUtxJz3owJAE07O/xFaFvotBIDHDY9RkpaH0owCFMZnUAGAoCy7iC4rSsqhdf2XPtmOnm8Nh&#x2B;3I3p32vKmoqCjL5XD8&#x2B;HGfffv2RYeGhpZCehf&#x2B;50n&#x2B;JXH0Z6SfEX8GBiYAvATyLyMB0Rc2UApzWm2exwQABobOKwLwknL&#x2B;mnxxpJ93PWH1/YzgM3QEGPe0hXGvLhi6/k1omesLXCdoz2UEbr&#x2B;MYeveQpcxrnRecUoOLAZ0R11VHcKP3EZ5ThG0bYxgPcwFxnZ2sJ/gBrvRfWA7qtcLN8PLjUiBgqoStK2NoKqnSZ38k24&#x2B;arGOgb0ZMh4loKG2nmYFEKR4h&#x2B;Hq2t0Y/f27uPfzaWhZGSHVJwLXvtkDwy6WSL4Thuuf7YKGhT5K01063blSV1dXm5aWluLj4xO&#x2B;adOmh&#x2B;Hh4aVoH8d&#x2B;Scz8pCX7ktTyS9KqTxKiL42xHyP9DAwMnVoAECUIQMyAK5ERIPcAzwYwBgYGoSKBsPT9JuM&#x2B;Qd0CJDUIZOIAw8sAcaePuxwIDRMdWA7pQU3rmlBfXduKjJMWe1P3rkFNWSV1sVfWUmuxPD8mHWcX/46a&#x2B;goYHrOGqZsd4i8HI&#x2B;KkN&#x2B;KvBKCqtIJjebUwcrSBWb9utMb&#x2B;/dA/X1qv&#x2B;8gTPvBa9DMMullhyq5VMHCyol4DxJiwMD4Txan5iL8agMzAOGia6kFW/qkgSASDGYfX0haGKYER2D/2v6ioKEWXAb0xeeeH0LE1haq&#x2B;Bhwm96cZAZ0BpG1fMofr168H//PPP4840l8iwMH/eUT825riLy7lXxrXfnHPneKM/SCBEAAx8xnpZ2Bg6DACgDjXf3F1/OLUWt6BmYGBoRORen5yLsiRnz&#x2B;6L6x7gKBthbUB5J1m5J/hZSE7NAle726mderv&#x2B;f0KBZVG9/ukG4&#x2B;Q7h8Nj09nCtyO1PCXZxfCfcXkFvNPzPkeM458hpLUXNz9/hhSfCKQGRVLTfr07S3RY&#x2B;hwmA9yhINnP6joNfoHvCzyX5qah7MrtsJt2QT0nD8SWpaGdL66oTbSH0Tj1DubkfMoESWleVCR1cSEbR&#x2B;0qONvWp9gwflNCN59FabuXdGP&#x2B;03knwgphPzT61y2417f9fX1dbm5uTk3btwI3L9/f6iPj09eaWlpbRsJfVsi/pL&#x2B;BYRnAwDSpfq3OdgkgsxLQ/qFCQeM9DMwMHQYAUCYGPBYSlFApAjAPbAzEYCBoRNBGFnnnyeoRICfyDfNF9Y9QND64uYzMDxvEFd6I2cb7kb4mLrXN&#x2B;HMki3QtTVD3w8mQVFNucU2FdlFuPTRNmps57bUk7b2qywsQ&#x2B;Spe8gNS0bEsTuUAJflFEJOWQ5u706E3ThX2Hu6Q0ld5aUcZxX3/ZLuhMJhojtk5BpT&#x2B;LMjkiEvLw/3DyajIq8Yvr&#x2B;dweP6BlgO7YGgw1eQ7BMGu5GuGDN7Mcz6doNxT2uh&#x2B;ydeBuTVWVDHgSP5RXfv3g3at29f8IULF7IqKytrIVlavjSO/c9C/kXV9r8I0s&#x2B;7L2HPpmI7VAkh7o8lIPaM9DMwMHQYAYBfCBA3mEqqyDLyz8DQSSGu1l9YhL6hoUFgij9/NgHv/hjhZ3iVoGmuj&#x2B;4zPRCw7TKqistpDTypcy8vK4FWtRF3krd89s8MjMepN3&#x2B;A8&#x2B;yhePjXWTzYehY15VVIuBpIo/36DhaI8LqHytpS2PXvg7evf0fr6182Dk3&#x2B;BvHeAZj6xxr0fX8iarnvXJ5dxL1KsHvwJ6jIL0FZeRF6ThuBGYfW0qcCQvjN&#x2B;ndj1&#x2B;vT8a6&#x2B;pKSk6OrVqw8uX74ce&#x2B;TIkdTy8vIm0t9Wx35h5L0t6f7As7fvk0QA4F&#x2B;/LW372pP0iyL&#x2B;jPQzMDC81gKAuDIASEjyZQXceJo8AJgIwMDQuR5oBab&#x2B;S9r6TxgxELQtb1YBv2DAwPAyod/dCiXpuTi/7HeYuNph0OezYO3ugtQHYShOyYWBk2XzukE7L6MyvwxFSZmQV1bCpY&#x2B;3oRrl0NExhusH4zDkk9nIj85A0p1HsBzg9EqQ//Bjd1GYmInZe7/A7Y1HoKiuirCjd5DhF436&#x2B;loUpefAcqAT7Me5ofvMwZBTVoDbsvHsxHgCjvQX379/P/Ds2bMRBw4cSCouLq6BdNF8aSL&#x2B;0pB/cRF&#x2B;SQz8JI36M9LPwMDABIAXRPghIemX1C1VmBBA/7IuAAwMnQu86f38pFwYURdnBijoPX8ZgaDPZWB4GYg86YNLq/&#x2B;BuqEOQk/cak6Pd5k7HIFnLyE7JLGFAFCckYuKwlKkeEfAcepAFKVkw24sR5ynD4ROFxO6DqmNtx3d66UeF&#x2B;kycPHDvzHhrw&#x2B;Q4R8HOTl5ZATGoSyzEEff2QAVRXUYutjA7YMJ6DKqN8z7d2vRtrCzo6ysrDQkJCRiz549Dzjyn0vM/CB9NF&#x2B;aiL8owQCQztn/MaQz9RM1LYl5n6j3op5ThRF3RvoZGBg6rQDAO6jJiBg4ZaQg/oLmNQsCLAOAgaFzQlS9viBBgHebpvmCOgHwiwgs&#x2B;s/wquHssq2oyCuB66Kx0LU3haWHI3IeJcFqmDO0VPSQERoPZwxtXr/v0gnov2IqNEx1oWllAEVV5Zd//dY30GMIO30HPWYMg6q&#x2B;JoqSshF9xpe69lsMdEJBSiZ8fj0BLWMDuM&#x2B;YhF5vj4T5gO6QV1ZgJ8ETVFRUlMdz2LZtm7evr2&#x2B;Ov79/Idrm2C9txL8ttf3StO/jJ/HiBABpavxfJulvE/FnpJ&#x2B;BgQkAr91zOgS3/gMkr/OX5Xvf/GIZAAwMnZP887r88xN0UibA7w8gqEyAN8LPvx/m9M/wKoKkxhfl5UBdRYuSZSUtVXj/cAzWY1ww58hXMO3XDQrqLQmy3Ti3V&#x2B;b7l6bnI3DnJcTdCERBYiaMe9mi37LGrgRm7g5469JG/Lv4F4zdvAQaJrrU7&#x2B;DCqj/gtsSTI//d2AnAobKysiIwMDDkzp07MUePHo0PCQkpQduj&#x2B;aJS99uT9Atr3wdInuoPCI/uS0v6xc1jpJ&#x2B;BgYEJAO0oBPD/FTWI894EZCCgDIB7yGcDJANDJ4eg9HxR5F2Sen9hggCv0MDA8LxAHO4TrgbBee6wFvNJff6kn1Yi7nIAEm&#x2B;G0BR4PSdzuC3wpMsdxvaD7aiXl8qfej8K1UWlsBzcA4rqLTMN0v2icXjaNzDsaQ3HiQNhNbQHzPp2bbGOYQ9r1NXU0ig/6UoQc&#x2B;4BCuOzGfnnhiSO9Ad7e3tH79u3LzIgIKAYkrvwS&#x2B;PU314R/mcl/aKmGelnYGBgAsArQuzbskySQVvQzaFJCGgIDQ3Nys/Pj9bT03NgpwgDQyd4Cn5C3nmj/E3GgLyp/U3z5Z7UR/NmAAjLDmjaj7BMAUb&#x2B;GaQ&#x2B;X7lzqiQtD6r6WiLN9eqrayGn9DRyX1VUjgur/kJOWDKGrpvH7SMfdZU1qK2o4kh2BHIjkqFppo93bnwHDRO95h72ru&#x2B;Nhaquxks51qKELByevA5KOqpwXzoZAz6e1mK5jKwM5p5eD1M3ezrNj/LcYhyetA7a1sYgl1xGQCzubzmFfqumdspzhzj4J3C4cOFCwPnz5&#x2B;Nv3ryZV1tbW49nq99vj4i/tI7&#x2B;kpr6SUr0pTH2e&#x2B;VJPyP&#x2B;DAwMoiDzKowPQh5&#x2B;ZfimZXjmyTwh67zz5Xjmy/LMkxXyV&#x2B;6JACLor4KxsbHKd999N2D48OEjzc3Ne8nLyyuz04WBoWOirKwM1dXVLer2m8Ym3nlNf/nJPu97so6w5bxiAX/JASsRYJAUx2d&#x2B;h8Q7Ieg&#x2B;xQMTt30ocB3S3s7r3S006j1lx2rIKsrTGvkzi7YgYO8luL3jiYQbwaivqkVhbhYUFZSh38UcE/9eSaPozwsVHCFX0lRtIUwIQ111LQ5O/ApdhvdG3xWTUFdVQ70GiDAhIycrXjxIycG&#x2B;UZ8jKzYBM7Z/BtfFY8nFhuK0PGp2KKck3ynOl/r6&#x2B;ro4DlevXg3hCH8yR/yzuPGuDu0TzZfEqV9Ssi8qwi8p8Zf0JUocEEbmhZF&#x2B;iJnPSD8Dw6tAel&#x2B;hZ6uXfal2lBIAQYOwDFqn&#x2B;wvLBuAvB2jIysqqWrhw4V1u2nft2rXd5s&#x2B;fP97Gxqa3qqqqDruEGBg6FnhT9AWRcP40fRLVFyQENK3DG/UXNNALKgkQ9fkMDM3nSF0Dd9N6jEH/mQXb0a7N80kv&#x2B;5R74TDr60Br3FO8w5EZEEcJ76PDt6DX1QwFsZkozSzibvwKeLj3PBSVlWFgZ4mu0/uhz7vjYNLH7rk74JO2ew5T&#x2B;kPLwqDVspB916BpagCbUT3p&#x2B;6qiMmQ8jKVmg5nB8Ui5G47K/FKM/fk9iT5L3UAbbovHo6G&#x2B;oZH8N16gAj&#x2B;7A5L&#x2B;&#x2B;qSkpMTbt2&#x2B;HcqQ/8dChQ6kk&#x2B;o/2c&#x2B;xvbzM/SUk/noH8Q4JlgGTRf0GkX5hwwEg/AwPDqyWGvEYZAE1/Bb1k0Tr6L8vzEpYBIIunUf&#x2B;mDAB5vunm96ampqoHDx6c3qdPnyEaGhoG7PRhYOgYKC0tRU1NTfN4xDsm8Uf3ebMB&#x2B;DMDeKP4ZDtR2QTCxj7efTEhgEEQGurqUZZVADkFBagZadN5SbceYf&#x2B;YL2HWrytmn/gSfn&#x2B;chbKmKqpKK5HiHYaasmqk&#x2B;IVyNz052I1yg71nX1gOdqKp8y/se9fW4e9&#x2B;H2LCL8thNaRllsG1z3fjyvc74TCgHxbd24zyvGKk3AnHhZV/oaakAvV1dSirKoDHilmYtHUlOwmEIC0tLeX&#x2B;/fthHOmP/&#x2B;uvvxLagdC3JeIv7i8gPCsAkK6&#x2B;/1lJPyB59F8U6YcI4s9IPwPDq0B6WQZAMzpi/ht/9B8QnAkgqCNAw5ObmwzPja/5fUZGRuXw4cOPWltbn1u2bJnT1KlThzk4OLixS4qBoQMMHEIc/fk9APi3EZYFwLtPYfNEvWfZAAzCkHovEocmrYOqgSbG/rgU3ab1h0kfe4zd/B7Of/gnkm6H0nT56z&#x2B;epGKBKbes66R&#x2B;0LMzgdtST5i6O7yUtncy3LWiZaaP/NiMFgJA2KFb/8/enYBXWd75//8mISwGBAXZFFREUBDZsSCKKGLdl6LV4k/t&#x2B;NNRB6yto7TWUefvtF5OZ/7T2opaW6xLO1YtoggiKCpSUCBgwpIFCFtYAiHshECW3zkp4To83M&#x2B;9PM9zsr5f15UrJycniwRO/Hye&#x2B;/7ekv3GXLn6qQdl2WufyPzn35Ocv82XouUbpOzQAWndtq2cedkA6fadPjLo/rH8BfAoLi7evmjRohUzZ87M&#x2B;etf/7oh9nZZyEDvF96DhH9d2I8y9Cc&#x2B;XiTYsX1Rhn5d8Cf0A6AAcAj13ifPFMOTtiT8IklR/HKpub8i4bY3/CfeX317/fr1B376059mPvPMM9n33ntvz/Hjx4&#x2B;88MILh2RkZJzMXymgYVKFbl0wT/wY1W3Vx6m&#x2B;jqoESPxYwGvL0tXSdWgvOWN4b5l&#x2B;/6&#x2B;l3dm/rN7zv&#x2B;3bAmmRcVL1MLx4wM798BvpfnEf2V9cIsMfuemECfrJtntdkRwpPSwdzj/jH/&#x2B;e0lKrv&#x2B;/49oRB9/5jSX7ZngPy9W8&#x2B;kNP6dI&#x2B;9dJPy/Yfk459Oltbt20n3kX1i/x0XSJ9xI&#x2B;W087vxg08Igjt27NiWlZWVN2PGjFXTp08vLCgoOCDJndhvG/510/t1S/6DLPUn9ANAIy4ATMWA7rV4nsxVqwBUswAqPAVB4jaEaocOHZIXX3wxP/ay9vLLL//48ccfHzVkyJDB7du37yz&#x2B;JxUAqH//Q&#x2B;27T98b6BNvJ54aoAr23qv/qlCvWhmgWgXg/Txoug7u2SOdhpwl51wxSLKmzK3&#x2B;jTXjJ5Nl06Ic6dT7LOl0wVly6rldq4&#x2B;5K161Sf7&#x2B;33&#x2B;zGroXtSW/n1FdQvzf&#x2B;f8lxTmFcsaI86V9z9NlxVufy7ZlBZL958&#x2B;lOHdT9WT&#x2B;&#x2B;G/g1Z8ukZYZJ8kVT94jg&#x2B;&#x2B;7Wtp2Z6ddopKSkp2ZmZkrvvzyy9WvvPJK/tEr/VFM7Le5kl/pEPajCP262zbD&#x2B;3RvqwJ&#x2B;Mib4E/oB1EsNZQZAzdvekwBM8wC8pwPU7PtPnA1gevGeEOC9fcLLlClTRl111VUXd&#x2B;nS5czYf1sqf82A&#x2B;m3v3r3VpwDUPB/VTPJPDOWJQV&#x2B;119&#x2B;7MsBmz7/f&#x2B;3S3KQPw5S/&#x2B;Il8&#x2B;&#x2B;5fYL7HU6qPtHt/xtnzx7J/l7FEXSreRfaRVuzZSkr9ZZk58WXJnL5QbJz8iQx&#x2B;8Tvs5KysqJDUt2gGA&#x2B;zbvlD2btkv787rJb3veK7e89bi0OrW1vDnmidhvyjTZv7tEmrduJdf&#x2B;10PVgw3XzFgiaSely61v/4wfck3Zc/Dg/oULFy5buXLl5meffXapIvQn64p/kEF&#x2B;pmX9TSH0Bwr&#x2B;hH6gzvJmnajrf/INrQAQUR8HKHL8sYCpoh4OmKooAtI0ZYAp9PsVAamtW7dufsMNN5zxwAMPjBwRk5aW1ox/ekD9LwASg37N2969/t7QrxoGmFggRFUCMBugaTu8v1SWvDRT2vc&#x2B;Q2Y98oqcel5XGfbP11VP1a&#x2B;qrKpe&#x2B;l/jyMEyWTs7UzbMWymjnvqBtGyXof6fkIpKmfWvv5dhD15ffVKA6v1//6&#x2B;/yUUTb5D0k1qYA&#x2B;vOfXJS&#x2B;zbVtysOHZa0ls2rv5c3YqE/Psxv/Mf/n/xxxL9Kq05tpNt3&#x2B;srAe66QrkN6HSshpKKq&#x2B;sjCpmzXrl0716xZsy4zM7Ng8uTJy2P2SfCr&#x2B;bql&#x2B;7UR&#x2B;v3usykAbAf7qd423UfoBygAKAAaQAGQGP79VgF4ywC/AsB0OoBpNYDuxft5Uq&#x2B;55pou995776BLL710aIcOHTrzTxConwWA31R/v/v9bqsKA10BoBoWaHpffftlhuQr/DpXPvnxq3Lvwv&#x2B;Wgzv2yEmntQ39Ob/90xzZll0g/X9wuXQ5eiJA/vRv5GDJPjnnykGy4p15Mvep1&#x2B;SBRS9K&#x2B;/POUBYExbmFkjNjgeS&#x2B;v1D63HyJjHx8XPX7Ni/Kk9OH9a6&#x2B;vWZWprx3x/PyyLrXpLRkr7Tp2l6atWzOD/Wo/fv37924cWPhnDlzsl566aWVeXl5&#x2B;8X&#x2B;an5tXPF3Ob5PxLzUX3eb0A&#x2B;AAiCJGlPNXvME7zcLQDUDoNJTJFQqSga/r&#x2B;P3iy3Nc1/azJkzt8Reirp16/blU089NXTMmDFDYrfPZFUAUI&#x2B;eQBRX1Gvuq9nr7/eYxF8sqj3&#x2B;8Y9PLAdsfimYhgT6zRJA4xWf5v9PC/6r&#x2B;nYU4f8ff3FSY8H9a&#x2B;l4/lnVBUB8JUHutIWy7LU50u&#x2B;e0bIrd6tUpaXK4QNlx31YZXmlLHr1Q8mftki2r9oo7c/rKr2uHSb977z82GMKPvv2WAFQnFdYXRakNU&#x2B;TU3p04YcZU1paenB9zPz581e98soryzMzM/dI&#x2B;P37UV7xD3N8H6Gf4A&#x2B;gnqrPAbTKEMK9Q/5Ugd/7JF8T0L0nA3hPBRDN27oiIE3xvmNfc9OmTfvvu&#x2B;&#x2B;&#x2B;ebHb8ydNmtTnrrvuuqRnz57nNm/evAV/FYG6Df/xl8SgnxjCVUvuEx&#x2B;j2pvvd6ygLqibHuv9mqYCA41Lanpa5J/z7CsulPY9H5NPf/6abFmSL5c&#x2B;9QNpc3r72N&#x2B;nSrnw&#x2B;6OlJHer5D2ySHatL5Iug8859nFF2eskd8bXcvaIC&#x2B;XGP/xY2nY7cWBf7tQF0rl/DylZu1Vm//RVOWtEP0k/qWWT/hnGnmMqc3Nzc2I2TJ48eencuXOLxf1qvssVf1MJ4HKMn8tQP78CIIpp/oR&#x2B;AAihPm8B0IVxv20A1f&#x2B;PJP5bAhIHAibe5zcYULU9wG&#x2B;rgGlLwQmzB9LT05v17t27Tex/Aq4eMmTIwFatWp3EX0mg9u3Zs&#x2B;e4IYCJIdu7fF&#x2B;19F&#x2B;1399vD7/quU&#x2B;1x1/1NXXPnYR/BAqk5RWS2ixNftXlB7J721Y5ve95Ev&#x2B;rdOZlF8o1v31Q9m7cIc&#x2B;deatc/OA4uW7yhGMfV3G4vPrjEucOeL086F9k87J8KU8pl37XjpLv/eVxadGm6f2aOxyzcePG9Xl5eZvefPPNb999993CysrKKCf2Rz3MzzTJ3&#x2B;WoPtPVfdNgP7EoAkT8j&#x2B;0j9AOod/&#x2B;fxAwAtwJAFfi995lOBbAZDJgaMNinWX7scV8vplm/fv1Ovuuuu8676aabvtOjR49z&#x2B;GcK1G0BkBi&#x2B;TdP9vYMDvR/j3cev2tdv2t9vCvuJJQSrAeAqZ&#x2B;rfZd&#x2B;2Esmb9o2smjNP7pvzG&#x2B;kxZmD1sv0/XvaYHCzeIw/n/MHpc25amCPZb86V1l1OkYsm3ug7iLAxKi8vP7Jt27atK1asWPvb3/72m1mzZm2Phf7ygIHeL6xXRBD6ReyX9UcV&#x2B;nXvE8siwCb0m4I9oR&#x2B;gAKAAaEAFgIjdKgBRBH/VCgDTMYGuxUCq4X7f&#x2B;zIyMtIfeeSR3rfccsvQPn36nNeyZctW/JMF6rYA8IZ8m/DvOsBPNwTQb/6A3&#x2B;oAwj&#x2B;CWjZljix99WMpWb9Nxj5/r/S/6wr5/Kk3JWfqAnloxUv8AWnEr&#x2B;rv2LGjKB76//jHPy6aOnXqltjzSrnYD&#x2B;SrjSv&#x2B;uoF&#x2B;tRH6Xd52Cf2q10FKAEI/QAFAAdBACgBvCeByOoBNCeBSCmiv9hvuO&#x2B;7lxhtv7Proo49eMmDAgL5t2rRpyz9dIDl2797tewpAzWtvAZC45N/2yr/qOc/18X5lgc3baNoqyo5IwaffStch50pGp3bV921fsUFO7dmleiJ/yeot8vuhP5Le139Hcj9cKOd/f7jc9PtHJWfaQtm/ZacMfeg6/hAVoX9nzMqVK/Nnzpy58le/&#x2B;lVuBIHetIc/qrBvs5fftgBIfEx9CP26oE/oBygAKAAaWAHgDf9&#x2B;qwD8tgKotgYkvvjNBUhxCPBpAYsE1eNTYuG/&#x2B;WuvvXb5ZZddNrR9&#x2B;/an8U8YSE4BkPicZAr33sepwrm3KPDOCTCFdtPjTLMBKACQaM&#x2B;G7fLqsEekbY9OcuMrP5IO53eT59p9Ty752e1y6ZO3y1&#x2B;ue1ryP14sFZXlclJGG7nu1Yel3x2jpGzvAUlJS5PmGS35QzyqpKSkOB76p0yZsuijjz7aUlxcXCbuR/DZFgQ2y/5NA/3ChH6/AkDEbh&#x2B;/7m1VwE/GMD9CP0ABQAHQQAoAvxLAZhWAiHorgOtwwBTLoJ6st4&#x2B;9dO7cueVtt9121t133z18wIABF6ampqbxzxmIpgA4dOjQP54Uji63r7niH3/tfY7y3qcrCWyCfZASQLcqwHsiQX385YfkmnbPf8vg&#x2B;6&#x2B;RbiPOl/LSw9KsVXM5vL9UVrw9Tz7511dl&#x2B;E9ulkt/foe8/39&#x2B;JXnTv5En9k2VTx75vWxYvEoG3/NdOWfMQGl3Vif/Gr7pqdq1a1fJ5s2bt/7hD3/4avr06ZsKCgoOSLRL&#x2B;KMc5Ocyyd8U&#x2B;r23Cf0AKAAacAHQGM6h9x4XWJVQBiTerkwI/jW3a95fISceD1jzuVIVv8RUy95qwnuVJ8zr3k71fKz37cRVBynbtm2reOGFF3J/97vf5d95553dYy&#x2B;Dhg0bNqBt27bt&#x2B;GcNhH8yVi3HT3ySTgzr8SMD/Y7jS3y86mg/731&#x2B;X9P79RPvs/l&#x2B;Tf&#x2B;daLyandRCWrQ9SXavK5LMP8ySK35xtxzcsaf6an7LNhlScfiIpKalyvWvPCw5U2&#x2B;X8kNHZNQz46uv8ifjuMGGau/evbtjv3uL3nzzzflvvfXWmvXr1x8MEeiDXPGPMvT73WdTAITd419boT9Q8Cf0A2hS/4/QwEO/Kvyn&#x2B;PwSSPG8nVgI1JQAiSsDKn1&#x2B;GaleUj23E8N&#x2B;ik&#x2B;4TzUUARWKj0v9R&#x2B;6oTH3jjTfWxV429OvX77Onn356xMiRIwd07Nixcwr/Zw&#x2B;ELgK84TtxRYDf1XW/&#x2B;4OEfN3nTHysqkhIfLxfGUEJ0Phd&#x2B;9uHJCUW8Ff875ey9E&#x2B;zZORj42TB/z9V5v3ubTkp42Tp2r9n9ePie/2rKqskrUUzadYynT&#x2B;42D&#x2B;bQzH5&#x2B;fmrp02blvn666&#x2B;vLigoOCjJGdoXVdjXHd8nYl7qr7sdNPSb7iP0A0AdaahbABLvT1E8zjQPwHZAYKribdWWAdMMAd32gRQxLP23ffnVr341eNy4cSO7d&#x2B;9&#x2B;Zmri4eUAtOJbAEpLS497PlJN/Ve9L/ExiUWBN3SbBv&#x2B;ppv&#x2B;bthN4iwSXowMpABqvXeu2ScZpbaV561bVx/i9OvzHcvVvHpQN87Kl4nCF9LxmsLQ74zTJn7FEPnzwN3LmiL5yz&#x2B;fPN&#x2B;k/syNHjhyOBf21M2bMWPrSSy&#x2B;tiof&#x2B;&#x2B;IA/n7Ae5op/0PAf5vg&#x2B;Qj/BHyD0sgWgQRUAdV0C&#x2B;J0W4FIKuLycsPRfUxacMKsgfozgyJEj2z///PPX9o1pFsM/eUCvpKTkuGMAE4N&#x2B;4jF8iXMBVGFc9dovfPuFf&#x2B;9j/IK/3/Oo6euqhhKi8aiMBf5lU2ZL31svkZbtMqrve/&#x2B;u/5bzbxkuvW8YLimp//h5b81cI29/7z&#x2B;kbM8BuWv2L6Xr0HObYug/snXr1i2zZs1a9Prrr69avHjx7thdFZL8Y/qCXOG32ctvc1SfTdB3meZP6AdAAUABUKsFgIh&#x2B;IKA4lACq0wJ0hYCuHIi6FHB&#x2B;SU9PTxs9evRpP/jBD/qMHTt2WJcuXU7nnz7gXwAkDgH0BurEYwC94dwvcKsW4Xiv3CduK/D7fLpAbxv8VV&#x2B;bkwIan48e&#x2B;p106nOmbF&#x2B;5QfrdebmccVFvWf9Ftvz56qfk9mn/JudeO&#x2B;y4x&#x2B;/ZuEMqyivk1B6dm8yf0eHDh8t2795dMnv27CWx0J/91Vdf7SwrKys3hPQorvgHXepvmuTvclSf6eq&#x2B;abCfWBQBYrif0A&#x2B;AAoAhgNH&#x2B;ecrxA/y8gwBt/rQrE0J7zd77mvkA3v3&#x2B;KXL8oMCUhF&#x2B;iqXL8DIBK0W8ZMF31d1o9cOTIkcrY/&#x2B;Bsjb0UdejQYeHTTz89cOzYsYN6xDRr1oyNnoDiydhvn3/N0L3EXyLxIYA1KwNUwdpveJ9pYJ/uc6h&#x2B;kelmCqiu8qtmCOjmF6DhaN&#x2B;za3XIr4z9OP/6vWelQ69usunrHDln7EDpPrLvCY9v271pnCpbXl5&#x2B;JH5s30cfffT1xx9/vHbq1KmbPcv7k33F3/a1iP2y/qhCv&#x2B;59InZX/1WhX1cEEPoBoC7LkAayAkDEfhWA97GmlQAi/scFuq4KSOYqAb&#x2B;jCZ1u33///T0eeuihUeeff/55zZs3b8E/AeAfKwDiMwBUV/lVV/Vrgr9qBoDuqn3Y4/9s9/TrZgd4CwFmAzQ&#x2B;h/aWyltX/Vy2Z6&#x2B;TM0b2ke&#x2B;9/phkdG56h8UUFxfv&#x2B;OKLL5bEAv&#x2B;q9957b/PR5f02V/NdhvaFHeZXVYeh3&#x2B;VtEfNUfxHz1X5CP4D6nDdrBVsAoikAoigBEmcBqOYC6O6LoggwrQyIdHvA2WefnfHiiy&#x2B;OHT58&#x2B;KCMjIw2PC2AAqD0hECvKgJUAd82fOuW39uEfG/xoPscpmX&#x2B;NiUFGnAJULJPDhbvlVN6dj22778JqNq9e/euJUuWLH/llVcWL126tKSgoOCA2F/Ndz2mzzX8i&#x2B;j3&#x2B;5uW&#x2B;VdZFgAibvv4kx36dcGf0A&#x2B;AAoACIHABEFUJ4DonIMgKgSArA1RX9G2GBWpv9&#x2B;vXr&#x2B;24ceN63H777SN69ux5LqcHoCnauXPnsRkAquCvCvw2gd5lVYDr/v6gKwBqfvG4DhkE6quSkpKd8&#x2B;fPX/r&#x2B;&#x2B;&#x2B;&#x2B;vXLBgwY78/Pz94nY1P8gxfab3i9gN&#x2B;TMN8LO96h9F6BeL&#x2B;wj9ACgAKABq9QeS4vD&#x2B;FJ&#x2B;P8YZ&#x2B;1X2pUjsrA3SrAIIePWhz&#x2B;4SXFi1aNHv44Yd733zzzQMHDBjQt1WrVhk8VaAJBYgTjgG0OQ4w7PJ&#x2B;3eezeb/Nx9TcNoV&#x2B;288P1If/d9q3b9/er7/&#x2B;etncuXPz33vvvQ1r1qzZL&#x2B;5X812v&#x2B;Icd6GczyV/1ON1tm&#x2B;F9LqHfrwQg9AOgAKAAqLMfSJQlgPcxrnMCoi4Cgq4QiHSrwGWXXXba008/fdnAgQMvaNu2bTueMtDYxVcA1BQAqlMAdPfbhHXd0vworugHLQxcZwsAdamioqI8FvoXf/HFF/l/&#x2B;tOf8hWhP5lX/IOEfZe9/JWKQK8L/WH2&#x2B;NdW6A8U/An9ACgAKABcCwBd&#x2B;DdtCTAVAX6lgGqLgK4IEIsCQFcM2KwGcN0ScMKKgVj4b/E///M/w6&#x2B;77roRHTp06JRCEkAjFV8BcODAAd8jABMLAL&#x2B;QbNrz77paQPd40xwBU&#x2B;ngtxrAtngAakt8gn9OTk7utGnTMj/66KP1ixYt2i3Br&#x2B;brjumLMvT7Hd8nYr/UX8T/6r5r6DfdR&#x2B;gHQAFAAVDvfyApAR4XZjVAYmDXlQI2MwNsCgDV67SAhUDol44dO7a8&#x2B;uqruz755JPXxo8RjAWhNJ5G0JjUrABIDMa6IYCmsBxkmn&#x2B;QUwR0hYRNQeFSKNTHX6BonA4fPlwWD/0ff/xx9meffbbx008/3SHuU/hd9uuHvcIfNvTrbjfa0E/wB0ABQAFQ1yWAiNtqANXbpuMEox4gqDtFIIpy4LhVAq1atUq79dZbu91yyy19R40aNaRdu3bteTpBYykA4isAVMG/ZvK&#x2B;dz6mbfjXhXpdEZA48d92ur9LiPd&#x2B;b6rTBVRfS/VYIKwjR44czs/PXx0L&#x2B;1nx0D99&#x2B;vRtEs3&#x2B;/bDh33Wiv2mon18BEMVgP0I/AFAANOoCwKUEqA9FgEjy5wXYFgKhb/fo0aP1c889d3FMv65du54R&#x2B;xlyegAafAEQl5aWduyJuaYA8Av6pqX0iY9THeHnVyrY7O1XLev326agC/u2RwayGgDJsHbt2tXz5s1bMXv27LVvv/12YYhA77LcP&#x2B;gSf9OSf9vgb5rmbzPYTyyKADHcT&#x2B;gHQAFAAdAgfyBhS4BkFgF&#x2B;JwioVgK4zgkwDQmMejWA8iW&#x2B;HeBnP/tZ33/6p38afWZMLDw14ykGDbkA8IZob5BXBWLdMYB&#x2B;gTxICRDkqEDVlX2/517dagDdxwC2KmJWxyxfvrzg/fffz5k2bdrm0tLScoluYn9Uw/xE7Pb5uxzVZ7uk3/aIPtvQ71ccEPoBUABQADToH0iyigC/YYI25UCq4n22AwNVBYDtqQFBtgeEuh3fHjBs2LBT//M///O7AwcOvDA9Pb0FTzVoKIqLi48NAawJv6ql/6awnUgV7F2m7rucAuAyCDBowNdtD6AMgOF/dCo3b95cuGTJktx33nln&#x2B;dSpU7eUlZUdEbtl&#x2B;S4T&#x2B;8OEf93efttJ/mFCf&#x2B;LnEp/3&#x2B;5UCutAvmuBP6AdAAUAB0OB/ICkhHh9mRYDqMUEHBiZ7e4CuFHDZKuC7ImDMmDGn3XjjjefGXr7TtWvXbpwegPpux44dcvDgweOCuir46pbYuwT4oEf/mbYeqEoIm5kBtkHfdgUCEFdUVLTl66&#x2B;/XvHZZ5&#x2B;tnjJlyroDBw7UhP6gE/v9wnuQ5f4i0RzfZxP0XfbxJzv064I/oR8ABQAFQIP9gdRFESASfE6AX&#x2B;gPe4pAqkMhEPn2gDZt2qQ/88wzA8eOHTugd0x6DE8/qK8FgN8xgKrwnfi4KI75cy0OvPeFPRbQ5vuwOTqQEgC7d&#x2B;/eNX/&#x2B;/MysrKzC5557bkVC6A87sT9s&#x2B;Ddd4bfZx29bABD6AYACgAKgjn4gtVEEqB7rOicgiu0B3sdEMS/AdauA74qB22&#x2B;//YzHH398zPnnn9&#x2B;7ZcuWrXgaQn0rAPbv318d7F2O8TO9L8wqAdPXi7IQ0D0f&#x2B;5Uguq9JGdC0bN&#x2B;&#x2B;fVtubu7ab775Zu0LL7ywqrCwsFTcr&#x2B;a7XPHXFQYibpP9XUO/7rbN8D7d26qAn4wJ/oR&#x2B;ABQAFACN/geSEvLxKZrPE3ZOQNjtAUG3CegKgchXA8jR7QHnnntu/PSAkVdcccXwk2MC/GyApBUAqqX/pi0ApsF/fisEwpYDpnBvuipvs4XApkTw/veZtgygcdi1a1dJQUHB&#x2B;lmzZmVPnjw5d8uWLaUW4TzMVP8we/tNy/qbQugPFPwJ/QAoACgAGsMPpL7PCUgM9363ddsDUiwKgbQQhYBrOaD82J49e7a59dZbz7rjjjsu6hsTLwd4akJd2b59e/UMAG949Qvhur32NlftXa/c604KUH1dmxkBrnv&#x2B;ba7u25QKaLj27du3d82aNQVz585d&#x2B;eqrr&#x2B;bk5eXtl&#x2B;BX83VL96MM/X7H94m4XfX3C/quod90H6EfACgAKAAacBEgmvBvUwToThIIsj0gyHGCusBvMyxQezs9PT3twQcf7HnzzTcPGDJkSP/WMTxFoS4KgPgMAO/&#x2B;flNottkCoArUQT&#x2B;n3&#x2B;OjmAFgsxrAVALYfi40HAcPHjyQk5OTl52dvf7FF1/MyszM3CP2V/Nr44q/zX5/l9Cvu03oBwAKAAqARvADqc/bA2yOEfRbDRBke0DYQiDUy5AhQ0557rnnRg8cOLBP&#x2B;/btOwjbA1CLBUB8C4A36NoMvbNdem86CcA7YNB7n251gk1xYFMouKwc8Huf7XGDqL/KyspK8/Pz1yxdunTNL3/5yyWx2wck/P79KK74u070t93fbxP6E79Gowj9BH8AFAAUAE39B5IS8mNq&#x2B;xhBkWDbA3SrBFIl2LwA12GB2tsdO3Zs9cQTT/S//fbbR5922mmdUr3rn4GIFRUVHVsBoDsGMOgRf2FXBehCv&#x2B;2VeJu5A37Px64fZ1sYoF6F/kOFhYWbv/3227zf/OY3S7766qsScb&#x2B;a73LF31QCuEz0dw3&#x2B;Lkf42ezxF4siQAz3E/oBgAKAAqCufhgBzq2vD9sDVLeDzAdwOU4wyu0BymMEr7/&#x2B;&#x2B;i5PPPHE1efFpMXw9IVkFQCJKwBsg7zu/aqr&#x2B;TW8V/RV99kWCKr7dd&#x2B;HriSwCfIuqwNsPwfqRmlp6YGdO3cWL1u2LH/y5MlLZs&#x2B;evb2ysjLKif1RD/OzDf0SIvyL5fuChn6/z0HoBwAKAAqAuv5hhCwCVAHfVASogr5N&#x2B;G/U2wPicwK&#x2B;//3vd7/&#x2B;&#x2B;ut7jx49euhpp53WkacxRF0A7Nu3TxlYXY/1cz1&#x2B;z2ZPv02IrikQ/L4f7&#x2B;f2bi/QfQ81BYL3&#x2B;/LbnqDbBmBTGiB5jsRs3769aOHChSteffXVZfHQHyLQ&#x2B;4X1ighCv4j/qgARt/39YUO/OBQButAvmuBP6AcACgAKgPryw0gJ9g3Wl&#x2B;0BtsMDdSVBmrgfJ5gqdicJ6G6fsGKgc&#x2B;fOrZ5//vnvXHrppf27d&#x2B;9&#x2B;FtsDEIVt27YdtwLAb4m&#x2B;6xYA3TGAute2X8PmPptVBaZg7jIDwOZxuiIDSfndVhX7O74lOzs7/6WXXlo0a9as7WVlZeViP5DPtiAIE/51V/ijCv2JjxcJdmxflKFfF/wJ/QBAAUABUB9&#x2B;GLW0PSDFcH/Q7QG6UiDI9gCX4wQjXxXwwAMP9PzRj340tlu3bmc2j&#x2B;GpDWEKAO8KANfXrqHfr1zw&#x2B;5ym0O0a7oN&#x2B;TtcSQDcI0K&#x2B;oQCS/zyp37NhRtGHDhs2TJ0&#x2B;eP3PmzK3bt28/JNEs4Q&#x2B;73F83vV9XCARZ6k/oBwBQAFAAhP9h1JPtAapyIFXMKwRMpYBqRYDt9gC/t6MqB45bJZCenp56ySWXdHjiiScuHTly5NAWLVq04ikOrrZu3VpdAOjCuW5KfuIy&#x2B;KBD/VyKBd37/eYOBD3uz6YQcC0WEkO/38chWBAsKSkp3rJly9Y//vGP8//85z&#x2B;vLy4uLgsQ6F2u&#x2B;Juu/NsM9Asa&#x2B;nW3bYb36d5WBfxkTPAn9AMABQAFQEP6YUS4PSDIMYIitb89wHVegG0hEPr2iBEj2t92223nXnfddcN69OhxTgqJAo4FgGpPu3eXie3Rf0Gu&#x2B;Ac9CcD0sa7H/nk/xnaIYNABgZwUEFxlzMGDB/evWrUq7&#x2B;23386Mhf51CVf6oxraF&#x2B;UgP9OyfkI/oR8AKAAoABrGD6OBbA/wrhCw3R6gOz7QZXuAqRAI/dKqVatmTz755IXXXHPNgD4xbA&#x2B;ATQGwd&#x2B;9ebXiO6nSAqN6X&#x2B;PW8xxf6DeFzvUJvKj50pUKQUoDhgPYOHTp0MDc3N/&#x2B;DDz5Y9rvf/S7Hc6W/Nq74Rxn6/e6zKQBsB/up3jbdF2XoDxT8Cf0AQAFAAdAAfhh1cIygLviLqFcBuG4P8CsAbE8NCLI9INTt&#x2B;IDAa665ptPTTz899rzzzuvVunXrNjz9QWXLli1WBYDrNH9dsHfdn2&#x2B;68h9maKBLyLf9nvxOBjAVGn4nE6A69JcWFhZuev/99xe9/vrreStXrtwnyTmmL6qwrxvuJ2Je6q&#x2B;7TegHAFAAUADUrx9GHW8PsCkHXF6SuT3AZkWA65aA41769u178mOPPTbopptuGn3yySe3ZXsAEm3evNm3APDuqdcFYdup/okBV7Vn32&#x2B;Zvu0pAX5hXjec0PtxifMEdOFdt5ffdiAgKwH8lZaWHti0aVNhLPB/9eWXX25ZtGjRriNHjlT4hPUwV/yDhv8wx/cR&#x2B;gn&#x2B;AEABQAHQOH8YjXB7gM3qANtVACkS/bBA5Uvnzp1bjh8/vsdDDz105dlnn92DIgA1BcCePXu0YT4x4JquaNtcxY/imECXEwd0BYHLcYG6x&#x2B;rKC1PA99u64LedoTErKys7VFRUtO39999f8OGHHxbMnTu3WKJZwm8K&#x2B;EGu8Nvs5bc5qs8m6LtM8yf0AwAoACgA6v6HUc&#x2B;2B7gOEHTdHuC3WkA3L8BUCITZKnDsY1u0aNHs4Ycf7nXllVeef9FFFw2IrwrgqZECwC&#x2B;oqwJzIt1V/MTb3mF63qXuUR0paBPEbYO6d1m&#x2B;y3GBqv8OXQng9/ugiQwJrIr9Pdw8e/bsxe&#x2B;&#x2B;&#x2B;27Oxx9/vN0ipEdxxT/oUn/TJH&#x2B;Xo/pMV/dNg/3EoggQw/2EfgCgAKAAoACot0WAX9D3Bn5TEeAa/m1LgaDbBGp1NUDNS79&#x2B;/U5&#x2B;7rnnLhs6dGifjh07duEpsukpLCxUrgBQHatnu/ReFaxdrrCbtgbYhmjVNP/Ez&#x2B;9yRd&#x2B;vOHAJ9EEeZ1MSNMjEX1VVuSNmwYIFWS&#x2B;99FLm0qVLdxUXFx&#x2B;SaIf2RRH&#x2B;ReyX9UcV&#x2B;nXvE8siQBX6dUUAoR8AKAAoACgA6n0ZEHR7gMsxgonh3u&#x2B;2bntAikUhkFaLhYBylUCHDh1aTpw48fz77rtvbMeOHTulpaU14&#x2B;myadi0adMJBYA37NoM7vMGa1OIdg33LlsC/AoLm1JCF7pdjyJ02QZgU0A0hi0BRUVFWz/77LPM9957L2fhwoXF27ZtOyR2V/NdhvaFHeZXVYeh3&#x2B;Vtl9Cvek3oBwAKAAoACoA6&#x2B;3Oo7e0BQeYEJF7xj2J7gMtxgjbh33VY4Am349sDxo0bd/rDDz88avDgwQMoAppOAWAbxL3L4YMO8vN&#x2B;rC5g2xYCNnvvXZbum8oA10DvV1a4fF/1&#x2B;Ze6SmVM7O/Xrs8//3xJLPivnjp16qajod/2ar7rMX2u4V9Ev9/ftMy/yrIAEHHbx5/s0K8L/oR&#x2B;AKAAoACgAGgQRYAq4HvfF2Z7gF/4120PMK0OsN0WEKQQCPVyyy23nB57OW/06NGDunbtegZPn43Txo0bjxUAieHe9Wg/VUngF6Z1A/lsgr4uHNvs91d9XZcl/WGPBTQFfF2R4fe4erYioOpQzJdffvlNLPTnvfbaa2uLi4vLxO1qfpBj&#x2B;kzvF7Eb8mca4Gd71T&#x2B;K0K8K&#x2B;MkY5kfoBwAKAAoACoAGVQSoQr1NSRBme4DNVgGbAkDE7tQAU/iPYligcnvAc889N&#x2B;yyyy678Oyzzz4nLYan0sZZAJiW8tsE9ZoCQPUcZ3u/qoTwmw3g973ZLO93GTCoC&#x2B;yuHxvkc6oCfn2bDbBv3749ixYtyoqH/qlTp27Iy8vbJ&#x2B;5X86M8ps92sr&#x2B;I&#x2B;1A/3W2b4X2EfgAABQAFAAVARGVAfdgeoLodZD6Ay3GCUW4POOElPT097c477&#x2B;w&#x2B;adKkq88666wzW7Ro0Yqn1IZvw4YN2i0Apv3&#x2B;utBtWiXgF8pdP5fNVXpdeeBXKCSuYtAVBn4fp/tv9Lti7/0Ym69Tl0XAwYMHD2RlZa2cNm3at9OnT9&#x2B;Yk5OzT&#x2B;yvzIe94h8k7Lvs5a9UBHpd6A&#x2B;zx7&#x2B;2Qn&#x2B;g4E/oBwAKAAoACoCGVgSoAr6pCFAFfZvw3&#x2B;i3B4wZM6bjhAkThlx11VWXtGzZ8iSeWhuu&#x2B;AqAXbt2GYO1d1WAKZCblv0HDftBPp9LcWAb9G0&#x2B;j&#x2B;3Xcrnt9z7daQZRKy0tPbhq1arcmTNnZs&#x2B;ZM2fjV199VSLh9u8nK/zbHN8nYl7qr7sdNPSb7iP0AwAoACgAmnYBEKIIUIV6m5KgNrYH6FYH&#x2B;JUEaRbFgM1qANctASesGOjfv3&#x2B;7u&#x2B;66q9f48eMv79SpU1eeYhue&#x2B;AqAeAFgCtou0/hd7jcVB6r7bT/GFNpN&#x2B;/NN&#x2B;/hdhg6aQr1LgeFSDET4O6JyxYoVq&#x2B;bOnbv8448/XvfJJ59sjyDQR7nc32aiP6Gf4A8AFAAUAPxAGloBELIMiKIIEKmf2wPSAhYCoV86duzY8rHHHus3atSo8/v169e3ZcuWbA9oYAWAKYT6lQF&#x2B;e/ZdjukLsszftNTfOyDPuwUg8X6/cG8b5k0lRZBQH7Q4iHIlQHl5&#x2B;ZF46F&#x2B;2bFnBe&#x2B;&#x2B;9lztnzpztR44cqZDwE/tthvm5hn3dRH/TUD&#x2B;/AiCKwX6EfgAAeZMCgAKgnhUB3mCvu9&#x2B;0FcBbDqSKeYWAXxEQxfYAv7ejKgdOWDEQ3x7wzDPPXHHBBRf0btu27Sk87dZv69evP2ELgCpkux4RGGRQYNDPnbgMXrfvPsxxf7Z7/3XlRNCTAXTHBppKAtenxsrKyop169YVLFy4MOd///d/VypCf5j9&#x2B;xUS/RA/05J/2&#x2B;BvmuZvM9hPLIoAMdxP6AcAUABQAFAAJLEIUIV6VREgYj5GUCTc9gCbUiBVgg0NdC0EQt/u3bv3yRMmTOh35513jokXAbEfTSpPwfWzACgpKdEuiVeFalUId92Xr7r6bgqyLsMDg&#x2B;zdV60MsN1WYFMYBD0W0DXoO64GqNoQ8/e//z2&#x2B;vH/1u&#x2B;&#x2B;&#x2B;W1hWVlYeMNAHueJv&#x2B;1rEbp&#x2B;/y1F9tkv6bQb3uYR&#x2B;XRFA6AcAUABQAFAA1EIZUJ&#x2B;2B&#x2B;hKAdPxgS7bA6JcDaB8adWqVbMJEyb0vvvuu0f2jeFpuH5Zt27dsQIgMZirQrE36Nvs1zc93u8xQV&#x2B;7hPOakG/7eW2PJXQN72Efb7s6IPH&#x2B;eBCMX&#x2B;lfsmRJXuxl469//ev8o1f6o57YHyb86/b2207yDxP6Ez&#x2B;X&#x2B;LzfrxTQhX7Va0I/AIACgAKAAqABFQGqx5pWBtisENCtBFAVALanBgTZHhDqdnp6eur9999/zvXXX3/BsGHD&#x2B;p1yyikdeEquewUFBcZTAFyu9nvDsU1Q120NsBn&#x2B;p7rC7p0FYLOKQReedeWGaYaA92N12yRMpYPuir7Ff0PV5s2bN2ZlZa2ZOXNmzquvvlqQsLzf5mq&#x2B;7RX/oMv9RcIf32dTAHgfH&#x2B;TYvihDvy74E/oBABQAFAAUALVUBPgVAEG2B5jKAdeXZG4P0JUCLlsFfF969&#x2B;7d5he/&#x2B;MXFw4cP79elS5fTU&#x2B;rTM1MTLADiKwD8wnqQK/G60Ooy8C/I43VhOMiWA5siQhe6bWcM2JQKpoLCrzAoLi4uysnJKZgxY0bWyy&#x2B;/vGbfvn1HxO1qvusxfTbhXyT48X1BlvoT&#x2B;gEAFAAUABQATakACFkG1MX2AO8AQZdBgeJQANgWApFvD8jIyEifOHFi7wkTJny3Y8eOXdJjeJquXWvXrj1uC0CYY/90E/dVAdX2c9sUC6qwbxPWXYK869F9tvfp7vcL9abPsWvXrpJY6F89d&#x2B;7cFVOmTFmzcePGg&#x2B;J&#x2B;Nd/lir/fx1aJ&#x2B;zF&#x2B;VeK2v19322Z4n&#x2B;5tVcBPxgR/Qj8AgAKAAoACoJEUAarHus4JiGJ7gPcxNvMCTIWA61YB3xUD48eP73bvvfdedOmll34nLS2tGU/XtVcA7Ny584TQbArppj3/uqn4YcsGv&#x2B;/NNeQHmfpver/fkEK/IK/bxmC7LeHo66rdu3fvWblyZe7SpUvXv/zyy8vz8/P3i/2e/DBX/IPs7Tct628KoT9Q8Cf0AwAoACgAKADqtgjwC/rewG8qAlzDv20pEHSbgK4QiHw1QM3L1Vdf3Wn8&#x2B;PF9r7322pHt2rVrz9N2cq1Zs0a7BSAxbCdOx/fu8U&#x2B;87XL13fZ&#x2B;XRngHeZnE9ITA7bfxH&#x2B;/vfqm8O4X4m2v&#x2B;ruUDwcOHNiXm5ubt3jx4jW/&#x2B;MUvlm3fvr1Mgl/N1y3djzL0&#x2B;x3fJ2K/1F8X9F1Dv&#x2B;k&#x2B;Qj8AgAKAAoACgDJAWQYE3R7gcoxgYrj3u63bHpBiUQikhSgEXMsB5cf26tWrzaRJkwZdfPHFfXr06NGT7QHJKwBqVgDYXGV3mQ9gUyroHueyLN&#x2B;0WsDvtW6Vgm7Sv83XNT3WVB54i4qa98VC/4GNGzduyMzMzPv1r3&#x2B;9dMWKFfvEfQq/y6T&#x2B;sFf4w4Z&#x2B;3e1GG/oJ/gAACgAKAAqAxlcEiCb82xQBUW8PcDlO0GY1gM2wQOPt&#x2B;PaASZMmXdmzZ89zWrVqlcHfzmgLgOLiYm1Q1l3tdw3j3hUEpoDuEvpdPpfNUL8g2wCCHvtnKjv279&#x2B;/N/Zz2r5kyZLcl156KXPhwoW7JPz&#x2B;fZthfUHCvm6iv&#x2B;1QP9ug7zLYj9APAKAAoADgB0IBkNQiQBXwve8Lsz0g1aII8FsNEGR7QNhCINTLJZdc0v7BBx8ceNNNN11OERCN/Pz86i0AquXufiE9yB7/IFfqEwsDl6&#x2B;junrucvXeNZxHVQ54P//hw4dLt8bEwn7273//&#x2B;6xFixaZQr/L/v0g4d9UBAQd6ufyoisH/MK8X&#x2B;gXw/2EfgAABQAFAAUARUDgMqChbA/QrRJIlWDzAlyHBWpv9&#x2B;jRo/W//Mu/9L3llltGnHXWWWfztzNcAVCzAsB7pT/s8Xx&#x2B;4T3okvww4d22fLAtJnRlSOIKB928ANXnrqysrCgsLNy0bNmy3JdffnnJ/Pnzi0MEepeCwPW1iNskfwkR/sXifSJ2V/9Vod&#x2B;vOCD0AwAoACgAKADQoLYHpBpuB5kP4HKcYJTbA054adeuXfNHH32079ixY/v16dOnV&#x2B;vWrU/mb2fwAiDIPn&#x2B;Xj0ksGfw&#x2B;xhTqXYbw6T7WpshwKR50ZYGubDj6/Fu5devWzQUFBRtfeeWVBZ9&#x2B;&#x2B;mnRwYMHD4cM9EGu&#x2B;Ltc4Tft5U926Bexv/qvC/2iCf6EfgAABQAFAAUAIisCVAHfVASogr5N&#x2B;G/02wMuvvji9v/&#x2B;7/9&#x2B;2aBBg/qccsopHfjbaScvL09ZAEQZ/KP8HKZAnXhVvuZtv2n&#x2B;rscAug4B9Lvqf/Q5t2Lnzp3bV6xYkffCCy8syMzM3LV3797DIQO9X3gPEv5Fgh3f5xr6Ex8vEuzYvihDvy74E/oBABQAFAAUAGgw2wNstgqYVgf4lQRp4n6cYKrYnSSgu33CioHu3btnTJw4se8Pf/jDq0455ZRTU1NT0/gbqi8AduzYoQzgfpPwow743n8&#x2B;ugGBfp9H9XHeWQBBTwqwLR787qu5XVFRUV5aWro3Ozt71TvvvLN06tSpG/fv339E/K/mh7ni7xr&#x2B;TVf4XQb4mQoAQj8AABQAFAAUAE22DIiiCBCJdnuA7eoAl1MDam01QM3Lo48&#x2B;et4dd9wxbPDgwYP4m6mWm5t7rACIh2W/Jfa6Y/FsJujrArUpZAeZ9u8S6E1zB7wFg2n1gWebQVUs5O/Lifnwww&#x2B;Xvvzyy6vj&#x2B;/wlmon9NlfyKx3CfhShX3fbZnif7m1VwE/GBH9CPwCAAoACgAIAtVoEeIO97n7TVgBvOZAqwY8R1K0IsN0e4Pd2VOXAcasE0tPTU&#x2B;&#x2B;8884zb7/99gH9&#x2B;/c/r1OnTl3426kuAFRL502DAXXBOMw0f&#x2B;/n9isY/Pbg24Z1b8D3Wy2gKyNU3/uBAwf2bdy4cf306dMX//Wvf10du33QIpxHccU/yN5&#x2B;07J&#x2B;Qj&#x2B;hHwBAAUABQAGAJBUBqlCvKgJEzMcIioTbHmBTCqRKsKGBroVA6Nvx7QH/8R//8Z1Ro0YNOCOG7QH/KACKioqUgdn2ar8qlNtexQ86zd/vyD&#x2B;/kwV0JYXquEDX0B9/iYX&#x2B;vbGgv/GNN96Y9/XXX2/LycnZd/Rqf5Cr&#x2B;bql&#x2B;7UR&#x2B;kXcrvr7BX3X0G&#x2B;6L8rQHyj4E/oBABQAFAAUAEhWGVCftgfoSgHT8YEu2wOiXA3g&#x2B;/KjH/2o18SJE8d269ate/OYpvp3ctWqVcetAKgJ/rrl/rrQbhvcdcWCS1mgm1Gg&#x2B;z5cCwe//5ZDhw4diE/w//DDDxfMnj17Q3yYn9hfza&#x2B;NK/42&#x2B;/1dQr/uNqEfAAAKAAoACgDUURGgeqxpZYDNCgHdSgBVAWB7akCQ7QGhb3//&#x2B;98/4&#x2B;677x48duzYS9PS0po1xQJg&#x2B;/btVlfiXY/ls93fbzsEMOgqAl3Ad1nWX/O6srKyfNu2bZvmzJmzaNq0aXmLFi0qkfD796O84u8y0T&#x2B;q0J/4eRpF6Cf4AwAoACgAKABQ10WAXwEQZHuAqRxwfUnm9gBdKRB0q8BxLyNGjDj1gQce6H/VVVdd1LFjxyYzJ6CmANCFYtv9&#x2B;zYT&#x2B;1UBOzHw6z6n6oq/bei3HTTo3RJQ8/3FQn9lLPSvnT179tIPPvggb&#x2B;XKlXsOHjx4RNyu5rtc8bcN/zbH&#x2B;LkM9fMrAKKY5k/oBwCAAoACgB8GApYBdbE9wDtA0GZQoOv2gFSHQiDy7QHdu3c/adKkSQNHjx7dr0dMixYtWjbmv3exIKssAEzh3vUEAFV49xswqCsLbFYE2L7fVBjEvt/KoqKizfPmzVsSC/2rsrOzd&#x2B;3Zs&#x2B;ewRDexP&#x2B;phfqZJ/i5H9dku6bc9oq9KE&#x2B;5VwZ3QDwAABQAFAAUARUBERYDqsa5zAqLYHuB9jM28AFMhEGarwHGf5&#x2B;abb&#x2B;7y05/&#x2B;9Io&#x2B;ffr0bt26dZvGWgDEhwCqQrFpCKBuOb/NLADV7cSVBq77922&#x2B;P03Yr34dH9q3e/fu7fPnz1/8xRdfrPn888&#x2B;3xt4uCxjo/cJ6RQShX8R&#x2B;WX&#x2B;yQ784FAE2od8U7An9AABQAFAAUABQBBgCvygCv6kIcA3/tqVA0G0CukIgKcMC4y9Dhgw5ZcKECf3HjRs3JiMjo1EVAStWrDhWACQu9fcL2apSIPF&#x2B;lyvztnv1VSsI/PbtuwwErHkdv9J/6NCh/QsWLPg6FvxXv/POOwWxt8vFfiCf7RX/MOFfN9CvNkK/y9suoV/1OkgJQOgHAIACgAKAAoAyQIJvD3A5RjAx3Pvd1m0PSLEoBNJCFAKu5YDyYzt27Njqscce63fDDTcM6dWr13mNrQDwOzrPG/BVAdx2u0CQUwF0rxOLC92KBdXX379/f8nixYszFy5cuHrmzJkbY38OpZK8if0uy/1NYd9mL79tAZD4mPoQ&#x2B;nVBn9APAAAFAAUABQBFQMRFgGjCv00R4D1GMOz2AJfjBG1WA7gOCzzhdkZGRvrDDz/c66abbhrUq1evnu3atTulof6dWr58ue8WANPVe9ul&#x2B;y5X/W2GCZpKhcTCIvH&#x2B;&#x2B;PdYWlq6Jzc3d8Unn3yS9emnn24qLCw8KNFM7DeF&#x2B;grHsJ/s0K&#x2B;b5m/ztirgJ2OYH6EfAAAKAAoACgCKgBBFgCrge98XZnuAX/jXbQ8wrQ6wPTWg1rcHDBw4sO2zzz57yUUXXTSgQ4zPn2m9LgC2bdvmG6ajHgwY1dwAm69XsyogFvr35&#x2B;fnr1qwYMGy&#x2B;J7&#x2B;&#x2B;DA/iXZif5SD/Fwm&#x2B;asep7tN6AcAgAKAAoAfCAVAEyoCVKHepiQIsz3AZquATQEgYndqgO32gDDDAk&#x2B;43aZNm&#x2B;Y/&#x2B;9nP&#x2B;t19991jOsfEgmdaQykAtm7dahXu/Zbfe5/PbK7imwYMqoK8y9c5fPjwgaysrKUrVqxY/&#x2B;WXX65bvHhxiQS/mq/bt18bod/vPpsCIMwef9N9UYb&#x2B;QMGf0A8AAAUABQAFAGVA8ooAkWi3B6huB5kP4HKcYJTbA5QvjzzyyLm33Xbb0OHDhw&#x2B;r739vsrOzjxUAiUMA/Yb/eafmuxQH3s&#x2B;jKgZsp/WrHl9RUXE4Nzc3a&#x2B;XKleumTp0ae7Vyj4Sb2B/1FX&#x2B;X4/tEzEv9dbcJ/QAAgAKAAoACgCJAWwSoAr6pCFAFfZvw36i3B8RXANxyyy1d77nnnsEjR44c1LZt23o5JyArK6u6AHCd/O8yBDDxftN&#x2B;fb9tCH6rAOK5f/369bnZ2dm506dPX5WZmVkSP8pPwu3fj/KKf5jj&#x2B;wj9BH8AACgAKAAoAJCUIkAV6m1KgmRsD7AdHqgrCdLE/TjBVLE7SUB3&#x2B;4QVAwMHDmw3adKk&#x2B;IqAC7t27Xp6s5j6VABs2bLFev&#x2B;/6wyAMI/xlgQJV/&#x2B;rCgsL18a&#x2B;9&#x2B;Vz5szJW7hw4fbDhw&#x2B;Xi9vV/CCT&#x2B;oNc4bfZy29zVJ9N0HeZ5k/oBwCAAoACgAIAlAGRFQEi0W4PsF0d4HJqQK0NC6x5efDBB8&#x2B;ZMGHCFT179jynefPmLer678a3335bvQIg8Qq7bq&#x2B;/zTR&#x2B;v6n&#x2B;qnBvcxTg0eBfvnnz5oLly5evWrly5eZ33nlnjedKf9iJ/VEP8zNN8neZ2h92mr9YFAFiuJ/QDwAABQAFAAUAmlAR4A32uvtNWwG85UCqmFcI&#x2B;K0EiGJ7gN/bUZUDJ6wYuO666zrff//9g7/73e&#x2B;OTo&#x2B;pq78Ty5YtO24IoE24twn63tLAG/oT71cd2Xf0dVVRUdH6/Pz8nLlz5&#x2B;bNmDFjY4hA73o8n8trEftl/VGFft37ROyu/qtCv64IIPQDAEABQAFAAYAmUASoQr2qCBAxHyMoUvvbA5JVCIS&#x2B;3b9//3Y//vGPB44ZM2bI6aef3q0uCgDVFgBvMLctAfwCv2l2QMLbVSUlJVvWr19fMH/&#x2B;/OV/&#x2B;9vf1paVlZWL/UA&#x2B;24IgTPjXDfSrjdDv8raI&#x2B;Sg/EfPVfkI/AAAUABQAFABogmVAfdoeoCsFTMcHumwPiHI1gPKlQ4cOLSZNmtT/2muvHXRmzEknnZRRWwXA5s2btSE/sQwwLdc3zRLwOUKwaufOnYXbtm3bNG/evKxZs2atLy4uPiTJm9jvstzfFPZNe/lVx/NFtY8/2aFfF/wJ/QAAUABQAFAAgCIg9PYAv9UAIu7bA/wKANtTA4JsDwh9&#x2B;6qrrur085//fNSAAQP6tWnT5uRk/tyXLl16QgFgE&#x2B;b9Hp94v&#x2B;7Ivlj4r9q3b9/ODRs25H3zzTerXnvttVUS3cR&#x2B;U6ivcAz7QQb42V71jyL0i8V9hH4AACgAKAD4gVAAIHQR4FcABNkeYFMOuLwkc3uArhSIZKtAz54920yaNGnAuHHjLm/Xrl37ZPy8MzMzqwsA08R&#x2B;i6v4vgP9Eo/xKy0t3R0L/Tnffvvt6ilTpmQdXd4f5cT&#x2B;KAf5uUzyVz1Od9tmeJ9L6PcrAQj9AABQAJA5KQAoAJCUMqAutgd4Bwi6DAoUhwLAthCIfHtA586dW06cOLHPTTfdNKRPnz4XRPkzjq8A2LRpU6Bj/3QFQM1zSvx2eXn5vljoXxP3l7/85dvCwsL9Yn9l3mXffm2Efr/7bAqAsHv8ayv0Bwr&#x2B;hH4AACgAKAAoAEAREPX2ANcBgq7bA/xWC&#x2B;jmBZgKgaBbBY57adWqVdq99957zvjx44f279//gtjbrcP&#x2B;bJcsWaLcAqA7FtDmmL9Dhw7tjtkay/z5b7311pK1a9fuNQT32r7i73J8n4h5qb/udtDQb7qP0A8AACgAKAAoAFAviwC/oO8N/KYiwDX825YCQbcJ6AoB29UApi0BJ3zeK6&#x2B;88rRHH310xODBgy9o3779abEfTWrQAqCwsPC4QO&#x2B;9rQv9ia/Ly8v379y5c0t2dnbWhx9&#x2B;uDw/P3&#x2B;PuO/FT&#x2B;YV/zDH9xH6Cf4AAFAAUABQAIAyIEAZEHR7gMsxgonh3u&#x2B;2bntAikUhkBaiEHAtB5SfKz09Pe3JJ5&#x2B;84J577hlzxhlnnJmauCbfwuLFi6sLANPAP&#x2B;9qgJrblZWVh3fv3l2Ym5u7fOrUqUtXrVq1yydYuw7tMwX8IFf4bfby2xzVZxP0XQb7EfoBAAAFAAUABQAoAgyv62p7gMtxgjarAWzLAd/TCuLbA8aPH3/WPffcc9Hw4cNH2BYBNQVAzZJ/3VX/hPsqYqF/Q0zBBx988E1WVtaOsrKyCgm2HD/sMX2ux/jZDvBzfRGxG&#x2B;wnFkWAGO4n9AMAAAoACgAKADTYIkAV8L3vC7M9INWiCPBbDRBke0DUhYBVCRB/HQvxaddcc03Hf/7nfx46fPjwIe3bt&#x2B;9oKgDiQwC9gb9GwpX/8j179myJPTb3jTfemB97vefAgQPlFiHb5ep9RQShX8R&#x2B;WX9UoV/3PhG7q/&#x2B;q0O9XHBD6AQAABQAFAAUAGmQRoAr1NiVBXW8P0K0SSJVo5wXYnEZwwvfaq1evjH/7t38bNmrUqGGdO3c&#x2B;PT09vYX3D/6bb745bgZAolj4P7J3797irVu3rvrss8&#x2B;WzJs3rzDh2D6/4Bx0FUBUV/hrO/S7vC1inuovYr7aT&#x2B;gHAAAUABQAFABo8GVAXW0PSDXcDjIfwOU4wbQA9&#x2B;len7DF4Yc//OGZP/nJT77bq1evC5o3b96y5g9y0aJFsnHjxmPPR7GXyljI311UVLT8q6&#x2B;&#x2B;Wjx16tQ1ot/frgvXUYd/U9g37eWvNJQXYfbxJzv064I/oR8AAFAAUABQAKBRFAGqgG8qAlRB3yb819ftAabBg9rwX/N2Wlpa6ujRo0/9yU9&#x2B;MuLyyy8f26JFi4z4CoB4AVBRUbF706ZN386bN&#x2B;/vCxYs2FJSUnLIJ7Sq9ru7HK1nG/5NKwpcBvjZXvUn9AMAAAoACgAKAKCOigBVqLcpCcJsD7DZKmBaHeBXEqSJ23GCqhLAb3uB6ftLLAJSbrjhhk733Xff0LKysl7Tp0//LCsra8uyZcuKKysrTVPoKwOUAKY9&#x2B;mGO77Md6qe7bTO8T/e2KuAnY4J/oCfq&#x2B;M809iKxnztPQgAAUABQAPADAermr38dFAEi0W4PsF0dEGZ7gO6xIv5zAJTh3/Bn5xc0TdPubUsAl/BvE/r97rMpAMLu8a&#x2B;t0B80&#x2B;NPqAgCAeqWu83czfgRA3T4HOBYBiY&#x2B;v0hQE3iCVovg8KZ7Hq8qBmhBdkXB/leJ2Ytiu8gTtKs/ryqOP83ttE/orxbwNwRv&#x2B;U8V/VYTpz9smFNuUAOIQ9nUnC4iYl/rrbgcN/ab7CP0AAAD1GAUA0LCLAL8yIEURvFIUH1OlCeopCaHRtD1A9bGpnq&#x2B;dGNqrNK9NBYHNKQS679fvOEXdn7WuCKjSBHHTYMAwx/cR&#x2B;gn9AAAAFABAIygCgpQBNqsCVEFddb&#x2B;I/yoBvwDttxLAr2QQcdseoNtSUCHqFQB&#x2B;Aw5t/4x1gTfoqQCue/ltjuqzCfoug/0aQugn&#x2B;AMAADhiBgDQAP6dhnh8kGMERRP0TVfV/U4MENEv0bc5RSDFUAqI2K0AELFbBWCaZG&#x2B;zGsBl337Qqf2mq/umwX5iUQSI4X5CPwAAgM3/yDADAIBl4AmyPUBXELhsDxDPY23Dv9/WAu/XVm0PqPQJ/DWPVV31T7xPRD0A0FSM6AKrNwTrBurZLNtPVujXvU/E7uq/KvTrigBCPwAAQD3HCgCggf7bDfH42jo9wBu&#x2B;dVfpbY8W1D3edvK/buWDLsjqlsfrluHb7t&#x2B;PKvS7vC1inuovYr7aT&#x2B;gHAACw&#x2B;R8cVgAACBGOwswJSFF8nqCnB6je9g4QtBkUqFodoJoZUCn6Sf8Vot7/bypATCHUJWi7bA2wKQC8j6/r0K8L/oR&#x2B;AACAeogCAKAIEEUgdt0eUOUJ2lFuD0jcDqAK/pWKx5lWKbj8menCsy5wVzrcJvQDAACAAgCAc4hKCfD4sKcH&#x2B;M0J8L6t2h7gva36WimagsD7OUxbE2xWAuiG3bkGcdtl/N6gXxnga&#x2B;kCfjIm&#x2B;BP6AQAAKAAA1IMyoDa3B7geI1jpE8L9Qn&#x2B;q4vtKXA1QKeYTCnSh36YA8Av/IvZX7YM&#x2B;rj6F/qABntAPAABAAQCgHhcBogjJftsDRBP8xSeY10zu1x3blyrHzwDwKymCLv23PQVAJNhWgDAT&#x2B;22m9RP6AQAAQAEAIFQRYFsGhNkeUCHm0wO8nzfFpwzQFQCmEsDlz8XmRIAoCgFCPwAAACgAAIQqAoKUAXW1PcCmGKiNAkAXpKM6kq8hh36CPwAAAAUAgHpeBiRre4Du87ieHuAN/C5hX7XPP&#x2B;gpALYFQJjQLxZFgBjuJ/QDAACAAgBAZEWAqQzwzgkIe3qAiPo0AV15IOK/AiDqAkACBPqwod/vcxD6AQAAQAEAwDrYu5YHrtsDvEWAanuAiP1xfrYT/8NuAdCVAFWassAm9Js&#x2B;1qaMIPQDAACAAgCAc9hL5vYA1QkCtqsCvGVAVZLDv234th0SmIzQrwv&#x2B;hH4AAABQAABIShHgVwaYjhH0rgoQTfBXfX9B9/y7HANoCvt&#x2B;4Z7QDwAAAAoAAA2mCAhSBgQ5RtD7eVSrAhIDf5Wotx74Bf8UixLAFLZtQnqQgX2EfgAAAFAAAKhXZUAy5wR4g3mVqFcAiE/or1IUD7rhfymWgd8UtnUD&#x2B;ZJ1pT9ogCf0AwAAUAAAQFKLANEEfW8I9q4KUJUBNqHfr3wI899tG8qrAr6f0A8AAAAKAAD1sggIUgbYDg3UlQEi/lsA/IJvSgT/raagXhXgMYR&#x2B;AAAAUAAAaFBlQNRFgKkMsPk&#x2B;VCcLhAnRNnvvqywfy7F9AAAAoAAA0KSKgKBlgCrUp1gE76i2L&#x2B;hCfJXj4wn9AAAAoAAA0GCLgCBh27RXP0UTpFMsvrbrLADXIYGujyX0AwAAgAIAQKMqA6JYFaAK7ykW4TqlFgO3TcAn9AMAAIACAABFgGUZoGMaBhjlf4/N/VVJ&#x2B;DoAAAAABQCARlcE&#x2B;AXhsEf7JaMAiCK0E/oBAABAAQCg0RUBQcqA&#x2B;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" />
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>